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Abstract 
Surviving subarachnoid haemorrhage (SAH) patients' experience significantly 
reduced health-related quality of life (HRQoL) in both the short- and long~term, 
as well as mysterious symptoms of fatigue and sleep dysfunction. Patients' 
family members and friends -who often act as their informal carers - can also 
experience psychosocial disability. The cause for these poor outcomes 
remains unknown. Traditional explanations focusing on the neurological 
sequelae associated with SAH or the characteristics of the illness are not 
satisfactory; nor are attempts to explain family members' difficulties on the 
basis of carer burden. 
The hypothesis which is tested in this thesis is that post-traumatic 
stress disorder (PTSD) may be abnormally high in both the SAH patient and 
'significant other' (SO) population and that this may explain their outcomes. 
SAH patients are known to be at risk of suffering from PTSD, but it is unknown 
if this explains their outcome. In terms of patients' SOs, they are known to 
experience psychiatric symptoms and I suggest these could be caused by 
their development of PTSD, but this has never been examined. 
In Part One (Chapter 2-5), I focus on patients' outcomes. Before 
examining my PTSD hypothesis, I present a meta-analysis (Chapter 2) I 
conducted of studies which have tried to explain patients' outcome using 
neurological factors. I conducted the meta-analysis as a tendency for prior 
studies to be underpowered and use unreliable statistics could have meant 
that the actual importance of traditional factors was obscured. The results of 
my meta-analysis however did not support this possibility and instead showed 
traditional neurological variables did not explain patients' outcome. With this in 
1 
mind, I then present a longitudinal study (Chapter 5) in which I examined one 
of the largest prospective series of SAH patients to establish PTSD's 
explanative importance. Using regression analyses, this study showed PTSD 
was the best predictor for patients' mental HRQoL - the domain most 
persistently impaired. It also helped predict patients' physical HRQoL. 
Moreover, PTSD was linked to sleep problems and may therefore cause 
fatigue. Crucially, to establish the cause of PTSD, logistic regression was 
performed. This showed that maladaptive stress coping strategies were the 
best predictor for PTSD development. 
In Part Two of the thesis (Chapter 6), I present my longitudinal study of 
one of the largest prospective samples of SOs. All SOs were assessed with a 
diagnostic PTSD measure and coping skills were assessed. An elevated 
incidence of PTSD was found in both the short- and long-term. Although SOs' 
PTSD did not impinge on the recovery of the SAH patients being cared for, 
given that it is important to ensure SOs continue caring, regression results are 
presented which show the cause of SOs' PTSD was (at least in the short-
term) due to the use of maladaptive coping strategies. 
The overarching conclusion is that the elevated incidence of PTSD in 
SAH patients and SOs helps explain why they experience psychosocial 
disability. In the final part of the thesis (Chapter 8) the clinical and theoretical 
implications of this conclusion are considered, such as that teaching patients 
and their SOs more effective coping skills might prevent PTSD and 
psychosocial disability. 
2 
Chapter 1 
General introduction 
3 
1.1 Introduction 
A spontaneous subarachnoid brain hemorrhage (SAH) is a subtype of stroke 
that affects mainly middle-aged persons. Advances in treatment have reduced 
the mortality associated with this illness. In spite of these medical advances 
occurring, patients who survive an SAH experience a particularly poor 
psychosocial outcome in the short- and long-term. Evidence also suggests 
that patients' family and friends - who often act as their informal carers - can 
also experience a substantial reduction in their health and well-being. 
After being ignored for a long-time, research has now begun to 
consider how best to rehabilitate and improve the outcome of both parties. 
Efforts to develop rehabilitation programs are however, hampered by a 
paradox. Specifically, patients' and their carers' high levels of psychosocial 
dysfunction are disproportionate to the relatively mild physical/ cognitive 
impairment induced by the SAH. Moreover, this psychosocial dysfunction 
cannot be explained using traditional neurological and illness-related factors. 
This thesis looks to try and resolve these paradoxes. Part One of this thesis 
primarily focuses upon explaining the paradoxically poor health-related quality 
of life (HRQoL) of SAH patients, whilst Part Two addresses the poor outcome 
of patients' family and friends. 
4 
1.2 Overview of Part One: SAH patients' health-related 
quality of life, psychosocial outcome and post-traumatic 
stress disorder 
In Chapter 2, I provide a brief explanation of what SAH is, outline what is 
known about its patients' outcome and describe patients' mysterious reduction 
in HRQoL. SAH patients' puzzling problems of fatigue and poor sleep quality 
are also discussed. I hypothesise that two explanations could explain why 
SAH patients' problems remain difficult to explain. The first possibility is that 
previous studies have failed to explain HRQoL using traditional neurological 
and illness-related factors because they were both statistically underpowered 
and used notoriously unreliable statistics by which to judge the importance of 
traditional predictors. Specifically, rather than - as is ideal - examining the 
degree of variability which these traditional factors share with HRQoL, studies 
have typically only looked at the statistical significance of their relationship 
with HRQoL. This could have served to obscure the actual explanative value 
of traditional factors. The second possibility raised is that SAH researchers in 
the past have been too restrictive in the factors they have used to try and 
explain SAH HRQoL. It is contended that we may need to consider other, 
more novel aspects of SAH patients' symptom profile when trying to explain 
their poor outcome. I argue here that the psychiatric problems of an SAH 
patient are an aspect which could hold real promise for explaining these 
patients' HRQoL reduction, but that this has so-far been ignored. 
In Chapter 3, I examine the first possibility- that the explanative value 
of traditionally considered variables for SAH patients' HRQoL has been 
obscured. In this chapter, I present the first ever meta-analysis on the cause 
5 
of SAH patients' HRQoL. The use of meta-analytic techniques allows for a 
more comprehensive examination of the explanative importance of traditional 
factors by considering criteria which are more appropriate than merely 
statistical significance - namely their predictive effect sizes for SAH HRQoL. 
In Chapter 4, I review the literature to explore possibility two - that 
psychiatric disturbance has not yet been taken into account when trying to 
explain SAH HRQoL. I review the psychiatric aspects of an SAH and highlight 
how post-traumatic stress disorder (PTSD) elicited in patients in response to 
an SAH has recently been found to be the main psychiatric disorder affecting 
these patients. I then draw on findings from the wider literature and suggest 
that PTSD could potentially help us better explain SAH patients' HRQoL, as 
well as their puzzling symptoms of fatigue and sleep dysfunction. 
Following this, in Chapter 5, I present a longitudinal study of a 
prospective sample of SAH patients in which I empirically examine whether 
PTSD in SAH patients can help us better explain their HRQoL reduction and 
their difficulties with fatigue and sleep. I also present analyses which look to 
try and predict which patients develop PTSD following an SAH, with particular 
attention being afforded to the role of the stress-coping strategies which a 
patient uses. 
1.3 Overview of Part Two: Family and friends of SAH 
patients - psychosocial outcome and post-traumatic stress 
disorder 
In Chapter 6, I describe how research to date on the family and friends of 
SAH patients has highlighted how these 'significant others' can experience 
6 
abnormally high levels of psychiatric difficulties and a poor psychosocial 
outcome, but that these difficulties remain unexplained. Following this, I detail 
my hypothesis that significant others' poor outcome could be explained by the 
never examined possibility that significant others could also develop PTSD in 
response to the trauma of an SAH. I then present a longitudinal study of a 
prospective sample of significant others in which I formally examine whether 
PTSD is abnormally present or not in this population. I also examine the 
impact of significant others' psychiatric status on SAH patients' cognitive, 
physical, psychiatric and psychosocial recovery in the early and later stages of 
recovery. Finally, I present analyses which look to determine whether it is 
possible to predict which significant others fare worst post-SAH. 
1.4 Overview of Final Chapter 
In Chapter 7, I summarise the main findings of both parts of this thesis, and 
discuss the implications of these findings for the treatment of SAH patients 
and significant others, as well the bearing they have on future research. 
7 
Part One 
SAH patients' health-related quality of life, 
psychosocial outcome and post-traumatic 
stress disorder 
8 
Chapter 2 
The impact of a subarachnoid haemorrhage on 
patients' health-related quality of life 
9 
2.1 Introduction 
A spontaneous, non-traumatic subarachnoid brain haemorrhage (SAH) is a 
rare type of stroke (6:1 00,000 per year) [4, 403, 730], which has a 
disproportionately high impact upon society [321, 681, 682]. For example, as 
Figure 2.1 illustrates, despite its relative infrequency (accounting for only -7% 
of all strokes) [19, 32, 672], the loss of productive life years associated with 
SAH is approximately double that of much more common types of stroke 
[681]. This is largely attributable to the following: (1) SAH affects much 
younger persons; with a mean age of 55 [4, 435], SAH strikes persons who 
are at the peak of their productivity and often supporting a young family [546, 
548], (2) SAH is associated with a high mortality (-50%) [11 0, 284, 653] and 
(3) SAH survivors experience a particularly poor psychosocial recovery, in 
both the short- and long-term [90, 285, 286, 336, 540, 541, 546, 746]. With 
such high societal costs, it is important to look to address the outcome of 
surviving patients' and offer them evidence-based rehabilitation tailored to 
their disease. Such rehabilitative efforts are however, not currently possible, 
as at present we do not know which factors impinge upon SAH patients' well-
being and cause their poor recovery. Indeed, we are yet to establish any 
factors which reliably predict patients' psychosocial outcome. Stark 
differences in patient age (the mean age of SAH patients being 55 years vs. 
73 and 75 years for ischemic and intracerebral strokes, respectively [4, 32, 
366]), as well as the kinds of brain damage (diffuse and focal vs. ischemic 
focal) and medical treatment (SAH patients typically undergo brain surgery 
whereas patients of other strokes do not), precludes simply looking to explain 
SAH outcome by referring to research which has examined the factors 
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Figure 2.1 Associated life-time costs (U.S. dollars) to society in 1990 of different 
types of stroke measured in terms of loss of potential productive life 
years. Based on Taylor's ( 1997) data [681]. 
SAH=subarachnoid haemorrhage; ICH= intracerebral haemorrhage; IS= ischemic stroke 
explaining outcome following more common (and better researched) types of stroke. 
In this chapter, I introduce the concept of health-related quality of life (HRQoL) 
and highlight how it has become the prime criterion by which SAH patients' outcome 
should be judged. I highlight how the HRQoL of SAH patients is especially low, not 
only compared to normative levels, but also compared to levels in patients suffering 
from different illnesses. I then present the results of a systematic (non-quantitative) 
review of prior studies on SAH patients which have taken HRQoL as a dependent 
variable and have looked to determine which factors are statistically associated with 
(and as such, presumed to cause) it. This literature review serves to set up the 
subsequent studies as it illustrates how previous attempts to explain SAH patients' 
outcome have proved largely futile, with traditional factors appearing to be poorly 
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associated with SAH HRQoL. I then conclude the chapter with a discussion of 
whether the factors which are traditionally being used to explain SAH HRQoL are 
useful and whether it might not be more promising to examine the psychiatric aspects 
of this illness which have previously been ignored. Before discussing all of these 
points however, I first need to provide an introduction to SAH and its treatment. Such 
an introduction will serve to familiarise the reader with the specific neurological 
sequelae and the characteristics of SAH (such as bleed severity/ distribution, origin of 
haemorrhage, type of treatment received) as these are factors which have 
traditionally been used to try to explain SAH patients' HRQoL. It will also look to draw 
to the reader's attention how although an SAH is life-threatening in the immediate 
stages, the medical prognosis for a surviving SAH patient, once discharged from 
hospital, is very good (in terms of chances of re-bleeding and neurological sequelae), 
making such patients' poor psychosocial outcome all the more intriguing. And finally, 
the introduction aims to illustrate to the reader how having and surviving an SAH can 
potentially be psychologically traumatic. 
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2.2 Subarachnoid haemorrhage tutorial 
2.2.1 Pathology 
The subarachnoid space which is filled with cerebrospinal fluid is found between the 
arachnoid layer and the pia matter. Together with the dura, these comprise the 
meninges which loosely encase the brain and spinal cord [666]. A spontaneous non-
traumatic subarachnoid haemorrhage (hereafter referred to as SAH) occurs when one 
or more blood vessels (which can run through the subarachnoid space) ruptures and 
extravasated blood enters into the space (Figures 2.2 and 2.3[a]) [33]. The rupture of 
-· 
a blood vessel is caused by' a vascular abnormality. The most common cause - in 
around 75-85% of cases - is the rupture is of an intracranial aneurysm, which is a 
blister-like weakening in the wall of a cerebral artery [4, 335, 712]. The most common 
sites for aneurysms are at the bifurcation and junctions of cerebral arteries [71 0], 
typically at the base of the brain, near or on the circle of Willis (24-41% of SAH occur 
on the internal carotid artery; 30-40% on the middle cerebral artery; 13-33% in the 
vertebrobasilar system and 24-41% on a anterior cerebral artery [588, 654, 767]). In 
10-20% of patients, repeated investigations fail to identify an origin for the patient's 
haemorrhage.[4] These idiopathic SAHs are typically referred to as an SAH of 
unknown aetiology, with the bleed typically being perimesencepahlic in nature [71 0]. 
This form of SAH is considered to be a benign subtype as it has an invariably 
uncomplicated clinical course [46, 115, 488, 71 0]. Other causes of SAH in -5% of 
cases include leaking from a cerebral arteriovenous malformation, arterial dissection 
and dural arteriovenous fistulas [711]. 
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Figure 2.2 The relationship between the basal cisterns (Arabic numbers) and the 
ventral cerebral arterial system (p. 17; reprinted by permission) [767]. 
A = At + A2 + Anterior =Olfactory cistern 
communicating artery 2a = Callosal cistern 
MCA = Middle cerebral artery 2b = Lamina terminalis cistern 
ICA = Internal carotid artery 3 = Chiasmatic cistern 
p.co.a. = posterior communicating artery 4 = Carotid cistern 
p.c. (P1) = posterior cerebral artery 5 = Sylvian cistern 
sea = superior cerebellar artery 6 = Crural cistern 
B = Basilar artery 7 = Interpeduncular cistern 
AICA = anterior inferior cerebellar artery 8 = Ambient cistern 
V.a. = Vertebral artery 9 = Prepontine cistern 
PICA = posterior inferior cerebellar artery 10 = Superior cerebellar-pontine cistern 
A.sp. = anterior spinal artery 11 = Inferior cerebellar-pontine cistern 
12 = Anterior spinal cistern 
13 = Posterior spinal cistern 
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Figure 2.3 (a) Computed tomographic (CT) scan showing diffuse subarachnoid blood (basal cisterns; Sylvian fissures; anterior inter-
hemispheric fissure) caused by ruptured left pericallosal aneurysm; (b) CT scan showing large temporoparietal 
intracerebral haematoma and extensive SAH caused by ruptured right middle cerebral artery aneurysm; (c) CT scan 
showing intraventricular blood and subarachnoid blood in interhemispheric fissure from rupture of an anterior-
communicating artery aneurysm. 
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The subarachnoid space is not strictly a free-flowing space, but rather a 
collection of discrete cisterns formed by arachnoid partitions and trabeculae (Figures 
2.2 and2.4) [666, 767]. The walls of the cisterns serve to retard and direct the flow of 
any extravasated blood. Consequently, different distributions of bleed are associated 
with different anatomically-located sources [712, 767]. 
Depending on the direction of blood flow, an SAH can also invade adjacent 
brain areas, with intracerebral extension occurring in up to 43% of aneurysmal SAH 
patients (Figure 2.3[b]) [688], intraventricular extension in around 50% of aneurysmal 
SAH patients [306, 391] (Figure 2.3[c]) and more rarely, the occurrence of a subdural 
hematoma [295]. These subsequent problems have all been found to worsen 
immediate prognosis and can necessitate additional surgical procedures, including 
surgical evacuation, hemicraniectomy and the insertion of an external ventricular 
catheter [231, 486, 511, 574, 575]. 
It is postulated that the presence of subarachnoid blood (or substances derived 
from its degradation) in the meninges is neurotoxic causing a global encephalopathy 
which results in diffuse cortical damage [130, 158, 213, 236, 250, 408, 409, 597, 643, 
720]. Although further research is needed [211], clinical and experimental evidence 
shows that blood in the subarachnoid space sets in motion a cascade of 
pathophysiological processes, including increased intracranial pressure which 
reduces cerebral perfusion and leads to ischemic damage [309], brain oedema and 
cerebral swelling [213] and blood-brain barrier dysfunction [158]. Germano et al. [213] 
for example, reported global brain dysfunction and enduring behavioural deficits in a 
rodent model after intracisternal injection of subarachnoid blood. The combination of 
this diffuse damage, as well as the focal brain damage resulting from intraventricular 
and intracerebral haemorrhage, means that an SAH 
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Figure 2.4 Schematic representation of some of the major subarachnoid cisterns in 
lateral view (p. 15. Reprinted with permission) [767]. 
is associated with a diverse array of difficulties, including cognitive impairment [750] , 
behavioural disturbances [57, 544] and hormonal dysfunction [325, 604, 679] . 
2.2.2 Clinical presentation 
An SAH precipitates one of the most dramatic and horrific clinical presentations in 
medicine [37], with the expelled blood immediately eliciting features of meningism 
(Figure 2.5) [338] . Though the initial symptoms depend upon the severity of the 
bleeding and the disruption to cerebral function , an unusually severe and sudden 
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Figure 2.5 The potentially traumatic experience of suffering and surviving a spontaneous subarachnoid haemorrhage 
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thunderclap headache is characteristic of an SAH [402, 71 0]. This headache is 
generally diffuse and described by patients as the most severe headache possible 
(e.g., "like being hit with a cricket bat") [295, 449, 555, 707]. Increasingly severe 
bleeds result in a clinical presentation that is dominated by coma. Indeed, up to 40% 
of SAH patients are in a state of somnolence or coma upon admission to hospital [76, 
221]. Other distressing symptoms include neck stiffness, vomiting, photophobia, focal 
neurological deficits and electrocardiographic changes mimicking myocardial 
infarction [353]. Onset seizures also occur in 4-16% of patients [94, 116, 533]. 
Importantly, an SAH can occur at any time, in states of rest (e.g., sleep), or in periods 
of activity (e.g., sexual intercourse, lifting) [184, 411, 497, 506, 602]. Although risk 
factors for SAH include smoking, alcohol consumption and cocaine use and 
hypertension [79, 330, 379], evidence suggests that for most patients, the SAH is 
their first experience of a serious illness [13, 187, 240, 502]. 
The severity of the patient's clinical presentation in hospital is judged according 
to their state of consciousness and the presence of certain neurological signs.[708] 
Two popular scales used to rate the severity are the World Federation of Neurological 
Surgeons scale (WFNS) [164] and the Hunt and Hess scale [293]. A higher score on 
both of these scales reflects a poor clinical status (for more details on these two 
scales which are both used in subsequent chapters, please refer to Appendices I and 
II where I provide further details on their contents and scoring). Clinical condition is 
largely related to the severity and impact of the initial haemorrhage [711]. The WFNS 
scale is the preferable scale because as well as having superior interrater reliability 
[401], it affords more weight to level of consciousness, which along with the patient's 
age and severity of bleed, is the most important prognostic factor for immediate 
outcome [164, 277, 334, 71 0]. 
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2.2.3 Diagnosis 
A diagnosis of an SAH is made if the presence of subarachnoid blood is confirmed, 
either by computed tomography {CT) or by lumbar puncture. In all patients, the first 
investigation is aCT scan of the head. The period of diagnosis (and hence access to 
appropriate treatment) in reality can be quite protracted for SAH patients (and their 
family) as misdiagnosis on first presentation to hospital occurs in 12-51% of cases [5, 
112, 332, 369, 436, 482, 603, 715]. The diagnostic yield of the head CT depends on 
the time interval since ictus, the resolution of the scanner and the skills of the 
radiologist [6, 361, 691, 704]. Patients may therefore, also require a lumbar puncture 
to detect the occurrence of an SAH (namely, xanthrochromia in the cerebrospinal 
fluid). 
Numerous scales exist to quantify and describe the severity and the 
anatomical distribution of a patient's bleed as seen on CT scans. Amongst the most 
commonly used is Fisher's-scale [191 ]. As Fisher's scale is used and discussed in 
subsequent chapters, I provide further details on its content and scoring in Appendix 
Ill. 
To identify the source of a person's SAH, a comprehensive cerebral 
angiography is performed. In the traditional angiography technique, a catheter is fed 
through the femoral artery and up to the carotid and vertebral arteries. Contrast dye is 
then injected into the catheter so that the vessels of the circle of Willis can be 
visualised and any abnormalities, such as a cerebral aneurysm, detected. The 
aetiology of the patients bleed is often used to classify (be it 'unknown', aneurysmal, 
or the specific arterial location of the ruptured aneurysm) and to try to predict an SAH 
patient's outcome 
20 
2.2.4 Management 
The initial haemorrhage is terminated by the "extravascular rise in pressure as a 
consequence of the bleeding and/ or by tamponade of the vacant surroundings" (p. 8) 
[295]. This termination is, however, only temporary. The cumulative risk of re-bleeding 
from a ruptured cerebral aneurysm is around 40% without intervention [278]. As these 
re-bleeds hold an extremely poor prognosis [573], the immediate therapeutic goal is 
to identify the source of the bleed and, where possible, permanently occlude it from 
circulation. Occlusion of a cerebral aneurysm is most commonly achieved via an 
invasive procedure, either neurosurgical clipping and/ or endovascular coiling. The 
former, more traditional procedure, entails a craniotomy and resection of the brain 
under general anaesthesia, where re-bleeding is prevented by the placement of a 
small spring-loaded metal clip across the neck of the aneurysm. This serves to 
exclude the aneurysm from circulation, whilst still preserving the parent and 
perforating arteries [468]. The coiling procedure on the other hand, entails an 
angiogram procedure (typically under general anaesthesia), whereby the tip of a 
catheter is positioned in the neck of the aneurysm, which is then packed with platinum 
coils, through a system of controlled detachment. The intent is to provoke reactive 
thrombosis of the aneurysm and so obstruct the lumen. No single craniotomy or 
coiling procedure is routine and can each take around 2-6 hours to complete [71 0). 
Although both procedures carry independent risks for the life of the patient, the results 
from recent randomised controlled trials suggest an absolute advantage for the coiling 
technique in terms of the rate of death and dependence [466, 467, 702]. Coiling 
negates the need for craniotomy and hence damage to the brain parenchyma. 
Furthermore, unlike the clipping techniques, it does not increase the possibility of 
secondary ischemic brain damage [77]. 
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In contrast to those patients whose haemorrhage is of an identified source, 
those with an SAH of an unknown origin, typically receive no surgical intervention and 
receive only conservative management. Given the potential differences in treatment 
impact, the type of intervention which a patient receives (be it conservative, clipping 
or coiling) is often used to classify patients and used to try and predict their outcome. 
2.2.5 Risk of re-bleeding and further SAH 
Empirical evidence indicates that re-bleeding in SAH patients is very rare [98, 131, 
307, 333, 466, 611, 695, 745]. Although former aneurysmal SAH patients have a 
statistically higher chance of suffering a further SAH compared to the general 
population [702, 7 45], the actual number of re-b leeds is very small. For example, a 
recent meta-analysis [702], including data from the largest medical follow-up study to 
date (namely, the International Subarachnoid Aneurysm Trial [466]), found that only 
1.2% of 1137 clipped patients and 2.6% of 1135 coiled patients had an episode of re-
bleeding up to one year following treatment. 
It can be concluded therefore, that coiling and surgical clipping procedures are 
effective treatments for the prevention of re-bleeding in the vast majority of patients. 
This, together with the fact that the majority (>95%) of deaths associated with the 
illness occur during the acute hospital stages of the illness [32, 413, 691], means that 
patients are naturally informed by their clinicians and patient information sources that 
they are very safe and should look to return to a normal, unrestricted life [202, 449, 
503]. In addition, patients are often reassured that, unlike most in the general 
population, they have had a detailed examination of their cerebral architecture and 
had there been any cause for concern this would have been identified. Moreover, 
patients treated by coiling, those with multiple aneurysms and those with an 
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aneurysm that was incompletely obliterated by clipping are actually monitored and 
undergo repeated angiography following hospital discharge, which allows for pre-
emptive treatment if required [449]. 
2.3 Health-related quality of life in the context of SAH 
2.3.1 Background on HRQoL and the measuring of SAH patients' outcome 
Progress in understanding the cause of SAH patients' poor psychosocial outcome 
has been particularly slow because research on this topic has only recently begun. 
The high mortality following SAH [110, 284, 653], as well as outcome research 
traditionally being conducted by neurosurgeons (for whom a "good" outcome 
constituted successful occlusion of a cerebral aneurysm), meant that research into 
patient recovery was for a long time, not considered a priority. Outcome had only 
been indexed in terms of mortality and patient survival time [268]. An improving 
survival rate and relatively stable incidence [284, 364, 370, 403, 653] has however, 
meant that it has become vital to now consider not only the quantity, but also the 
quality of SAH patients' survival [183]. 
With the increased attention on SAH patients' outcome, it became noticeable 
that researchers and clinicians needed to be equipped with sensitive measures to 
gauge patients' global outcome [214, 752]. A wealth of evidence has illustrated that 
the classic measures of outcome available within neurosurgery and neurology, 
measures such as the Glasgow Outcome Scale (GOS) [318], are far from satisfactory 
(please see Appendix IV for a description of the content and scoring of the GOS). 
Such crude, clinician-led measures were designed only to evaluate patient outcome 
with respect to physical disability, and are as such, too restricted in their focus to 
capture the broad array of difficulties which SAH patients can experience. An 
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infrequency of profound physical disability in the SAH population for example, means 
that although 80-85% of patients are rated as having made either a "good" or 
favourable outcome on such scales [303, 434], up to 60% of these patients illustrate 
chronic cognitive dysfunction [303, 438, 507, 540, 541, 643], around 50% experience 
personality change (including irritability, hostility, emotional lability) [57, 537, 746], 
50% do not return to work [90, 540, 541], approximately 20% show reduced social 
participation [540, 541], 25% consider death preferable to the quality of their survival 
[90], and many also show severe hormonal disturbance [604]. 
The revelation that a positive appearance [17, 25, 45, 303, 313, 409, 507, 643] 
did not necessarily equate with a full recovery, forced neurosurgeons to engage in a 
debate on how it defined and measured SAH patients' outcome. Seminal 
contributions to this discussion revealed that neurosurgery's definition of outcome had 
been, for the most part, atheoretical. It was highlighted how the judgement of patient 
outcome following an SAH was not informed by the patient's own opinion, but rather 
was centred upon the treating neurosurgeon's own beliefs. Buchanan et al. [90] in a 
small, but important study, illustrated that this approach was wholly unsuitable 
because the frame of reference used by these two parties drastically differed. Whilst 
patients and their families evaluated outcome according to "what was", 
neurosurgeons, being acutely aware of the potential of an SAH to kill or profoundly 
disable, compared patients' outcomes "with what could have been". Consequently, 
though patients often experienced troublesome neurobehavioural sequelae, 
difficulties other than obvious physical impairment were viewed by neurosurgeons as 
'minor' and permissible [44, 45, 90]. "Good" recovery, it was found, lay very much in 
the eye of the beholder. 
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As a result, the neurosurgical community recognised that it was crucial that a 
patient's perspective was taken into account when judging outcome after an SAH. It 
was seen that a more holistic approach to assessment was needed, whereby the 
entire patient as he/she exists and functions in his/her own world was evaluated [17, 
44, 45, 295, 313, 383, 397, 398, 592]. As is the case for other illnesses [59, 234, 239, 
384, 757], it is now widely accepted that measures of patients' 'health-related quality 
of life' (HRQoL) fulfil these aims and that such measures are well-suited to provide a 
sensitive index of the personal burden that an SAH places on its survivor [1 03, 137]. 
Indeed, in line with the US. Food and Drugs Administration's guidelines [137, 214], 
HRQoL is now used as "hard" criterion by which to evaluate different treatments for 
SAH[3,91, 144,239,362,410,686,693]. 
Despite this increased emphasis being placed on HRQoL, no single definition 
exists in the medical sciences [59, 186, 219, 329]. Nonetheless, HRQoL is commonly 
understood to be a multidimensional construct which measures the extent to which 
one's usual or expected physical, emotional and social well-being is affected by a 
medical condition or treatment [1 09]. HRQoL is distinct from the broader construct of 
quality of life which encompasses the influence of other aspects of life not amenable 
to health care services, such as adequacy of housing and income [59]. Importantly, it 
is recognised that HRQoL can only be effectively accessed by asking the patient 
themselves for their opinion [59, 186]. Furthermore, not only does HRQoL measure 
for some of the neurophysical impairments resulting from an illness (e.g., loss of 
movement in a limb) and its associated disability (i.e., the functional loss associated 
with these impairments), but it also heavily loads on the handicap which these 
impairments and disabilities cause (i.e., the disadvantages the person experiences as 
a result of the illness which limits or prevents them from fulfilling a normal role, such 
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as working). HRQoL therefore, represents an indicator of a patient's overall abilities in 
daily life. It exceeds the level of pure physical function and constitutes a more general 
outcome criterion than cognitive function [285, 305]. Given this multidimensional 
nature, HRQoL accords well with the World Health Organisation's models of disease 
[1, 2] which contend that an illness can affect a person in a multitude of ways, that its 
effects are context specific and can ultimately often only be evaluated by the patient 
themselves [84, 232, 748]. Importantly, HRQoL is a double-sided concept, allowing 
for both positive, as well as negative effects, of illness [59]. 
Both disease specific and generic HRQoL measures have been used to 
assess SAH patients' outcome [43, 546, 734]. These self-report questionnaires 
evaluate HRQoL by asking the patient to indicate their personal experience of the 
presence, frequency, or intensity of various symptoms, behaviours, capabilities and 
feelings. The key HRQoL domains which are commonly examined by such 
instruments include the person's physical functioning (i.e., limitations in performance 
due to their poor health in all physical activities including bathing and dressing), 
physical role limitations (i.e., problems with work and/ or daily activities as a result of 
their physical health), bodily pain (i.e., severity and limitations of pain), general health 
(i.e., evaluate their personal health as poor and asked whether it is likely to get 
worse), energy (i.e., whether they feel tired and worn out all the time), social 
functioning (i.e., whether they experience extreme and frequent interference with 
normal social activities due to physical or emotional problems) and mental health (i.e., 
whether they feel nervous and depressed all of the time) [735]. Principal component 
analyses reveal that scores from these domains essentially relate to two broad 
HRQoL dimensions - namely physical HRQoL and mental HRQoL [732]. Not only 
does the use of these summary scores obviously reduce the number of statistical 
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comparisons which are needed when analysing data, but it also simplifies 
interpretation and means that the two aspects can be examined separately. 
Although disease-specific HRQoL instruments have the advantage that they 
can be highly sensitive, with items being tailored to the disease in question, such 
instruments have been slow to develop for SAH patients. To date, only one such SAH 
measure has been developed and it is still very much in the early stages of 
psychometric evaluation [546]. Consequently, the highly reliable and widely validated 
generic HRQoL measures - often referred to as health-status questionnaires [168, 
186] - have been favoured in SAH studies. The Medical Outcomes Study Short Form 
questionnaires [731, 735] and the Sickness Impact Profile [43] are the most popular 
of the generic instruments in the field of SAH (as revealed by my review of the SAH 
HRQoL literature presented later in this chapter). The great advantage of such 
instruments is that normative data have been collected so that it can be determined to 
what degree SAH patients' HRQoL strays from normality [59]. Scores can also be 
compared to those reported in relation to patients with/after other illnesses which 
allows for SAH patients' impairment to be placed in the context of more thoroughly 
researched diseases. 
2.3.2 Patients' HRQoL after SAH 
Having been employed in SAH research since 1995, HRQoL measures have been 
instrumental in exposing the true extent and seriousness of an SAH for its survivors. 
Though a few exceptions exist [40, 75, 451], and a minority of patients note some 
positive consequences of the illness (e.g., a renewed sense of appreciation for life) 
[285], an overwhelming amount of literature now demonstrates that many SAH 
patients experience substantial degrees of HRQoL impairment compared to general 
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population controls [116, 144, 189, 240, 283, 285, 286, 302, 305, 336, 377, 438, 609, 
639, 703]. This impairment is seen in both the early [144, 285, 336, 358, 438] and the 
later stages following the illness [116, 144, 189, 240, 286, 302, 305, 377, 609, 639]. 
For example, Hutter et al. [302] examined a sample of 58 SAH patients using a study-
specific HRQoL measure and found that approximately 50% of those patients still 
reported impairment 1-5 years post-SAH. 
The severity of SAH HRQoL impairment is reflected even at the group mean 
level, where it could be expected that its effect would be less pronounced. Using the 
data from 10 major studies which together examined over 600 SAH patients [144, 
240, 283, 322, 336, 358, 377, 470, 569, 639], I present in Figure 2.6 the (weighted) 
average mental and physical HRQoL reported by SAH patients (as measured by the 
Medical Outcome Study Short-Form questionnaires [733, 734]). Crucially, I also 
include in the figure, the average HRQoL reported on the same measure by persons 
with health conditions which have been better researched and are recognised as 
being debilitating, such as cancer [676]. The use of a linear t-score transformation 
(where the mean normative score for each condition is 50) means that scores across 
the different health conditions can be compared. Although some caution should be 
exercised when interpreting the summary scores for SAH patients' HRQoL (since I 
did not formally examine the homogeneity of the scores from the contributing studies), 
the figure does nevertheless, quite clearly illustrate that an SAH - even at group-level 
- exerts a negative influence on HRQoL comparable to that of the other chronic 
illnesses. In fact, it can be observed that the HRQoL of SAH patients is worse than 
that caused by all other illnesses included in the figure, except Major Depressive 
Disorder. That an SAH can profoundly reduce a person's HRQoL agrees with those 
studies which more formally contrasted SAH patients' psychosocial outcome with 
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Figure 2.6 Comparison of Mental and Physical health-related quality of life 
associated with SAH and other illnesses. 
SAH scores are weighted averages for 604 patients derived from 10 independent studies [144, 240, 283, 
322, 336, 358, 377, 470, 569, 639); Data for comparison health conditions from European Prospective 
Investigation into Cancer (676); Scores less than 50 indicate a negative deviation from normality; Higher 
scores indicate better outcome; HRQoL= Health-related quality of life; MOS= Medical Outcome Study; 
Myocardial infarc.= myocardial infarction. 
other patient groups [264, 304, 451, 465, 545, 627]. Though an SAH can cause 
significant reductions in all areas of HRQoL [189], the most prominent reduction has 
been found to occur in the Mental HRQoL. Katati et al. [336] for example, found that 
impairment in the domains mental health (47.1%), energy reduction (42.9%) and role 
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limitations due to emotional problems (40%) were amongst the most impaired areas 
of HRQoL post-SAH, whilst Kreitschmann-Andermahr et al. [377] found twice the 
impairment in Mental HRQoL compared to Physical HRQoL post-SAH. 
2.4 Previous studies failure to explain SAH patients' reduced 
HRQoL 
As we have seen, a person's HRQoL is especially impaired following an SAH. Does 
current the evidence allow us to explain this reduction? In order to answer this 
question, I conducted a systematic (non-quantitative) review of the literature to 
identify those studies which have looked to explain SAH HRQoL. Figure 2.7 illustrates 
the selection process for the articles used in this review. Further methodological 
details of this review, such as the terms used for the searching of electronic data-
bases and exclusion criteria, are not presented here but instead can be found in the 
methods section of the next chapter (Chapter 3), as the current literature review forms 
the basis for the articles used in the meta-analysis which I present there. 
The results from the systematic (non-quantitative) literature review are shown 
in Tables 2.1 and 2.2. These results show that whilst the complexity of an SAH has 
meant that a plethora of variables have so far been implicated in trying to explain 
SAH HRQoL (in fact, over 45), previous studies have failed to identify any factor 
which is reliably associated with SAH HRQoL and so can help explain these patients 
impairment (see column titled 'Findings' in the two tables). In addition to showing that 
most studies (81 %; see Figure 2.7) on the topic have used either one of the MOS or 
SIP HRQoL questionnaires to measure HRQoL, the results also show that most 
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12 articles excluded 
I I 
8 articles excluded 
b/c they did not b/c utility-based or 
measure HRQoL non self-report 
HRQoL measure 
used 
Exclusion 2 I I Exclusion 3 
2, 658 potentially relevant articles 
identified and screened for retrieval 
84 articles reviewed in more 
detail 
7 articles excluded 1 0 articles excluded 
b/c HRQoL measure b/c they were a 
had no proven doublet 
reliability 
Exclusion4 Exclusion 5 
2, 573 excluded b/c 
SAH patients not studied 
Exclusion 1 
6 articles excluded 
b/c they did not 
examine predictors 
Exclusion 6 
27 independent studies with usable information on 46 predictors of SAH HRQoL. 
22 (81 %) of studies used MOS or SIP measure, 5 studies using another measure 
14 articles excluded 
b/c SAH data 
merged with other 
pathologies 
I I Exclusion 7 
Figure'2.7 Flow diagram describing the selection process of the articles included in the systematic (non-quantitative) review. 
b/c=because; HRQoL=health-related quality of life; MOS=Medical Outcomes Study Short-Form Questionnaires; SIP=Sickness Impact Profile. 
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Table2.1 Acute SAH factors which have been examined for their value in explaining SAH patients' HRQoL 
Acute factors Study N HRQoL measure Timing (yrs.) Analysis Finding(s) 
Age Claassen et al. [116] 247 SIP Total 1.0 Statistical MR ns. 
Crago et al. [123] 74, 76 SF-36 PF .25, .5, 1.0 Hierarchical LR ns. 
Hackett et al. [240] 174 SF-36 all domains 1.2 Univariate ns. 
Hutter et al. [305] 116 SIPt Total, PCS, MCS 4.0-5.0 Univariate; Stepwise MR; OF sig. Total, PCS 
Katati et al. [336] 70 SF-36 Total and domains .33 MR ns. except for PF 
Kreitschmann-Andermahr et al. [377] 35 SF-36 PCS, MCS; 2.3 Covariate in MR for SF-36; 
NHP domains; Qol-AGHDS Stepwise MR ± for others ns. except NHP social isolation 
Lindberg et al. [397] 104 VAS 7.0 Univariate ns. 
Pritchard et al. [546] 105 WPCQ .5-1.0 Univariate ns. 
Pritchard et al. [548] 136 WPCQ .5 Univariate ns. 
Aneurysm Hutter et al. [305] 116 ALQI Total, PCS, MCS 4.0-5.0 Univariate ns. 
Location Pritchard et al. [546] 105 WPCQ .5-1.0* Univariate ns. 
Pritchard et al. [548] 136 WPCQ .5 Univariate Ns 
Aneurysm Hutter et al. [305] 116 ALQI Total, PCS, MCS 4.0-5.0 Univariate ns. 
number 
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Table 2.1 Cont'd. 
Acute factors Study N HRQol measure Timing (yrs.) Analysis Finding(s) 
Aneurysm Mocco et al. [463] 35 SIP Total, PCS, MCS .25, 1.0 Univariate ns. 
treatment Pritchard et al. [546] 105 WPCQ .5-1.0 Univariate ns. 
Pritchard et al. [548] 136 WPCQ .5 Univariate Ns 
Anosmia Wermer et al. [744] 74 VAS 7.33 
Aspirin Hop et al. [283] 42 SF-36 domains; SIP domains, PCS, MCS .33 Univariate ns. except 'sleep and rest' on SIP 
Therapy 
Bleed Crago et al. [123] 74, 76 SF-36 PF .25, .5, 1.0 Hierarchical LR ns. 
Severity Hutter et al. [305] 116 SIPt Total, PCS, MCS 4.0-5.0 Univariate; Stepwise MR; DF ns. 
Katati et al. [336] 70 SF-36 Total and domains .33 MR ns. 
Kreitschmann-Andermahr et al. [377] 35 SF-36 PCS, MCS; NHP domains; Qol- 2.3 Stepwise MR ± ns. 
AGHDS 
Pritchard et al. [546] 105 WPCQ .5-1.0 Univariate ns. 
Pritchard et al. [548] 136 WPCQ .5 Univariate ns. 
Soehle et al. [63~] 29 SF-36 domains, PCS, MCS 1.0 Univariate ns. except for PF 
Brain sag Komotar et al. [367] 48 SIP Total .25 Univariate ns. 
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Table 2.1 Gont'd. 
Acute factors 
Cardiac 
Complications 
Clinical 
severity 
Co-morbidities 
Delay to 
Treatment 
· Study 
Crago et al. [123] 
Claassen et al. [116] 
Crago et al. [123] 
Fertl et al. [189] 
Hutter et al. [305] 
Katati et al. [336] 
Kreitschmann-Andermahr et al. [377] 
Pritchard et al. [546] 
Pritchard et al. [548] 
Tseng et al. [694] 
Hutter et al. [305] 
Hutter et al. [306] 
Hackett et al. [240] 
N 
74, 76 
247 
74, 76 
40 
116 
70 
35 
105 
136 
69 
116 
39 
174 
HRQol measure 
SF-36 PF 
SIP Total 
SF-36 PF 
Lancaster QoL Profile 
ALQI Total, PCS, MCS 
SF-36 Total and domains 
SF-36 PCS, MCS; NHP domains; QoL-
AGHDS 
WPCQ 
WPCQ 
SF-36 PCS, MCS 
ALQI Total, PCS, MCS 
ALQI 
SF-36 all domains 
Timing (yrs.) 
.25, .5, 1.0 
1.0 
.25, .5, 1.0 
1.8 
4.0-5.0 
.33 
2.3 
.5-1.0. 
.5 
. 5 
4.0-5.0 
2.0-3.0 
1.2 
Analysis 
Hierarchical LR 
Statistical MR 
Hierarchical LR 
Univariate 
Univariate: Stepwise MR; DF 
MR 
Stepwise MR ± 
Univariate 
Univariate 
Statistical MR 
Univariate 
Univariate 
Univariate 
Finding(s) 
Sig. at 3 and 6 mo. only 
ns. 
ns. 
ns. 
ns. except DF Total 
ns. except PF, PRL, EN 
ns. 
ns. 
ns. 
Sig . 
Sig. 
ns. 
ns. 
34 
Table 2.1 Cont'd. 
Acute factors Study N HRQoL measure Timing (yrs.) Analysis Finding(s) 
Education Claassen et al. [116] 247 SIP Total 1.0 Statistical MR sig. 
English fluency Claassen et al. [116] 247 SIP Total 1.0 Statistical MR ns. 
Ethnicity Claassen et al. [116] 247 SIP Total 1.0 Statistical MR sig. 
Crago et al. [123] 74, 76 SF-36 PF .25, .5, 1.0 Hierarchical LR ns. 
Fever Fernandez et al. [188] 353 SIP poor/ good QoL cut-off .25 Hierarchical LR ns. 
Hydrocephalus HUtter et al. [305] ±± 116 ALQI Total, PCS, MCS 4.0-5.0 Univariate ns. 
Tseng et al. [694] 69 SF-36 PCS, MCS .5 Statistical MR sig. for PCS only 
Immediate Tseng eta. [694] 69 SF-36 PCS, MCS .5 Statistical MR sig. 
Operative 
deficits 
Infarction Claassen et al. [116] 247 SIP Total 1.0 Statistical MR ns. 
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Table 2.1 Cont'd. 
Acute factors · Study N 
Initial Kowalski et al. [369] 482 
Misdiagnosis 
Intracerebral Hutter et al. [305]* 108 
Bleed 
Intraoperative Hutter et al. [305] 116 
aneurysm 
rupture 
Intraventricular Hutter et al. [305] 116 
Bleed 
Pravastatin Tseng et al. [694] 69 
treatment 
Re-bleed Claassen et al. [116] 247 
HRQol measure Timing (yrs.) 
SIP .25, 1.0 
ALQI Total, PCS, MCS 4.0-5.0 
ALQI Total, PCS, MCS 4.0-5.0 
ALQI Total, PCS, MCS 4.0-5.0 
SF-36 PCS, MCS .5 
SIP Total 1.0 
Analysis 
Univariate 
Univariate 
Univariate 
ANCOVA 
Statistical MR 
Statistical MR 
Finding(s) 
ns. except for just good grade 
patients at 3 mo. 
sig. 
ns. 
ns. 
sig. 
sig. 
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Table 2.1 Cont'd. 
Acute factors Study N HRQol measure Timing (yrs.) Analysis Finding(s) 
Resection of the Hutter et al. [305] 116 ALQI Total, PCS, MCS 4.0-5.0 Univariate ns. 
gyrus rectus 
Sepsis Tseng et al. [694] 69 SF-36 PCS, MCS .5 Statistical MR sig. 
Sex Crago et al. [123] 74, 76 SF-36 PF .25, .5, 1.0 Hierarchical LR ns. 
Hackett et al. [240] 174 SF-36 all domains 1.2 Univariate ns. 
Katati et al. [336] 70 SF-36 Total and domains .33 MR sig. male better, except SF 
Kreitschmann-Anderrnahr et al. [377] 35 SF-36 PCS, MCS; 2.3 Covariate in MR 
NHP domains: Qol-AGHDS Stepwise MR ± ns. except NHP social isolation 
Lindberg et al. [397] 104 VAS 7.0 Univariate ns. 
Pritchard et al. [546] 105 WPCQ 5-1.0 Univariate ns. 
Pritchard et al. [548] 136 WPCQ .5 Univariate ns. 
Tseng et al. [15] 69 SF-36 PCS, MCS .5 Statistical MR sig. male better 
Temporary Hutter et al. [305] 116 ALQI Totai,PCS, MCS 4.0-5.0 Univariate sig. except for MCS 
clipping 
37 
Table 2.1 Cont'd. 
Acute factors 
Vasospasm 
Ventriculitis 
E4 allele 
Study 
Hutter et al. [305] 
Soehle et al. [639] 
Tseng et al. [15] 
Morris et al. [470] 
N 
116 
29 
69 
70 
HRQol measure 
ALQI Total, PCS, MCS 
SF-36 domains, PCS, MCS 
SF-36 PCS, MCS 
SF-36 
Timing (yrs.) Analysis Finding(s) 
4.0-5.0 Univariate ns. except for PCS 
1.0 Univariate ns. 
.5 Statistical MR sig.forMCS 
1.2 Univariate ns. 
Note: ALQI= Aachen Life Quality Index; DF=discriminant function analysis; HRQoL=health-related quality of life; LR=Iogistic regression; MCS=Mental/ Psychosocial HRQoL Component Score; 
MR= Multiple regression n=number; NHP=Nottingham Health Profile; ns.=statistically non-significant; PCS=Physical HRQoL Component Score; PF=Physical Functioning; Qol-AGHDS=Quality of Life 
Assessment of Growth Hormone Deficiency; SF-36=Short Form-36; sig.=statistically significant; SIP=Sickness Impact Profile; VAS= Visual Analogue Scale; WPCQ=Wessex Patient Carer 
Questionnaire; yrs.=years; ±=Stepwise type unclear; ±±=Delayed hydrocephalus (3-48 weeks after discharge); *=Location of ICH in cohort was 'frontal' (11.2%), with the 6.8% of patients with ICH at 
other locations excluded from analysis. 
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Table:2.2 Other, non-acute SAH factors which have been examined for their value in explaining SAH patients' HRQoL 
Other factor Study n HRQol measure Timing (yrs.) Analysis Finding(s) 
Anxiety Mayer et al. [438] 137 SIP Total, PCS, MCS .25 Hierarchical MR excluded due to collinearity with 
depression 
Cognitive Mayer et al. [438] 137 SIP Total, PCS, MCS .25 Univariate: hierarchical MR sig. 
Function Scott et al. [613] 573 SIP Total, PCS, MCS 1.0 Univariate sig. 
Depression Fertl et al. [189] 40 Lancaster QoL Profile 1.8 Univariate sig. 
Lindberg et al. [397] 104 VAS 7.0 Univariate: DF sig. 
Mayer et al. [438] 137 SIP Total, PCS, MCS . 25 Hierarchical MR sig . 
Epilepsy Claassen et al. [116] 247 SIP Total 1.0 Statistical MR sig. 
.•. 
Family Fertl et al. [189] 40 Lancaster QoL Profile 1.8 Univariate ns. 
functioning 
Untreated van der Schaaf et al. [703] 69 SF36 domains; EURO-QOL 7.1, 9.1 Univariate ns. 
aneurysm 
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Table 2.2 Cont'd. 
Other factor Study n HRQol measure Timing (yrs.) Analysis Finding(s) 
Hormone Kreitschmann-Andermahr et al. [377] 35 SF-36 PCS, MCS; NHP domains; QoL- 2.3 Stepwise MR ± ns. except Qol-AGHDA, NHP 
dysfunction AGHDS mobility, sleep, social isolation, 
emotional reaction, energy 
Univariate ns. 
Leisure and Lindberg et al. [7] 104 VAS 7.0 Univariate; DF sig. 
social activities 
Physical Hop et al. [285] ±± 55 SIP; SF-36; VAS .3 Univariate 
disability Hop et al. [286] 48 SIP; SF-36; VAS 1.5 Univariate sig. SIP 'household and SF-36 PF, 
PRL, ERL, MH, EN. 
Hutter et al. [305] 116 SIPt Total, PCS, MCS 4.0-5.0 Univariate 
Katati et al. [5] 70 SF-36 Total and domains .33 MR sig. except SF 
Kreitschmann-Andermahr et al. [377] 35 SF-36 PCS, MCS; NHP; QLAGHDS 2.3 Stepwise MR ± ns. except SF-36 PCS, NHP pain 
Lindberg et al. [7] 104 VAS 7.0 Univariate ns. 
Number of Pritchard et al. [546] 105 WPCQ .5-1.0 Univariate ns. 
children Pritchard et al. [548] 136 WPCQ .5 Univariate ns. 
Sleep quality Schuiling et al. [609] 83 SF-36 domains 1.7 Univariate sig. 
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Table 2.2 Cont'd. 
Other factor 
Smoking 
Time since 
illness 
Working capacity 
Study 
Ballard et al. [31] 
Hop et al. [286] 
Lindberg et al. [7] 
Maceo et al. [1 OJ 
Pritchard et al. [8] 
Pritchard et al. [9] 
Fertl et al. [189] 
Lindberg et al. [7] 
n 
152 
48 
104 
35 
105 
136 
40 
104 
HRQol measure Timing (yrs.) 
SIP Total .25 
SIP; SF-36; VAS 1.5 
VAS 7.0 
SIP Total, PCS, MCS 25, 1.0. 
WPCQ 5-1.0 
WPCQ .5 
Lancaster QoL Profile 1.8 
VAS 7.0 
Analysis 
Univariate 
Univariate 
Univariate 
Univariate 
Univariate 
Univariate 
Univariate 
Univariate 
Finding(s) 
ns. 
Sig. improve with time SF-36 PF & 
PRL. Sig. worse SIP 'household 
management', 'recreation and 
pastimes' & eating. 
ns. 
sig. 
ns. 
ns. 
ns. 
ns. 
Note: ALQI=Aachen Life Quality Index; HRQoL=health-related quality of life; MCS=Mental HRQoL Component Score; NHP= Nottingham Health Profile; PCS=Physical HRQoL Component Score; 
QLAGHDS= Quality of Life Assessment of Growth Hormone Deficiency in Adults; SF-36= Short Form-36; ±=Stepwise method unclear; ±± Significance testing of associations precluded on the basis of 
small sample size [633]. When both summary and sub-domains scores available, the association with just summary scores is presented. 
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previous attempts to explain SAH patients' HRQoL reduction have centred on either 
(1) the clinical characteristics of the illness and the patient- such as patient age, sex, 
clinical severity on admission to hospital, severity and distribution of the 
haemorrhage, its aetiology and its treatment - or (2) on the neurological sequelae 
which they experience post-SAH. The reasons why these two sets of predictors have 
so dominated prior studies looking to explain SAH HRQoL are quite comprehensible. 
In terms of clinical characteristics of the illness and the characteristics of 
patient, it is no doubt because these factors have previously been established as the 
best indicators for more immediate aspects of outcome following SAH, such as gross 
physical morbidity, mortality and some aspects of cognitive impairment [18, 52, 253, 
271' 306, 334, 373, 381' 386, 387, 432, 511' 512, 540, 558, 560, 590, 595, 649]. 
Whilst in terms of the focus on neurological sequelae, it is because whilst SAH does 
not cause the cardinal neurological problems of 'stroke' (i.e., hemiplegia, aphasia, 
anosognosia and neglect) [302, 303, 382, 399, 460], it does nevertheless still cause 
cognitive dysfunction akin to that of closed-head injury in 25-55% of patients and to a 
lesser extent, some reduced physical independence [34, 295, 297, 303, 306, 505, 
507, 687], which the wider literature on other illnesses suggest cold potentially be 
debilitating [35, 61, 180, 282, 344, 523, 71 9]. Specifically, whilst general intellectual 
function is unaffected [25, 228, 302, 303, 409, 412, 504, 507, 596, 617, 660], 
cognitive tests reveal that SAH patients can experience a pattern of chronic 
impairment in the areas of attention (such as in speed of information processing, 
sustained concentration and selective attention) [52, 146, 169, 242, 301, 304, 438, 
450, 507, 644, 720] executive functioning (such as in tasks of planning, organisation, 
sequencing and monitoring of complex behaviours) [52, 146, 169, 242, 297, 300, 304, 
382, 438, 450, 507, 644, 649, 720] and, to the largest extent, in learning and memory 
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(such as in figural short-term memory and verbal long-term memory) [13, 34, 145, 
169,242,296,300-304,382,388,434,438,460,507,540,541,557,649,685,687, 
722]. This impairment it could be speculated could have been disruptive to a patients' 
quality of life. Indeed, the central place that neurological factors have been assumed 
to have in explaining SAH patients' psychosocial outcome is reflected in the 
rehabilitative programmes currently offered to SAH patients which predominantly look 
to moderate only the impact of the cognitive and physical consequences of the illness 
[159, 160,462,499,555,587,661,734,747, 766) 
So, how can the mysterious reduction in SAH patients' HRQoL be explained? 
Two possible explanations present themselves. The first possibility is that in most 
previous studies, only statistical significance has been used for the evaluation of a 
predictor's importance. This, combined with the fact that many studies have been 
statistically underpowered, could mean that the actual importance of the traditional 
factors which they had considered, may not have been revealed. The second 
explanation is that because SAH is a neurological illness, researchers have been 
blinkered into concentrating on only classical, neurological and illness-related factors 
to explain patient outcome and have not taken into account other possible 
explanations. In reading the literature, it is clear that SAH patients' symptom profile is 
also very often dominated by psychiatric disturbance [57, 469, 537, 544, 649, 652). 
Psychiatric disturbance has however, not been incorporated into explanative models. 
This is surprising, considering that evidence from the wider psychiatric literature has 
shown that psychiatric disturbance can be highly debilitating [1 0, 49, 93, 532]. 
In the next three chapters, I empirically examine these two possibilities. In 
Chapter 3, I examine possibility one that traditional factors may be important in 
explaining SAH HRQoL but that the lack of statistical power in prior studies and their 
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reliance on notoriously unreliable statistics has served to obscure their actual 
importance. To do this I present a meta-analysis of prior research on the traditional 
predictors. In Chapters 4 and 5, I present a further literature review and my 
prospective study of a large sample of SAH patients, which together are used to 
explore the second possibility that there might be a so-far ignored consequence of an 
SAH which has not been taken into account. 
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Chapter 3 
Possibility one - The explanative value of traditionally 
considered variables for SAH patients' health-related 
quality of life has been obscured 
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3.1 Introduction 
A subarachnoid brain haemorrhage (SAH) can not only pose a serious threat to 
someone's life, but it can also negatively impinge upon the well-being of those who 
survive it [544]. Studies consistently find that a large proportion of its survivors- up to 
55%, in fact [302, 377, 397]- report chronic and dramatic reductions on measures of 
both their Physical and Mental health-related quality of life (HRQoL). In Chapter 2, I 
showed how traditional efforts to explain SAH patients' reduced HRQoL have focused 
on the degree of neurological sequelae experienced post-SAH, intrinsic information 
about the patient and the characteristics of their haemorrhage (see Tables 2.1 - 2.2 in 
that chapter). It has for example, been argued in the SAH literature that increasing 
patient age [305, 306, 694], being female [336, 694], presenting in a worse 
neurological state on initial admission to hospital [188, 265, 305, 336, 639, 694], 
suffering a more severe haemorrhage [305, 306, 377, 639], greater physical disability 
and cognitive impairment [285, 286, 305, 336, 377, 438, 613] are associated with 
worse HRQoL scores. The time which elapses between haemorrhage occurrence and 
HRQoL assessment has also been proposed as being key when explaining patients' 
HRQoL outcome. It is those assessments which occur the soonest following 
haemorrhage which yield the worse HRQoL scores [286, 397, 463, 546, 548]. 
These traditional variables have not however, proved to be robust predictors 
[105, 116, 189,286, 305, 397,438, 689, 721]. Whilst some studies have found them 
to be associated with SAH patient HRQoL, the majority have not [116, 123, 189, 240, 
285, 286, 305, 336, 397, 463, 546, 548, 639, 694]. This would suggest that future 
studies should focus on more novel aspects of SAH patients' outcome to explain the 
reduction in HRQoL. There remains the possibility however, that traditional factors do 
explain S.A:H HRQoL, but that the manner in which their importance has been 
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assessed has served to prevent their true importance from being recognised. To date, 
studies examining a predictor of HRQoL have almost exclusively relied upon the 
statistical significance of its association with HRQoL when evaluating its importance. 
By itself, this is however, a notoriously unreliable method. Specifically, any 
information which a P-value carries about the practical predictive importance of a 
relationship is always confounded by the statistical power of the study in question to 
actually detect the effect [108, 117,210,452, 751]. Studies with small samples for 
example, may find a large effect but this may not prove to be statistically significant 
because of inadequate statistical power [404]. Conversely, a small effect may prove 
statistically significant simply as a function of it being measured in a study with a large 
sample size. Therefore, the preferable means by which to judge the importance of 
these predictors is to examine the size of their predictive effect on SAH patients' 
HRQoL. In other words, how much variance in HRQoL can each of the predictors 
actually explain? This information is contained in standardised measures of effect 
size, of which there are two main families; the d family (such as Cohen's d, Hedges' g 
and Glass's delta) and the (correlation coefficient) r family [583]. Unlike P-values, 
these measures are relatively unaffected by sample size (although, as with any 
quantitative test, the larger the sample, the closer this statistic will approximate the 
true effect). Given the evidence that a lack of statistical significance does not 
necessarily equate with a lack of practical explanative importance, it is imperative that 
the ill-considered effect sizes of traditional predictors of HRQoL are considered before 
they are hastily discarded. An examination of their effect sizes will be able to inform 
us which, if any, of the predictors are truly important from an explanative perspective 
and should be retained. 
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With this in mind, the present chapter reports the results from a meta-analytic 
study which I conducted to examine the predictive effect size of each of the following 
7 traditional predictors of SAH HRQoL: patient age, bleed severity, clinical severity on 
admission, cognitive function, physical disability, sex and time since illness. In the 
meta-analysis, the predictive effect sizes for the variables of Physical HRQoL and 
Mental HRQoL is examined separately. The basis for which predictors and articles to 
include in the meta-analysis were the results from the systematic (non-quantitative) 
literature review which I presented in the previous chapter. For each of the 7 
predictors included, standard procedures [404, 472, 580] were used to calculate the 
size of their predictive effect in each of the included articles. In order to produce the 
most accurate estimates of their true effect size, meta-analysis pooled the effect size 
estimates from individual studies on the same predictor to produce single overall 
effect size estimates. When combining the effect size estimates from separate 
studies, the greatest weight was given to those estimates taken from the larger 
studies as these will usually be more precise in their measurement than the estimates 
from the smaller studies [260]. 
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3.2 Methods 
The meta-analysis presented in this chapter followed directly on from the results of 
the systematic (non-quantitative) literature review which I presented in Chapter 2. 
That particular review was conducted to examine which variables had been used in 
previous studies to try and explain SAH HRQoL. It revealed that a total of 46 
predictors had, to differing extents, been examined for SAH HRQoL. It was this set of 
46 predictors which formed the initial sample of predictors which were considered for 
inclusion in the meta-analysis. I shall now describe the process by which predictors/ 
articles were selected for both the initial systematic (non-quantitative) review and for 
the present meta-analysis. 
Selection Procedures 
For the initial systematic review presented in Chapter 2, several techniques were 
used to identify full journal articles, published in English, which had examined 
potential predictors of SAH patients' HRQoL. Firstly, a search of the Medline (1951 to 
June 2008), IS/ Web of Science (1945 to May 2008) and Psyc/NFO (1887 to May 
2008) databases was made. The databases were searched using the following key 
words in all relevant combinations: aneurysm, subarachnoid h(a)emorrhage, 
arteriovenous malformation, perimesencepahlic, quality of life, Qol, recovery, Short-
Form 36, SF-36, Sickness Impact Profile, SIP, functional and psychosocial. Secondly, 
the journal Stroke (the highest impact journal for SAH studies) was hand-searched 
from January 1994 to June 2008 for potentially relevant studies. The starting date for 
this hand search was one year before the first SAH HRQoL study by Hutter et el. was 
published [302]. Finally, the bibliographies of all retrieved publications were examined 
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and a forward Medline search was made using the names of the author(s) of already 
identified studies. 
Inclusion and Exclusion Criteria 
For the systematic literature review, each identified predictor/ article was scrutinized 
and excluded if it met any of the following predetermined exclusion criteria: (1) SAH 
patients had not been studied in the article, (2) HRQoL had not actually been 
measured (studies measuring more specific aspects of psychosocial outcome, such 
as social participation or work status, were excluded), (3) a utility-based, rather than 
psychometric-based HRQoL measure had been used, (4) a HRQoL measure which 
had no proven reliability or validity had been used, (5) the article was a 'doublet' for 
another article in that it used the same data set and addressed the same question 
(when such multiple articles existed, I included the most comprehensive article or the 
article with the largest sample size), (6) the predictors of SAH HRQoL had not been 
examined and finally, (7) the article had merged the HRQoL data of SAH patients with 
that of other patient groups. The review initially identified 2,657 potentially relevant 
articles. The majority (N=2,573 articles) of these articles were however, excluded at 
the outset as their abstracts revealed that they had not studied SAH patients 
(Exclusion criteria 1 ). The full articles of the remaining 84 studies were then 
examined. Of these studies, 58 were excluded on the basis of the remaining six 
exclusion criteria. This resulted in the identification of 46 variables which had, to 
differing extents, been examined for their predictive value of SAH HRQoL by 27 
articles (see Figure 2.7 in Chapter 2 for flow diagram describing the selection process 
for the systematic literature review). In the majority of studies (81.5%), either one of 
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the Sickness Impact Profile questionnaires [43, 298, 299] or Medical Outcomes Study 
questionnaires had been used to measure HRQoL (731, 734]. 
The selection process for the present meta-analysis involved examining the 46 
predictors identified by the initial systematic review for possible inclusion. A visual 
presentation of the selection process for the meta-analysis is given in Figure 3.1. The 
meta-analysis included only predictors which were considered to be 'traditional 
predictors' - defined as having been examined in at least 3 independent and eligible 
articles (Exclusion criteria 8). Articles were only included if the dependent variable of 
HRQoL in the original study had been measured using either (1) the Sickness Impact 
Profile (SIP) HRQoL questionnaire (includes Sickness Impact Profile-136 (43], the 
Anglicized version known as the Functional Limitations Profile [525, 526]; and the 
Aachen Life Quality Index (ALQI) [298, 299]) or (2) the Medical Outcomes Study 
(MOS) Short-form HRQoL questionnaires (includes Short Form-36 [734] and Short 
Form-12 [731]; Exclusion criteria 9). Articles/ predictors were also excluded if 
insufficient data was provided in the article which meant that the effect sizes for its 
predictors could not be calculated (Exclusion criteria 1 0), or if only a limited part of the 
SIP or MOS instrument had been used to measure HRQoL (Exclusion criteria 11 ). It 
should be noted that if a study did fail to report sufficient information for the 
calculation of the effect size (or indeed, reported an effect size with more than one 
degree of freedom), attempts were made to contact author(s) of these articles, who 
were asked to provide either the univariate effect size(s) or the raw data necessary 
for their calculation (the positive response rate was 45%, with 9 of the 20 contacted 
authors being able to provide the necessary information for inclusion of their study in 
my meta-analysis; see Acknowledgements). 
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Figure 3.1 
From systematic review: 
46 predictors of SAH HRQoL had 
been examined to some extent in 27 
articles. 
Additional data: 
19 articles excluded from systematic 
review under Exclusion criteria 6 or 7 
were re-entered for re-consideration in 
meta-analysis. 
46 articles/ 46 predictors reviewed for possible 
inclusion in meta-analysis on traditional predictors. 
37 articles/13 predictors 
24 articles/ 7 predictors 
13 articles/ 7 predictors 
7 predictors included in meta-analysis; 12 
articles. 
Selection of articles and predictors included in meta-analysis. 
b/c=because; HRQoL=health-related quality of life; MOS=Medical Outcomes Study Questionnaires: 
SAH=subarachnoid haemorrhage; SIP=Symptom Impact Profile; *Anderson et al. [12], Brilstra et al. [75], 
Claassen et al. [116], Czechowsky and Hill [129], Deane et al. [144], Hamedani et al. [244], Hop et al. [286], 
Kim et al. [354), Komotar et al. [367], Mayer et al. [438] and Schulling et al. [609]. 
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The exclusion of studies which had not used a SIP or MOS instrument for the 
measurement of patients' HRQoL was necessary to ensure that the aggregation in 
the meta-analysis of results from different studies was statistically and conceptually 
meaningful. The comparability of the content and scoring of the SIP [43, 298, 299] 
and MOS [731, 734] measures meant that it was acceptable to merge the results from 
studies using them. To provide more detail, the MOS questionnaires assess patient 
HRQoL in the 8 areas: (1) physical functioning, (2) physical role limitations, (3) bodily 
pain, (4) general health, (5) energy, (6) social functioning, (7) emotional role 
limitations and (8) mental health. SIP questionnaires assess HRQoL in broadly 
similar areas: (i) ambulation, (ii) mobility, (iii) body care and movement, (iv) social 
interaction, (v) alertness behaviour, (vi) emotional behaviour and (vii) communication. 
Crucially, scores on both sets of measures can be reduced to two similarly composed 
summary scores- one which represents patient Physical HRQoL (scales 1-4 of the 
MOS and i-iii of the SIP) and one which represents Mental HRQoL (scales 5-8 of the 
MOS and iv-vii of the SIP; Figures 3.2 and 3.3). These two summary scores were 
used in the present meta-analysis as two separate dependent variables of patients' 
HRQoL. The effect sizes which the predictors had with these two dependent 
variables were examined separately. Although the ALQI [298, 299] is not an official 
version of the SIP, it was, nevertheless, here deemed to be such, because its 
German developers constructed it to specifically follow the SIP's content and 
structure. Like the other SIP measures, HRQoL scores on the ALQI can be 
represented by a Mental HRQoL summary score (composed of answers to questions 
concerning mobility, housework, ambulation, autonomy and activation) and a Physical 
HRQoL summary score (composed of answers to questions concerning free-time 
activities, family relations, social contacts, communication, and cognition). 
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Items Scales Summary measures 
3a Limited vigorous activities 
3b Limited doing moderate activities * 
3c Limited lifting or carrying groceries 
3d Limited climbing several flights of stairs * r ,_ 
3e Limited climbing one flight of stairs l Physical functioning 3f Limited bending, kneeling, stooping 
3g Limited walking more than a mile 
3h Limited walking half a mile 
3i Limited walking one hundred yards 
3j Limited bathing or dressing one-self 
4a Cut down amount of time spent on work 
4b Accomplished less than would like * 
--1 Physical role limits I 4c Limited in the kind of work * 
4d Difficultv oerformina the work 
Physical HRQoL 
7 Pain - magnitude Bodily pain 
,_ 
8 Pain - interference * 
1 Overall rating of general health* 
11a Ill more easily than other H ~ 11b Healthy as anybody I know General health 11c Health to get worse 
11d Health is excellent 
9a Feel full of life 
9e Have a lot of energy * I Energy r-9g Feel worn out I 9i Feel tired 
6 Social activities -extent of limitations 
-I 
Social functioning ~ 10 Social activities -time course of !_imitations * 
Mental HRQoL 
Sa Cut down time spent working I I 5b Accomplished less than would like * I Emotional role limits 5c Did not do work as carefully as usual * 
9b Been a nervous person 
9c Felt down in the dumps I Mental health ~ 9d Felt calm and peaceful * I 9f Felt downhearted and low* 
9h Been a happy person 
Figure 3.2 Schematic of the structure of the Medical Outcomes Study Short Form questionnaires. 54 
Selected items 
Walk shorter distances or stop to rest often 
Do not walk at all 
Stay within one room 
Stay away from home only for brief periods of time 
Do not bathe self at all, bathed by someone else 
Very clumsy in body movements 
Doing fewer social activities with groups of people 
Isolate self as much as can from rest of the family 
Difficulty reasoning and solving problems, learning new things 
Behave as if confused or disoriented in place or time 
Laugh or cry suddenly 
Irritable and impatient with self 
Trouble writing or typing 
Do not speak clearly when under stress 
Sit during much of the day 
Sleep or nap during the day 
Eating no food, nutrition is taken through tubes or intravenously 
Eating special or different food 
Not working at all 
Often irritable toward work associates 
Not doing prior maintenance/ repair work around house 
Not doing heavy work around house 
I am going out for entertainment less 
I am not doing any of my usual physical recreation or activities 
Scales 
Ambulation 
Mobility 
Body care and movement 
Social interaction 
Alertness behaviour 
Emotion behaviour 
Communication 
Figure 3.3 Schematic of the structure of the Sickness Impact Profile 
Summary measures 
Physical HRQol 
Mental HRQol 
Total HRQoL Score 
HRQoL=health-related quality of life. Note the Mental Component of the SIP is officially referred to as 'Psychosocial HRQoL'. 
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Additional motivating factors for including studies using either the SIP or MOS 
were that, firstly, they are - by far- the most popular measures of HRQoL used 
within SAH studies. This meant that only a minimal number of studies had to be 
excluded (see Figure 2.7, Chapter 2). Secondly, both families of measures (including 
the ALQI) have been extensively validated and have been found to have satisfactory 
psychometric properties [59, 137, 138, 295, 731, 734]. Indeed, they are preferable to 
other HRQoL instruments used in SAH studies, such as the Euroqol [237] and the 
Nottingham Health Profile [292], as they have been found to illustrate superior 
sensitivity to gradations in poor health [59]. 
The use of all of the exclusion criteria in resulted in the inclusion in the meta-
analysis of the following 7 traditional predictors of SAH patients' HRQoL: (1) patient 
age, (2) bleed severity, (3) clinical severity on admission to hospital, (4) post-SAH 
cognitive impairment, (5) post-SAH physical disability, (6) patient sex and (7) the time 
between illness onset and HRQoL assessment. In an attempt to increase the number 
of studies in the meta-analysis, the authors of those articles which were already 
identified for inclusion, but which had collected data on one (or more) extra 
predictor(s), but not included it in the original article, were contacted and asked to 
provide either the effect size or the raw data necessary for calculation. In addition, 
authors of those studies which had used the SIP or MOS to measure SAH patients' 
HRQoL, but which had been excluded from the initial systematic review because they 
had not explicitly examined predictors (Exclusion criteria 6) or because they had 
merged SAH patient data with that of other patient groups (Exclusion criteria 7), were 
also contacted. In total, 12 articles were finally included in the meta-analysis on the 7 
predictors. 
56 
Data Analysis and Extraction 
Using a standardized data extraction form, the 12 articles were coded for the 
following information: author name(s), year of publication, journal, sample size, 
participants' illness characteristics and population demographics, study context, 
location of study population and measures used to assess HRQoL and predictors. 
Each of the articles was examined and standard procedures [580], were used to 
calculate separate effect sizes for each of the predictors of Mental HRQoL and 
Physical HRQoL which had been studied. Effect size estimates from the studies for 
the individual predictors were then combined using the popular random-effects model 
to create overall estimates of the effect size for each of the predictors [274, 583]. In 
combining effect size estimates, the greatest weight was given to those estimates 
from studies with the least variance. It is for this reason that the combined effect size 
for each predictor is referred to as the weighted effect size. All effect sizes are 
presented in the familiar scale of the correlation coefficient r, along with their 95% 
confidence interval (CI). This interval reflects the precision of the effect size estimate 
[580, 582, 583]. An interval which does not incorporate zero indicates a significant 
effect at P=O.OS. For the purposes of all computations, Fisher's [192] z-transformation 
was applied to the r-values from the original studies to normalize their distribution. 
Cohen's [117] effect size guidelines were used to judge the explanative importance of 
each predictor. Specifically, effect sizes of .1 0, .30 and .50 were taken to indicate 
small, medium and large effect sizes, respectively. Each weighted effect size was 
squared (R'2) to reflect the amount of variance in either Mental HRQoL or Physical 
HRQoL that it could explain. Finally, as recent guidelines suggest, the power of each 
of the meta-analyses to detect the weighted effect size was also calculated [260, 473, 
474]. This was done as although it is often implicitly assumed that the issue of 
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statistical power is not important in meta-analyses, it is as pertinent as in primary 
studies. Moreover, presenting these figures serves to inform future studies on the 
topic of SAH HRQoL how large their sample size should be in order to detect certain 
effects. Muncer et al. [475] suggest that adequate power for a meta-analysis in the 
context of health-related studies constitutes a value of ~.50. According to this guide, 
sufficient power was present in 11 of my meta-analyses, although it should be noted 
that in the 3 other meta-calculations, the size of the effect which was to be detected 
was so minute that the statistical power of the analysis was less than satisfactory. 
As the studies included in the meta-analyses for each predictor had used 
diverse methodologies, the random-effects model - rather than the fixed-effects 
model - was deemed the most suitable for the combining of individual effect sizes. 
These between-study differences meant that it could not be assumed (as it is in the 
fixed-effects model) that any variance in effect size estimates between studies on the 
same predictor was simply due to within study variance (namely, sampling error). 
Rather, as the random effects model assumes, the true effect size was likely to vary 
from one study to the next, as a function of both within- and between-study variance. 
It should be borne in mind therefore, that the overall effect sizes calculated for each 
predictor using this model represent an estimate of the mean of a population of 
randomly distributed effect sizes, not an estimate of one true effect size for each of 
the predictors [149, 257]. As is recognised [621], the weighted effect size estimates 
produced under a random-effects model tend to be more conservative. For this 
reason and in order that their importance could be further explored in the meta-
analyses, the weighted effect sizes for each predictor were also calculated under the 
fixed-effect model. Furthermore, weighted estimates were calculated when the 
influence of significant outlying study estimates was removed. An outlying study was 
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defined as one whose standardised residual effect size estimate exceeded (+/-) 2.00 
[258]. 
The homogeneity between studies in terms of their effect size estimates for 
each predictor of Mental and Physical HRQoL was tested using the Q-test, with an 
alpha set of 0.05. The Q-test for a given predictor was computed by summing the 
squared deviations of each study's effect size estimate from the overall effect size 
estimate, with the contribution of each study weighted by its inverse variance. 
However, as this test is subject to a lack of power, the parameter /-squared (f) was 
also calculated to describe heterogeneity in between study effect sizes as it is not 
dependent on the number of studies included in the analysis [252, 275]. f represents 
the percentage of the total variation between studies in effect sizes which was due to 
heterogeneity rather than chance [272]. Either a significant Q-statistic or a f value of 
>50% was taken to indicate that the effect size estimates for a given predictor were 
more heterogeneous between studies than expected from sampling error alone [404]. 
The robustness of the calculated weighted effect size for the predictors from 
the (potential) impact of publication bias was assessed using the classic fail safe N 
calculation [581]. Publication bias is the tendency for journals to publish only those 
studies which report statistically significant results (or those based on larger studies) 
[156, 396]. Having largely included only published studies in the present meta-
analysis, there was the potential that I introduced upward bias into the meta-analysis 
(i.e. significant effects for the traditional predictors were more likely to have been 
found than would have been the case if all actual completed studies had been 
included). For any significant effects detected by the meta-analysis, I therefore used 
the fail-safe N formulae to determine the number of unpublished (or un-retrieved) 
studies which on average found no significant effect of the predictor that would be 
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needed to reduce the significant effect to below the level of significance (alpha set at 
0.05). The calculated number of studies was then judged in the context of SAH 
HRQoL research to evaluate the likelihood that such a number actually existed. 
Meta-analysis assumes that the effect size estimates being combined are 
independent. Consequently, when the same predictor had been assessed within a 
study using more than one measure (e.g., several measures of physical disability 
were used), then the average of these effect size estimates was used for the analysis 
[404, 427, 472]. If a study presented an effect size for the relationship between a 
predictor and HRQoL from different assessment points, then the effect size for the 
assessment furthest away from illness onset was used. Such effect sizes, it was felt, 
would be most representative of the predictor's effect on patients' chronic HRQoL 
state. 
Differences in the instruments used to measure HRQoL and some of the 
predictors in the studies, meant that higher scores did not always have the same 
meaning. For example, on the MOS measures, a higher score typically indicates a 
better HRQoL, whilst the opposite is true for scores on the SIP measures. To address 
this, when effect sizes were calculated the+/- sign of the r-value was changed, which 
ensured standardisation of the interpretation of the effect sizes. For the purposes of 
this meta-analysis, a high score on the MOS and SIP measures indicates a better 
HRQoL. The reader should also note that for the meta-analysis higher scores on the 
predictor variables, clinical severity, bleed severity, physical disability and cognitive 
impairment indicated worse neurological state on admission, a more severe bleed, 
worse physical disability and more cognitive impairment, respectively. Also, in coding 
the dichotomous variable 'sex', males were always scored as the baseline group. 
Thus, a positive correlation between sex and HRQoL meant that being female was 
60 
associated with a better HRQoL, whilst a negative correlation indicated that being 
male was associated with a better HRQoL. 
The calculation of the effect sizes for a Brazilian study by Rocha-Filo et al. 
[569] which was included in this meta-analysis deserves mention here. Specifically, 
one of the standard steps used for the calculation of their patients' MOS Mental 
HRQoL and Physical HRQoL was not possible to complete exactly as stated by 
available guidelines (733]. The step that proved troublesome involved all eight of the 
patients' MOS subscale scores being standardised using a linear z-score 
transformation. Z-scores are usually calculated by subtracting the MOS subscale 
means for the local population from each individual's subscale score and then 
dividing the difference by the standard deviation of the local population. The 
documented lack of local MOS population scores for Brazil however [717], meant that 
it was necessary to use non-local normative data for the z-score calculations. My 
choice of which surrogate normative scores to use was informed by the limited 
Brazilian MOS normative data which do exist. Specifically, unpublished mean MOS 
scores (and not standard deviations) are available [619] and it is these that were used 
by Rocha-Filo et al. for crude visual comparisons in their original study. I however, 
used published normative scores from a large Swedish sample (N=8930) as these 
were the most comparable to the Brazilian population scores in terms of subscale 
means (673]. Appendix V presents a breakdown of the exact comparability of the 
Swedish MOS normative scores (as well as other countries) to those of Brazil. 
Tests analogous to analysis of variance were conducted to examine the 
validity of my having combined effect size estimates for predictors from studies which 
differed in the HRQoL questionnaire they used. The individual effect sizes for each 
predictor were grouped according to whether they were derived from a study using 
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the MOS or the SIP and then contrasted to evaluate whether the measure used, 
moderated the effect size estimate. Significant heterogeneity was deemed to exist 
between the two groups' average effect size ( Oa statistic) if their mean effect size 
differed by more than sampling error [404]. 
All analyses were conducted using commercially available software (SPSS, 
Comprehensive Meta Analysis) and the freeware programme G*Power [174]. 
3.3 Results 
Characteristics of the Studies included in the Meta-Analysis 
As previously noted, 12 articles (Table 3.1) studying the 7 traditional SAH HRQoL 
predictors formed the basis of the meta-analysis. Of these articles, 10 had examined 
the predictor patient age, 9 had examined the predictor sex, 7 had examined clinical 
severity, 7 physical disability, 6 had studied bleed severity, 4 the time since illness 
and 3 cognitive impairment. Most of the studies reported in the articles had been 
conducted in Europe (67%), all were published between 2000 and 2008 (median= 
2005) and were typically published in North-American neurological and neurosurgical 
journals. Most (67%) of the studies had used a MOS questionnaire to measure 
patients' HRQoL. In terms of their sample characteristics, most studies had focused 
exclusively on those SAH patients whose haemorrhage was of an aneurysmal origin 
(75%) and who were in a favourable clinical state on admission to hospital. Sample 
size ranged from 10 to 573 (median=63, interquartile [IQR] range=33-110). Nine of 
the 12 studies had assessed the SAH patients' HRQoL at only a single follow-up 
assessment: 3 studies had assessed SAH patients <6months post-ictus, 1 ;;::6-12 
months, 2 between 13-23 months and 2 ;;::24 months post- SAH. In the studies, the 
predictor 'physical disability' had been measured using the Glasgow Outcome Scale 
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Table 3.1 Details of studies included in the meta-analysis 
Study Location Treatment Sample HRQol Follow-up Clinical Bleed severity Clinical Treatment Age Sex 
period size(s) measure point(s) Severity details 
Hackett et al.[240] Australia 1995-1998 174 SF-36 1.2 83% HH I-ll - ASAH; Clipped (46% early) 50.9 Most female 
(acute) SAHuo 
Hop et al. [286] Netherlands 1995-1996 48 SIP .33, 1.5 86%WFNS 1-11 - ASAH - 51.9 70.3% 
female 
HOtter et a I. [305] Germany 1989-1992 116 ALQI 4.0-5.0 57% HH 1-11 59% Fisher4 ASAH Clipped (74% early) 50.3 66% female 
Jonsson et al. Sweden 2001-2002 10-13 SF-36 .33, 1.3 - - - - 52.0 76.9% 
[322] female 
Katati et al. [336] Spain 2003-2005 70 SF-36 .33 75.7% HH 1-11; 43% Fisher4 ASAH Clipped or coiled. 48.9 57% male 
71.4% WFNS 1-
II 
King et al. [358] u.s. 2001-2004 91 SF-12 - - - ASAH Most clipped. 51.3 Most female 
Kreitsch'. [377] Germany 1997-2002 35 SF-36 2.3 55% HH 1-11 65% Fisher 3 ASAH 95% clipped 43.8 65% female 
63 
Table 3.1 cont'd 
Study Location 
Maceo et al. [463] U.S. 
Morris et al. [470] U.K. 
Rocha-Filo et al. Brazil 
[569] 
Scott et al. [613] U.K. 
Tseng et al. [694] U.K. 
Treatment 
period 
1996-2002 
1998-1998 
2002-2003 
1994-2002 
2004-2004 
Sample 
size(s) 
35 
32-49 
66 
512-573 
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HRQol 
measure 
SIP 
SF-36 
SF-36 
FLP 
SF-36 
Follow-up 
point(s) 
.25, 1.0 
1.2 
.4 
1.0 
.5 
Clinical 
Severity 
64% HH IV; 
36% HH V. 
84% WFNS 1-11. 
All GCS 15 
Most WFNS I-ll* 
57.4% WFNS I-
ll. 
Bleed severity 
48% Fisher 3 
53% Fisher 3 
-
-
86.2% Fisher 3-
4 
Clinical 
details 
ASAH 
ASAH; 
SAHuo 
ASAH 
ASAH* 
ASAH 
Treatment Age Sex 
Clipped or coiled. 53.0 Most female 
77% clipped 45.2 Most female 
Clipped 44.6 64% female 
Clipped or coiled. 
65% clipped. 52.9 55% female 
Note: ALQI=Aachen Life Quality Index; ASAH=aneurysmal subarachnoid haemorrhage; Fisher=Fisher CT grading scale; FLP=Functional Limitations Profile; GCS=Giasgow Coma Scale; HH=Hunt 
and Hess scale; Kreitsch'=Kreitschmann-Anderrnahr et al.; SAHuo=subarachnoid haemorrhage of unknown origin; SF-12=Short Forrn-12; SF-36=Short Forrn-36; SIP=Sickness Impact Profile; 
WFNS=World Federation of Neurological Surgeons Grading scale; -=unknown. 
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(original and extended version) [318, 758], the modified Rankin Scale [550] and the 
Barthel Index [421]. The predictor 'clinical severity' had been measured using either 
the World Federation of Neurological Surgeons Scale [164] or the Hunt and Hess 
Scale [293]. 'Bleed severity' on the other hand, had been measured in all studies 
using Fisher's CT rating scale [191]. For the measurement of the predictor 'cognitive 
impairment', one study used the Mini-Mental State Examination [197], a well-known 
global measure of cognitive impairment which has been found to be a sensitive and 
reliable measure of post-SAH cognitive dysfunction [354, 357, 438]. The other two 
studies employed comprehensive batteries of neuropsychological tests chosen 
primarily on the basis of their proven ability to detect post-SAH impairment [470, 613]. 
Measures of cognitive impairment, as well as physical disability, were completed 
almost always at the same appointment at which the patients' completed the HRQoL 
questionnaires. The measures of physical disability, clinical severity and bleed 
severity used in the studies included in the meta-analyses are further described in the 
appendices (Appendices I-IV and VI-VII). 
Effect size for predictors of HRQoL 
Physical HRQoL 
Table 3.2 presents the weighted effect size estimates for the 7 traditional predictors of 
Physical HRQoL which were calculated using the random effects model. As can be 
seen, the weighted effect size for 6 of the 7 variables proved to be significantly 
associated with SAH patients' Physical HRQoL. Older age (Z= -4.15, P<0.001 ), a 
more severe bleed (Z= -3.86, P<0.001 ), a worse neurological state on admission to 
hospital (Z= -2.88, P<0.001 ), more post-SAH cognitive impairment (Z= -3.42, 
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Table 3.2 Summary of weighted effect sizes for predictors of Physical HRQoL 
Predictor No. of Population 
size 
Cl Q-statistic Fail-safe Power 
studies N 
Age -.20*** 4.00% 10 1224 -.29 -.10 17.71* 87 1.00 
Bleed severity -.13*** 1.69% 6 879 -.20 -.06 4.67 8 .98 
Clinical severity -.19*** 3.61% 7 1055 -.30 -.06 18.22** 43 .99 
Cognitive impairment -.14*** 1.96% 3 615 -.22 -.06 0.03 3 .96 
Physical disability -.54*** 29.2% 7 865 -.63 -.44 13.74* 413 1.00 
Sex -.13* 1.69% 9 1070 -.24 -.02 19.29* 30 .99 
Time since illness .09 0.81% 4 127 -.12 .30 6.88 .26 
Total 42.96% 
Note: Cl=confidence interval; No.=number;r,.=weighted correlation coefficient (r,.=0.10, r=0.30 and r=0.50 are small, medium 
and large effect sizes, respectively); R2 ... =variance explained; *=P<0.05; **=P<0.01; ***=P<0.001. For the dichotomous variable 
'sex', males were scored as the baseline group. Thus, a positive correlation means that being female was associated with a 
better HRQoL, whilst a negative correlation indicates the opposite. 
P<0.001 ), greater physical disability (Z= - 8. 75, P<0.001) and being female (Z= -2.32, 
P<0.05) were all associated with a worse Physical HRQoL. Information about the time 
which had elapsed between a patient's SAH and assessment of their HRQoL was not 
significantly associated with SAH patients' Physical HRQoL: Z= 0.86, P>0.05. 
Importantly, with the exception of physical disability, the size of the effect of the 
significant predictors of Physical HRQoL was minimal, with each of these predictors 
being able to account for only 1.69-4% of the variance in patients' Physical HRQoL 
scores. As noted above, physical disability was the exception. It was found to have a 
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uniquely large predictive effect on SAH patients' Physical HRQoL. With a weighted 
effect size of-.54, this variable could, by itself, account for approximately 29% of 
variance in the SAH patients' Physical HRQoL. 
The size of the fail-safe Ns associated with the predictors which were 
significantly associated with Physical HRQoL (see Table 3.2), suggests that most of 
these effects, namely age, clinical severity, physical disability and sex, were not 
susceptible to the potential influence of publication bias. The need for only a small 
number of studies to nullify the significance of the relationships that bleed severity 
and cognitive impairment hold with Physical HRQoL does however, raise the 
possibility that these variables' significant association with Physical HRQoL may not 
be reliable. 
Figures 3.4 - 3.10 present Forrest plots for each of the traditional predictors of 
Physical HRQoL, illustrating the individual effect sizes found in each study included in 
the meta-analysis. Importantly, as these figures illustrate, the weighted effect size 
estimates for each of the traditional HRQoL predictors did not substantially change 
when calculated under the less constrained fixed-effect model or when the influence 
of outlying effect size/s had been removed. The heterogeneity statistics presented in 
Table 3.2 and Figures 3.4 - 3.10 indicate that 4 of the 7 predictors- namely, patient 
age (0=17.71 (9), P<0.05; f= 49%), clinical severity (0= 18.22 (6), P<0.01; f= 
67%), physical disability (0=13.74 (6), P<0.05; /2= 56%) and sex (0=19.29 (8), 
P<0.05; f= 59%)- did not uniformly predict Physical HRQoL between studies. This 
underlines that the use of the random-effects model was most appropriate. 
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Study Statistics for each study Correlation and 95% Cl Residual !Fixed! Power (R andoml 
Lower Upper 
Correlation Total lim it limit Z-Value P-Value 
Std 
Residual P-Value 
Hackett et al. -0.32 174 -0.45 -0.18 -4.40 0.00 
---
-2.25 0.02 .85 
HOtter et al. -0.26 116 -0.42 -0.08 -2.83 0.00 .....,._ -1.00 0.32 .71 
JOnsson et al. -0.68 13 -0.90 -0.21 -2.63 0.01 
-
-2.08 0.04 .17 
Katati et al. -0.32 70 -0.51 -0.09 -2.67 0.01 - -1.26 0.21 .52 
King et al. -0.14 91 -0.34 0.07 -1.32 0.19 
-
0.35 0.73 .61 
Kreitschmann -Andermahr et al. 0.09 35 -0.25 0.41 0.53 0.60 
,_ 
,- 1 .55 0.12 .32 
Morrisetal. -0.29 48 -0.53 -0.01 -2.03 0.04 
-
-
-0.86 0.39 .40 
Rocha-Filo et al. -0.10 66 -0.33 0.14 -0.80 0.42 
-
0.62 0.54 .50 
Scott et al. -0.11 551 -0.19 -0.03 -2.59 0.01 ... 2.12 0.03 .99 
Tseng et al. -0.06 60 -0.31 0.19 -0.48 0.63 0.88 0.38 .47 
Axed -0.18 1224 -0.23 -0.12 -6.12 0.00 • Q= 17.71 (9), p<O.OS; f= 49.18 
Random -0.20 1224 -0.29 -0.10 -4.15 0.00 .. 
-1.00 -0.50 0.00 0.50 1.00 
Worse Qol Better Qol 
Fixed outliers removed -0.18 486 -0.27 -0.09 -3.94 0.00 Q= 6.64 (9), P>0.05; f= 9.57 
Figure 3.4 Forrest plot of effect size estimates of individual studies examining the association between age and Physical HRQoL 
Note: A negative correlation indicates that increasing age was associated with worse Physical HRQol. 
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Study Statistics for each study Correlation and 95% Cl Residual !Fixed! Power (Random I 
Lower Upper Std 
Correlation Total limit limit Z-Value P-Value Residual P-Value 
Hotter et al. -0.11 116 -0.2 9 0.07 -1 .17 0.24 I I ....... 0.2 4 0.81 .40 
Katati et al. -0.26 70 -0.46 -0.02 -2.13 0.03 I I~ -1.10 0.27 .29 
Kreitsch mann -A nderm ahr eta!. 0.11 32 -0.25 0.44 0.61 0.54 I I 
--t- 1.34 0.18 .18 
Morris et al. -0.18 49 -0.44 0.11 -1 .2 1 0.23 I 1-- -0.32 0.75 .23 
Scott et al. -0.15 552 -0.23 -0.06 -3.42 0.00 I I 
-
-0.57 0.57 .92 
Tseng et al. 0.03 60 -0.22 0.28 0.25 0.80 I I 
-+ Fixed -0.13 879 -0.20 -0.06 -3.86 0.00 I I • 1.29 0.20 .26 Q= 4.67 (5). p>0.05; 1'=00.00 
Random -0.13 879 -0.20 -0.06 -3.86 0.00 I I • 
-1 .0 0 -0.50 0.00 0.50 1.00 
Worse Qol Better Q ol 
Fixed outliers removed Not applicable 
Figure 3.5 Forrest plot of effect size estimates of individual studies examining the association between bleed severity and 
Physical HRQoL. 
Note: A negative correlation indicates that increasing bleed severity was associated with worse Physical HRQoL. 
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~ Statistics for each study Correlation and 95% Cl Residual IFixedl f'_ower 1Random I 
Lower Upper Std 
Correlation Total limit limit Z-Value P-Value Residual P-Value 
Hackettet al. 0.05 174 -0.10 0.20 0.63 0.53 3.22 0.00 .82 
HOtter et al. -0.19 116 -0.36 -0.01 -2.04 0.04 -0.17 0.86 .67 
Katati et al. -0.34 70 -0.53 -0.11 -2.85 0.00 -1.45 0.15 .48 
Kreitschmann -Andermahr et al. 0.0 5 35 -0.29 0.38 0.29 0.77 1.31 0.19 .30 
Morris etal. -0.20 49 -0.46 0.08 -1.40 0.16 
-0.20 0.84 .38 
Scott et al. -0.20 551 -0.28 -0.12 -4.72 0.00 t: -0.84 0.40 .99 Tseng et al. -0.45 60 -0.63 -0.22 -3.69 0.00 I I I -2.42 0.02 .44 Fixed -0.18 1055 -0.23 -0.12 -5.69 0.00 Q= 18.22 (6), p<0.01; /'= 67.10 
Random -0.19 10 55 -0.30 -0.06 -2.88 0.00 I I ~ 
-1.00 -0.50 0.00 0.50 1.00 
Worse QoL Better QoL 
Fixed outliers removed -0.20 821 -0.27 -0.13 -5.76 0.00 Q= 3.95 (4), p>0.05; /2 = 56.33 
Figure 3.6 Forrest plot of effect size estimates of individual studies examining the association between clinical severity and 
Physical HRQoL. 
Note: A negative correlation indicates that increasing clinical severity was associated with worse Physical HRQoL. 
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.s..tu.d.lL Statistics for aac:h studv Correlation and 95% Cl Residual IFixedl P~wer IRan dom l 
Lower Upper Std 
Correlation Total limit limit Z-Value P-Value Residual P-Value 
Hackett et al. -0.15 174 -0.29 -0.00 -1 .96 0.05 
---
-0.23 0.82 .53 
JOnsson et al. -0.72 13 -0.91 -0.28 -2.88 0.00 - -2.4 7 0.01 .11 
-
Katati et al. -0.33 70 -0.53 -0.10 -2.82 0.00 - -1.78 0.08 .29 
-
King et al. -0.03 91 -0.23 0.18 -0 .2 6 0.79 
-
1.04 0.30 .34 
Kreitschmann -Andermahr et al. 0.16 35 -0.18 0.4 7 0.94 0.35 - 1.72 0.09 .19 
-
Morris et al. -0.33 49 -0.56 -0.05 -2.33 0.02 - -1.46 0.15 .23 
-
Rocha- Filo et al. -0.07 66 -0.31 0.17 -0.58 0.56 - 0.50 0.62 .28 
-
Scott et al. -0.14 512 -0.22 -0.05 -3.1 9 0.00 ... -0.23 0.81 .91 
Tseng et al. 0.13 60 -0.13 0.37 1.01 0.31 - 2.08 0.04 .26 
-
Fixed -0.13 1070 -0.19 -0.07 -4.33 0.00 ........ Q= 19.29 (8), p<O.OS; f= 58.52 
Random -0.1 3 1070 -0.24 -0.02 -2.31 0.02 
D I I I I 
-1.00 -0.50 0.00 0.50 1.00 
Worse Qol Better Qol 
Fixed outliers removed -0.14 997 -0.20 -0.08 -4,43 0.00 Q= 9.088 (6), p>0.05; f= 33.98 
Figure 3.7 Forrest plot of effect size estimates of individual studies examining the association between sex and Physical HRQoL. 
Note: For the dichotomous variable 'sex', males were scored as the baseline group. A negative correlation thus means that being female was associated with a worse Physical 
HRQoL. 
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Study Statistics for each study Correlation and 95% Cl Residual (Fixed) Power (Random) 
Lower Upper Std 
Correlation Total limit limit Z-Value P-Value Residual P-Value 
JOnsson et al. -0.20 10 -0.73 0.50 -0.52 0.60 
-
-
-0.16 0.88 .11 
Morris et al. -0.15 32 -0.4 7 0.21 -0.80 0.43 
-
-
.19 -0.05 0.96 
Scott et al. -0.14 573 -0.22 -0.06 -3.29 0.00 
• 0.12 0.91 .96 
Fixed -0.14 615 -0.22 -0.06 -3.42 0.00 
• 
Q= 0.03 (2), p>0.05; i'=OO.OO 
Random -0.14 615 -0.2 2 -0.06 -3.42 0.00 
• 
-1.00 -0.50 0.00 0.50 1.00 
Worse Qol Better Qol 
Fixed outUers removed Not applicable 
Figure 3.8 Forrest plot of effect size estimates of individual studies examining the association between cognitive impairment 
and Physical HRQoL. 
Note: A negative correlation indicates that increasing cognitive impairment was associated with worse Physical HRQoL. 
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~ Statistics for each study Correlation and 95% Cl Residual IFixedl P_owuJRandoml 
Lower Upper Std 
Correlation Total limit lim it Z-Value P-Value Residual P-Value 
Jonsson etai. -0.75 13 -0.92 -0.33 -3.04 0.00 I • I I I I -0.97 0.33 .71 
Katati et al. -0.55 70 -0.69 -0.36 -5.03 0.00 I I I 0.36 0.72 .99 
King et al. -0.35 91 -0.52 -0.15 -3.41 0.00 I I I 2.91 0.00 .99 Kreitschmann -Andermahr et al. -0.34 35 -0.61 -0 01 -2.02 0.04 I I 1.72 0.08 .98 
Morris et al. -0.64 48 -0.78 -0.43 -5.09 0.00 I I I -0.70 0.48 .99 
Scott et al. -0.61 548 -0.66 -0.56 -16.66 0.00 I .I I I I -224 0.02 1.0 
Tseng et al. -0.57 60 -0.72 -0.37 -4.88 0.00 I J I I I 0.08 0.93 .99 Fixed -0.58 865 -0.62 -0.53 -19.07 0.00 I Q= 13.74 (6), p<0.05; f= 56.33 
Random -0.54 865 -0.63 -0.44 -8.75 0.00 I .. 
-1.00 -0.50 0.00 0.50 1.00 
Worse Qol Better Qol 
Fixed outliers removed -0.56 226 -0.64 -0.46 -9.17 0.00 Q= 4.25 (4 ), p>O .0 5; I'= 5.81 
Figure 3.9 Forrest plot of effect size estimates of individual studies examining the association between physical disability and 
Physical HRQoL. 
Note: A negative correlation indicates that increasing physical disability was associated with worse Physical HRQoL. 
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s.t.w1y_ Statistics for each studv Corrolatlon and 9S% Cl Rosjdua! (Fixed) Power !Rando ml 
Lower Upper Std 
Correlation Total limit lim it Z-Value P-Value Residual P-Value 
Hopetal. 0.00 48 -0.28 0.28 0.00 1.00 -1.05 0.29 .16 
JOnsson et al. 0.03 13 -0.5 3 0.57 0.09 0.9 3 -0.37 0.71 .09 
Mocco et al. 0.29 35 0.13 0.44 3.41 0.00 I--- 2.60 0.01 .14 
Rocha-Filoetal. -0.06 66 -0.30 0.18 -0.49 0.62 -1.88 0.06 .19 
Fixed 0.14 162 0.02 0.26 2.23 0.03 Q= 6.88 (3), p>0.05; /2= 56.38 
Random 0.09 162 -0.12 0.30 0.86 0.39 
I I 
-1.00 -0.50 0.00 0.50 1.00 
Worse Qol Better Qol 
Fixed outliers removed -0.03 127 -0.21 0.15 -0.34 0.74 Q= 0.14 (2), p>O.OS; /2= 00.00 
Figure 3.10 Forrest plot of effect size estimates of individual studies examining the association between the time between illness 
onset and assessment and Physical HRQoL. 
Note: A positive correlation indicates that the longer the time between the HRQoL assessment and illness onset, the better the Physical HRQoL. 
74 
Mental HRQoL 
Table 3.3 presents the weighted effect size estimates for each of the traditional 
predictors for patients' Mental HRQoL. Of all the predictors, only cognitive impairment 
proved to be significantly associated with patients' Mental HRQoL: Z= -3.26, P<0.001 
Table 3.3 Summary of weighted effect sizes for predictors of Mental HRQoL 
Predictor fw Rw No. of 
studies 
Population 
size 
Cl Fail-safe Power 
statistic N 
Age 0.07 0.59% 10 1225 -0.03 0.17 19.42* .79 
Bleed severity 0.01 0.01% 6 879 -0.13 0.14 12.38* .08 
Clinical severity -0.08 0.64% 7 1044 -0.18 0.03 12.72* .82 
Cognitive impairment -0.13*** 1.69% 3 615 -0.21 -0.05 0.80 n/p .94 
Physical disability -0.15 2.25% 7 866 -0.46 0.18 93.69*** .99 
Sex -0.05 0.25% 9 1070 -0.17 0.08 24.55** .49 
Time since illness 0.10 1.0% 4 162 -0.09 0.29 5.26 .35 
Total 6.43% 
Note: Cl-confidence interval; No.-number; n/p=calculation not possible due to differences between the formulae for classic 
fails safe N and modern meta analysis means that according to fail-safe formulae the weighted effects size was not statistically 
significant and so the fail safe N not computable; rw= weighted correlation coefficient (rw=0.10, r =0,30 and r =0.50 are small, 
medium and large effect sizes, respectively); R2 w·= variance explained; *=P<0.05, **=P<0.01; ***=P<O.OO. For the dichotomous 
variable 'sex', males were scored as the baseline group. A positive correlation thus means that being female was associated 
with a better HRQoL, whilst a negative correlation indicates the opposite. 
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(fail-safe N not calculable, see Discussion for comment). The weighted effect size 
estimate for this predictor was, nevertheless, still small (weighted r= -.13) - with 
cognitive impairment being able to account for only 1.69% of variance in SAH 
patients' Mental HRQoL. The Forest plots in Figures 3.11 - 3.17 illustrate that the 
effect size estimates for each of the predictors calculated using the random-effects 
model were comparable to those calculated using the fixed-effect model. Moreover, 
they were also comparable when calculated with any study with an outlying effect size 
estimate having been removed. It is also seen that significant heterogeneity existed in 
effect size estimates between studies for the predictors: patient age (0=19.42 (9), 
P<0.05; P=54%), bleed severity (0=12.38 (5), P<0.05; P=60%), clinical severity 
(0=12.72 (6), P<0.05; P=53%), physical disability (0=93.69 (6), P<0.001; P=94%) 
and sex (0=24.55 (8), P<0.01; P=67%). 
Validity of combining effect sizes from studies using the MOS and studies using the 
SIP 
Tables 3.4 and 3.5 report the results from the analyses which examined whether the 
HRQoL measure used by a study moderated the effect size estimate which it found 
for a given predictor. The results show that in the vast majority of cases, the effect 
size estimates were homogenous between studies using different HRQoL measures. 
This result provides evidence that in most cases, it was valid to combine the results 
from studies using the SIP measure with the results from studies using MOS 
measures. Although no significant effect was found for any of the predictors of 
Physical HRQoL, significantly different effect size estimates were produced by studies 
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Studv Statistics for each study Correlation and 95% Cl Residual !Fixed! power !RJ!ndom I 
Lower Upper Std 
Correlation Total limit lim H Z-Va lue P-Value Residual P-Va lue 
Hackett el al. 0.11 174 -0.04 0.25 1.44 0.15 I I 
-'-- I I 0.53 0.60 .23 
HOtter et al. -0.17 116 -0.34 0.01 -1 .82 0.07 -2.73 0.01 
.08 
Jonsson et al. 0.57 13 0.03 0.85 2.06 0.04 1.84 0.07 
.18 
Katati et al. -0.08 70 -0.31 0.15 -0.69 0.49 -1.32 0.19 .14 
King et al. 0.18 91 -0.02 0.3 8 1.75 0.08 1.11 0.27 
.16 
Kreltschmann -Andermahr et al. 0.35 35 0.02 0.61 2.05 0.04 1.6 6 0.10 .11 
Morris et al. 0.16 48 -0.13 0.43 1.10 0.27 0.62 0.54 .12 
Roch a-Fila et al. -0.14 66 -0.3 7 0.11 -1 .09 0.28 -1.71 0.09 .14 
Scott et al. 0.10 552 0.01 0.18 2.26 0.02 0.74 0.46 .50 
Tseng etal. 0.13 60 -0.1 3 0.3 7 0.96 0.34 0.42 0.68 .13 
Fixed 0.07 1225 0.02 0.1 3 2.52 0.01 Q= 19.42 (9), p<0.05: f= 53.66 
Random 0.07 1225 -0.03 0.17 1.43 0.15 
I I .- I I 
-1 ,0 0 -0.50 0.00 0.50 1.00 
Worse Qol Better Q ol 
Fixed- o uttiers removed 0.10 1109 0.04 0.16 324 0.07 Q= 11.95 (8), p>0.05; t'= 33.07 
Figure 3.11 Forrest plot of effect size estimates of individual studies examining the association between age and Mental HRQoL. 
Note: A negative correlation indicates that increasing age was associated with worse Mental HRQoL. 
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Study Statistics for each studv Correlation and 95% Cl Residual !Fixed) Power IR andoml 
Lower Upper 
Correlation Total limit lim it Z-Value P-Value 
Std 
Residual P-Value 
Hotter et al. -0.11 116 -0.29 0.07 -1.17 0.24 -0.4 8 0.63 .06 
Katati et al. 0.20 70 -0.04 0.41 1.62 0.11 2.27 0.02 .06 
Kreitsch mann -Andermahr et al. 0.30 32 -0.05 0.59 1.68 0.09 2.09 0.04 .06 
Morris et al. -0.06 49 -0.34 0.22 -0.4 1 0.68 0.06 0.95 .06 
Scott et al. -0.13 552 -0.21 -0.05 -3.02 0.00 -2.34 0.02 .08 
Tsengetal. 0.08 60 -0.18 0.33 0.60 0.55 1.15 0.25 .06 
Fixed -0.07 879 -0.13 -0.00 -2.01 0.04 
Q= 12.38 (5), p<0.05; !"= 59.64 
Random 0.01 879 -0.13 0.14 0.10 0.92 
-1.00 -0.50 0.00 0.50 1.00 
Worse Qol Better Qol 
Fixed outliers removed -0.05 225 -0.18 0.08 -0.73 0.46 Q= 1.36 (2), p>0.05; i'= 00.00 
Figure j.12 Forrest plot of effect size estimates of individual studies examining the association between bleed severity and Mental 
HRQoL. 
Note: A negative correlation indicates that increasing bleed severity was associated with worse Mental HRQoL. 
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Study Statistics for each stud'L Correlation and 95% Cl Residual IFixedl Power IRan dom 1 
Lower Upper Std 
Correlation Total limit limit Z-Value P-Value Residual P-Value 
Hackett et al. 0.00 174 -0.15 0.15 0.00 1.0 0 1.76 0.08 .28 
HOtter et al. -0.1 7 116 -0.34 0.01 -1.82 0.07 -0.55 0.58 .22 
Katati et al. 0.08 70 -0.16 0.31 0.66 0.51 1.73 0.08 .16 
Kreitsch mann -Andermahr et al. 0.23 35 -0.11 0.52 1.34 0.18 2.07 0.04 .12 
Morris et al. -0.09 37 -0.40 024 -0.52 0.60 0.20 0.84 .12 
Scott et al. -0.19 552 -0.27 -0.11 -4.51 0.00 
-
-2.39 0.02 .59 
Tseng et al. -0.19 60 -0.42 0.07 -1.44 0.15 • I I I -0.52 0.60 .15 
Fixed -0.12 1044 -0.18 -0.06 -3.94 0.00 ~I I I Q= 12.72 (6), p <0.05; I'= 52.86 
Random -0.08 1044 -0.18 0.03 -1.42 0.16 
-1 .0 0 -0.50 0.00 0.50 1.00 
Worse QoL Better QoL 
Fixed outliers·removed -0.06 457 -0.15 0.03 -1.32 0.19 Q= 4.35 (4), p>0.05; f= 8.06 
Figure 3.13 Forrest plot of effect size estimates of individual studies examining the association between clinical severity and Mental 
HRQoL. 
Note: A negative correlation indicates that increasing clinical severity was associated with worse Mental HRQoL. 
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Study Statistics for each stud'L_ Correlation and 95% Cl Residual IFixedl Power IRan dom I 
Lower Upper Std 
Correlation Total limit limit Z-Value P-Value Residual P-Value 
Hackett et al. -0.06 174 -0.20 0.09 -0.72 0.4 7 0.15 0.88 .15 
JOnsson et al. 0.59 13 0.05 0.86 2.12 0.03 2.34 0.02 .07 
Katatietal. -0.37 70 -0.55 -0.14 -3.14 0.0 0 -2.69 0.01 .10 
King et al. 0.14 91 -0.07 0.34 1. 31 0.1 9 2.01 0.04 .11 
Kreitsch mann -Andermahr et at. -0.39 35 -0.64 -0.06 -2.30 0.02 -1.96 0.05 .08 
Morris et al. -0.04 49 -0.32 0.24 -0.29 0.7 8 0.16 0.87 .09 
Rocha-Filo et at. -0.04 66 -0.28 0.21 -0.3 0 0.76 0.22 0.82 .10 
Scott et al. -0.09 512 -0.18 -0.01 -2.08 0.04 -0.84 0.40 .27 
Tseng et at. 0.21 60 -0.05 0.44 1.61 0.11 2.16 0.03 .10 
Fixed -0.07 1070 -0.1 3 -0.00 -2.11 0.0 3 Q= 24.55 (8), p<0.01; I'= 67.41 
Random -0.05 1070 -0.17 0.08 -0.70 0.49 
-1.00 -0.50 0.00 0.50 1.00 
Worse Qol Better Qol 
Fixed outliers removed -0.09 836 -0.16 -0.02 -2.57 0.01 Q= 3.705 (4), p>0.05; I"= 00.00 
Figure 3.14 Forrest plot of effect size estimates of individual studies examining the association between sex and Mental HRQoL. 
Note: For the dichotomous variable 'sex', males were scored as the baseline group. A negative correlation thus means that being female was associated with a worse Mental 
HRQoL. 
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Study Statistics for each studv Correlation and 95% Cl Residual I Fixed) Power !Random) 
Lower Upper Std 
Correlation Total limit limit Z-Value P-Value Residual P-Value 
Jonsson et al. 0.20 10 -0.50 0.73 0.52 0.60 
-
-
0.88 0.38 .10 
Morris et al. -0.10 32 -0.44 0.25 -0.56 0.58 
-
-
0.16 0.87 .18 
Scott eta!. -0.14 573 -0.22 -0.06 -3.29 0.00 
• 
-0.54 0.59 .94 
Fixed -0.13 615 -0.21 -0.05 -3.26 0.00 • Q= 0.803 (2), p>0.05; f=OO.OO 
Random -0.13 615 -0.21 -0.05 -3.26 0.00 • 
-1.00 -0.50 0.00 0.50 1.00 
Worse QoL Better QoL 
Fixed outliers removed Not ap piic able 
Figure 3.15 Forrest plot of effect size estimates of individual studies examining the association between cognitive impairment and 
Mental HRQoL. 
Note: A negative correlation indicates that increasing cognitive impairment was associated with worse Mental HRQoL. 
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~ Statistics for each study Correlation and 95% Cl Residual !Fixed) Power (Random) 
Lower Upper Std 
Correlation Total limit limit Z-Value P-Value Residual P-Value 
JOnsson et al. 0.33 13 -0.2 7 0.74 1.08 0.28 -
-
2.20 0.03 .13 
Katati et al. 0.37 70 0.15 0.56 3.22 0.00 -
-
6.35 0.00 .35 
King et al. 0.21 91 -0.00 0.39 1.95 0.05 
-
5.54 0.00 .42 
Kreitschmann -Andermahr et al. -0.08 35 -0.40 026 -0.46 0.64 -
-
1.55 0.12 22 
Morris et al. -0.59 48 -0.75 -0.37 -4.56 0.00 -2.26 0.02 27 
Scott et al. -0.47 549 -0.53 -0.40 -11.83 0.00 -6.10 0.00 .97 
Tseng etal. -0.55 60 -0.70 -0.34 -4.65 0.00 -2.07 0.04 .31 
Fixed -0.34 866 -0.40 -0.28 -1 0.20 0.00 • Q= 93.689 (6), p<0.0001; f=93.59 
Random -0.15 866 -0.46 0.1 8 -0.89 0.3 7 
-1.00 -0.50 0.00 0.50 1.00 
Worse Qol Better Qol 
Fixed outliers removed Not possible as only onestudynotdeemed an outlier 
Figure 3.16 Forrest plot of effect size estimates of individual studies examining the association between physical disability and 
Mental HRQoL. 
Note: A negative correlation indicates that increasing physical disability was associated with worse Mental HRQoL. 
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S1u..d.lL Statistics for each stu dv Correlation and 95% Cl Residual (Fixed) Power IR andoml 
Lower Upper Std 
Correlation Total limit lim it Z-Value P-Value Residual P-Value 
Hop et al. 0.00 48 -0.28 0.28 0.00 1 .00 -0.68 0.49 .23 
JOnsson e I al. 0.53 13 -0.03 0.84 1.85 0.06 1.64 0.10 .12 
Mocco et al. 0.23 35 -0.12 0.52 1.29 0.20 0.92 0.36 .19 
Rocha- Filo et al. -0.01 66 -0.25 0.24 -0.05 0.96 -0.95 0.34 .28 
Fixed 0.09 162 -0.07 0.24 1.05 0.30 Q= 5.255 (3), p>0.05; i'=42.91 
Random 0.10 162 -0.09 0.29 1.05 0.29 
-1.00 -0.50 0.00 0.50 1.00 
Worse Qol BetterQol 
Fixed outliers removed Not applicable 
Figure 3.17 Forrest plot of effect size estimates of individual studies examining the association between the time between illness 
onset and assessment and Mental HRQoL. 
Note: A positive correlation indicates that the longer the time between the HRQoL assessment and the illness' onset, the better the Physical HRQoL. 
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using the two sets of measures when examining the relationship between bleed 
severity and Mental HRQoL (MOS weighted r= .12; SIP weighted r= -.12; P<0.01) and 
between clinical severity and Mental HRQoL (MOS weighted r= -.002; SIP weighted 
r=-.19; P<0.01 ). The difference in effect sizes produced by studies using the different 
measures was .24 for bleed severity and .18 for clinical severity. 
Table 3.4 Moderating effect of HRQoL measure on predictors of Physical HRQoL 
Predictor Measure Studies Correlation Lower Upper Z-value Between group 
Limit Limit heterogeneity 
Age MOSmeasure 8 -0.21··· -0.32 -0.09 -3.50 
SIP measure 2 -0.17 -0.34 O.o1 -1.90 aa=0.14 (1) 
Bleed severity MOS measure 4 -0.10 -0.24 0.04 -1.38 
SIP measure 2 -0.14 •• -0.23 -0.04 -2.78 Qa=0.17 (1) 
Clinical severity MOS measure 5 -0.18. -0.35 -0.1 E-02 -1.98 
SIP measure 2 -0.19 -0.42 0.05 -1.56 aa=0.01 (1) 
Cognitive impairment MOS measure 2 -0.16 -0.45 0.17 -0.95 
SIP measure -0.14··· -0.22 -0.06 -3.29 aa=0.01 (1) 
Physical disability MOS measure 6 -0.51··· -0.62 -0.39 -7.12 
SIP measure -0.61··· -0.75 -0.43 -5.40 aa=0.87 (1) 
Sex MOS measure 8 -0.14 -0.28 0.01 -1.79 
SIP measure -0.14 -0.45 0.20 -0.82 Qa=O.OO (1) 
Time since illness MOS measure 2 -0.04 -0.33 0.25 -0.29 
SIP measure 2 0.19 -0.03 0.39 1.66 Qa=1.52 (1) 
Note: MOS=Medical Outcome Study Short Form questionnaires - either Short Form-36 or Short Form-12; SIP=Sickness 
Impact Profile questionnaires- Sickness Impact Profile-136 or Aachen Life Quality Index; ·=P<0.05.; ••c:P<0.01; •••=P<0.001. 
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Table 3.5 Moderating effect of HRQoL measure on predictors of Mental HRQoL 
Predictor Measure Studies Correlation Lower Upper Z-value Between group 
Limit Limit heterogeneity 
Age MOS measure 8 0.11 -0.02 0.24 1.70 
SIP measure 2 -0.02 -0.22 0.19 -0.16 Qa=1.10 (1) 
Bleed severity MOS measure 4 0.12 -0.02 0.25 1.70 
SIP measure 2 -0.12*** -0.20 -0.05 -3.23 Oa=9.29 (1)** 
Clinical severity MOS measure 5 -0.2E-02 -0.11 0.10 -0.05 
SIP measure 2 -0.19*** -0.26 -0.11 -4.86 Oa=8.11(1)** 
Cognitive impairment MOS measure 2 -0.04 -0.36 0.27 -0.27 
SIP measure -0.14*** -0.22 -0.06 -3.29 Oa=0.29(1) 
Physical disability MOS measure 6 -0.09 -0.45 0.30 -0.43 
SIP measure -0.47 -0.89 0.39 -1.08 Oa=0.68 (1) 
Sex MOS measure 8 -0.03 -0.20 0.14 -0.36 
SIP measure -0.09 -0.45 0.29 -0.46 Oa=0.78 (1) 
Time since illness MOS measure 2 0.16 -0.22 0.49 0.81 
SIP measure 2 0.11 -0.24 0.43 0.60 Os=0.04 (1) 
Note: MOS=Medical Outcome Study Short Form questionnaires - either Short Form-36 or Short Form-12; SIP-Sickness 
Impact Profile questionnaires -Sickness Impact Profile-136 or Aachen Life Quality Index; *=P<0.05; **=P<0.01; ***=P<0.001. 
3.4 Discussion 
This chapter has presented a study which used the techniques of meta-analysis to 
comprehensively examine the practical explanative importance of the variables 
traditionally used to explain SAH patients' reduced HRQoL - namely, patient's (1) 
age, (2) severity of bleed, (3) clinical severity on admission to hospital (4) post-SAH 
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cognitive impairment (5) physical disability, (6) sex and (7) the time occurring 
between the SAH and the assessment of HRQoL. 
In respect to SAH patients' Physical HRQoL, the results from the meta-
analysis showed that all, but one, of the traditional predictors were significantly 
related to patients' Physical HRQoL in terms of their P-values. Increasing age, a 
more severe haemorrhage, worse clinical status on admission to hospital, being 
female, and more cognitive impairment and physical disability were all (from a 
statistical perspective) significantly associated with a worse Physical HRQoL. The 
weighted effect sizes for 6 of these predictors calculated under random effects 
models showed that the practical importance of these variables was nevertheless 
typically small, thus emphasising the importance of not solely relying on P-values 
when judging importance. The variables could typically each explain only 2- 4% of 
actual variance in SAH patients' Physical HRQoL scores (effect sizes ranged -.13 to-
.20). The exception to the rule was the degree of physical disability which the patient 
experienced. Physical disability, it was found, was an important predictor of Physical 
HRQoL, both statistically and practically. The variable physical disability could by 
itself, account for approximately 30% of variance in patients' Physical HRQOL scores 
(weighted r= -.54). 
In striking contrast to the numerous significant predictors of Physical HRQoL, 
only 1 of the 7 traditional predictors - namely, cognitive impairment - proved to be 
associated with SAH patients' Mental HRQoL scores. Increasing cognitive impairment 
was seen to be associated with worse Mental HRQoL. The magnitude of this effect 
was however still small, with it explaining less than 2% of variance in patients' Mental 
HRQoL (weighted r= -.13). 
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To further examine the explanative value of the 7 traditional predictors for SAH 
HRQoL, the total variance accounted for by each of these predictors (i.e., the square 
of their weighted effect size [R2 w·D was summed together, regardless of whether or 
not an effect had proved statistically significant. It was found that together, the 7 
variables could explain approximately 43% of variance in SAH patients' Physical 
HRQoL, but only 6% of variance in patients' Mental HRQoL scores. Consequently, a 
large proportion of variance in SAH patients' Physical HRQoL can be accounted for 
(although over 55% still remains mysterious), but nearly 95% of variance in SAH 
patients' Mental HRQoL remains unexplained. In fact, two reasons mean that the 
estimates of the total variance explained in Physical and Mental HRQoL by the 
traditional predictors could actually be too high. Firstly, it remains to be established 
whether the variance explained by each of the contributing predictors is actually 
unique. The summed R2 w values were based on the squaring of the individual 
weighted effect sizes which are simply zero-order correlations . Given that many of 
the predictors are closely related to one another, it is highly plausible that much of the 
variance accounted for by the individual predictors was actually shared. Clinical 
severity on admission is known for instance, to be largely the function of the severity 
of a patient's bleed [711], whilst neurological impairment is known to be related to 
age, clinical severity and bleed severity [306]. The other reason for the estimate of 
total explained variance possibly being too high, is that I included in its calculation the 
effect sizes for all predictors regardless of whether they had proved to be statistically 
significant or not in the meta-analysis. A more conservative approach of including 
only those predictors which had actually proved significant and were not chance 
results would have reduced the variance explained. However, as noted earlier in the 
'Data Analysis and Extraction' section of this chapter, the diminutive size of some of 
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the effects meant that despite the large sample size, in a few instances the power of 
the analysis was below the desired level (<.50). Given the resultant elevated chance 
of committing a Type II error for these particular predictors, I felt it wise to adopt a 
more relaxed inclusion criteria. 
The findings of this meta-analysis are clear: Traditional predictors of SAH 
patients' HRQoL on the whole, demonstrate minimal predictive ability and cannot 
satisfactorily explain the concerning reduction in HRQoL which many of these 
patients illustrate. All traditional predictors (except physical disability when predicting 
Physical HRQoL) had only a small effect size (!'S.20). These findings strongly 
suggest that the hypothesis that traditional predictors could actually explain patients' 
mysterious HRQoL reduction if only studies were sufficiently powered and considered 
more than statistical significance, cannot be supported. These findings strongly 
support the possibility that the reason researchers have struggled to explain SAH 
HRQoL is because they have so far failed to consider more novel aspects of these 
patients' outcome- aspects such as their psychiatric disturbance. 
The failure of cognitive and physical disability and clinical information to 
explain the vast majority of SAH patients' profoundly low levels of HRQoL, although 
likely surprising to many people, is in fact, quite understandable. In terms of 
neurological sequelae, whilst important neurological changes do occur post-SAH -
and we know from the wider literature that neurological impairment can be debilitating 
[35, 61, 180, 282, 344, 523, 719] - the actual nature of SAH patients' impairment 
tends only to subtle. Mild to moderate cognitive impairment is only revealed by the 
most complex of cognitive tasks [295, 541, 750] and profound physical disability is 
uncommon [220, 295, 302, 382, 398, 460]. It would be surprising therefore, if such 
mild impairment were to account for the profoundly poor HRQoL which SAH patients 
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experience. Indeed, testimony to the unhelpfulness of using neurological disability to 
explain SAH patients' HRQoL, are the findings reported by Pritchard et al. [545]. 
These researchers compared SAH patients' HRQoL to that of a group of patients with 
an acoustic neuroma (a benign form of brain tumour which develops on the 
vestibulocochlear nerve) who were broadly similar in demographics. It was reported 
that despite the acoustic neuroma patients experiencing greater neurological 
disability, it was the SAH patients who reported significantly worse HRQoL. The 
failure of clinical information to explain HRQoL even though it can explain immediate 
aspects of outcome after an SAH, is also in line with research on other health 
conditions (including other types of stroke). In several studies it has been suggested 
that those factors affecting long-term outcome are often different to those affecting 
immediate outcome [524, 759, 763]. The lack of a meaningful relationship between 
aspects of clinical information, such as patient age and sex, and HRQoL is even less 
surprising as in health psychology in general, it is recognised that the influence of 
these factors on HRQoL though significant, is not profound [1 0, 179]. 
It is important to note that the results and conclusions of this meta-analytic 
study do, however, need to be considered in the context of some potential limitations. 
Firstly, the inclusion of diverse studies meant that there was often a lack of 
homogeneity existing between studies in terms of their effect size estimates. This 
means that there is the possibility that the calculated weighted effect sizes for the 
predictors could be unrepresentative of their true effect size. As is typical for clinical 
research, the methodology often varied between the studies included in the meta-
analyses and so this is a possible cause for the heterogeneity in effect size estimates 
for the same predictor. Unfortunately, the small number of studies which have so far 
examined SAH HRQoL and which were available for inclusion in the meta-analysis, 
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meant that there was not sufficient statistical power to formally examine which, if any, 
of the studies' methodological features moderated the effect size for predictors [259]. 
As is often the case in meta-analysis, there were simply too few studies to compare 
studies with different methodological aspects in a meaningfully way [273, 583]. As 
further empirical studies accumulate, patterns in effect sizes will possibly emerge and 
moderating variables identified [157, 256, 273]. The search for these moderator 
variables could however, be protracted given that the relative infrequency and high 
mortality of SAH means that generating a sufficient sample size to complete a HRQoL 
study can be difficult. It should also be noted that no index of the studies' 
methodological qualities was used because such indices remain to be validated for 
observational studies [323, 385, 404]. It is important to note however, that the 
standard degree of heterogeneity for the predictors was only moderate. Higgins and 
Thompson [275] who developed the P measure used in this study to index 
heterogeneity, for example, suggested that notable heterogeneity constituted an /2 
value substantially greater than 50 percent. For the predictors included in this meta-
analysis, the median heterogeneity value for Physical HRQoL was only 56.33 
(IQR=00.00-58.52) and 52.86 (IQR=29.64-67 .41) for Mental HRQoL. Moreover, as I 
previously noted, the re-calculated effect sizes under the fixed-effect model when 
outlying studies were removed, were broadly similar. Nevertheless, one instance in 
which substantial and significant heterogeneity in effect sizes did exist warrants 
comment. Specifically, it was found that the effect of physical disability when 
predicting Mental HRQoL illustrated a large amount of heterogeneity (see Figure 
3.16), with some studies finding that physical disability was associated with worse 
Mental HRQoL (up to -.59), whilst an equal number of studies found a positive effect 
on Mental HRQoL (up to .37). This discrepancy is hard to explain. One obvious 
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explanation could be that a data entry mistake occurred, especially given that high 
scores on the different measures of physical disability which studies used did not 
always carry the same meaning (e.g., a high score on the Barthel Index in its original 
format indicates less disability, whilst the opposite is true for the modified Rankin 
Scale). A re-examination of the data however, showed that the scoring directions had 
been suitably standardised. Methodological characteristics of the divergent studies 
also do not seem to explain the discrepancy, with the studies being similar in terms of 
the samples they studied, the instruments they used and the timing of their HRQoL 
assessment. The only discernible difference between the studies finding the different 
effects is that those reporting a negative impact of physical disability on Mental 
HRQoL were conducted in the U.K. and that two of these were conducted as part of 
clinical trials. Still, it is hard to see how this can explain the appreciable discrepancy, 
even if the potential for increased bias resulting from demand characteristics 
introduced as part of a trial are considered. Instead, the explanation for what 
moderates the impact of physical disability on SAH patients' Mental HRQoL needs to 
await further study. The large discrepancy between the two groups of studies in their 
effect size estimates does nevertheless, raise the possibility that the actual effect of 
physical disability on SAH Mental HRQoL is not well represented by the overall 
weighted effect size calculated for it by this meta-analysis. The presence of 
substantial heterogeneity means that the overall effect size for this predictor is an 
average (albeit weighted) of two sets of extreme values and so physical disability may 
better explain SAH Mental HRQoL than the results of this meta-analysis would 
suggest. Nevertheless, even if we assume one of the largest of the extreme effect 
size estimates (i.e., either -.59 or .37) is more representative of the actual effect of 
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physical disability, the magnitude of the size of these effects means that a large 
majority (65-86%) of variance in Mental HRQoL still remains unexplained. 
A second limitation of the meta-analysis was that it was only possible to 
include just over half of the studies which the systematic review identified as having 
(or were likely to have) measured the relationship between the traditional predictors 
and SAH patients' HRQoL. The remaining articles which had (or were likely to of 
have) considered the predictors could not be included because insufficient data was 
provided in the articles to calculate effect sizes and the corresponding authors could 
not provide any further information (because for example, the data was un-retrievable 
or the authors had yet to publish some of the data themselves) [12, 75, 116, 129, 144, 
244, 285, 354, 367, 438, 609]. It is however unlikely that including the data from these 
studies would have noticeably changed the results of the meta-analysis since the 
results of these un-included studies (where available) broadly support the conclusions 
of this meta-analysis (Table 3.6). As in the meta-analysis, age, sex and cognitive 
status are seen to be either largely unimportant predictors of SAH HRQoL or to have 
only a modest effect. Moreover, when significant effects are reported, these traditional 
predictors seem to be more relevant for Physical HRQoL than Mental HRQoL. Finally, 
as was the case in the present meta-analysis, physical disability seems to be the 
most important of all the traditional predictors. 
A third potential limitation to this study is a problem common to all reviews 
(both qualitative and quantitative), namely publication bias. Given that there is a 
greater likelihood that studies with significant results and the largest samples are 
published, there is the possibility that meta-analyses which -such as this one- are 
(mostly) based on published data, could result in an overestimation of true effects [39, 
- - -
63]. In response to this argument, I would highlight that as the effect sizes estimates 
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Table 3.6 Summary of studies identified by systematic review which could not be included in meta-analysis 
Which predictors did the study examine? 
Study Sample Age Bleed Clinical Sex Cognitive Physical Time Comments 
size severity severity impairment disability since 
illness 
Anderson et al.[12] -17 X X X 
Brilstra et al.[75] 25 X X X 
Claassen et al. [116]* 247* X X X X X X Age and clinical severity not included in final multivariate model as predictors of 
Total SIP. 
Czechowsky & Hill 2 X X X X X 
[129] 
Deane et al.[144] 29 X X X X X 
Hamedani et al. 83 X X X X X 
[244] 
Hop et al.[285] 55 X X X X According to an asymmetrical index (Somers' D), physical disability had a small-
moderate relationship with mental HRQoL (0.2-0.4) and a moderate-strong 
relationship with physical HRQoL (0.3-0.06).[633] 
Kim et al.[354] 385 X X X X X X A composite SF-36 score was sig. correlated (r= -.37) with physical disability and 
cognitive impairment (r= -.38). 
Komotar et al.[367] 48 X X X X X X 
93 
Table 3.6 cont'd. 
Which predictors did the study examine? 
Study Sample Age Bleed Clinical Sex Cognitive Physical Time Comments 
size severity severity impairment disability since 
illness 
Mayer et al.[438] * 113 X X X X X X PCS- Sig. multiple adjusted ?-value of 18.8% for 'demographic variable' (effect 
direction unknown). After controlling for demographics and depression, global 
cognition and psychomotor function sig. associated with reduced PCS: additive 
adjusted r -value of 10. 7%. 
MCS- Sig. multiple adjusted r-value of 0.08% for 'demographic variable' (effect 
direction unknown). After controlling for demographics and depression, global 
cognitive function and visuospatial function were sig. associated with MCS: 
additive adjusted r-value of .06%. 
Schuiling et al.[609] 247 X X X X X X 
Total number of studies 11 4 8 11· 5 10 6 
Physical HRQoL Fail-safe N 87 8 43 30 25 45 n/a 
Mental HRQoL Fail-safe N n/a n/a n/a n/a n/p n/a n/a 
Note: HRQoL=health-related quality of life; n/a=calculation not applicable as weighted effect size not statistically significant; n/p=calculation not possible; r"=variance explained; SF-36= Short 
Form-36; sig.=significant; SIP= Sickness Impact Profile; X= variable examined by study; *=these two studies are not independent. Mayer eta I.'s [438] study was an earlier assessment of the same 
sample studied by Claassen et al. [116]. =variable not examined by study. 
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produced by the present meta-analysis were typically small and often insignificant, 
the possible impact of publication bias for most of this study's results seems 
negligible. In fact, it could even be argued, that the data used in this meta-analysis 
was less prone to the forces of publication bias (at least directly). For example, the 
effect size data on predictors of HRQoL often came from studies where the 
examination of the predictors of HRQoL was not actually the prime concern and/or 
novelty of published articles [240, 358, 470, 613, 694]. Therefore, a non-significant 
effect of a predictor for HRQoL could still have been published as a function of it 
being part of a much broader publication which had significant findings in response to 
its primary research question. Even with this in mind, for those effects in this meta-
analysis which did prove to be statistically significant, the number of unpublished (or 
not included studies) with non-significant effects needed to nullify each significant 
effect was so high for most that it seemed unlikely that they existed (in the context of 
the SAH research field; see last three rows of Table 3.6). In fact, the number of 
required studies was often large enough that it approximated the criteria used for 
meta-analyses of much broader research fields (i.e., where the potential impact is felt 
to be negligible if the fail-safe N>5K+10, where K is the number of studies in the 
meta-analysis) [582]. Nevertheless, the significance of the effects of cognitive 
impairment and bleed severity when predicting Physical HRQoL were potentially less 
robust, with only 3 and 8 studies respectively being needed to nullify their significant 
effects. This implies that the ability of traditional variables to explain SAH Physical 
HRQoL could be even less important than suggested to be the case by this meta-
analysis. Differences in the formulae used by contemporary meta-analysis and the 
classic fail safe N to calculate statistical significance (i.e., fail-safe N algorithm 
computes a P-value for each study and then combines these P-values, whereas 
meta-analysis computes an effect size for each study, combines the estimates, and 
then computes the P-value for the weighted effect), meant that whilst the effect size 
for cognitive impairment when predicting Mental HRQoL proved to be significant 
according to the meta-analysis, it did not according to the fail-safe N calculation. 
Regrettably, it was therefore, not possible to determine the number of studies needed 
to nullify its significant effect. Alternative techniques for determining the robustness of 
this effect, such as inspection of Funnel plots, were not feasible because they are 
suitable only for meta-analyses which are based on a much larger number of primary 
studies [39, 170]. 
A fourth limitation that needs highlighting is that only those studies which had 
originally measured the dependent variable of HRQoL using either an MOS or SIP 
measures were included in the meta-analysis. This restriction was necessary as the 
other measures which have been used to assess SAH HRQoL are so diverse that to 
involve the results from studies using those measures would not have been 
meaningful, or indeed, at times, even possible. Some instruments for instance, 
measure HRQoL using a single question (such as the visual analogue scale), whilst 
others measured HRQoL using multidimensional questionnaires whose scores cannot 
be collapsed to one single score. To have included data from studies using measures 
other than MOS or SIP questionnaires would have meant that even further 
heterogeneity in effect sizes would have introduced into the meta-analysis data and I 
would have committed what some have evocatively referred to as combining "apples 
and oranges" [243, 583]. I chose to include studies using either MOS or SIP 
questionnaires as not only were they the most popular HRQoL measure used in SAH 
studies (used in 81% of all SAH HRQoL studies; see Figure 2.7), but, the two sets of 
measures are broadly similar in their content and structure. Although there is some 
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preliminary evidence from a few SAH studies (mostly published in abstracts) that the 
MOS and SIP measures may exhibit different sensitivities, responsiveness and 
discriminative properties [121, 286, 437, 439], by far the majority of evidence from the 
literature suggests that these two sets of instruments do measure the same construct 
of HRQoL [102, 241, 337, 480, 484, 699, 737]. This conclusion corresponds with the 
evaluation undertaken as part of this meta-analysis to assess the validity of 
combining results from those studies using these two sets of measures. It was found 
that for all but 2 of the 14 predictors, the effect sizes were homogenous between 
studies using the different measures. The exceptions were bleed severity and clinical 
severity when predicting Mental HRQoL. In these two cases, the use of the SIP was 
associated with a larger, more negative effect of bleed severity and clinical severity 
on Mental HRQoL. One likely explanation for this is that there are subtle differences 
in the content of the Mental HRQoL scales of the two sets of measures. Whilst the 
MOS Mental HRQoL summary is composed of questions relating to the patient's 
perception of how much their health has impacted upon their energy, social activities 
and emotional and mental well-being, the SIP scale in addition includes questions 
pertaining to the person's performance on cognitive tasks, such as reasoning, 
orientation and communication. Therefore, given that bleed severity and clinical 
severity are both known to be related to cognition post-SAH, it could be that the 
larger, negative relationship of the predictors with the SIP reflects the undue influence 
of the relationship between the predictors and cognition. Other differences between 
the SIP and MOS measures, such as the time of reference for their questions (the 
SIP uses the day of examination, whilst the MOS uses either the past week or 4-
weeks) and that the SIP questions are more behaviour-based, whilst the MOS are 
97 
directed more at the subject's perceptions [241 ], could also be involved in explaining 
the difference. The reasons for this are however, less clear. 
On a final note, I would like to briefly discuss a possible reason why some of 
the traditional variables- namely bleed severity and cognitive impairment- proved so 
poor in predicting HRQoL (i.e., for bleed severity 1.69% of Physical HRQoL and 
0.01% of Mental HRQoL; for cognition 1.96% of Physical HRQoL and 1.69% of 
Mental HRQoL). Rather than bleed severity/distribution and cognitive impairment not 
being related to HRQoL, the explanation could be that they are actually better related 
than the current evidence suggests, but that the instruments used in studies to 
measure these aspects are too crude to capture the information needed. In terms of 
bleed severity for example, the crudeness of Fisher's CT rating score [191] (which is 
almost always used to index bleed severity/distribution) means that it does not 
capture the variability in bleed severity. The rationale for this particular speculation 
comes from a single study by Hutter et al. [305] which suggested that specific 
characteristics of a person's haemorrhage, not sufficiently captured by Fisher's scale, 
may be better related to HRQoL than the results of the present meta-analysis would 
suggest. Using univariate tests, Hutter et al. examined the predictive value of firstly, 
an SAH with intracerebral bleed extension (ICB) on SAH patients' HRQoL and then of 
SAH with intraventricular bleed extension (IVB). Crucially, it was found that ICB and 
IVB had different predictive values for SAH HRQoL, but Fisher's scale affords equal 
weight to ICB and IVB, grouping persons with either haemorrhage extension type 
together. Specifically, Hutter and colleagues found that thirteen aneurysmal SAH 
patients with frontal intracerebral invasion experienced a significantly worse physical 
(r=-.27) and mental (r=-.21) HRQoL compared to 95 SAH patients with no ICB who 
were treated contemporaneously and who were socially and clinical comparable. The 
98 
presence of IVB however, was not associated with HRQoL. Indeed, the effect sizes 
for ICB are potentially even larger than those which I cite above as HOtter et al. only 
examined the effect of frontal I CBs. The use of the Fisher scale in prior studies could 
therefore, serve to obscure the unique HRQoL explanative value associated with 
bleed severity and explain why studies (including this meta-analysis) find bleed 
severity to explain so little variance in SAH HRQoL. It is quite plausible that ICB and 
IVB could have a different impact on patient HRQoL. We already know for instance, 
that ICB and IVB each hold unique predictive values for mortality and gross morbidity 
following SAH [261, 306, 441, 442], and that they each can cause different types of 
focal brain damage [261, 626, 709]. The potential drawback of this scale is not 
something which I was able to address in this thesis, but which future studies would 
be wise to consider (see discussion section 3.3.3, Chapter 7). In relation to the 
measurement of cognitive impairment, previous studies have not assessed cognitive 
impairment using instruments with a high degree of ecological validity. Instead prior 
studies have typically used only classic neuropsychological tests which are designed 
not to predict behaviour, but rather to localise lesions [203, 276]. It may be therefore, 
that the use of such measures serves to artificially attenuate the actual relationship 
between cognitive impairment and HRQoL. Given this, in my subsequent empirical 
study of SAH patients which I present in Chapter 5, I made an explicit effort to use 
only cognitive tests with a high degree of ecological validity. 
3.5 Conclusions 
The results of this meta-analysis lead to the conclusion that traditional predictors (with 
the exception of physical disability when predicting Physical HRQoL) cannot 
satisfactorily explain SAH HRQoL. Moreover, their importance has not been overly 
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obscured by previous studies' over-reliance on statistical significance when 
evaluating their effect on SAH HRQoL. According to this meta-analysis, even after 
traditional predictors have been taken into account, between 53-57% of variance in 
SAH patients' Physical HRQoL and 90-94% of variance in SAH patients' Mental 
HRQoL remains unaccounted for. Future studies therefore, need to consider more 
novel aspects of patients' outcome when looking to explain SAH HRQoL. 
Although most of the traditional predictors seem unimportant for explaining 
SAH HRQoL, now that this meta-analysis has comprehensively established their 
predictive value, these values could be used as a useful yardstick by which to make 
an informed judgement on the importance of other predictors. 
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Chapter 4 
Possibility two: Psychiatric disturbance has not been 
taken into account 
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4.1 Introduction 
Following a spontaneous subarachnoid haemorrhage (SAH), many patients 
experience an extremely poor health-related quality of life (HRQoL). This reduction 
however, remains largely unexplained. Classical neurological factors- such as bleed 
severity, clinical severity and neurological disability - which have traditionally been 
employed to try and explain the reduction have proved (in both primary studies and in 
my meta-analysis presented in the previous chapter) inadequate. How then can the 
HRQoL reduction be explained? Following injury to the brain, there is an 
understandable tendency to assume that it is this damage which is central to a 
patient's ultimate outcome. We know however, from pioneering studies following 
other illnesses, such as traumatic brain injury and stroke [61, 180, 344, 405, 591], that 
while classical neurological factors are key to immediate outcome, a patient's later 
recovery and HRQoL is also determined by 'non-neurological' factors. One possibility 
therefore, is that the failure to explain much of SAH patients' HRQoL is because 
research to date has not considered these 'non-neurological' factors. One highly 
promising 'non-neurological' candidate variable which could help us further explain 
SAH HRQoL, but which has so-far been ignored is the psychiatric disturbance which 
SAH patients can often experience.[57, 469, 537, 746] 
In this chapter, I shall provide a review of the psychiatric problems faced by 
SAH patients, the studies which have measured these problems, how SAH 
psychiatric problems are best conceptualised and finally, discuss the potential of 
certain conceptualisations to explain SAH patients' reduced HRQoL (and other 
aspects of their psychosocial outcome). 
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4.2 Psychiatric disturbance in SAH patients 
As several commentators have concluded [46, 57, 306, 537, 544, 750], it is clear that 
SAH patients experience alarmingly high levels of psychiatric disturbance compared 
to healthy controls. In Table 4.1, I present a review of studies of psychiatric problems 
in SAH patients. It was necessary to exclude many studies from this review as, 
although rich in description of patients' psychiatric outcome, they were limited by their 
use of unofficial nomenclature, their measurement of nebulous concepts (such as 
'emotional disturbance' and 'psychiatric problems') and/or their use of non-validated 
instruments [8, 25, 78, 99, 150, 185, 409, 412, 428, 501, 510, 513, 553, 632, 643, 
649, 659, 667-669, 678, 685, 721' 722]. 
My review highlights that the psychiatric profile of SAH patients is largely 
dominated by a state of anxiety (:554%) [48, 265, 314, 469, 540, 541, 652, 703, 725, 
7 46]. An examination of the literature reveals that a sense of worry and fear over 
haemorrhage recurrence dominates SAH patients' anxiety ( 18-89%) [295, 412, 652, 
728, 729]. Generalised psychological disturbance [48, 90], personality change (e.g., 
increased irritability, impulsivity, apathy) [8, 58, 302, 419, 504, 510, 643, 659, 685, 
721], as well as more peculiar symptoms of sleep dysfunction and fatigue are also 
seen to be part of patients' psychiatric profile [313, 314, 409, 510, 609, 649, 746]. As 
seen in Table 4.1, although symptoms of depression/ mood reduction are also 
reported by SAH patients [44, 45, 105, 189, 265, 280, 302, 377, 397, 418, 504, 507, 
508, 540, 609, 687, 703, 746, 752], they have not been found to be the main 
symptoms [265, 314, 377, 469, 540, 541, 703, 746]. For example, Jarvis et al. [314] in 
one of the largest studies to date (with a sample of 62 aneurysmal SAH patients), 
found that 14% of patients reported clinical levels of depressive symptoms, but 35%, 
reported clinical levels of anxiety. The tendency of SAH studies to have utilised 
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Table 4.1 
Study 
Bellebaum et al.[40] 
Beristain et al. [44, 
45) 
Berry et al. [48) 
Summary of studies examining psychiatric disturbance in SAH patients using a validated instrument(s) 
N Type 
32 ASAH 
15 ASAH 
48 ASAH 
Sample 
characteristics 
1 00% GOS 1-11. 
81% H&H 1-11 
Measure 
BDI 
53% H&H I-ll; 93% BDI; BRS 
GOS 1-11 
Most WFNS I-ll BDI; GHQ; 
STAI 
Follow-
up (yrs) 
1.9-2.4 
.5 
.7 
Findings 
BDI: Compared to healthy controls, SAH patients treated with aneurysm clipping showed sig. more depression. 
Clipped patients also reported sig. higher depression compared to SAH patients treated by aneurysm coiling 
(unadjusted r=.31, 9.7%; adjusted r=.41, 16.9%*:j:). Coiled patients depression scores not sig. different compared to 
controls. 
BDI: 20% of SAH patients mild-moderately depressed (13-19), 25% moderately-severely depressed (20-29) and 
6.6% severely depression (>29). 
BRS: Merging data with other patient groups precludes reporting of results. 
BDI: SAH patients were sig. more depressed than healthy controls. 
GHQ-28: SAH patients reported sig. more psychological and psychiatric disturbance. 
STAI: Compared to health controls, SAH patients reported sig. more STAI-state anxiety, but not SATI-trait anxiety. 
Depression and general psychiatric disturbance was not sig. associated with memory performance. 
State anxiety sig. associated with worse verbal recognition and recall (both unadjusted r-.33, 11.3% and adjusted 
r-.44, 19.9%*:j:). 
Psychiatric disturbance not sig. associated with physical independence. 
Table 4.1 Cont'.d 
Study N 
Berry et al. [47] 28 
Buchanan et al. [90] 24 
Carteret al. [1 05] 179 
Claassen et al. [116] 247 
Type 
ASAH 
ASAH; 
SAHavm 
ASAH 
ASAH; 
SAHuo 
Sample 
characteristics 
Referrals to clinical 
psychology 
service. 
100% good 
neurological 
recovery 
100% GOS 1-11 
96% GOS I-ll; 61% 
H&H 1-11 
53% H&H 1-11 
Measure Follow-
up (yrs) 
Diagnostic .5 
interview 
(DSM-111-R 
PTSD) 
BSI 1.6 
ZSRDS 1.0-6.0 
CES-D; 1.0 
STAI 
Findings 
Diagnostic interview: 32% met the diagnostic criteria for PTSD in relation to their SAH. 
BSI: 58% met caseness criteria (2:63) for psychological distress. 13% of patients acknowledged suicidal ideation 
during the previous 7 days. 
ZSRDS: 11.7% of patients reported mild depression (50-59) and 25.1% severe depression (60-1 00). 
Time, clinical severity and age not sig. associated with depression. 
Physical disability was sig. associated with depression (r= .29, 8.9%*) 
CES-D: Depression scores not sig. associated with post-SAH 12-month epilepsy. 
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Study N 
Claassen et at. 
cont'd. 
Fertl et al. [189] 40 
Fontanella et al. 53 
[198] 
Germano et al. [212] 20 
Type 
ASAH 
ASAH; 
SAHuo 
ASAH 
Sample 
characteristics 
100% GOS 1-
11;.65% H&H 1-11 
100% WFNS 1-11; 
100% GOS I. 
100% GOS I; 
100% H&H 1-11; 
Patients selected 
as, considered to 
likely make 
favourable 
recovery: 
Measure 
BDI 
BDI; STAI 
HARS; 
HDRS 
Follow-
up (yrs) 
1.8 
.5 
1.0 
Findings 
STAI-state: In multiple regression, worse state anxiety sig. associated with non-white ethnicity (OR=4.0) and 12-
month post-SAH epilepsy (OR=4.8). Age, education, fluency in English, clinical grade (GCS), aneurysm re-bleed, 
infarction and delayed cerebral ischemia did not enter into final model. 
BDI: 27.5% of SAH patients mildly-moderately depressed (12-26). 
Depression sig. associated with cognitive and physical impairment (r= .36, 13.5% variance) and reduced working 
capacity (r= .56, 31.8% variance)*±. 
BDI: No sig. mood disturbance compared to healthy controls. 
STAI: No sig. disturbance on both 'state' and 'trait' scales. 
Psychiatric state not associated with treatment (clipping vs. coiling) or aetiology of bleed (aneurysmal vs. unknown 
origin). 
HARS: 100% of SAH patients mildly anxious. SAH patients' mean anxiety score was not sig. different to controls. 
HDRS: 15% of SAH patients mildly-moderately depressed, 5% moderately- severely depressed. SAH patients' mean 
depression score was not sig. different to controls. 
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Study N 
Hadjivassiliou et al. 80 
[242) 
Hellawell et al. [265] 26, 
Hillis et al. [280) 
23, 
19 
27, 
6 
Type 
ASAH 
ASAH; 
SAHuo 
ASAH 
Sample 
characteristics 
91% GOS 1-11; 78% 
WFNS 1-11 
Most WFNS I-ll 
Average H&H II 
Measure 
BDI 
HADS 
ZSRDS 
Follow-
up {yrs) 
1.0 
.5, 1.0, 
2.0 
.25 
Findings 
BDI: Depression scores not sig. associated with aneurysm treatment type (clipping vs. coiling). 
HADS-Anxiety: 
At 6 months, 11% borderline anxiety, 8% clinically anxious. 
At 12 months, 17% were borderline and 13% clinically anxious. 
At 24 months, 21% borderline and none were clinically anxious. 
HADS-Depression: 
At 6 months, 92% scored in the normal range. Just 8% illustrated clinically significant depressive scores. 
At 12 months, 9% reported borderline depression and 9% scored in the clinically depressed range. 
At 24 months, 5% of patients scores were borderline and 5% of patients' scores were in the clinical range. 
Note that at 12 month appointment, total HADS score sig. positively correlated with clinical severity (unadjusted 
r-.46, 21.2%; adjusted r-.64, 42.0%*+:1:). Note no corrections were made for multiple comparisons. 
ZSRDS: 36% were minimally to moderately depressed (50-59), 23% moderately to markedly depressed (60-69), and 
5% severely depressed (<:80). 
SAH patients' depression scores not sig. higher than those of non-SAH patients surgically treated for an un-ruptured 
aneurysm. 
6 patients were seen again at 1 year post-SAH and no sig. change in their depression scores was found. 
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Study N 
Hutter et al. [297, 58 
302] 
Hutter et al. [295] 45 
Jarvis & Talbot [314] 62 
Type 
ASAH; 
SAHuo 
ASAH; 
SAHuo 
ASAH 
Sample 
characteristics 
100% GOS 1-11 
Measure 
BDI 
BDI; IES;; 
Diagnostic 
interview 
(DSM-IV 
PTSD) 
HADS; IES 
Follow-
up (yrs) 
3.0 
4.0 
.25 
Findings 
BDI: 30% of patients reported clinically relevant depression scores (BDI >1 0). No sig. differences in depression 
scores by SAH type (ASAH vs. SAHuo) or aneurysm location (ACoA vs. other sources). 
IES: Compared to a control group of 25 medical studies who had dissected their first corpse a week before, SAH 
patients had sig. higher IES avoidance and total traumatisation symptoms, but not intrusion symptoms. 
No sig. difference between IES scores by SAH type (ASAH vs. SAHuo). 
IES intrusions sig. associated with clinical severity (r=.32, 1 0.2%) and bleed severity (9.6%), but not vasospasm. 
Intrusion score also sig. correlated with score on measure offronto-cortical function completed 4 years earlier. (r=-
.35, 12.3%). IES intrusion (r-.52, 27.0%) and avoidance (r-.45, 20.3%) scores both sig. correlated with concurrent 
BDI depression scores. 
Diagnostic interview: 26% of SAH met diagnostic criteria for PTSD. 
HADS-Anxiety: 35% of SAH patients reported clinically relevant anxiety (11 + ). 
HADS-Depression: 14% of SAH patients reported clinically relevant depression (11 + ). 
IES: 37% of SAH patients reported clinically relevant PTSD score (15+). 
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Study N 
Kreitschmann' (377] 35-
40 
Lindberg et al. (397] 104 
Madureira et al. [418] 18 
Mayer et al. (438] 113 
Type 
ASAH 
ASAH 
PMSAH 
ASAH; 
SAHuo 
Sample 
characteristics 
90% GOS 1-11; 55% 
H&H 1-11 
-
94% H&H 1-11 
84% NIHSS 0; 
56% WFNS 1-11 
Measure 
BDI; IES 
ZSRDS 
HDRS 
CES-D; 
STAI 
Follow-
up (yrs) 
2.3 
7.0 
3.25 
.25 
Findings 
BDI: 27.5% of SAH patients reported mild-moderate depression (11-17) and 10% severe depression (>17). 
Depression sig. associated with basal cortisol value (r= -.56, 31.3%) and physical disability (r= -.44, 19.3%). 
IES: 34% of SAH patients reported mild-moderate PTSD response (IES<15). 
ZSRDS: 22% of SAH patients were reported to be experiencing clinically relevant levels of depression (40-80). 
Depression not sig. associated with time between SAH and assessment, age, sex, cognitive impairment or physical 
disability. 
Depression was sig. associated with ability to work (r-.27, 7.5%* t) and a decrease in leisure activity (r= .26, 7.2%*). 
HDRS: 33% of SAH patients scored in the depressed range (~13). 
Depression not sig. associated with age, sex or time between SAH and assessment. 
Depression sig. correlated with memory deficits (r-.72, 53.0%*±), but not global cognitive function. 
CESD: After controlling for age, education and race, global cognitive function sig. associated with depression (r-.24, 
5.8%* t). Domain-specific cognition not sig. associated with depression. 
STAI: After controlling for age, education and race, global cognitive function sig. associated with state anxiety (r-.29, 
8.4%* t), but not trait anxiety. Domain-specific cognition not sig. associated with either state or trait anxiety scores. 
Anxiety and depression sig. correlated, but coefficient not provided in article. 
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Study N Type Sample Measure Follow- Findings 
characteristics up (yrs) 
Morris et al. [469] 52 ASAH; 44% had a good BDI; GHQ; 1.4 BDI: 28% of SAH patients reported mild-moderate depression (10-18) and 22% reported moderate-severe 
SAHuo GOS-E;84% HADS;STAI depression (~19). 
WFNS 1-11 GHQ: 41% of the 46 SAH patients who completed the measure scored above the 4/5 threshold indicating poor 
subjective mental health. 
HADS-Anxiety: 16% of SAH patients reported mild anxiety (8-1 0) and 38% reported moderate-severe anxiety (~11 ). 
HADS-Depression: 21% of SAH patients reported mild depression (8-10) and 17% reported moderate-severe 
depression (~11 ). 
STAI: 58% of SAH patients reported trait anxiety scoring above 80th percentile and 46% above 80% on state anxiety. 
None of the mood scores were sig. associated with clinical severity, bleed 
severity, aneurysm location, type of SAH (ASAH vs. SAHuo), delay to treatment or sex. 
HADS and STAI scores scales were all sig. correlated with physical disability (unadjusted rs=.42, 18.4%; adjusted 
rs=.50, 25.2%).*:tJ: 
Morris et al. [470] 70§ ASAH; 84% WFNS 1-11 HADS; 1.2 Possession of E4 allele not sig. associated with any anxiety or depression scores. 
SAHuo STAI; BDI 
Ogden et al. [504] 16 ASAH; 100% GOS=I; 56% ZSRDS 4.0 ZDRS: 25% of SAH patients reported at least moderate depression (~50). 
SAHuo Botterel Grade 1-2 
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Study 
Ogden et al. (507] 
Ogden et al. (508] 
N 
89, 
66 
71' 
62 
Type 
ASAH; 
SAHuo 
ASAH; 
SAHuo 
Sample 
characteristics 
Measure 
98% GOS 1-11; 89% BDI 
GCS 13-15 
98% GOSI-11; 57% BDI 
good clinical 
admission state as 
per Mee et al. 
scale. 
Follow-
up (yrs) 
.2, 1.0 
.20, 1.0 
Findings 
BDI: At 10 weeks, 19% of SAH patients reported mild-moderate depression (10-19) and 5.6% moderately severe 
depression (20-29). 
At 12 month assessment, 17% of SAH patients reported mild-moderate depression and 3% moderately severe 
depression. 
Depression was not sig. associated with cognitive performance. 
BDI: 
At 10-week assessment, 13% of SAH patients reported mild depression (10-15), 10% moderate depression (16-23) 
and 1% severe depression 
(24-63). 
At 12 month assessment, 14% of SAH patients reported mild depression, 3% moderate depression and 2% severe 
depression. 
Depression score was notsig. associated with age, sex, aneurysm site, type of SAH (ASAH vs. SAHuo), clinical 
complications (vasospasm; ischemic deficit; hydrocephalus), marital status, pre-morbid occupational status, pre-
morbid IQ, estimated BDI for month preceding SAH or severity 
of life stress for preceding year. 
10-week depression scores were sig. associated with worse a clinical grade (effect size not calculable). Significant 
reduction in BDI scores with time (r-.16; 2.56%). 
111 
Table 4.1 Cont'd. 
Study 
Ogden et al. [51 0] 
Oyebode et al. [519] 
Powell et al. [540] 
N 
123 
20 
44-
50 
Type 
ASAH; 
SAHuo 
ASAH; 
SAHavm 
ASAH 
Sample Measure Follow-
characteristics up (yrs) 
Most GOS=I; Mean ESS 4.0-7.0 
GCS 13.2 
(SD=2.14) 
Referrals to clinical Diagnostic 8.0 
psychiatry unit. interview 
100% GOS 1- BDI; HADS; .25, .75 
11;.100%1 WFNS I-ll IES 
Findings 
ESS: 35% of SAH patients reported experiencing excessive daytime sleepiness/ fatigue. 
Excessive sleepiness/ fatigue sig. correlated with reports of difficulties maintaining night-time sleep (reported by 26%; 
r-.34, 11.6% ), personality changes (r-.30, 9.0%) and complaints of poor memory (r-.32, 10.2% ). 
Diagnostic interview: 70% of SAH patients met criteria for major depressive disorder, 5% bipolar depression with 
mania, 10% schizoaffective disorder, 10% generalised anxiety and 5% erectile impotence. 
BDI: 
At the 3 month assessment, 9.1% of SAH patients reported clinical relevant depression (19+). 
At the 9 month assessment, 11.4% of SAH patients reported clinically relevant depression. 
HADS-Anxiety: 
At the 3 month assessment, 16.0% reported clinically relevant anxiety (11+). 
At the 9 month assessment, 17.0% reported clinically relevant anxiety. 
At both 3 and 9 months, SAH patients reported sig. more anxiety than controls. 
HADS-Depression: 
At the 3 months assessment, 14.0% of SAH patients reported clinically relevant depression (11 +) 
At the 9 months assessment, 8.5% of SAH patients reported clinically relevant depression. 
SAH patients' depression scores were sig. higher than controls at 3 month assessment, but not at 9 month 
assessment. 
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Study N Type Sample Measure Follow- Findings 
characteristics up (yrs) 
Powell et at. cont'd. IES: 
At the 3 month assessment, 30% scored in the clinically indicative PTSD range on both the intrusion (<:12) and 
avoidance (<:14) scales. 
At the 9 month assessment, 15% scored in the clinically indicative range 
on both the intrusion and avoidance scales. 
There was a sig. reduction with time on IES scales (both r= .33, 11.5%). 
Univariate analysis showed no significant recovery on either HADS scales or BDI with time. 
In predicting overall of mood outcome (HADS + IES). 45% of variance in this composite was accounted for by a final 
model made up of information about a patient's prior mental health (15%), prior physical health (12%), experience of 
dysphasia (8%) and prose recall at the 3 month assessment (5%). Age, sex, physical disability and stresses for the 
year proceeding SAH did not enter into final model. 
Powell et al. [541] 49 ASAH 100% GOS 1-11; BDI;HADS; 1.5 BDI: 16.3% of SAH patients reported clinically relevant depression (<:19). 
100% WFNS 1-11 IES HADS-Anxiety: 18.4% of SAH patients reported clinically relevant anxiety (<:11 ). Compared to controls, SAH patients 
reported sig. higher anxiety. 
HADS-Depression: 10.2% of SAH patients reported clinically relevant depression (<:11 ). Patients did not report more 
depression than controls. 
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Study N 
Powell et a/. cont'd. 
Preiss et al. [543] 75 
Salmond et al. [589] 20 
Type 
ASAH 
ASAH 
Sample 
characteristics 
100% GOS 1-11. 
Average WFNS I-
ll. Only MCA or 
PCoA aneurysm 
bleeds. 
Measure 
BDI-11 
BDI 
Follow-
up (yrs) 
1.0 
5.7 
Findings 
IES: 6% of SAH patients scored in the clinically indicative PTSD range on both the intrusion (~12) and avoidance 
scales (~14). 
Compared to 9 month (cf. [540]), was no sig. improvement in HADS Anxiety or Depression scores or BDI scores. 
Compared to data from 9 month assessment (cf. Powell et al. 2002), there was a sig. recovery for PTSD IES 
intrusion scale score (r=.38; 14.85% variance*), but not on avoidance scale. 
No sig. predictive model could be established for overall mood outcome at 18 months (HADS+IES)- potential 
variables included age, sex, physical disability, dysphasia, prose recall at 3 months, prior life stresses and prior 
physical and mental health problems. In univariate analysis, overall mood was sig. associated with prior mental 
health (r= -.29; 8.4% *). 
BDI: Mean depression scores of two groups of SAH patients treated differently (clipping vs. coiling) were both within 
the minimal depression range. 
Depression scores not sig. related to aneurysm treatment or sex. 
BDI: Depression scores not sig. higher compared to healthy controls. 
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Study N Type Sample 
characteristics 
Samra et al. [590] · 185 ASAH 96%WFNS Grades 
1-99% GOS 1-11. 
Satzger et al. [594] 44 ASAH 100% no 
neurologic 
deficit.91% H&H 1-
II; 
Schuiling et al. [609] 83 ASAH; 82% WFNS 
SAHuo Grades 1-11, 
Measure Follow· 
up (yrs) 
BDI .75 
Befindlickeit 2.9-3.2 
s-Skala 
APSG; BDI; 1.7 
SDL, 
Findings 
BDI: SAH patients had sig. more symptoms of depression than healthy controls. 
Befindlickeits-Skala: Mean score of two SAH patient treatment groups (early surgery vs. late surgery) both 
indicated no presence of depression (<56). 
Age, timing of surgery, clinical severity and aneurysm location (ACoA vs. other) were not sig. associated with 
depression. 
SOL: 34% had severe sleep problems (a score of 0!:3 on either the SDL sleepiness or excessive daytime sleepiness 
scales). 
APSG: In 20 of the patients with SDL scores indicating severe sleep problems scores APSG was conducted. None of 
these patients had a normal sleep. Severe sleep fragmentation, sleep apnoea, restlessness leg syndrome/ periodic 
limb movement, or a combination these disorders of sleep and wake occurred in 19 patients (95% ). 
BDI: Four patients (including the 1 patient without sleep fragmentation) had insomnia from inadequate sleep hygiene 
(staying in bed too long and daytime napping). 45% of patients had depression (BDI>16). 
Sleep dysfunction on the SDL was not sig. associated with treatment (clipping vs. coiling), physical disability or bleed 
severity. 
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Study N Type Sample 
characteristics 
Sheldrick et al. [627] 27- ASAH; -
38 SAHuo 
Stegen & Freckman 87 ASAH 93.1% good 
[652] neurological 
recovery. 
Tidswell et al. [687] 37 ASAH -
Measure Follow-
up (yrs) 
DTS :S.04, .10-
.15,23-
. 29 
STAI 1.0 
BDI 2.2 
Findings 
DTS: At s2 week assessment 18.4% reported clinically relevant PTSD Symptoms (>40). 
At 5-7 week assessment, 35.5% reported clinically relevant PTSD symptoms . 
At 11-14 week assessment, 18.5% reported clinically relevant PTSD symptoms. 
Compared to myocardial infarction patients, SAH patients' scores at all time points were higher, but the difference 
was notsig. 
A mixed design analysis found time to be sig. related to PTSD scores for both groups. Change over time was 
homogenous between groups. 
Pair-wise comparisons found there to be a sig. decrease in scores between assessments two and three for the two 
groups as a whole (effect size not calculable). 
STAI: Increased anxiety noted. 
Patients whose SAH was caused by rupture of an MCA aneurysm had sig. worse anxiety than those with ACA 
aneurysms (r-.17, 3.1%). 
BDI: 16% of patients in the "depressed" range (>13). 
Depression was not sig. associated with cognitive performance or aneurysm location (anterior vs. non-anterior). 
116 
Table 4.1 Cont'd. 
Study N Type 
van der Schaaf et al. 69 ASAH 
[703] 
von Voges lang et al. 62 ASAH 
[725] 
Wermer et al. [746] 584 ASAH 
Sample 
characteristics 
76.8% mRS 0-1 
All good 
neurological 
recovery ( GOS I-
ll). 
57%mRS 0-1 
Measure 
HADS 
STAI-state 
HADS 
Follow-
up (yrs) 
7.1 & 9.1 
.08-.25 
8.75 
Findings 
HADS-Anxiety: 17.4% of SAH patients reported possible anxiety (8-1 0) and 5.8% reported probable anxiety (>1 0). 
HADS-Depression: 15.9% of SAH patients reported possible depression ( 8-1 0) and 7.2% reported probable 
depression (>1 0). 
Neither anxiety nor depression was sig. associated with having a small identified aneurysm being left untreated. 
STAI-state: Compared to general population guidelines, SAH patients illustrated higher STAI-state scores, but this 
was not statistically compared. 
Using a quasi-experimental design, anxiety scores were compared between a retrospective 'treatment as usual' 
control group and a prospective intervention group who received enhanced oral and written information about their 
illness (including its treatment, potential consequences and contact information for patient associations). There was 
no sig. difference in anxiety scores between these two groups or between sexes. 
HADS-Anxiety: 13.5% of SAH patients reported possible anxiety and 11.1% probable anxiety. SAH patients' mean 
anxiety score was not sig. higher than that of controls. 
HADS-Depression: 19.5% of SAH patients reported possible depression (8-10 score) and 9.4% probable 
depression. SAH patients' mean depression score was significantly higher than controls. 
Time since SAH was not sig. associated with either anxiety or depression. 
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Study N Type Sample 
characteristics 
Measure Follow· 
up (yrs) 
Findings 
Will & Philipp [752] 65 ASAH Mean H&H=2.4 . BDI 4.0 BDI: 13%of SAH patients reported mild depression and 19% clinically relevant depression. 
Notes: ACoA= Anterior communicating artery; APSG=Ambulatory polysomography; ASAH=Subarachnoid haemorrhage of aneurismal origin; Befindlickeits-Skala=self mood evaluation scale [700]; BDI=Beck Depression 
Inventory [36]; BRS=Behavioral Rating Scale [269]; BSI=Brief Symptom Inventory [148]; CES-D=Center for Epidemiologic Studies-Depression Scale [549]; DSM-111-R= Diagnostic and Statistical Manual of Mental Disorder Third 
Edition-Revised [21]; DTS=Davidson Trauma Scale [132]; ESS=Epworth Sleepiness Scale [320];GCS=Giasgow Coma Scale (range 3-15; 15= best clinical presentation) [683];GHQ=General Health Questionnaire [227]; 
GOS=Giasgow Outcome Scale (range 1-V; grade 1-ll=good/ favourable neurological recovery no/modest physical impairment, needs no help in daily activities) [318]; GOS=E=Giasgow Outcome Scale-Extended version [758]; 
H&H= Hunt and Hess grading scale for neurological state on admission (range 1-V; grades 1-11 good clinical presentation) [293]; HADS=Hospital Anxiety and Depression Scale [772];HARS/ HDRS=Hamllton Anxiety/ Depression 
Rating Scales [245, 246];1ES= Impact of Events Scale [[288]; Kreitschmann'= Kreitschmann-Andermahr et al; MCA= middle cerebral artery; Mea et al. scale=Ciinical status neurological grading scale (range 1-6; 1-2= good 
neurological status, oriented with only minimal cranial nerve deficit) [456]; mRS=modified Rankin Scale score (range 0-6; 0-1=good neurological recovery, needs no help In daily activities) [550]; NIHSS= National Institute of 
Health Stroke Scale (range 0-30;0 =no neurologic impairment) [230]; OR=odds-ratio; PCoA=posterior communicating artery; PTSD=Posttraumatic stress disorder; SAHavm=Subarachnoid haemorrhage resutting from an 
arteriovenous malformation; SAHuo=Subarachnoid haemorrhage of unknown origin; Sl!ll=The Sleep Disorders Questionnaire [163]; sig.=significant(ly); STAI=State-Trait Anxiety Inventory [647]; WFNS= World Federation of 
Neurological Surgeons grading scale for neurological state on admission (range 1-V; grades 1-11 good clinical presentation) [164]; ZSRDS=Zung Self-Report Depression Scale [774]; • effect sizes (r )for 1 dftests calculated where 
possible [580, 583]; :1: adjusted effect size also presented as per Glass et al. [222] formulae to account for 5% power reduction associated with use of Mann-Whitney test; :1::1: adjusted effect size also presented to account for 9% 
power reduction associated with use of Spearman's-correlation test [633]; ±effect size based on p-value and conversion to z-value, but not corrected for less power associated with non-parametric test as Fisher exact used in this 
case is the most powerful tests for the dichotomous, nominally scaled data [633]; t effect size could be slightly larger as exact sample size for calculation based on entire population, rather than just who completed measure/ or 
were of working age as these number were not available in the article;§ exact sample size likely smaller, but only starting sample number not account for missing data is cited in article. 
Studies not included in table if psychiatric data merged with that of non-SAH patients,[17, 244, 359, 569] if the study used only a personality inventory,[247, 308] provided insufficient details on psychiatric outcome,[25, 377, 433, 
570, 571] was not an independent study [31] or was a case report.[312, 577] 
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screening measures for depression, rather than anxiety when exploring psychiatric 
disturbance in this population (seen in Table 4.1), should not be taken to indicate that 
symptoms of depression are most prominent. Instead, it reflects the influence within 
the neurosciences of the seminal work by Robinson and colleagues on ischemic 
stroke patients, which publicised the possibility of depression following 
cerebrovascular incidents [565-568]. 
It is important to note at this point, that the psychiatric problems of SAH 
patients are considered to be new difficulties which occur following their 
haemorrhage. There is - despite some early proposals [506] - no convincing 
evidence to suggest that this population experienced abnormal levels of 
psychopathology or stress prior to their haemorrhage [540]. 
As noted earlier, one particularly distinctive feature of SAH patients' anxiety is 
a sense of fear and a preoccupation with the possibility of a further SAH occurring, 
despite their relative safety [25, 47, 57, 75, 99, 295, 313, 314, 412, 449, 465, 559, 
643, 652, 728, 729]. "Oh God, I'm on my own, I'm out now. Will it happen to me 
again?" (p.1433) is something repeatedly stated by SAH patients [313]. Hutter [295] 
for example, found that in a sample of 45 aneurysmal SAH patients assessed 4 years 
post-SAH, only 11% never feared recurrence and 33% were either 'frequently' or 
'permanently' afraid of a haemorrhage recurring. Crucially, many SAH patients also 
have flashbacks and often feel as if the haemorrhage is recurring [47, 313, 314, 449, 
716]. This can be precipitated by a tendency in the SAH population to catastrophically 
misinterpret normal bodily sensations (such as headaches and tingling sensations in 
the operation site) as indicating the onset of another SAH [47, 285, 545, 546, 548]. 
The sense of fear reported by SAH patients is of clinical concern because it is 
considered to be both persistent and potentially debilitating [25, 57, 78, 295, 313, 437, 
465]. Its abnormality is illustrated by the fact that significantly less patients following 
treatment for other types of brain pathology exhibit such fear [545]. Although it has 
often been presumed that SAH patients' worries could reflect a lack of knowledge , 
about their illness [302, 313, 314, 449, 469, 546, 548, 627, 652], it has been found 
that this anxiety and fear is not abated through clinicians providing the patients with 
extensive reassurance about their relative safety [47, 313, 652, 725]. Stegen and 
Freckman (652] for example, assessed a sample of 69 aneurysmal SAH patients 12 
months post-SAH and found that despite admitting that the illness had been 
sufficiently explained and being aware of their safety, 79% of patients still feared 
recurrence. The functional impairment caused by SAH patients' fear is illustrated by 
these patients' avoidance of thinking about their haemorrhage and by placing 
restrictions on themselves, such as not participating in certain activities (such driving, 
lifting, sexual intercourse) in case they elicit sensations which are similar to those 
experienced at the time of the haemorrhage and/or trigger harmful processes which 
they feel could cause a further bleed [57, 285, 314, 437, 449, 703]. 
Patients' fears can also place extra strains on relationships with their family 
and friends. For instance, patients may continually seek reassurance from their loved-
ones about their health and may not allow themselves to be left alone [314, 664]. 
Their array of symptoms is concisely depicted in the following typical patient comment 
derived from Jarvis' [313] qualitative study of SAH patients: "I felt very very (sic) 
frightened about it happening again. I thought if it's happened once, it can happen 
again. I felt very vulnerable - I had flashbacks of the night it happened. When I went 
to bed ... I was reliving everything of it and couldn't get it out of my mind. I learned to 
open my eyes when this happened so I would forget about it ... Even though I knew 
120 
the facts about the chance of another haemorrhage, I still have the flashbacks of the 
night it occurred because I'm so frightened of it happening again" (p.1433). 
In order for the psychiatric difficulties of SAH patients to be better understood 
and ultimately treated, it is necessary to move beyond the simple description of 
symptoms and to determine which psychiatric disorder (or disorders) underlies their 
symptoms. Whilst the results from studies using screening measures have been 
important in highlighting that the dominant presenting symptoms of SAH patients are 
anxiety and a sense of fear, the ubiquitous nature of these symptoms to many major 
psychiatric disorders [23, 190, 576], means that these studies alone cannot delineate 
which specific disorder is responsible for the difficulties experienced by SAH patients 
[53, 96, 122, 341, 345, 453, 561, 610, 636, 736]. According to the American 
Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV-TR) [23, 190], when patients present with a symptom profile dominated by 
anxiety and fear, the set of potentially relevant disorders includes, generalised anxiety 
disorder, adjustment disorder and posttraumatic stress disorder (PTSD). As Figure 
4.1 illustrates, although these various conditions are associated with symptoms of 
anxiety and fear, they are not synonymous and they can be differentiated on the basis 
of the nature and content of the anxiety which they produce (e.g., whether or not the 
anxiety is in response to a stressor, what the patient is afraid of, what situations are 
avoided) [190, 340]. Fortunately, efforts have now been made to determine which of 
the potential psychiatric disorders seen in Figure 4.1 best accounts for SAH patients' 
symptom profile. Indications from these recent studies suggest that PTSD is the best 
explanation for SAH patients' psychiatric symptom profile. Therefore, in the next 
section I shall discuss why PTSD is so good at accounting for SAH patients' 
psychiatric difficulties. 
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Due to the direct physiolo gical 
effects of a substance (e.g., a 
drug ofabuse,a medication, 
a toxin) 
Recurrent unexpected Panic 
Attacks plus am onth of worry, 
concern about:attacks, or 
change in behaviour 
No 
Ag crap hob ia, i.e. anxiety 
about being In places from 
which escape might be 
difficult or embarrassing in the 
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Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
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or em ba rrassin g In the event 
of having a Panic Attack 
6-month period of 
excessive anxiety and 
worry plus anxiety 
symptoms 
No 
Anxiety in response to a 
severe trauma tic event 
No 
Anxiety that does not meet 
criteria for one of the 
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and develops in response 
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symptoms that do not 
meet criteria for a specific 
Anxietv Disorder 
No 
No Anxiety Disorder 
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or avoid a nee that are not 
clinically sign lficant) 
Yes 
Figure 4.1 Decision tree for differential diagnosis of psychiatric disorders accounting for anxiety symptoms (Adapted from DSM-IV-TR [23]). 
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4.3 Post-traumatic stress disorder (PTSD) provides best 
explanation for SAH patients' psychiatric difficulties 
Before discussing the evidence on PTSD being the disorder which can best account 
for SAH patients' psychiatric difficulties, it is first necessary to discuss the diagnosis of 
PTSD in general, its characteristics and risk factors. 
First recognised by psychiatry in 1980 [20], PTSD is an abnormal and highly 
distressing psychiatric reaction that follows the experience of a traumatic event that 
involves "actual or threatened death or serious injury, or a threat to the physical 
integrity of self or others" (p.467) [23]. Characterised by intrusive recollections of the 
trauma, active avoidance of stimuli associated with the trauma, emotional numbing 
and persistently increased arousal (Table 4.2), it is an independent disorder whose 
pathophysiology and treatment is distinct from other psychiatric conditions [23, 100, 
204, 205, 339, 495, 554, 630, 631, 670, 765]. PTSD is known to interfere with 
interpersonal relations, cause marital conflict and lead to job loss on the part of the 
patient. In addition to its diagnostic symptoms, patients who develop PTSD can also 
illustrate impulsive behaviour, somatic complaints, hostility, social withdrawal and a 
change in personality [23]. It is a complex disorder, with a high rate of psychiatric co-
morbidity. Major depression, panic disorder and social phobia are amongst the most 
common disorders that are also found in persons with PTSD [351]. Although persons 
can spontaneously recover from PTSD, those individuals who still meet its diagnostic 
criteria at around 6 months post-trauma are, without intervention, unlikely to recover 
[351]. Crucially, we know a great deal about PTSD's causes/ risk factors and how 
best to treat it. Recent research has, for example, established that who does and 
does not develop PTSD following a trauma is not a purely random phenomenon, but 
rather its development can be reliably predicted by several established risk 
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Table 4.2 American Psychiatric Association's [23] criteria for PTSD in adults 
A. The person has been exposed to a traumatic event in which both of the following were present: 
(1) person experienced, witnessed, or was confronted with event or events that involved actual or threatened death or 
serious injury, or a threat to the physical integrity of self or others 
(2) the person's response involved intense fear, helplessness, or horror 
B. The traumatic event is persistently re-experienced in one (or morel of the following ways: 
(1) recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions. 
(2) recurrent distressing dreams of the event 
(3) acting or feeling as if traumatic event were recurring (e.g., a sense or reliving the experience, illusions, 
hallucinations, and dissociative flashback episodes, including those that occur on awakening or when intoxicated) 
(4) intense psychological distress at exposure to internal or external reminders of the traumatic event 
(5) physiological reactivity on exposure to internal or external reminders of the traumatic event 
C. Persistent avoidance of stimuli associated with the trauma and numbing of general responsiveness (not present 
before the trauma), as indicated by three (or morel of the following: 
(1) efforts to avoid thoughts, feelings, or conversations associated with the trauma 
(2) efforts to avoid activities, places, or people that arouse recollections of the trauma 
(3) inability to recall an important part of the trauma 
(4) markedly diminished interest or participation in significant activities ("psychic numbing" or "emotional numbing") 
(5) feeling of detachment or estrangement from others 
(6) restricted ability to feel emotions (especially those associated with intimacy, tenderness and sexuality) 
(7) sense of foreshortened future (e.g., does not expect to have a career, marriage, children, or a normal life span) 
D. Persistent symptoms of increased arousal (not present before the trauma), as Indicated by two (or morel of the 
following: 
(1) difficulty falling or staying asleep (often due to recurrent nightmares during which the trauma is relived) 
(2) irritability or outbursts of anger 
(3) difficulty concentrating or completing tasks 
( 4) hypervigilance 
(5) exaggerated startie response 
E. Duration of the disturbance (symptoms in Criteria B, C and D) is more than 1 month. 
F. The disturbance causes clinically significant distress or impairment in social, occupation, or other Important areas of 
functioning. 
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factors [521]. It has been found, for example, that key to the development of PTSD is 
the manner by which the person reacts and responds to the stress of the trauma [328, 
390]. This response is mediated by the coping strategies which the person 
consciously employs when confronted with stress [217]. Therefore, whilst meta-
analyses find that factors such as age, sex, education and psychiatric history have 
only a minimal predictive effect for PTSD development [73, 521], coping strategies 
are found to be one of the most powerful and robust predictors for PTSD 
development [87, 88, 172, 217, 328, 490, 493]. In a variety of studies, including those 
which fortuitously measured coping style prior to exposure to a real-life trauma [217, 
490], a causal relation appears to exist between coping and PTSD development. 
Those who tend to use denial as a coping strategy (e.g., "I say to myself 'this isn't 
real'"), self-distraction (e.g., "I turn to work or other activities to take my mind off 
things"), self-blame (e.g., "I blame myself for things that happened"), venting (e.g., "I 
express my negative feelings"), substance abuse (e.g., "I use alcohol or other drugs 
to help me get through it") and behavioural disengagement (e.g., "I give up trying to 
deal with it") when dealing with stress are most likely to develop PTSD. The classic 
explanation for why these coping strategies prove maladaptive and promote PTSD 
refers to the slightly paradoxical phenomenon that by actively avoiding thoughts or 
situations which lead to anxiety and fear, we in fact maintain their fear-inducing 
quality. A host of experimental evidence for example, shows that attempts to 
suppress unwanted thoughts are doomed to failure, and are, in fact, 
counterproductive with the thoughts returning even more strongly [7 43]. In contrast, 
successful adaptation to the experience of a trauma (as reflected in most 
psychological treatments for PTSD which involve exposure therapy) appears to 
involve the accessing of aversive emotions about the event, which permits habituation 
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to anxiety and the modification of one's trauma-related beliefs (i.e., disconfirming 
beliefs) through the processing, assimilation and accommodation to the experience 
[88, 165, 1 93]. 
Studies now consistently demonstrate that the experience of having suffered 
an SAH can be so traumatic that the patient can develop PTSD (see Table 4.1). 
Crucially, recent studies also provide compelling evidence that it is PTSD which is the 
most parsimonious explanation for SAH patients' psychiatric disturbance [47, 295, 
314, 377, 540, 541, 627], with PTSD being found to account for more of SAH patients' 
psychiatric symptoms than any other psychiatric disorder [47]. Supporting PTSD's 
ability to explain SAH patients' abnormally high psychiatric disturbance is the finding 
of an abnormally high incidence of PTSD in the SAH population. Whilst the life-time 
prevalence of PTSD in the general population is between only 1-8% [23, 267, 351], 
two studies (using diagnostic criteria) have reported that 26-32% of SAH patients 
warrant a clinical diagnosis of PTSD following SAH [47, 295]. This represents at least 
three-times the normal rate. 
Although there are some obvious caveats to applying the DSM-IV-TR 
diagnostic criteria and its associated features in a "rote or cookbook fashion" (p. xv), 
[1 90], it is clear that the symptom profile of SAH patients corresponds extremely 
closely to PTSD. SAH patients' misinterpretation of bodily sensations and feeling as if 
the haemorrhage were recurring for example, can be seen to reflect the PTSD 
symptoms of re-experiencing, whereby patients can act or feel as if they are actually 
reliving the traumatic experience [47, 313]. In addition, avoidant symptoms can be 
seen to be reflected in SAH patients' self-imposed restrictions which prevent them 
from thinking about their haemorrhage or from participating in activities and 
frequenting places that could remind them of the SAH [437]. Finally, the sense of 
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perpetual fear which SAH patients experience concurs closely with the well-known 
feature of PTSD [74, 171], whereby patients are found to feel anxious about the 
future, even though the trauma lies in the past. Such patients alter their beliefs, 
attributions and expectations about themselves, others and the world, in an extreme 
and maladaptive way [372]. For example, in the case of a female rape victim who 
develops PTSD, the woman comes to believe that all men could be potential rapists 
and/ or that the world is not a safe place. In line with the suggestion that SAH 
patients' unfounded fears of re-bleeding are a consequence of the development of 
PTSD is Hutter's [295] finding that SAH patients' degree of fear of haemorrhage 
recurrence is highly correlated in a positive manner with the degree to which they 
experienced different PTSD symptoms (r's ~.62, all p<0.001). 
To date, the available evidence suggests that PTSD is the best explanation for 
SAH patients' psychiatric symptom profile. Even though most SAH studies have 
examined relatively small samples (median size=47, interquartile range 39-59) [47, 
295, 314, 377, 540, 541, 571, 627], the effect of PTSD in SAH patients has been of a 
sufficient magnitude that all but one of these studies [571] has detected concerning 
levels of PTSD (please note that this latter study is not included in Table 4.1 as 
insufficient details on SAH patients' psychiatric outcome was provided in the article 
which precluded its inclusion). It is important to recognise that the studies identifying 
PTSD in SAH patients have not only relied on screening measures, but also used 
more rigorous and comprehensive techniques, including the "gold-standard" 
technique of differential diagnosis [365]. This is important as many screening 
instruments often only measure for the presence of some PTSD symptoms, do not 
separate new from pre-existing symptoms, do not ask about the duration of the 
symptoms and do not assess the resultant functional impact that these symptoms 
127 
have [483]. Such measures can, therefore, potentially inflate the number of patients 
who are identified as having PTSD [615, 684]. 
As SAH patients' psychiatric symptoms occur within the context of the patients 
having a medical illness, it is important to highlight that the possibility of an alternative 
DSM-IV-TR diagnosis of Anxiety due to a General Medical Condition has been 
considered. However, it has not been found to be a more appropriate explanation for 
patients' symptoms. Such a diagnosis is appropriate only when the psychiatric 
disturbance is the direct physiological consequence of a medical condition and 
another primary disorder does not better account for the symptoms [23, 637]. No 
evidence suggests that SAH patients' psychiatric disturbance is aetiologically related 
to the haemorrhage (or its treatments). For example, no acute illness index, such as 
the severity and distribution of the person's SAH, its treatment, or its cause, has 
proved to be reliably associated with SAH psychiatric disturbance [1 05, 116, 242, 
265, 280, 295, 297, 302, 469, 507, 543, 594, 687]. Moreover, indirect mechanisms 
by which medical conditions can cause psychiatric disturbance, such as via induced 
neuroendocrine dysfunction, have also not proved important [315, 539]. For example, 
Kreitschmann-Andermahr et al. [377] found that PTSD symptoms in SAH patients 
were not associated with any concurrent measure of their hormonal function. 
Psychiatry officially recognises that medical events can precipitate PTSD [23, 
455]. This is illustrated by its definition of a traumatic event as one which involves 
"actual or threatened death or serious injury, or a threat to the physical integrity of self 
or others" (p.467) [23]. Despite this official stance, the conceptualisation of a medical 
event (and hence an SAH) within the PTSD nosological framework is not without its 
difficulties [92, 476, 684), with some persons having questioned the validity of 
diagnoses of PTSD in medical patients. As this is an important point of debate, I will, 
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in the next section, briefly discuss some of the proposed difficulties in diagnosing 
PTSD in medical patients. Importantly, I will describe how I believe most criticisms 
over these persons' diagnoses can be potentially resolved and how the case for 
PTSD in SAH patients should not be viewed as ill-fated. 
4.4 The validity of PTSD diagnoses in medical patients 
Prior to 1994 [22], psychiatry did not officially recognise that a medical illness could 
elicit PTSD because it had been stated that only events 'outside the range of usual 
human experience' (p.236) could precipitate such a reaction [21]. It was 
epidemiological research however, which forced psychiatry to adopt its current, much 
broader definition of what actually constitutes a trauma, as it was repeatedly 
illustrated that there are few events which are truly rare from a statistical perspective 
and so outside usual human experience. Moreover, the actual events which caused 
PTSD were found to be more common than uncommon (e.g., assault, rape, motor 
vehicle accidents) [70, 134, 491 ]. Therefore, despite traditionally being associated 
with external traumatic events, such as natural disasters [417] and military combat 
[640], it is now officially recognised that medical events (30, 81, 89, 128, 167, 476, 
534, 684], such as HIV infection (:535%) [355], myocardial infarction (:516%) [380] and 
cancer (:532%)[479] can elicit PTSD. In re-examining the clinical events which SAH 
patients will typically experience (see Figure 2.5 in Chapter 2), it becomes clear that a 
spontaneous SAH and its treatment are (as the DSM-IV-TR's PTSD diagnostic 
criteria necessitates) not only life-threatening, but also have the potential to be 
intensely frightening [23]. In fact, it is already known that intensive care treatment 
(which SAH patients often receive) can alone frequently elicit PTSD [684]. 
129 
Amongst the main reasons for current scepticism over the diagnosing of PTSD 
following a medical event are: 1) the methods of diagnosis (e.g., self-report 
measures) have not been validated on patients who have experienced a medical 
illness and patients could therefore confound traumatological symptoms with the 
direct effects of the illness and/ or its treatment (e.g., Criterion D symptoms of 
hyperarousal, such as insomnia, concentration difficulties, irritability) [20,21], 2) 
differences exist in the manner in which some patients experience some PTSD 
symptoms. For example, 're-experiencing' (Criterion B) is defined in terms of thoughts 
about past events (e.g. flashbacks to event, feeling like it was happening again), but 
some patients (e.g., cancer patients) who face the real possibility of relapse, have 
intrusions which are more future-orientated (e.g., 'Will the cancer progress to the 
point that I'm in so much pain that I would want to die?' 'Will my family be provided for 
once I am gone?') [14,22,23], and 3) it is unclear how a minority of patients develop 
PTSD following a medical trauma, despite having lost consciousness at the time. It 
has been understood that a person needs to have felt fear, helplessness or horror at 
the time of the trauma and that explicit memories of the trauma are necessary for the 
generation of and maintenance of PTSD (Criterion A). 
There are some clinical difficulties in awarding a diagnosis of PTSD following a 
medical trauma (such as SAH). However, I do not believe that these issues raise any 
serious threat to the validity of diagnoses of PTSD in SAH patients, rather they 
represent theoretical and diagnostic challenges which future studies will need to 
address. In support of my argument is the fact that there is still much debate about 
the way PTSD expresses itself even in the case of more traditional traumas. For 
example, some question the diagnosis of PTSD in children who have experienced a 
traditional trauma because their symptomatology can be expressed in divergent ways 
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[136]. With regards to the issue of lack of memory of the event and how it is that 
persons following medical events can still develop PTSD, work is already beginning to 
emerge (from the field of traumatic brain injury) that helps to explain this. The work 
shows that a lack of consciousness at the time of the trauma does not preclude PTSD 
because the person can ( 1 ) still experience the traumatic event after they regain 
consciousness, (2) processing can occur at an implicit level, by-passing cortical 
structures (i.e., through the amygdala and related structures) during periods of 
impaired consciousness and (3) because some people appear to reconstruct 
memories or experiences which then 'become memories' that may provide the basis 
for the generation of PTSD symptoms [86, 218, 599]. Also, in the case of the 
difficulties of symptom overlap, evidence from the use of screening measures such as 
the Hospital and Anxiety Depression Scale [772], which are used for more general 
psychiatric disturbance, suggests that with the refinement of measures, it is possible 
to begin to control for the 'noise' of concurrent somatic disorders which can potentially 
present themselves when assessing a patient's psychiatric status. One of the most 
important pieces of evidence that supports the diagnoses of PTSD in some medical 
patients comes from a recent study by Pitman et al. [534] of cancer patients who had 
been diagnosed with PTSD using interview techniques. Pitman et al.'s study built 
upon the finding that classical PTSD patients are known to illustrate a triad of unique 
correlates on psychophysiological measures - namely, elevated arousal during 
periods of rest, an exaggerated startle response and physiological reactivity on 
exposure to cues symbolising or resembling an aspect of the traumatic event [516, 
517, 535, 536, 624]. Crucially, Pitman et al. found that the cancer patients with PTSD 
illustrated exactly the same psychophysiological 'signature' as those persons who 
had suffered more traditional traumas (including military combat, sexual assault and 
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terrorism). Such findings appear to provide a 'biological' validation of medical patients' 
PTSD diagnoses, as the precision of 'objective' psychophysiological tests is not, like 
traditional interview techniques, vulnerable to the reliability of patients' reports or a 
clinician's ability to differentiate whether patients' symptoms are psychiatric in origin 
or not. 
In summary, the available evidence supports the diagnosing of PTSD in SAH 
patients. With this in mind, in the next section I shall discuss some anecdotal 
evidence which motivates me to examine if the abnormally high incidence of PTSD in 
the SAH population can help explain SAH patients' poor psychosocial outcome. 
4.5 Potential of PTSD to explain SAH patients' HRQol and 
other unexplained disturbances? 
Although it has never been comprehensively examined, the following tentative 
evidence hints that the abnormal incidence of PTSD in the SAH population could help 
explain SAH patients' reduced HRQoL. Firstly, PTSD in the wider literature is known 
to cause particularly severe levels of disability and handicap [82, 177, 348-350, 352, 
459] which lead to a pattern and level of HRQoL impairment very comparable to that 
generally reported by SAH patients. Both conditions (i.e., SAH and PTSD in general) 
have been found to lead to worse HRQoL than that caused by other illnesses, 
including heart disease and diabetes (see Figure 2.6 Chapter 2 for SAH HRQoL 
profile compared to other illnesses) [1 0, 249, 422, 459, 514, 551, 585, 608, 662, 760]. 
In fact, the severity of this reduction in HRQoL in both conditions is second only to 
that associated with a Major Depressive Disorder. Secondly, although PTSD 
sufferers (like SAH patients) are known to experience impairment in both the Phys_i<:;al 
and Mental domains of HRQoL, they too experience especially pronounced 
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reductions in Mental HRQoL [1 0]. Although most evidence on the link between PTSD 
in general and HRQoL comes from cross-sectional studies, which precludes causal 
statements (e.g., it is not possible to conclude that HRQoL did notpre-date the onset 
of PTSD [464]), evidence is amounting to suggest a causal link between PTSD and 
HRQoL, as the treatment of PTSD results in improvement in HRQoL [56, 64, 422, 
429,454,552,656,696]. 
In the context of discussing PTSD's potential explanative power for SAH 
HRQoL, it is interesting to note that PTSD could also explain two other mysterious 
aspects of SAH patients' outcome, namely, post-SAH chronic fatigue and sleep 
dysfunction [8, 90, 176, 185, 264, 265, 285, 313, 314, 360, 400, 409, 428, 465, 487, 
504, 508, 510, 513, 572, 579, 609, 617, 643, 646, 649, 667, 669, 685, 718, 746]. 
SAH patients report persistently feeling excessively tired, weak, without energy and 
needing rest following even the most menial of tasks [313]. They also note that they 
have difficulty falling asleep, repeat awakenings and difficulty returning to sleep [609]. 
Even the most conservative of estimates suggests that a third of patients experience 
debilitating levels of fatigue [579], whilst around 20% report severe sleep dysfunction 
up to 7 years after the haemorrhage [51 0]. 
Although prior studies considering SAH patients' fatigue and sleep quality are 
limited by a failure to use validated instruments or to compare patients' complaints to 
normative levels, the two sets of difficulties have recently come to the fore as 
preliminary evidence suggests that they could be integral to patients' post-SAH social 
participation, including their work and socialisation [118, 313, 487, 541]. 
Unfortunately, these difficulties have gone untreated within clinical practice, often 
dismissed because their severity has not been properly gauged, but also because 
their origin has never been established [544]. Efforts have been made to explain their 
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presence as a result of the brain damage induced by an SAH (and its treatment) [65, 
377, 509], but this mechanism does not stand up to much scrutiny (at least not as the 
principle cause of the problems). Kreitschmann-Andermahr et al. [377] for instance, 
reported that whilst in a group of 35 patients, SAH-induced neuroendocrine 
dysfunction was related to sleep and fatigue, 84% and 70% of variance in these 
respective scores was not accounted for by the hormonal dysfunction. In another 
study, Brandt et al. [65] found that in 10 patients reporting post-SAH fatigue, only 3 
experienced obvious neuroendocrine disturbance. PTSD could potentially much 
better explain the development of the fatigue and sleep disturbance. Sleep 
dysfunction (as a result of intrusive nightmares and/or a difficulty getting to sleep and 
staying asleep) is a DSM-IV-TR symptom of PTSD [23, 251, 420], and increased 
somatic complaints, including fatigue, are well known to form part of the PTSD 
syndrome following other traumatic events [143, 199, 326, 392, 481]. Despite this 
strong indication that PTSD could cause these symptoms, this has never been 
examined. Nor has the relationship between sleep dysfunction and fatigue in SAH 
patients been determined. 
As can be seen in Table 4.3, several small studies have found that psychiatric 
symptoms in general could be useful in explaining other aspects of SAH patients' 
psychosocial outcome. An exhaustive review of the literature identified only one 
(somewhat obscure) study published in a small book chapter [295], which had 
considered the value of PTSD symptoms for SAH patients' HRQoL. Although the 
study in question did provide some important insights and suggested a potential role 
for PTSD, it did not, for several reasons, satisfactorily resolve its importance. Firstly, 
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Table 4.3 
Study N 
Artiola i Fortuny & 204 
Prieto-Valiente[17] 
Carteret al. [1 05] 179 
Fertl et al. (189] 40 
Hutter et al. (294] 58 
Hutter [295] 45 
Lindberg et al. [397] 104 
Studies which formally examined the relation between SAH patients' psychiatric difficulties and psychosocial outcome 
Psychiatric Psychosocial 
predictor measure 
GHQ Work; Leisure 
activities 
ZSRDS Work; Social 
participation (RNL) 
BDI Work; Life satisfaction 
(LQoLP) 
BDI Life satisfaction (FPI-
R) 
IES HRQoL (ALQI); Life 
satisfaction (FPI-R) 
ZSRDS Work; Leisure activity 
HRQoL(VAS) 
Follow-up 
(yrs) 
1.5-5.5 
1.0-6.0 
1.8 
3.0 
4.0 
7.0 
Finding(s) 
Work: Psychiatric disturbance sig. associated with reduced work capacity. (Effect size not calculable). 
Leisure activities: Psychiatric disturbance sig. associated with reduced work capacity. (Effect size not calculable). 
Work: In multivariate model, reduced mood sig. associated with reduced working capacity (odds ratio converted r=-.54, 
29%*). 
Social participation: In multivariate model, reduced mood negatively associated with participation (odds ratio converted r=-
.60, 36%*). 
Work: Reduced mood sig. associated with a reduced working capacity (r= -.56, 31%). 
Life satisfaction: Reduced mood sig. associated with reduced life satisfaction (r= -.46, 21%). 
Life satisfaction: Reduced mood sig. associated with reduced life satisfaction (r= -.40, 16%). 
HRQoL: PTSD symptoms of avoidance and intrusion sig. associated with reduced HRQoL: Physical HRQoL r= -.40, 16%, 
Mental HRQoL r= -.50, 25%. 
Work: Reduced mood sig. associated with reduced working capacity (r= -.27, 8%). 
Leisure activity: Reduced mood sig. associated with reduced leisure activity (r= -.26, 7%). 
HRQoL: Reduced mood sig. associated with reduced HRQoL (r-.21, 4.4%). 
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Table 4.3 Cont'd. 
Study N 
Mayeret al. 133 
[438) 
Morris et al. 36-52 
[469) 
Ogden et al. 16 
[504] 
Powell et al. 48 
[540) 
Powell etal. 49 
[541) 
Psychiatric Psychosocial measure Follow-
predictor up (yrs) 
CES-D HRQoL(SIP) .25. 
HADS-Anxiety Work; Leisure activities 
HADS-
Depression 
ZSRDS Broad measures of 5.0 
social outcome (PAl) 
Composite score Work status (BICR0-39) .75 
(HADS; IES) 
Composite score Work status (BICR0-39) 1.5 
(HADS; IES) 
Finding(s) 
HRQol: In multivariate model controlling for demographics, reduced mood sig. associated with reduced HRQoL: Physical 
HRQoL, additive adjusted 1=15%; Mental HRQoL, additive adjusted 1=56%. 
Work: Reduced mood on both scales associated with reduced working capacity: HADS-Anxiety r= -.36, 13%; HADS-
Depression r= -.27, 8%).* 
Leisure activities: Reduced mood associated with reduced leisure activities: HADS-Anxiety r= -.48, 23.0; HADS-
Depression r= -.56, 31%.** 
Social outcome: ns. 
Work: ns. 
Work: ns. 
Note: ALQI=Aachen Life Quality Index [299, 302);BDI=Beck Depression Inventory [36); BICR0-38=The Brain Injury Community Rehabilitation Outcome-39 scales [542]; CES-D=Center for 
Epidemiologic Studies Depression Scale [549]; FPI-R=Freiburger Personality Inventory-Revised [181, 182);GHQ=General Health Questionnaire [226); HADS=Hospital Anxiety and Depression Scale 
[772); HRQol=Health-related quality of life; IES=Impact of Events Scale [288); LQoLP=Lancaster Quality of Life Index [515); sig.=significantly; ns=not statistically significant; PAI=Portland Adaptability 
Inventory [393); RNL=the Reintegration into Normal Living Index [764]; SIP=Sickness Impact Profile [43); VAS=Visual Analogue Scale [7]; ZSRDS=Zung Self Rating Depression Scale [774); *effect 
size r for depression converted from odds ratio from multivariate model using conversion (In( odds ratio)/1.81) [114, 580, 677]; **effect not adjusted for use of non-parametric data as Fisher exact test 
most powerful test for nominal data used.[633) Three studies which are doublets for Mayer et al. [438) have also been published as abstracts, but these are not included in the table. [118, 440, 578) 
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the SAH patients' PTSD symptoms were indexed using only a screening measure 
(i.e., the Impact of Event Scale [288]), rather than an instrument which was 
explicitly tied to the DSM-IV-TR's diagnostic criteria. Secondly, only bivariate 
statistical analyses were conducted between PTSD and HRQoL. Therefore, we 
know nothing about the relative importance of PTSD compared to the traditional 
predictors used for HRQoL, such as age, clinical severity, cognitive impairment 
and physical disability. Thirdly, the relationship between PTSD and HRQoL came 
only from a single follow-up assessment with the patients, 4-years following their 
SAH. Therefore, the study tells us nothing about the importance of PTSD over 
time and whether or not it can help us to explain patients' HRQoL in both the 
short- and the long-term - information that is clearly important from a clinical, 
rehabilitative perspective. Fourthly, the sample on which the results were based 
was small (N=45) and seemingly selective, which raises questions as to the 
generalisability of the study's findings for the SAH population as a whole. And 
finally, the study in question did not examine whether any of the robust risk factors 
for PTSD in the wider literature - such as the use of maladaptive coping - were 
useful in predicting the development of PTSD in SAH patients, in either the short-
or long-term. 
4.6 Conclusions 
In this theoretical review chapter I have argued that PTSD seems to hold great 
promise in being able to help us better explain SAH HRQoL. With this in mind, in 
the next chapter (Chapter 5), I present a comprehensive study in which I 
empirically examined the value of PTSD in explaining SAH patients HRQoL. The 
study also examined whether SAH patients' trait-coping style can help to predict 
the development of PTSD in both the short- and long-term. In respect to patients' 
fatigue and sleep dysfunction, I also measured SAH patients' complaints of these 
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difficulties using validated instruments, compared their scores to those of the 
general population (i.e. matched control subjects), and finally, evaluated the 
usefulness of PTSD in explaining their presence. 
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Chapter 5 
An examination of the explanative value of PTSD in 
predicting patients' short- and long-term psychosocial 
outcome after a subarachnoid haemorrhage 
Work presented in this chapter has previously appeared in: 
Noble, A.J., Baisch, S., Mendelow, A.D., Allen, L., Kane, P. & Schenk, T. (2008). Posttraumatic 
stress disorder explains reduced quality of life in subarachnoid hemorrhage patients in both the 
. short- and long-term. Neurosurgery, 63: 1095-1105. 
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5.1 Introduction 
Outcome research on subarachnoid haemorrhage (SAH) is confronted with a 
paradox. Conventional clinical measures such as the Glasgow Outcome Scale 
[318], which focus on the disability level of the disorder, suggest most SAH 
survivors can expect a moderate to good outcome, with little disability [90, 303]. In 
contrast, the more handicap-orientated measures of health-related quality of life 
(HRQoL) show that SAH patients experience a significantly reduced perceived 
sense of well-being in both the short- and long-term [377, 746]. Put simply: While 
neurologists/ neurosurgeons are mostly pleased with the outcome, patients and 
their carers are typically not [90]. How can this discrepancy be explained? 
Neither the physical nor the cognitive impairments which are typically 
experienced post-SAH are severe enough to explain the HRQoL reduction [540, 
541]. A meta-analysis which I presented in the previous chapter has also shown 
that other traditional SAH outcome predictors, such as age, sex, clinical severity 
and bleed severity are not useful explanative variables. As such, we have to look 
beyond traditional factors to find an explanation. One particularly promising 
candidate is post-traumatic stress disorder (PTSD). 
Numerous recent studies have reported that an SAH can be sufficiently 
traumatic to elicit a PTSD-reaction, with SAH patients illustrating aspects of the 
disorder in both the short- and long-term [47, 295, 314, 377, 540, 541, 627]. Two 
such studies used diagnostic criteria and reported (at least) three times the 
'normal' rate of PTSD in the SAH population [23, 47, 267, 295, 351]. Since PTSD 
has only recently been recognised as a disorder which can follow an SAH, its 
value in explaining patients' poor HRQoL has however, never been examined. 
Given that this disorder in general is known to cause significant functional 
impairment to its sufferers [10, 249, 422, 459, 514, 551, 585, 608, 662, 760], 
together with the fact that it is, on the whole, readily treatable and has known risk 
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factors (such as the use of maladaptive coping) [255], means that it is imperative 
that we examine and confirm whether or not it is a key determinant of SAH 
patients' poor HRQoL. 
Interestingly, the arrival of the concept of PTSD to SAH research could also 
mean that other mysterious aspects of SAH patients' psychosocial outcome could 
be explained. In particular, patients frequently complain of excessive fatigue and 
sleep difficulties following their haemorrhage [541, 553, 571]. The failure for them 
to be properly measured and for their cause to be established though, has meant 
that they are often dismissed by neurosurgeons (who tend to classify them as 
purely subjective and therefore not deserving of treatment [544]). PTSD could 
however, offer a reasonable explanation for their presence. After all, we know that 
sleep dysfunction (in the form of nightmares and difficulties falling and staying 
asleep) is a diagnostic symptom of PTSD [23] and that somatic complaints are 
highly associated with the presence of PTSD. Therefore, SAH patients' reports of 
fatigue and sleep dysfunction could simply be illustrations of the abnormal 
presence of PTSD in the SAH population [29, 135, 143, 173, 291, 326, 531, 769]. 
In fact, it is even plausible, that the sleep dysfunction induced by PTSD causes 
their fatigue with day-time somnolence [119, 254, 663]. This proposed causal path 
from PTSD to sleep dysfunction to fatigue however has never been examined. Any 
such examination however in SAH patients, would also need to take into account 
the possible role of patients' neuropsychological deficits and neurological 
impairments which could also plausibly lead to fatigue and sleep dysfunction [705, 
714]. 
To summarise the main points of the first part of this chapter, the evidence 
suggests that elevated levels of PTSD are found in the SAH population. This 
raises the possibility that PTSD could explain why SAH patients have low HRQoL, 
despite comparatively little physical/ cognitive disability [314, 409, 540, 541]. The 
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presence of PTSD could also explain these patients' mysterious symptoms of 
fatigue and sleep. 
In this study, I therefore address the following questions: 
(1) Can PTSD explain reduced HRQoL in SAH patients in both the short- and 
long-term? 
(2) Is PTSD a better predictor of HRQoL than more traditional predictors, including 
physical/ cognitive disability? 
(3) Is PTSD in the acute stages of recovery associated with worse HRQoL in the 
long-term? 
(4) Why do some SAH patients develop PTSD while others do not? 
(5) What is the relationship between PTSD, fatigue and sleep dysfunction? 
To do this, a sample of SAH patients were followed with consecutive 
neuropsychological examinations at approximately 3 and 13 months post-ictus 
(assessment one and assessment two respectively). Patients were assessed with 
a comprehensive battery and regression analysis established the predictive values 
of PTSD, age, sex, clinical severity, time since illness and physical and cognitive 
disability for patients' HRQoL in the early and later stages of recovery. The 
relationship between PTSD, fatigue and sleep dysfunction was also examined and 
the role of coping-strategies in PTSD development following SAH was explored. 
In designing this study to answer the above questions, I paid particular 
attention to addressing limitations within previous SAH studies. It is necessary to 
briefly discuss some of the resultant features of my study and the rationale behind 
them. 
Firstly, the study examines a prospectively recruited sample, rather than a 
retrospective sample as is common to many prior SAH studies [12, 83, 129, 144, 
189, 279, 302, 358, 376, 548, 752]. Prospective recruitment involves waiting for 
new SAH cases to occur and then attempting to recruit these participants. Given 
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the relative infrequency of SAH, retrospective techniques have proved more 
popular because these involve drawing participants from a large pool of patients 
who have already been treated (e.g., searching neurosurgical department records 
and recruiting from follow-up review clinics) [692]. This approach has the obvious 
advantage of (potentially) being able to generate sufficient numbers of participants 
in a shorter period of time as one can search departmental records as far back as 
needed until a sufficient sample size has been established. Retrospective 
recruitment techniques are however, amongst other things, especially susceptible 
to recruitment bias. For example, patients still under medical care or who have not 
been able to return to work may be more likely to participate in studies due to their 
increased availability [507]. Another disadvantage is that the samples of SAH 
participants generated by this technique are very heterogeneous, in terms of for 
example, the time since they had their SAH. Moreover, the rapid developments in 
the medical care of SAH, means that patients who have received different 
standards of treatment may be combined to form a single sample. Thus, in short, 
retrospective samples are not representative and are heterogeneous; prospective 
ones are more representative, homogeneous and therefore more likely to have the 
required sensitivity. 
Secondly, despite their tendency to use retrospective designs, previous 
studies have typically examined only small samples of patients [123, 129, 189, 
240,244,305,306,336,367,369,377,397,470,546,548,609,613,694, 703]. I 
on the other hand, study a large sample (in the context of the infrequent 
occurrence of SAH), by recruiting patients from two, rather than one regional 
neurosurgical treatment centre. This meant that a sample of 105 patients was 
recruited. This ensured that the statistical results are robust (e.g., the case-
variable ratio assumption for multiple regression models was met). 
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Thirdly, a representative sample of patients was recruited. This is in 
contrast to nearly all previous studies which used very restrictive inclusion criteria 
which resulted in only a select group of the SAH population typically being 
included - namely those who presented at hospital in the acute stages, in a good 
clinical state and had made a favourable physical recovery at the point of 
discharge. Though these patients are less challenging to recruit, the restricted 
inclusion criteria meant that a proportion of patients who are perfectly able to 
provide informed consent and participate are always excluded. Studies have also 
often excluded the 15-25% of SAH patients whose haemorrhage was not due to 
the rupture of a cerebral aneurysm. This is because it has been assumed that 
most of these excluded patients- namely, those whose bleed was of an unknown 
origin - have suffered what is considered a benign sub-form of SAH because it is 
associated with a less dramatic clinical course (i.e., a more gradual onset, no 
ischemic damage, no surgical intervention, limited extension of blood [71 0]). 
Increasing evidence however, suggests that this assumption is incorrect and that 
SAH patients' neuropsychological and psychosocial outcome is largely 
independent of the aetiology of the bleed, with a common pattern of deficits 
resulting regardless of the origin of the haemorrhage [78, 176, 301, 302, 324, 428, 
502, 504, 572, 628, 644]. In fact, some contend that those patients whose bleed 
was of an unknown origin could experience a worse psychiatric outcome. It has 
been argued for example, that a patient whose bleed was of an identifiable origin, 
such as a ruptured aneurysm, may leave the hospital more confident as the 
source of their haemorrhage has been "cured" and knowing that their chances of a 
further SAH are minimal. In contrast, a person whose bleed was of an unidentified 
origin and so remains untreated, may worry more about the likelihood of a further 
SAH. It has been postulated that these patients may be burdened by this 
additionally, (though unfounded) ever-present peril [211, 295, 306, 504, 572]. 
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A final limitation of previous studies addressed by the present study is that 
patients' neurological disabilities have not previously been measured using 
instruments with a high degree of ecological validity. Prior studies for example, 
used only classic neuropsychological tests which are designed not to predict 
behaviour, but rather to localise lesions [203, 276]. The use of these measures 
could have served to attenuate the relationship ·between patients' scores on 
cognitive tests and their HRQoL. Since in this chapter I am examining the relative 
value of PTSD, I felt it sensible to adopt a conservative approach and compare its 
explanative value next to neurological variables indexed using sensitive measures 
with a high degree of ecological validity. 
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5.2 Methods 
Patients 
A prospective and consecutive series of 105 non-institutionalised patients was 
studied. Patients were recruited from a potential population of 186 first-time victims 
of spontaneous SAH, admitted to Newcastle General or James Cook University 
Hospital between April 2005 and August 2006. Of the non-participators, 6 were 
excluded for geographic reasons, 1 did not speak English and 7 4 declined 
particip9tion. 
SAH diagnosis was established by CT, or if negative, xanthrochromia in 
cerebrospinal spinal fluid was considered diagnostic. Aneurysms were 
demonstrated by spiral computed tomography or catheter angiography. 
Age and sex-matched controls were recruited from the U.K. general 
population to provide sleep and fatigue data to compare to that of SAH patients. 
Control subjects were recruited through personal contacts and recreational clubs. 
This study was granted multi-centre approval by the Central Manchester 
Research Ethics Committee. Informed consent was obtained from all participants. 
Procedure 
Patients completed two comprehensive neuropsychological assessments at their 
homes or at a laboratory at Durham University. Following a brief introductory 
interview, the patient's HRQoL, attention, memory and executive function were 
examined. Patients were then left with a series of self-report measures to examine 
their psychiatric status, fatigue and sleep dysfunction. These were then either 
returned to me using a pre-paid envelope or collected at a later date. The two 
appointments were conducted at approximately 3 (Assessment 1) and 13 
(Assessment 2) months post-ictus. The neuropsychological appointments lasted 
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approximately 3.5 hours (including regular breaks taken according to the 
requirements of the individual patient). 
Measures 
Instruments were chosen on the basis of having robust psychometric properties 
and ecological validity for cognitive tasks [95, 107, 139, 194, 197, 238, 563, 657, 
734, 754-756]. Each of these items is detailed below. A complete list of these 
instruments along with a shortened description can also be found in Table 5.1. 
Please note that parallel versions of the TEA and RBMT-E were used at 
assessments one and two. 
The Short-Form 36 (SF-36) [734] assesses HRQoL across 8 domains: 1) 
'Physical Functioning', 2) 'Physical Role Limitations', 3) 'Bodily Pain', 4) 'General 
Health', 5) 'Energy', 6) 'Social Functioning', 7) 'Emotional Role Limitations' and 8) 
'Mental Health'. Scores range from 100 (no reduction) to 0 (maximum reduction). 
Standard algorithms - derived from principal component analyses - aggregated 
scores from the eight domains into two summary scores for regression: 'Physical 
HRQoL' and 'Mental HRQoL'. Scores from domains 1-4 mostly contribute to 
'Physical HRQoL', whilst domains 5-8 contribute most to 'Mental HRQoL' (see 
Figure 3.2, Chapter 3 for schematic of the structure and questions of the SF-36) 
[733]. 
The Post-traumatic Diagnostic Scale [194] assesses whether patients 
warrant a DSM-IV-TR diagnosis of PTSD (see Table 4.2, Chapter 4 for diagnostic 
symptoms of PTSD) [23]. It provides a PTSD symptom severity score and a 
functional impairment index for those diagnosed. For use in some regression 
analyses, a 'PTSD Symptom Severity' score was calculated for all patients 
regardless of PTSD diagnosis. PTSD is usually only diagnosed if patients have 
experienced intense fear, helplessness or horror at the time of the trauma. Given 
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Table 5.1 
Purpose 
Screening 
Global mental status 
Health-related quality 
of life 
Post-traumatic stress 
disorder 
Fatigue 
Summary of neurological, neuropsychological and psychosocial instruments used in the study 
Test 
Behavioural Inattention Test (BIT) [756]; 
Short Token Test [139]. 
Mini-Mental State Examination (MMSE) [197]. 
Short-Form-36 (SF-36) [734]. 
Post-traumatic Stress Diagnostic Scale (PDS) [194]. 
Multidimensional Fatigue Symptom Inventory-Short Form 
(MSFI-SF) [657]. 
Information 
These tests screened for unilateral visual neglect and linguistic deficits. They were completed at assessment one and were used 
to establish whether administration of the remaining battery was appropriate. 
This was completed at assessment one only and was used to establish global cognitive status for all patients. This brief index was 
then used in missing value analysis to assess if those failing to complete a subsequent test significantly differed in cognitive status 
from those with complete data. 
Measured health-related quality of life (HRQoL) across 8 domains (see Figure 3.2, Chapter 3). 'Physical HRQoL' and 'Mental 
HRQoL' summary scores were generated for regression analyses using standard algorithms. 
This measure assesses whether a patient warranted a DSM-IV diagnosis of post-traumatic stress disorder (PTSD) in relation to 
their SAH experience. 
It provides a PTSD symptom severity score and a functional impairment index. 
PTSD is usually only diagnosed if patients experienced intense fear, helplessness or horror at the time of the trauma. Given SAH 
can lead to loss of consciousness at the time of trauma, this criteria was relaxed. The effect of this modification was minimal and 
merely permitted diagnosis of PTSD in two more patients at assessment one and three more patients at assessment two. 
Fatigue measured across the following scales: General Fatigue, Physical Fatigue, Mental Fatigue, Emotional Fatigue and Vigour. 
The sum of the fatigue subscales minus the 'Vigour' scale generated a Total Fatigue Score. 
148 
Table 5.1 Cont'd. 
Purpose 
Cognition 
Sleep 
Physical disability 
Coping 
Test 
Test of Everyday Attention (TEA) [563]; Behavioural 
Assessment of the Dysexecutive Syndrome (BADS) [754]; 
Rivermead Behavioural Memory Test- Extended (RBMT-E) 
[755]. 
Pittsburgh Sleep Quality Index (PSIQ) [95]. 
Functional Independence Measure- Motor Scale (FIM-MS) 
[238]. 
Brief Cope Inventory [1 07]. 
Information 
Attention tasks: 'Visual Elevator', Telephone Search', Telephone Search Dual Task', 'Elevator Counting' and 'Lottery'. 
Executive subtests: 'Rule Shift Cards', 'Key Search', 'Modified Six Elements', Temporal Judgment', and 'Zoo Map'. 
Memory subtests: 'Story Immediate' and 'Delayed', 'Picture Recognition', 'Face Recognition', 'Orientation and Date', 'First Name~ 
'Second 
Names', and 'Appointments and Belongings'. 
Sleep measured across the following scales: Subjective Sleep Quality, Latency, Duration, Habitual Sleep Efficiency (hours slee 
hours in bed}, Disturbances, Sleep Medication Use, Daytime Dysfunction and Global Sleep score. 
Independence was measured across 13 tasks. Increasing values indicate greater levels of independence inmobility, self-cal 
and continence. 
Measured patients' dispositional use of 'Maladaptive Coping Strategies', 'Venting', 'Denial', 'Substance Use', 'Behaviour 
Disengagement' and 'Self-Distraction'. This measure was completed at assessment one only. 
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that SAH can sometimes lead to loss of consciousness around ictus and so the 
aforementioned feelings are not necessarily experienced, this criterion was 
relaxed. The effect of this modification in my use of the diagnostic criteria was 
minimal, but allowed me to include two more patients at assessment one and 
three more patients at assessment two (patients who would have otherwise been 
excluded). The prevalence of sub-threshold/ sub-syndromal PTSD (i.e., a 
syndrome of symptoms below the threshold for the DSM-IV diagnosis of fuii-
PTSD) in the patient sample was also recorded. Sub-threshold/ sub-syndromal 
PTSD (hereafter referred to as just sub-syndromal PTSD) was defined, according 
to recent guidelines [477], as a syndrome in which the threshold for Criterion C 
(Avoidance) and/or D (Arousal) was not reached, but there was at least one 
symptom of each of these criterion present. These symptoms, along with those of 
Intrusion (Criterion B), must have been present for at least one month (Criterion E) 
and have caused significant distress and/ or functional impairment (Criterion F). 
The Multidimensional Fatigue Symptom Inventory - Short Form (MFSI-SF) 
[657] assesses how much patients experience fatigue symptoms. The MFSI-SF is 
comprised of the following 5 subscales: 1) General Fatigue (e.g., "I feel 
shattered"), 2) 'Physical Fatigue' (e.g., "My legs feel weak"), 3) 'Mental Fatigue' 
(e.g., "I am confused"), 4) 'Emotional Fatigue' (e.g., "I am distressed") and 5) 
'Vigour' (e.g., "I feel energetic). Subjects are asked to base their responses on 
their experience of the preceding week. Higher scores, except for 'Vigour', 
indicate more fatigue (0-24 ). The sum of the fatigue subscales minus the 'Vigour' 
subscale generates a Total Fatigue Score (ranging from -24 to 96). 
The Functional Independence Measure - Motor Subscale (FIM-MS) [238] 
measures physical disability. Physical independence is measured on ?-point 
scales across the following 13 tasks: eating, grooming, bathing, dressing (lower 
body, upper body), toileting, bladder management, bowel management, transfers 
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to/from bed/chair/wheelchair, transfers to/from toilet, transfers to/from 
bath/shower, walking and stairs. Increased values indicate greater levels of 
independence in mobility, self-care and continence. 
The Test of Everyday Attention (TEA) [563] assesses attention. The 
following tasks were used: 'Visual Elevator', 'Telephone Search', 'Telephone 
Search Dual Task', 'Elevator Counting' and 'Lottery'. 
The Behavioural Assessment of the Dysexecutive Syndrome (BADS) [754] 
measures executive skills. The following tests were used: 'Rule Shift Cards', 'Key 
Search', 'Modified Six Elements', 'Temporal Judgment', 'Key Search', 'Zoo Map' 
and 'Modified Six Elements'. 
The Rivermead Behavioural Memory Test - Extended (RBMT-E) [755] 
measures everyday memory function. This battery was specifically designed to 
detect milder, more subtle memory deficits. The following tests were used: 'Story 
Immediate' and 'Delayed', 'Picture Recognition', 'Face Recognition', 'Orientation 
and Date', 'First Names', 'Second Names' and 'Appointments and Belongings'. For 
further details on the specific memory tests which comprise this battery, as well as 
for the tests included in the attention and executive batteries, please refer to 
Appendix VIII. 
The Pittsburgh Sleep Quality Index (PSIQ) [95] measures sleep quality over 
the preceding month. The sleep component scores generated were: 'Subjective 
Sleep Quality', 'Latency', 'Duration', 'Habitual Sleep Efficiency' (hours sleep: hours 
in bed), 'Disturbances', 'Use of Sleep Medication' and 'Daytime Dysfunction'. 
Component scores ranged from 0-3. The sum of these yielded a 'Global PSIQ 
Sleep' score (0-21 ), where higher scores indicate worse sleep. 
The Brief COPE Inventory [1 07] measured patients' dispositional use of 
'Maladaptive Coping Strategies' ('Venting', 'Denial', 'Substance Use', 'Behavioural 
Disengagement', 'Self-Distraction' and 'Self-Blame'). Higher scores denote more 
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frequent use. Internal consistency was satisfactory. This measure was only taken 
at assessment one. 
The Mini-Mental State Examination (MMSE) [197] was completed at 
assessment one only and was used to establish global cognitive function in 
patients. This brief index was then used in missing value analyses to assess 
whether those failing to complete a subsequent test significantly differed in 
cognitive status from those with complete data. 
Behavioural Inattention Test (BIT) [756]. The BIT Line Bisection and Star 
Cancellation tests were used to screen for signs of unilateral neglect. 
The Short Token Test [139] screens for linguistic deficits by asking patients 
to follow increasingly complex commands. This and the two previous tasks were 
used to establish whether administration of the remaining test battery was 
appropriate. 
Data Analysis 
With large numbers of comparisons in some analyses, alpha levels were adjusted 
(Bonferonni) as appropriate to compensate for family-wise error and keep the 
alpha-level at 5%. The adopted values are reported in the corresponding 
paragraphs of the Results section. When missing data exceeded 5%, a missing 
value analysis assessed its impact on the results' generalisability by examining if 
incompleteness was dependent on any variable (Little MCAR test) and whether 
cases with missing data were comparable to those without (t-tests; variables 
considered age, sex, clinical severity, haemorrhage type, treatment type and 
MMSE). For the purposes of brevity, I only report on the results of missing variable 
analyses when a significant result was found. Spearman's correlations were used 
to examine the correlations between the main outcome measures of 'Mental 
HRQoL', 'Physical HRQoL', PTSD, fatigue and sleep at each assessment. For 
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regression analyses, beta values (standardized B) and squared semi-partial 
correlations (sr2;) indicated relative and unique predictor contributions. The 
backward elimination method of variable entry/ selection (likelihood ratio test for 
logistic regression) was used in the regression analyses to identify. the most 
parsimonious predictor variables. Stepwise block entry regression was also used 
in a few instances to examine the unique explanative ability of a variable once the 
variance accounted for by other variables was controlled for. Case-variable ratios 
were satisfactory for regression models. Where possible, effect sizes (ES) in the 
form of the correlation coefficient r are reported for all results. Analyses were 
conducted using commercially available software (SPSS). 
Health-Related Quality of Life (HRQoL). Kruskai-Wallis one-way analyses 
of variance determined the normality of patients' SF-36 scores by comparing their 
scores to reference values [60]. Three- and thirteen month 'Physical HRQoL' and 
'Mental HRQoL' determinants were explored using Spearman's correlation and 
multiple linear regression. Parametric regression techniques were most 
appropriate for this ordinal data due to the number of occupied categories, and 
due to the fact that it was fair to assume an underlying continuum and an equal 
distance between each ordinal point of the SF-36 [727]. Predictors considered 
were: age, sex, clinical severity as indexed by the World Federation of 
Neurological Surgeons (WFNS) scale [164], history of previous illness vs. none, 
the 'Overall Cognitive Function' index, 'FIM-MS' score and 'PTSD Symptom 
Severity' score from the same assessment point. Further regression analyses, 
this time using stepwise variable entry (2 blocks), were conducted to examine 1) 
the unique ability of SAH patients' PTSD detected at the short-term assessment to 
predict the HRQoL these patients reported at the long-term assessment and 2) 
any change that had occurred between patients' short-term HRQoL and long-term 
HRQoL (indexed as a patient's long-term HRQoL minus their short-term HRQoL). 
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In the first block, traditional variables from the acute stages of a patient's illness 
and short-term assessment - namely their age, sex, WFNS score, history of 
previous illness vs. none, 'Overall Cognitive Function' score and 'FIM-MS' score -
were entered and formed the predictive model. The variance which these 
predictors accounted for was therefore controlled. In the second entry block, the 
patient's 'PTSD Symptom Severity' score from the short-term assessment was 
then entered into the model and its unique explanative value was established. The 
Wilcoxon matched-pairs signed-ranks test compared patients' assessment one 
and assessment two SF-36 scores. 
Post-traumatic Stress Disorder (PTSD). The severity and functional 
impairment of the PTSD for those diagnosed is described. The rate of PTSD in the 
SAH sample (both at assessments one and two) was compared to that expected 
in the general population [23]. Logistic regression examined the following 
predictors for PTSD at both time points: age, sex, WFNS grade, psychiatric history 
vs. none, aneurysmal SAH (ASAH) vs. non-ASAH, surgery vs. not, endovascular 
vs. not, education and dispositional use of 'Maladaptive Coping Strategies'. For 
this kind of analysis the odds ratio (OR) can be used to interpret the two 
regression models. The OR indicates the change in the odds of having or not 
having PTSD when the value of a predictor increases by one unit. The c-statistic 
measures the discriminative power of the two regression equations. Varying from 
0.5 (predictions are no better than chance) to 1.0 (model predicts without error), it 
is the percentage of case pairs to which the models correctly assigns a higher 
probability. The Wilcoxon matched-pairs signed-ranks test and McNemar's test of 
symmetry were used to compare the PTSD reported at assessments one and two. 
Sleep. and Fatigue. Kruskai-Wallis analyses compared patients' PSQI and 
MFSI-SF scores to those of controls to determine the normality of SAH sleep and 
fatigue. Fatigue or sleep levels which were equal to or greater than the levels 
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found at the lower borders of the 90th quantiles were judged to be abnormal. The 
proportion of abnormal fatigue ('Total Fatigue' score) and sleep ('Global PSIQ 
Sleep' score) were calculated. Determinants of fatigue ('Total Fatigue' score) and 
sleep quality at assessments one and two ('Global PSIQ Sleep' score) were 
explored by regression. Again, with assumptions (see comments in the paragraph 
on the use of linear regression analysis for HRQoL), parametric regression 
procedures were used to identify the predictors for these two ordinal variables. 
Predictors considered for sleep were: age, sex, WFNS grade, ASAH vs. other 
type, 'Overall Cognitive Function' index, 'psychiatric history vs. none' and 'PTSD 
Symptom Severity' score. The predictors of fatigue were the same except for the 
addition of a 'Global PSIQ Sleep' score. Mann-Whitney U tests were used to 
further explore the sleep and fatigue experienced by those with and those without 
PTSD, whilst Spearman's correlation tests examined the relationship between 
sleep quality and concurrent fatigue. The Wilcoxon matched-pairs signed-ranks 
test compared the quality of sleep and fatigue reported at assessments one and 
two. 
Physical Disability. Median scores across 'FIM-MS' items were calculated. 
The proportion of patients with disability at assessments one and two was 
calculated ( <6 indicates dependence). The Wilcoxon matched-pairs signed-ranks 
test compared FIM-MS scores from assessment one and two. 
Cognition. Using normative data [564, 754, 755], 'Attention', 'Memory' and 
'Executive Function' indexes were generated from performances on the 
assessments. Indexes are based on the following scale: 4-Exceptional, 3-Good, 2-
Average, 1-Poor and 0-lmpaired. Scoring instructions from the RBMT-E and BADS 
manuals generated the 'Memory Function' and 'Executive Function' indexes 
respectively. For the 'Executive Function' index, the labels adopted were mapped 
onto the labels used in the BADS as follows: "very superior'' = 4-excellent, "high 
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average/ superior" = 3-good, "average" = 2-average, "borderline/low average" = 1-
poor and "impaired" = 0-impaired. As no standard TEA procedure exists for 
generating an 'Attention Function' index, I scored TEA subtest performances 
(directed by accepted guidelines [248]) as follows: TEA '=:98% = 4-excellent, '=:75% 
= 3-good, '=:25% = 2-average, '=:2% = 1-poor and <2% = 0-impaired. TEA lottery 
task performance, which in its original format is scored according to cut-offs, was 
awarded the following: TEA "impaired" = 0-impaired; "borderline" = 1-poor and 
"normal" = 3-good. The 'Attention Function' index was the median score on the 
subtests. For the purposes of regression analyses, 'Overall Cognitive Function' 
indices were generated for patients to represent cognitive performance on each 
respective assessment. These indices were calculated by summing the 'Attention', 
'Memory' and 'Executive' indexes from the respective assessment. Changes in 
cognitive performance from assessment one to assessment two were analysed by 
Wilcoxon test. 
5.3 Results 
The recruited patient group consisted of 60 women and 45 men. No differences 
existed between participators and non-participators in age, sex, WFNS grade, 
haemorrhage type, or treatment (all P>0.05; Little's MCAR: P=.082). All 105 
patients were examined at assessment one, but 10 patients (9.5%) were lost from 
the sample at assessment two (Table 5.2). The reason for the reduced sample 
was due to one patient death and the remaining nine patients declining to 
participate in assessment two. No significant differences existed between the 
patients who were examined at assessment two and those who were not (P>0.05), 
with no pattern to the missing data being found (Little's MCAR: P=.549). Average 
follow-up for assessment one was 109 days after SAH (SO 49.95; range 24-251) 
and 406 days after SAH for assessment two (SO 47.82; range 335-672). In total, 
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Table 5.2 Demographic and clinical data of patients examined at 
assessments one and two 
Factor 
Mean age at assessment± SD (range) (yr) 
Women 
Education (yr) 
Aneurysmal SAH 
Location of ruptured aneurysm 
ACoMIACA 
/CA 
MCA 
Vertebrobasi/ar 
Unknown origin 
Other origin 
WFNS grade 
II 
Ill 
IV 
v 
Primary treatment 
Endovascular 
Surgery 
Conservative 
Significant history * 
Physical only 
Psychiatric only 
Both 
Value(%) 
Assessment one (N=1 05) 
52.4 ± 11 (31-80) 
60(57.1) 
11.6± 1.51 (10-20) 
77 (73.3) 
34 (44.2) 
19 (24.7) 
19 (24.7) 
5 (6.5) 
25 (23.8) 
3 (2.9) 
74 (70.5) 
15 (14.3) 
5 (4.8) 
10 (9.5) 
1 (1) 
47 (44.8) 
32 (30.5) 
26 (24.8) 
18(17.1) 
15 (14.3) 
16(15.2) 
Assessment two (N=95) 
53.0 ± 11 (32-81) 
54 (56.8) 
11.6± 1.6 (10-20) 
67 (70.5) 
31 (46.3) 
14 (20.9) 
17 (25.4) 
5 (7.5) 
25 (26.3) 
3 (3.2) 
66 (69.5) 
13 (13.7) 
5 (5.3) 
10 (10.5) 
1 (1.1) 
40 (42.1) 
29 (30.5) 
26 (27.4) 
15 (15.8) 
15 (15.8) 
15 (15.8) 
Note: ACA=anterior cerebral artery; ACoM=anterior communicating artery; ICA=internal carotid artery; n=number; 
MCA=middle cerebral artery; N=number; SD=standard deviation; Vertebrobasilar =vertebrobasilar system artery; 
WFNS=World Federation of Neurological Surgeons; yr=year. *Self-reported illness receiving/ received formal treatment. 
Physical illness: benign intracranial hypertension; cancer; epilepsy; Guillain-Barre syndrome; human immunodeficiency 
virus; hypothyroidism; ischemic stroke; kidney cyst; meningioma; multiple sclerosis; myocardial infarction; pulmonary 
emphysema; Reynaud's phenomenon; recurrent pneumothorax; rheumatoid arthritis; road traffic accident Injuries; sleep 
apnoea; spondylosis; transient ischemic attack; tuberculosis. Psychiatric illness: Anxiety unspecified diagnosis; Depression 
unspecified diagnosis and Alcohol abuse. 
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87 controls were recruited to complete the sleep and fatigue measures. Controls 
were comparable to their matched SAH patient in age (assessment one M=53.28, 
SD 9.68, range 28-77; assessment two M=52.73, SD 10.94, range 28-77) and sex 
(assessment one 43 females; assessment two 51 females; all P>0.05). 
Outcome measures 
Assessment one 
Health-Related Quality of Life (HRQoL). HRQoL was assessed in 103 
patients, with patients scoring significantly worse across all domains compared to 
reference values (Adjusted alpha P<0.006; Figure 5.1 ). 
Post-traumatic Stress Disorder (PTSD). PTSD was assessed in 97 patients. 
Thirty-six (37.1 %) patients were diagnosed with PTSD. In the general population a 
prevalence of ::;8% is expected [23, 267, 351]. Symptom severity for those 
diagnosed at assessment one was "moderate to severe" (median 22, interquartile 
range [IQR]=14-31) and caused "severe" functional impairment (75%). A further 10 
patients (10.3%) met the criteria for sub-syndromal PTSD. The severity of these 
patients' PTSD syndrome was categorised as mild (median=9.5, IQR=6-10), but 
nevertheless, still severely impaired the majority (80%). A missing value analysis 
revealed that those with missing data (7.6%) were more cognitively impaired at a 
global level (MMSE; t7.4= 3.2, P<0.02). 
Fatigue and Sleep. Fatigue and sleep measures were completed by 73 
patients. Patients showed significantly worse fatigue compared to controls across 
all domains, with 59% experiencing pathological fatigue (all P<0.002; Adjusted 
alpha P<0.008). The sleep of 45% of patients at assessment one was 
pathological. SAH patients illustrated significantly poorer sleep quality in terms of 
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Figure 5.1 Graph showing the SF-36 HRQoL profile of patients at assessments 
one and two. Deviations from reference data are expressed in mean 
standard scores. All deviations from reference values are significant 
(P<0.05), except 'Emotional Role Limitations' at assessment two. 
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Table 5.3 Comparison of fatigue and sleep of patients and controls at assessments one and two 
Factor Assessment one Assessment one Assessment ES Assessment two Assessment two Assessment ES Assessment ES 
SAH patients Matched controls one patients SAH patients Matched controls two one vs. 
vs. controls patients vs. assessment 
P-value controls two patients 
P-value p-value 
N Median IQR N Median IQR N Median IQR N Median IQR 
Fatigue- MFSI-SF 
General Fatigue 73 13.0 5.0- 16.5 73 5.0 2.0- 8.0 <0.0001 .41 87 8.0 4.0-17.0 87 4.0 2.0-8.0 <0.0001 .28 ns .11 
Physical Fatigue 73 6.0 3.0- 12.0 73 1.0 0.0-4.0 <0.0001 .47 87 5.0 2.0-10.0 87 2.0 0.0-5.0 <0.0001 .34 ns .05 
Emotional Fatigue 73 5.0 1.0- 11.0 73 2.0 0.0-5.0 <0.002 .28 87 4.0 1.0-10.0 87 2.0 0.0-5.0 <0.002 .25 ns .05 
Mental Fatigue 73 8.0 4.0- 13.5 73 3.0 2.0- 6.0 <0.0001 .36 87 8.0 5.0-13.0 87 3.0 1.0-6.0 <0.0001 .41 ns .19 
Vigour 73 8.0 5.0- 12.0 73 13.0 9.0- 15.0 <0.0001 .41 87 8.0 6.0-12.0 87 13.0 10.0-17.0 <0.0001 .44 ns .16 
Total Fatigue 73 26.0 3.0-44.0 73 0.0 -8.0- 13.0 <0.0001 .45 87 18.0 2.0-39.0 87 -2.0 -10.0-12.0 <0.0001 .43 ns .04 
Sleep- PSIQ 
Subjective Sleep 73 1.0 0-2.0 73 1.0 0- 1.0 ns .14 87 1.0 1.0-2.0 87 1.0 0.0-1.0 <0.02 .20 ns .18 
Quality 
Sleep Latency 73 1.0 0-3.0 73 1.0 1-2.0 ns .11 87 1.0 0.0-2.0 87 1.0 0.0-2.0 ns .08 ns .01 
Sleep Duration 73 0.0 0- 1.5 73 1.0 0- 1.0 ns .07 87 1.0 0.0-2.0 87 1.0 0.0-1.0 ns .05 ns .09 
Habitual Sleep 73 1.0 0-3.0 73 0.0 0- 1.0 <0.007 .33 87 1.0 0.0-2.0 87 1.0 0.0-1.0 ns .14 ns .05 
Efficiency 
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Table 5.3 Cont'd. 
Factor Assessment one Assessment one Assessment ES Assessment two Assessment two Assessment ES Assessment ES 
SAH patients Matched controls one patients SAH patients Matched controls two one vs. 
vs. controls patients vs. assessment 
P-value controls two patients 
P-value P-value 
N Median lOR N Median lOR N Median IQR N Median lOR 
Sleep - PS/Q Cont'd. 
Sleep Disturbances 73 1.0 1-2.0 73 1.0 1-2.0 ns .13 87 1.0 t.0-2.0 87 1.0 1.0-2.0 ns .06 ns .08 
Use of Sleep 73 0.0 0-0.0 73 0.0 0-0.0 ns .14 87 0.0 0.0-0.0 87 0.0 0.0-0.0 ns .07 ns .04 
Medication 
Daytime 73 1.0 1-2.0 73 1.0 0-1.0 <0.009 .22 87 1.0 1.0-2.0 87 1.0 0.0-1.0 <0.007 .21 ns .10 
Dysfunction 
Global PSIQ Sleep 73 7.0 3.5- 10.5 73 6.0 3.5-8.0 <0.04 .17 87 6.0 4.0-11.0 87 6.0 4.0-8.0 ns .14 ns .01 
Score 
Note: ES=effect size (r); IQR = interquartile range; MFSI-SF = Multidimensional Fatigue Symptom Inventory- Short Form; N =number; ns =non significant. PSIQ =The Pittsburgh Sleep Quality Index; higher 
PSIQ scores denote greater sleep difficulties. For comparisons between patients and controls, the critical alpha =<0.05. The adjusted alphas for comparison of patients' fatigue and sleep scores from assessment one 
and two were <0.008 and <0.006 respectively. Higher MFSI-SF scores denote more fatigue, except for the factor 'vigour'. Values are expressed as medians 
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'Habitual Sleep Efficiency' (Adjusted alpha P<0.007; Table 5.3). 
Physical Disability. The physical status of 99 patients was examined. Only 
4.0% of patients illustrated dependence (Table 5.4). 
Cognition. There was notable decline in memory function, with 33.3% of the 
102 assessed patients being classified as "impaired". This contrasts with the 
2.12% found within healthy controls as reported by test makers. Less attentional 
(5.8%) and executive (12.7%) impairment was found (Table 5.4). 
Assessment two 
Health-Related Quality of Life (HRQoL). HRQoL was assessed in 94 
patients. Compared to reference values and using an unadjusted alpha level of 
0.05, patients scored significantly worse across all domains at assessment two, 
except in 'Emotional Role Limitations' (P=0.202; Figure 5.1 ). According to an 
adjusted alpha of P<0.006, SAH patients' HRQoL was also no longer different to 
reference values in terms of Physical Functioning (P=0.023) and General Health 
(P=0.031 ). Patients' scores did however, still significantly differ in the areas of 
Physical Role Limitations (P<0.003), Bodily Pain (P<0.006), Energy (P<0.0001 ), 
Social Functioning (P<0.001) and Mental Health (P<0.004). 
Post-traumatic Stress Disorder (PTSD). PTSD was assessed for in 89 
patients. Thirty-three (37.1 %) patients were diagnosed with the disorder. Symptom 
severity for those diagnosed was "moderate" (median=18, IQR=12-30) and caused 
"severe" functional impairment for the majority (82%). A further 12 (13.5%) 
patients fulfilled the criteria for sub-syndromal PTSD. These patients' syndromes 
were typically only mild in severity (median=6.0, IQR=5-1 0), but still caused 41.7% 
of the patients "severe" functional impairment. 
Fatigue and Sleep. Fatigue and sleep measures were completed by 87 
patients. Patients showed significantly worse fatigue compared to controls across 
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Table 5.4 Summary of results from cognitive and physical examinations in assessments one and two 
Factor 
N 
Cognition 
RBMT-E Memory Function 102 
BADS Executive Function 102 
TEA Attention Function 103 
Physical 
FIM-motor scale 99 
Assessment one 
SAH patients 
Median IQR Percentage in 
clinical range 
1.0 0.0- 1.0 33.3 
2.0 1.0-2.0 12.7 
2.0 1.0-2.0 5.8 
7.0 7.0- 7.0 4.0 
N 
95 
95 
95 
87 
Assessment two 
SAH patients 
Median IQR Percentage in 
clinical range 
1.0 0.0- 1.0 29.5 
2.0 1.0-3.0 13.7 
2.0 1.0-3.0 8.4 
7.0 7.0- 7.0 8.0 
Assessment 
one versus two 
P-value 
ns 
ns 
ns 
ns 
ES 
.15 
.06 
.04 
.09 
Note: BADS=Behavioural Assessment of the Dysexecutive Syndrome; FIM-motor scale=Functional Independence Measure motor scale items. FIM-
motor scale scores range from 1 (total dependence) to 7 (totally independent); IQR=interquartile range; N=number; ns=non significant; RBMT-E=Rivermead 
Behavioural Memory Test; TEA=Test of Everyday Attention. Cognitive function indexes range from 0 (impaired) to 4 (Excellent). Percent in clinical range for 
FIM was a median total motor score <6 (dependent on other person) and for cognitive tests it was a function score of 0 ("impaired"). For comparison of 
assessment one and two cognitive performances adjusted alpha P=0.01. Alpha for comparison of FIM-motor scale score P=0.05. Values are expressed as 
medians. 
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all domains - 36% reported pathological levels of fatigue (all P <0.002; Adjusted 
alpha P<0.0008). The only significantly reduced sleep score was seen in the 
domain of 'Daytime Dysfunction' (Adjusted alpha P<0.007). Sleep function was 
pathological in 37% of patients (Table 5.3). 
Physical Disability. The physical status of 87 patients was examined. Eight 
percent of patients illustrated dependence (Table 5.4 ). 
Cognition. In total, 95 patients were cognitively assessed. There was 
substantial memory dysfunction, with 29.5% of patients classified as "impaired" at 
assessment two. Much less attentional impairment (8.4%) and executive 
impairment (13.7% at assessment two) impairment was found (Table 5.4). 
Comparison of assessment one and two performances 
Health-Related Quality of Life (HRQoL). For the 93 patients who completed 
the SF-36 at both assessments, significant improvements in scores were seen at 
assessment two in the domains of 'Physical Functioning' (P<0.001, r-.36), 
'Physical Role Limitations' (P<0.0001, r-.54), 'Bodily Pain' (P<0.006, r-.29), 
'Social Functioning' (P<0.001, r-.57) and 'Emotional Role Limitations' (P<0.001, 
r-.36; Adjusted alpha P<0.006). Importantly, no significant improvement in SF-36 
was seen in 'General Health' (P= 0.77, r-.03), 'Energy' (P= 0.03, r-.22) or 'Mental 
Health' (P= 0.13, r-.16). 
Post-traumatic Stress Disorder (PTSD). For the 82 patients who completed 
PTSD assessments at both time points, the Wilcoxon test did not detect any 
significant difference in the number (P= 0.80; r-.03) or severity of PTSD symptoms 
experienced (P= 0.33; r-.11 ). Nor did it detect any significant difference in the 
experience of intrusive (P= 0.632; r-.05), avoidant (P= 0.189; r-.15) and arousal 
symptoms (P= 0.693; r-.04) at the two assessments (Adjusted alpha P< 0.01 ). A 
non-significant McNemar's test of symmetry indicated that the proportion of 
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patients with and without PTSD at the two assessments was comparable (P>0.05): 
Specifically, 75.6% of patients had the same PTSD status at the two assessments. 
A missing value analysis found that those without complete PTSD data (21.9%) 
from the first and second assessment were more cognitively impaired according to 
the MMSE (t2s.1= 2.9, P<0.009). 
Fatigue and Sleep. Wilcoxon analyses of the Global PSIQ Sleep score and 
MFSI-SF Total Fatigue score from the 58 patients examined at both assessment 
points, revealed no significant change in sleep quality or fatigue levels (both 
P>0.05; Table 5.3). 
Physical Disability. A Wilcoxon analysis of the physical disability scores of 
the 86 patients with complete 'FIM-MS' data from both assessments did not detect 
any significant change in physical status between assessments (P>0.05; Table 
5.4). 
Cognition. Wilcoxon analyses found there to be no significant improvement 
between assessments one and two, as measured by the 'Memory' (n=94; P= 
0.157), 'Executive' (n=93; P= 0.542) or 'Attention' (n=93; P= 0.694) indexes 
(Adjusted alpha P<0.02; Table 5.4). 
Correlation matrix 
Tables 5.5 and 5.6 present the correlations between the main outcome 
variables of 'Mental HRQoL', 'Physical HRQoL', 'PTSD Symptom Severity', 'Total 
Fatigue' score and 'Global Sleep Quality' score at assessment one and 
assessment two respectively. 
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Table 5.5 Matrix of correlations between main outcome variables at assessment one 
Assessment one 'Mental HRQoL' (SF-36 MCS) 'Physical HRQoL' (SF-36 PCS) 'Total Fatigue Score' (MFSI-SF) 'Global Sleep Quality' (PSQI) 
N 
'· 
P-value N 
'· 
P-value N 
'· 
P-va/ue N 
'· 
P-value 
'Mental HRQoL' (SF-36 MCS) 
'Physical HRQoL' (SF-36PCS) 93 .010 ns 
'Total Fatigue Score' (MFSI-SF) 68 -.588 <0.0001 68 -.272 <0.03 
'Global Sleep Quality Score' (PSQI) 69 -.475 <0.0001 69 -.243 <0.05 68 .507 <0.0001 
'PTSD Symptom Severity' (PDS) 93 -.630 <0.0001 93 -.240 <0.0001 68 .783 <0.0001 69 .575 <0.0001 
Note: Assessment one= approximately 3 months post-ictus: MCS= Mental Component Score; MFSI-SF= Multidimensional Fatigue Symptom Inventory- Short Form: N=number: 
ns= non-significant P>0.05; PCS= Physical Component Score: PDS= Post-traumatic Stress Diagnostic Scale; PSIQ= Pittsburgh Sleep Quality Index; SF-36= Short-Form-36. 
Table 5~6 Matrix of correlations between main outcome variables at assessment two 
Assessment one 'Mental HRQoL' (SF-36 MCS) 'Physical HRQoL' (SF-36 PCS) 'Total Fatigue Score' (MFSI-SF) 'Global Sleep Quality' (PSQI) 
N 
'· 
P-value N 
'· 
P-value N 
'· 
P-value N 
'· 
P-value 
'Mental HRQoL' (SF-36 MCS) 
'Physical HRQoL' (SF-36PCS) 85 .267 <0.02 
'Total Fatigue Score' (MFSI-SF) 78 -.782 <0.0001 78 -.365 <0.002 
'Global Sleep Quality Score' (PSQI) 79 -.450 <0.0001 79 -.188 Ns 78 .509 P<0.0001 
'PTSD Symptom Severity' (PDS) 80 -.688 <0.0001 80 -.310 <0.006 78 .761 P<0.0001 79 .535 <0.0001 
Note: Assessment two= approximately 13 months post-ictus; MCS= Mental Component Score; MFSI-SF= Multidimensional Fatigue Symptom Inventory- Short Form: N=number; 
ns= non-significant P>0.05; PCS= Physical Component Score; PDS= Post-traumatic Stress Diagnostic Scale; PSIQ= Pittsburgh Sleep Quality Index: SF-36= Short-Form-36. 
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Predictive models 
Table 5.7 provides a survey of those factors which proved significantly 
predictive in regression analyses for each outcome measure. 
Table 5.7 A survey of those factors which proved to be significant risk factors in 
regression analyses 
Outcome Risk factor 
Mento! HRQoL' Age 
(SF-36 MCS) Sex 
Clinical severily (WFNS) 
His10ty of P<IMOUS iDness 
Overall ~we fmction (TEA: RBMT·E: BAOS) 
Physical dlsabthly (FIM-MS) 
PTSD symplom severily (PDS) 
Model Summary 
Physical HRQoL' Age 
(SF.J6 PCS) Sex 
PTSO" (POS) § 
Clinical sevorlly (WFNS) 
HlsiOry of prov'oous Illness 
Ovenll a>gni~ve fmction (TEA: RBMT ·E: BAOS) 
Physical dlsabthly (FIM-MS) 
PTSD symplom severily (POS) 
Model Summary 
Sex 
Clinical severily (WFNS) 
Ps)'(:hialrlc history 
Aneurysmal vs. non aneurysmal haomorrhage 
SUrgery vs non·surgical inletVention 
Endovascular vs. noo-endovascuar lniA!<VenllOn 
Education 
Maladapllve coping (Brief COPE) 
Model Summary 
Assessment one As.sassment two 
IS/OR s?, P-value IS/OR S?, P-vatu• 
ns Ns 
ns Ns 
ns Ns 
ns Ns 
ns Ns 
ns Ns 
·.581 30% <0.0001 · .626 35% <0.0001 
R' = 0.44; F,,.•16.70, P<0.0001 R' = 0.48; Fut= 35.98. P<0.0001 
ns Ns 
ns Ns 
ns Ns 
-.334 11% <0.0001 Ns 
ns Ns 
.424 18% <0.0001 .429 18% <0.0001 
ns ·.411 15% <0.0001 
R'= 0.30; Fz.oo• 18.80, P<0.0001 R' = 0.43; F,,,. = 19.42, P<0.0001 
0.92 <0.005 Ns 
ns Ns 
ns Ns 
ns Ns 
ns Ns 
ns Ns 
ns Ns 
ns Ns 
3.67 <0.0001 3.22 <0.0001 
c=.85; x' l3. N• 9SJ=32.n. P<0.0001 c•.78: x'11. N=8tJ =t8 41 . P<o.ooo1 
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Table 5.7 Cont'd. 
Outcome 
(MFSI·SF} 
Risk factor 
Age 
Sex 
Clinical seve<ity (WFNS) 
Aneurysmal vs. non aneurysmal haemorrhage 
Ove<all cognitive function (TEA; RBMT-E: 
BADS) 
Psyclliatric his lory 
Sleep function (Global PSIQ Score) 
PTSD symptom severity (PDS) 
Model Summary 
Assessment one 
41 OR s?J P-value 
Ns 
Ns 
Ns 
Ns 
Ns 
Ns 
Ns 
.786 49% <0.0001 
R'• 0.64; F, .. = 37.75. P<0.0001 
Assessment two 
IJIOR s?1 P·valuo 
Ns 
Ns 
ns 
ns 
ns 
ns 
ns 
.796 58% <0.0001 
R1• 0.58; F, .... 58.31. P<O.OOOI 
Sleep• (PSIQ) Age Ns ns 
Sex 
Clinical severity (WFNS) 
Aneurysmal vs. non aneurysmal haemorrhage 
Overall cognilive funclion (TEA: RBMT-E: 
BADS) 
Psyclllalrlc hlslory 
PTSD symplom severity (PDS) 
MOdel Summary 
.532 27% 
Ns 
Ns 
Ns 
Ns 
Ns 
<0.0001 
R'• 0.38: F1.or= 20.71 P<0.0001 
.652 42% 
ns 
ns 
ns 
ns 
ns 
<0.0001 
R' = 0.45: F,...• 34.98 P<0.0001 
Nole: ·= <0.007: ··= <0.005; ···= <0.006; Assessmenl one= approxlmalely 3 monlhs posi·SAH; assessmenllwo= approximalely 13 monlhs 
posi-SAH: B=slandardlsed bela coeffiCient MFSI·SF• Mullidimensional Faligue Symptom Inventory - Short Form; OR• Odds.rallo: P= P-value; 
PDS= Post-trauma lie Stress [);agnostic Scale; PSIQ• Pittsburgh Sleep Qualily Index: SF·36 MCS= Short-Form·36 Menial oomponenl heallh-relaled 
quality of life soore: SF-36 PCS• Shorl Fonm·36 Physical heallh·relaled quallly of life componenl Soore: sr2i= squared semi-partial correlations; §= 
Logistic: regression. rather than linear regression. -; PredictOf not significant This table preseniS the explanative Importance and P·vatues of 
significant predictors in the regression analyses. Backward elimination methods (likelihood ratio 1ests In the case of logistic regressions) were used to 
identify parsimonious predictors. Please refer to the 'Data anafysis' section for further information on the predictors included In eaCh regression model. 
Assessment one 
Health-Related Quality of Life (HRQoL). Due to missing data of some of the 
patients, regression analysis was based on 93 patients. Bonferonni-correction led 
to the adoption of a test-wise alpha of P<0.007. 
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'Mental HRQoL': 44% of variance in 'Mental HRQoL' was accounted for 
(R2= 0.443; F4,84= 16.698, P<0.0001 ). Only 'PTSD Symptom Severity' scores were 
significantly predictive (squared semi-partial correlation [sli]=30%; standardized 
B= -.581; P<0.0001 ). Demographic, cognitive and physical disability information 
demonstrated no predictive value for 'Mental HRQoL' (Figure 5.2). 
'Physical HRQoL': 30% of variance in 'Physical HRQoL' was accounted for 
(R2= 0.304; F2,86= 18.801, P<0.0001 ). Physical disability contributed most (FIM-
MS; sli= 18%; standardized B = .424; P<0.0001 ), followed by history of significant 
illness (sli = 11 %; standardized B = -.334; P<0.0001 ). 
Post-traumatic Stress Disorder (PTSD). Due to missing data, this 
regression analysis was based on 95 patients. Bonferonni-correction led to the 
adoption of a test-wise alpha of P<0.005. 
A significantly effective logistic model to predict PTSD was generated (X2 [3, 
N= 95] = 32.767, P< 0.0001 ). Predominant use of 'Maladaptive Coping Strategies' 
(OR= 3.670, Cl 1.967 - 6.845; Wald= 16.707 (1) P<0.0001) and younger age 
(OR= 0.917, Cl 0.867- 0.971; Wald= 8.726 (1 ), P<0.005) significantly increased 
the probability of PTSD. Using a probability criterion of .5, predictive classification 
was excellent (c= 0.85), with the model assigning 85% of all possible pairs the 
correct probability of having PTSD (sensitivity= .71; specificity= .87; Figure 5.3). 
Table 5.8 presents a comparison of the symptoms and coping skills of those 
patients with and without PTSD. 
Fatigue. Bonferonni-correction led to the adoption of a test-wise alpha of 
P<0.006. 
A significantly predictive model for the 73 who completed the MFSI-SF at 
assessment one was generated -accounting for 64% of variance in 'Total Fatigue' 
scores (r= 0.797; R2= 0.635; F3,65= 37.750, P<0.0001 ). The model was based 
solely 
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Figure 5.2 Graphs of relationship between 'Mental HRQoL' and 'PTSD 
Symptom Severity' (upper), 'Cognition' (middle) and 'Physical 
Disability' (lower) at assessment one. 
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Figure 5.3 Graph depicting the relationship between probability of PTSD at 
assessments one and two with use of maladaptive coping strategies 
(upper; assessment one OR = 3.670; age held at mean; assessment 
two OR = 3.216) and relationship between PTSD and age at 
assessment one (lower; OR = 0.917; with use of maladaptive coping 
strategies held at mean level). 
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Table 5.8 Comparison of symptoms and coping skills of patients with and without post-traumatic stress disorder at assessments 
Factor Assessment one Assessment one P-value ES Assessment two Assessment two P-value ES 
With PTSD Without PTSD With PTSD Without PTSD 
N Median IQR N Median lOR N Median lOR N Median lOR 
PTSD- PDS 
Intrusions 36 4.0 2.0- 5.0 61 1.0 0.0-2.0 <0.0001 .62 33 3.0 2.0-5.0 56 1.0 0.0-2.0 <0.0001 .66 
Avoidance 36 5.0 4.0-6.0 61 2.0 1.0- 3.0 <0.0001 .67 33 4.0 4.0-7.0 56 1.0 0.3-2.8 <0.0001 .74 
Arousal 36 4.0 3.0- 5.0 61 2.0 1.0-3.0 <0.0001 .58 33 4.0 3.0-5.0 56 2.0 1.0- 3.0 <0.0001 .60 
Symptom Severity 36 22.0 14.0- 31.0 61 5.0 3.0- 11.0 <0.0001 .69 33 18.0 12.0- 30.0 56 5.0 3.0- 8.0 <0.0001 .73 
Coping - Brief COPE § 
Maladaptive coping 35 4.0 3.2-4.7 59 2.8 2.3- 3.3 <0.0001 .45 29 3.7 3.0-4.6 53 2.5 2.3-3.4 <0.0001 .47 
Self Distraction 35 5.0 3.0- 7.0 59 4.0 3.0- 5.0 <0.005 .32 29 5.0 3.5-7.0 53 4.0 2.0-5.0 <0.01 .29 
Denial 35 4.0 2.0-6.0 59 2.0 2.0- 3.0 <0.0001 .45 29 3.0 2.0-5.0 53 2.0 2.0-3.0 <0.0001 .39 
Substance Use 35 2.0 2.0- 3.0 59 2.0 2.0- 2.0 Ns .10 29 2.0 2.0-4.0 53 2.0 2.0-2.0 ns .14 
Behavioural Disengagement 35 3.0 2.0- 5.0 59 2.0 2.0- 3.0 <0.005 .30 29 2.0 2.0-4.0 53 2.0 2.0-3.0 ns .18 
Venting 35 3.0 2.0- 5.0 59 3.0 2.0-4.0 Ns .16 29 3.0 3.0-4.5 53 2.0 2.0- 3.0 <0.005 .33 
Self-Blame 35 4.0 3.0- 6.0 59 2.0 2.0-4.0 <0.002 .35 29 4.0 3.0- 5.5 53 2.0 2.0-4.5 <0.003 .34 
Notes: ; lOR- interquartile range; N- number;; ns =non significant p>0.05; PDS- Posttraumatic Stress Diagnostic Scale; PDS scoring is presented as the median number of intrusive (e.g., "reliving the brain 
haemorrhage, acting or feeling as if it was happening again"), avoidant (e.g., "trying to avoid activities, people or places that remind me of the brain haemorrhage") and arousal (e.g., "feeling irritable or having fits of 
anger") symptoms experienced; § Brief COPE results taken at assessment one (3-months post-SAH) used for prediction of PTSD at both assessment points. Brief COPE scoring ranges from 1 ("strategy usually not 
used") to 4 ("strategy usually used a lot"). Values are expressed as medians. 
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on 'PTSD Symptom Severity' scores (si;= 49%; standardised B= .786; P<0.0001 ). 
Patients with PTSD reported significantly more 'Total Fatigue' than those without 
(Mann Whitney, P<0.0001; r-.44). 
Sleep. Bonferonni-correction led to the adoption of a test-wise alpha of 
P<0.007. 
A significantly predictive model for the 73 who completed the PSIQ 
accounted for 38% of variance in 'Global PSIQ Sleep' scores (r= 0.618; R2= 0.382; 
F2.61= 20.708 P<0.0001). The model was based solely on 'PTSD Symptom 
Severity' scores (si;= 27%; standardised B= .532; P<0.0001 ). Significantly worse 
sleep ('Global PSIQ Sleep' score) was reported by patients with PTSD (Mann 
Whitney, P<0.0001; r-.28). Sleep quality was significantly associated with 
concurrent fatigue (rs= .49, P<0.0001 ). 
Assessment two 
Health-Related Quality of Life (HRQoL). Due to missing data, regression 
analysis was based on 89 patients. Bonferonni-correction led to the adoption of a 
test-wise alpha of P<0.007. 
'Mental HRQoL': 48% of variance in 'Mental HRQoL' was accounted for (R2 
= 0.477; F2.19 = 35.979, P<0.0001 ). Only the 'PTSD Symptom Severity' score was 
significantly predictive (si; = 35%; standardised B = -.626; P<0.0001 ). 
Demographic, cognitive and physical disability information demonstrated no 
predictive value (Figure 5.4 ). 
'Physical HRQoL': 43% of variance in 'Physical HRQoL' was accounted for 
(R2 = 0.428; F3.1a = 19.415, P<0.0001 ). Physical disability scores (FIM-MS; si; = 
18%; standardized B = .429; P<0.0001) contributed most, followed closely by 
'PTSD Symptoms Severity' scores (si; = 15%; standardised B = -.411; P<0.0001 ). 
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Figure 5.4 Graphs of relationship between 'Mental HRQoL' and 'PTSD 
Symptom Severity' (upper), 'Cognition' (middle) and 'Physical Disability' (lower) at 
assessment two. 
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Prediction of patients' long-term HRQoL by their experience of PTSD in the 
acute stages: Due to missing data, analysis was based on 83 patients. 
Bonferonni-correction led to the adoption of a test-wise alpha of P<0.007. 
'Mental HRQoL': A patient's experience of PTSD in the short-term ('PTSD 
Symptom Severity' assessment one) held a large and negative relationship with 
the 'Mental HRQoL' which they experienced in the later stages (assessment two): 
rs= -.597, P<0.0001. 
Regression analysis using stepwise block entry revealed that the degree to 
which a patient experienced PTSD in the short-term had a unique predictive effect 
for their longer-term 'Mental HRQoL' (Table 5.9). An initial predictive model based 
on information about the severity of a patient's illness, their demographics and the 
degree to which they experienced neurological sequelae in the short-term could 
explain around 23% of variance in patients' long-term 'Mental HRQoL': R2 = 0.226, 
F6,76= 3.703, P<0.004). The addition of information about the patient's experience 
of PTSD in the acute stages - namely 'PTSD Symptom Severity' score from 
assessment one - significantly improved the model's overall predictive ability: 
F1,7s= 20.101, P<0.0001. With its inclusion, a total 39% of variance in 'Mental 
HRQoL' could be accounted for (R2 = 0.390, F7.75= 6.843, P<0.0001 ). Increasing 
PTSD severity was associated with a worse 'Mental HRQoL': 13= -.484; t= -4.483, 
P<0.0001. 
'Physical HRQoL': A patient's experience of PTSD in the short-term ('PTSD 
Symptom Severity' assessment one) held only a small and negative relationship 
with the 'Physical HRQoL' which they experienced in the later stages (assessment 
two): r5= -.248, P<0.03. 
Stepwise regression analysis revealed that once the variance accounted for 
by traditional predictors was controlled for, patients' PTSD symptomatology in the 
short-term holds no unique significant predictive effect for long-term 'Physical 
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HRQoL': F1.15= 3.595, P>0.05; Table 5.9. The initial predictive model based on 
traditional predictive information was however, significantly predictive - explaining 
approximately 30% of variance in patients' long-term ' Physical HRQoL': R2 = 
0.284, F6,76= 5.031 I P<0.0001. 
Prediction of improvement in patients' HRQoL between assessment one 
and two by information about the patients' experience of PTSD in the acute 
stages: Due to missing data, analysis was .based on 83 patients. Bonferonni-
correction led to the adoption of a test-wise alpha of P<O.OO?. 
'Mental HRQoL': A patient's experience of PTSD in the short-term ('PTSD 
Symptom Severity' assessment one) did not hold a significant bivariate 
relationship with the change in their 'Mental HRQoL' that occurred between 
assessment one and two: rs= .148, N=85 P>0.05. 
The subsequent stepwise regression analysis revealed that it was not 
possible to significantly predict the change in patients' 'Mental HRQoL' that 
occurred between assessments one and two using either the initial model based 
on traditional predictors (R2 = 0.133, F6,76= 1.939, P>0.05), or with the addition of 
information about the patients' experience of PTSD at assessment one (R2 = 
0.137, F1,16= 0.368, P>0.05; Table 5.9). 
'Physical HRQoL': A patient's experience of PTSD in the short-term ('PTSD 
Symptom Severity' assessment one) did not hold a significant relationship with the 
change in their 'Physical HRQoL' that occurred between assessments one and two: 
rs= -.032, N=85 P>0.05. 
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Table 5.9 The unique predictive ability of PTSD at assessment one (short-
term) for patients' HRQoL at assessment two (long-term) 
Factor Model1 Model2 
N n s?1 P-value N ll s?1 P-value 
Predicting improvement in HRQol 
'Mental HRQol' (SF-36 MCS) 
Age 83 -.152 .022 ns 83 ·.128 .014 Ns 
Sex 83 .188 .032 ns 83 .164 .021 Ns 
Clinical severity (WFNS) 83 .175 .025 ns 83 .175 .030 Ns 
History of previous illness 83 .039 .001 ns 83 .022 .441 E-03 Ns 
Overall cognitive function (TEA; RBMT-E; BADS) 83 -.038 .001 ns 83 -.034 .961E-03 Ns 
Physical disability (FIM-MS) 83 .273 .062 <0.03 83 .291 .070 <0.02 
PTSD Symptom Severity 83 078 .004 Ns 
Model summary R2= 0.13; Fs.7s= 1.94, P>0.05 R2= 0.14; F1.1s= 0.37, P>0.05 
'Physical HRQol' (SF-36 PCS) 
Age 83 -.156 .023 ns 83 -.196 .032 Ns 
Sex 83 .005 .256E-03 ns 83 .046 .002 Ns 
Clinical severity (WFNS) 83 .018 .289E-03 ns 83 .017 .256E·03 Ns 
History of previous illness 83 .120 .013 ns 83 .148 .020 Ns 
Overall cognitive function (TEA; RBMT-E; BADS) 83 .110 .010 ns 83 .104 .010 Ns 
Physical disability (FIM-MS) 83 .032 .001 ns 83 .003 .100E-04 Ns 
PTSD symptom severity (PDS) 83 -.129 .012 Ns 
Model summary R2= 0.05; Fs.1s= 0.61, P>0.05 R2= 0.06; F1.1s= 0.93, P>0.05 
Predicting long-term HRQol 
'Mental HRQol' (SF-36 MCS) 
Age 83 .247 0.060 <0.02 83 .099 0.008 Ns 
Sex 83 -.036 0.001 ns 83 .133 0.010 ns 
Clinical severity (WFNS) 83 .190 0.030 ns 83 .186 0.030 ns 
History of previous illness 83 -.274 0.070 <0.02 83 -.169 0.024 ns 
Overall cognitive function (TEA; RBMT-E; BADS) 83 .166 0.022 ns 83 .144 0.016 ns 
Physical disability (FIM-MS) 83 .185 0.030 ns 83 .075 0.005 ns 
PTSD Symptom Severity 83 -.484 0.163 <0.0001 
Model Summary R2= 0.23; Fs.1s= 3.70, P<0.004 R2= 0.39; F1.7s= 20.10, P<0.0001 
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Table 5.9 Cont'd. 
Factor Model1 Model2 
N 8 s?, P-value N 8 s?, P-value 
Predicting long-term HRQoL Cont'd. 
'Physical HRQol' (SF-36 PCS) 
Age 83 -.115 0.013 ns 83 -.180 0.030 83 
Sex 83 -.009 0.640E4! ns 83 0.058 0.003 83 
Clinical severity (WFNS) 83 .046 0.002 ns 83 .044 0.002 83 
History of previous illness 83 -.247 0.060 <0.02 83 -.201 0.034 83 
Overall cognitive function (TEA; RBMT-E; BADS) 83 .010 0.810E4! ns 83 .000 0.000 83 
Physical disability (FIM-MS) 83 .435 0.160 <0.0001 83 .386 0.120 83 
PTSD Symptom Severity 83 -.216 0.033 83 
Model Summary R2= 0.28; Fs.1s= 5.03, P<0.0001 R2= 0.32; F1.1s= 3.60, P>0.05 
Note: Assessment one= approximately 3-months post-ictus; Assessment two= approximately 13-months post-ictus; !!.= standardise 
beta coefficient; BADS=Behavioural Assessment of the Dysexecutive Syndrome; FIM-MS=Functional Independence Measure-Molal 
HADS-A=Hospital Anxiety and Depression Scale - Anxiety score; HADS-D=Hospital Anxiety and Depression Scale - Depression scorE 
HRQol= Health-related quality of life; MCS= Mental Component Score; MFSI-SF=Multidimensional Fatigue Symptom lnventory-Sho1 
Form; N=sample size; ns= non-significant (P>0.05); PCS=Physical Component Score; PDS=Posttraumatic Stress Diagnostic Scale 
PSQI=Pittsburgh Sleep Quality; f?!=variance explained by model; RBMT-E=Rivermead Behavioural Memory Test-Extended; SF 
36=Short Form-36; sr,=squared semi-partial correlation; TEA=Test of Everyday Attention. Hierarchical step-wise entry (2 blocks) wa 
used to examine the unique predictive ability of patients' experience of PTSD in the acute stages for their later HRQoL. In Model 
traditional predictors of SAH patients' outcome from assessment one were entered into the model and the variance in assessment tw 
HRQoL which these predictors accounted for was controlled (constant+ Patient age+ Sex, Clinical severity+ History of previous illnes 
+ Overall cognitive function + Physical disability). In Model 2 patients' experience of PTSD at assessment one (PTSD Symptor 
Severity) was entered into the predictive model and its additive explanative importance established. 
Stepwise regression analysis revealed that it was not possible to 
significantly predict the change in patients' 'Physical HRQoL' that occurred 
between assessments one and two using the initial model based on traditional 
predictors (R2 = 0.046, F6,76= 0.611, P>0.05), nor with the addition of information 
about patients' experience of PTSD at assessment one (R2 = 0.058, F7,76= 0~929, 
P>0.05; Table 5.9). 
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Post-traumatic Stress Disorder (PTSD). Due to missing data this regression 
analyses was based on 81. Bonferonni-correction led to the adoption of a test-wise 
alpha of P<0.005. 
A significantly effective logistic model to predict PTSD was generated (X2 [1, 
N= 81] = 18.409, P< 0.0001). The only variable included in the final model was 
information about the patients' coping skills. A disposition to use 'Maladaptive 
Coping Strategies' (OR= 3.216, Cl 1.761 - 5.873; Wald= 14.452 (1), P<0.0001) 
significantly increased the probability of having PTSD. Using a probability criterion 
of .5, predictive classification was excellent (c= 0.78), with the model assigning 
78% of all possible pairs the correct probability of having PTSD (sensitivity= .48; 
specificity= .79; Figure 5.3). Table 5.8 presents a comparison of the symptoms 
and coping skills of those patients with and without PTSD. 
Fatigue. Bonferonni-correction led to the adoption of a test-wise alpha of 
P<0.006. 
A significantly predictive model for the 87 patients who completed the 
MFSI-SF at assessment two was generated - accounting for 57% of 'Total 
Fatigue' variance (r= . 762; R2= 0.581; F2.84= 58.310, P<0.0001 ). The model was 
based solely on 'PTSD Symptom Severity' (s?i= 58%; standardised B= .796; 
P<0.0001 ). Patients with PTSD reported significantly more Total Fatigue than 
those without (Mann Whitney, P<0.0001; r-.56). 
Sleep. Bonferonni-correction led to the adoption of a test-wise alpha of 
P<0.007. 
A significantly predictive model for the 88 who completed the PSIQ at 
assessment two accounted for 45% of variance in 'Global PSIQ Sleep' scores (r= 
0.672; R2= 0.451; F2.as= 34.977 P<0.0001 ). The model was based solely on 'PTSD 
Symptom Severity' scores (s?i= 42%; standardised B= .652; P<0.0001 ). 
Significantly worse sleep ('Global PSIQ Sleep' score) was reported by patients 
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with PTSD (Mann Whitney, P<0.0001; r-.38). Sleep quality was significantly 
associated concurrent fatigue (rs= .51, P<0.0001 ). 
5.4 Discussion 
Post-traumatic stress disorder (PTSD) is a severe psychiatric condition that can be 
elicited by the experience of traumatic, life-threatening events. In line with earlier 
reports, this study has confirmed that the experience of having and surviving a 
subarachnoid haemorrhage (SAH) can elicit PTSD [23, 47, 295]. Moreover, PTSD 
was found to be abnormally prevalent in the SAH population. Crucially, PTSD was 
found to be the single best predictor of patients' Mental health-related quality of life 
(HRQoL) - the domain most persistently impaired - in both the short- and long-
term. In accord with the results of my meta-analysis presented in Chapter 3, none 
of the other variables in the model (including clinical grade, physical and cognitive 
disability) made significant contributions to the patients' Mental HRQoL. PTSD 
also proved to be significantly predictive of Physical HRQoL at the second follow-
up assessment. Importantly, I also found that the degree to which patients 
experienced PTSD in the short-term held a large and unique predictive effect for 
patients' long-term HRQoL. Specifically, it was those patients who experienced 
more severe PTSD symptoms in the early stages post-ictus who experienced 
worse Mental HRQoL in the long-term. Together the findings from my study 
suggest that it is the frequent occurrence of PTSD (37%) after SAH which is partly 
to blame for the surprisingly low HRQoL found in many SAH patients who, in other 
respects, make a good recovery. Although it has not traditionally been considered 
as a high priority within SAH care, my findings highlight the importance of 
recognizing and addressing the psychological adjustment of patients to their 
experience of SAH. In particular, given that the experience of PTSD in the short-
term is uniquely predictive of a poor long-term Mental HRQoL, the evidence 
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indicates that patients' psychiatric dysfunction should be treated aggressively as 
early as possible. 
The proposal that PTSD can affect a patient's Mental HRQoL seems 
intuitive given that this domain is concerned with the degree to which the person 
feels their health has impinged upon their mood and vitality and the degree to 
which their emotional well-being has limited their social interaction and ability to 
work [23, 514]. The means by which PTSD can affect the physical aspects of an 
SAH patient's HRQoL may however, seem counterintuitive, given that Physical 
HRQoL concerns patients' physical functioning (e.g., "my health severely limits me 
from lifting or carrying"), physical role limitations (e.g., "my physical health has 
caused me to cut down on the amount of time spent on work"), bodily pain and 
general health (e.g., "I expect my health to get worse"), whereas PTSD 
presumably causes primarily non-physical impairment. Interestingly though, the 
association between PTSD and Physical HRQoL which I found is not unique to the 
present study. Indeed, several reviews in the wider literature have now concluded 
that in contrast with other psychiatric disorders, PTSD can impact on Physical 
HRQoL. In fact, its effect on Physical HRQoL can at times, be almost as severe as 
its effect on Mental HRQoL [514, 614]. The means by which PTSD could reduce 
Physical HRQoL include the fact that those who develop PTSD are known to 
experience increased physical symptoms, including elevated pain, headaches, 
joint and muscle aches, bowel symptoms and dizziness, which together with core 
PTSD symptoms, such as avoidance and anxiety, would simply make it harder for 
the patient to complete physical tasks, or to simply do things as one commentator 
notes[69, 133,175,229,289,368,406,415,437,438,448,530,622,641, 761]. 
PTSD was highly prevalent in my sample at both assessment points post-
haemorrhage and most patients who warranted a diagnosis of PTSD at 
approximately 3 months, still warranted the diagnosis at 13 months. Obviously, my 
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conclusions on the incidence of PTSD are limited to 13 months post-SAH, but they 
are in line with evidence that PTSD is often a persistent and chronic disorder [417, 
529]. Evidence from two recent studies does however, suggest that mood 
disturbance is a persistent problem post-SAH [295, 746]. Hutter, for example, 
assessed patients four years post-SAH and found PTSD in a similar proportion of 
patients [295]. It is likely that the largely stable nature of SAH patients' PTSD 
explains why in regression analyses, I found that PTSD could not account for the 
improved HRQoL which patients reported at the second assessment. It is 
interesting to note that I also found that more traditional predictors, such as 
patients' cognitive function and physical disability, also could not account for the 
improvement in patients' HRQoL between assessments. This is not surprising 
given that these factors, as revealed by my comparison of patients' performances 
at the two assessments, also had not significantly improved at the second 
assessment. The improvement in patients' HRQoL scores is instead, likely due to 
improvement between assessments in other aspects of the patients' outcome 
which I did not measure/ incorportate into the predictive models (for example, the 
de-conditioning associated with their convalescence) and/ or the possible 
insensitivity to change of my measures. 
It is interesting to note that in the present study the incidence of PTSD 
detected in the SAH patient population is remarkably high. At both the short- and 
long-term follow-up appointments, 37% of SAH patients were found to warrant a 
diagnosis of fuii-PTSD. It is usually assumed that that the prevalence of PTSD 
(and psycho-pathology in general) following such internal traumas is lower relative 
to that which follows traditional traumas [476, 701]. For example, whilst 
approximately 35-50% of patients are expected to develop PTSD following 
traditional traumas such rape or military combat [71, 125, 351 ], 0-16% develop 
PTSDfollowing myocardial infarction [41, 42,152,380,500,616, 706], 10-18% 
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following cardiac surgery [151-153, 665, 671], 3.3% following variceal 
haemorrhage [498], 9.8% following others strokes [615] and 1-5.6% following 
child-birth [26, 126, 749]. Indeed, even the DSM-IV-TR [23] notes in its discussion 
of PTSD that the disorder tends to be more severe (or long-lasting) when the 
stressor event is external and of human design (e.g., rape, torture). So how can 
this high incidence in the SAH population be explained? The similarity of the 
results from the present study and prior SAH studies which used "gold standard" 
diagnostic interview techniques (fuii-PTSD estimates 26-32%) [47, 295], means 
that the high incidence I detected cannot be explained by my use of a 
questionnaire measure of PTSD which can at times, 'over-diagnose', particularly 
with medical patients [500, 674, 675]. Indeed, unlike many of the aforementioned 
studies on other medical illness, the methodology of the current study could have 
potentially underestimated the incidence of PTSD as it involved the patients being 
left with the PTSD questionnaire and having them return it to me. One could 
speculate that this method would have led to an underestimation of the disorder, 
with those patients with PTSD (who by definition wish to avoid thinking about their 
illness) having been less likely to have completed and returned the measure [684]. 
The high incidence is also surprising as it has been suggested that in certain 
medical populations, symptoms of PTSD are frequently expressed in nuanced and 
idiosyncratic ways which may make the likelihood of them fulfilling its diagnostic 
criteria less likely, or at least, being captured by a generic PTSD questionnaire 
[310, 327, 498, 684]. For instance, an SAH typically occurs in a patient's everyday 
environment (such as in their homes), many experience ongoing internal 
consequences (e.g., neuropsychological sequelae) and external consequences 
(e.g., surgical scars) of their illness and can have reminders of the SAH externally 
imposed upon them (e.g., follow-up angiograms, medications). This means that 
SAH patients may, unlike those who have experienced more traditional traumas, 
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find it more difficult to actually avoid trauma reminders and so not fulfill the 
'avoidance' criteria for the diagnosis of PTSD. SAH patients do however, still often 
fulfill this criteria and this could be explained by the fact that in reality the questions 
which ask patients about their avoidance behaviours only ask whether they have 
made efforts to avoid reminders and not about the success of their attempts [23]. 
Given that methodological features do not seem able to explain the high incidence 
of PTSD in the SAH population, it could be that there is something uniquely 
traumatising about the experience of an SAH. This is something deserving of 
future study, a point which I discuss further in Chapter 7 (see section 7.4.1 ). 
Studies in the past had reported a comparatively good physical and 
cognitive recovery after SAH [432, 507, 558, 590, 649]. It was suspected that the 
relative infrequency of severe problems post-SAH might in part, be a consequence 
of those studies having used insensitive tests and pre-selected samples. I avoided 
these problems in the present study by investigating a large unselected sample 
and using ecologically valid instruments. Nevertheless my findings confirm that on 
average, patients surviving SAH show a good physical and cognitive recovery. 
This underlines the importance of shifting focus from classical 
neurological/neuropsychological problems to the less examined field of 
neuropsychiatric sequelae in order to understand the poor HRQoL experienced by 
patients. Furthermore, where considered, no significant value was found to be 
associated with clinical information for HRQoL [306, 469, 510, 543, 546, 577, 590, 
609,649, 722]. 
That I did not detect any significant improvement in cognition between 
assessment one and assessment two in the present study is not entirely 
unexpected. Whilst some prospective studies have reported improvements [507, " 
590, 649], others, like mine, have not [432, 558]. When improvements in cognition 
have been found, it appears that the effect is only modest and tends to be 
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detected by studies with the largest samples [432, 507, 558, 590, 649]. Moreover, 
the findings appear very dependent on the specific neuropsychological test that a 
study has employed and improvement often disappears when statistical 
corrections are made for multiple comparisons. The largest prospective study to 
date for example conducted by Samra et al. [590] examined a starting sample of 
185 ASAH patients with a restricted (but sensitive) battery of 4 cognitive tests 
tapping memory, executive function, attention and visuospatial skills at 3, 9, and 
15 months post-SAH. This study reported that no improvement occurred between 
9 and 15 months, but that a significant improvement in overall cognition did occur 
between 3 and 9 months. Nevertheless, the size of the effect of improvement was 
small (r-.13) and even with the large sample size studied, its statistical 
significance was borderline (P=0.05) [117]. 
Since PTSD is a major determinant of how well a patient mentally and 
physically adjusts after an SAH, an understanding of why these patients develop 
PTSD is relevant for the design of rehabilitation regimes. I found that use of 
maladaptive coping strategies (and to a lesser extent also young age in the early 
stages) significantly predicted a higher likelihood of post-SAH PTSD. In fact, using 
only these predictors led to a classification accuracy of between 78-85%. This 
means it is possible to predict who is at risk of developing PTSD after an SAH. 
Maladaptive coping likely promotes PTSD because evidence suggests that 
successful adaptation to the experience of a trauma involves the accessing of 
aversive emotions about the event, which permits one to habituate to anxiety and 
the modification of trauma-related beliefs [193] - something not at all promoted by 
maladaptive coping strategies. The predictive value of maladaptive coping for 
PTSD found in this study complements evidence that they are also key in the 
development of PTSD after a variety of other traumas [88, 172, 217]. It has long 
been speculated that coping style is somehow involved in explaining SAH patients' 
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poor outcome, but its role had never been seriously examined [189, 294, 295, 297, 
397, 469, 510, 689]. The important insight that this study's finding now offers is 
that it might be possible to reduce the incidence of PTSD and improve the HRQoL 
in patients after SAH by teaching patients better coping strategies. To my 
knowledge, there has been no evaluation of the clinical efficacy of programs to 
improve the coping strategies employed by SAH patients. However, findings from 
the wider literature show that patients' coping skills are amenable to change via 
brief and relatively inexpensive programs which could be delivered by trained 
volunteers or non-specialist clinicians [196]. Along with clinicians needing to be 
more aware that SAH patients are at a high risk of developing PTSD, these coping 
skills programs (with modifications for a cognitively impaired group) could lead to 
SAH patients increasing their use of adaptive skills and decreasing their use of 
maladaptive ones, thereby improving emotional well-being - as previously shown 
by persons with a variety of other health problems, including HIV+ [113], spinal 
cord injury [346] and breast cancer [7 42]. Encouraging in this context, is the 
finding by Rodholm et al. [571], which demonstrates an absence of PTSD in an 
SAH sample who received illness information and advice on how to cope with 
neuropsychiatric symptoms. 
Although these findings are encouraging, it is important to acknowledge the 
fact that use of maladaptive coping strategies are probably not the only factor 
which leads to PTSD after SAH. This becomes particularly obvious when we look 
at the regression model for assessment two. This model had a substantially lower 
sensitivity (i.e., a lower proportion of true positives were correctly predicted by the 
model) than the predictive model for assessment one, suggesting that additional 
factors become involved at later stages. This is something which clearly warrants 
study in the future. 
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We also need to discuss alternative explanations for why maladaptive 
coping emerges as a significant predictor of PTSD. One possibility is that given 
that avoidant behaviours are both an aspect of maladaptive coping and a 
diagnostic symptom of PTSD (i.e., Criterion C 1-2), maladaptive coping may be a 
consequence, rather than the cause of SAH patients' PTSD. However, as Bryant 
et al. [88) note in regard to the relationship more generally, this seems unlikely as 
intentional avoidance behaviours describe only 2 of the 17 symptoms that define 
PTSD. Furthermore, evidence from studies that fortuitously measured individuals' 
preferences for coping skills prior to a trauma, show that it is pre-trauma 
preferences for maladaptive coping which are predictive of subsequent PTSD 
[172, 217]. 
A second possible explanation is that maladaptive coping is not actually a 
premorbid risk factor, but is a consequence of the cognitive deficits associated 
with an SAH. For example, it could be argued that the deficits lead the SAH patient 
to not remember adaptive strategies that they used pre-morbidly and/or patients 
post-SAH lack the attentional focus to maintain the use of (arguably) more 
demanding adaptive strategies and/ or because the patient now does not notice 
the problems that are caused by the use of maladaptive strategies [88]. Partial 
support for this suggestion comes from a recent small study by Tomberg et al. 
[689] which suggested that SAH patients use different coping skills compared to 
healthy-controls. This could be taken to imply that the brain damage experienced 
by SAH patients leads them as a group to cope differently to those without brain 
injury. The cross-sectional nature of the present study means that this possibility 
cannot definitely be ruled-out. The hypothesis that maladaptive coping is a 
consequence of the cognitive deficits associated with SAH does not however 
remain so convincing when it is considered that Tomberg et al. found only subtle 
differences in SAH patients' coping compared to controls. Specifically, only 2 
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meaningful and significant differences in SAH patients' coping compared to 
controls (both P<0.05) were found from a measure of 14 aspects of patients' 
coping. Indeed, it is even debatable whether these 2 significant differences in 
SAH coping were not simply chance results given no correction was made by the 
authors for the potential family-wise error that resulted from the 14 t-tests they 
conducted for the analysis. In any case, teaching patients more adaptive coping 
skills could still reduce the prevalence of PTSD in the SAH population. 
Should the reader wish to consider another explanation for why 
maladaptive coping emerged as a significant predictor of patients' PTSD in the 
current study, they are directed to Appendix IX. There, I empirically examine and 
refute the possibility that the relationship was detected due to many patients 
having suffered a psychiatric illness prior to the SAH which could have promoted 
the use of such coping and so be the real predictive factor. In discussing the cause 
of SAH patients' PTSD, the reader may also wish to refer to Appendix X where I 
give empirical consideration to the predictive value of the location of SAH patients' 
ruptured cerebral aneurysms. Aneurysm location was not included as a potential 
predictive factor in my main examination of the cause of SAH patients' PTSD, as 
contemporary SAH studies (and indeed my own, presented in the supplementary 
analyses) have consistently found it unhelpful. 
Fatigue and sleep disorders are two important aspects of the SAH sequelae 
which have not received sufficient attention. Although previous studies reported 
that patients complain about fatigue [507, 541, 553] and sleep difficulties [609], 
these problems were not properly assessed. Using standardised measures, I have 
reported, for the first time within the literature, that fatigue and sleep problems 
occur significantly more often in SAH PC1tients than in a matched control sample. 
Fatigue and sleep dysfunction were persistent problems for SAH patients with over 
30% of patients being afflicted by each difficulty more than a year post-
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haemorrhage. No significant improvement in these domains was detected 
between assessments. Alarmingly, the fatigue in the SAH population was at times, 
in fact, even higher than in cancer patients undergoing chemotherapy - a group 
known to experience incapacitating fatigue [407]. Regrettably, due to restrictions in 
recording of control subjects' educational/ occupational levels, the recruited fatigue 
and sleep controls were matched to patients only on the basis of age and sex. 
This less-than-favourable matching procedure could potentially lead to an 
overestimation of fatigue and sleep dysfunction. However, as no appropriate 
normative values for the fatigue and sleep measures exist, my calculation of 
impairment results in a more conservative estimate than that which would result 
from the only alternative, namely employing non U.K.-based cut-off scores 
associated with the measures [95, 407]. 
Interestingly, as shown by my regression analyses, PTSD seems to 
consistently play a major role in the development of both fatigue and sleep 
problems. The likely mechanism linking these disorders is that PTSD induces 
sleep problems, which in turn leads to much of the fatigue. This model 
corresponds with previous findings where sleep disturbance is noted as core to 
PTSD and a much ignored association between sleeplessness and 
fatigue/daytime sleepiness which was previously found in SAH patients [510]. In 
fact, the nature of the studied SAH patients' sleep dysfunction (i.e. reduced sleep 
efficiency) accords with measurement of sleep functions in PTSD patients in 
general where persistent arousals cause impaired sleep continuity [420]. Indeed, 
in the only objective SAH sleep study, patients reporting primary insomnia were 
most afflicted by 'sleep fragmentation' [609]. However, PTSD cannot explain all 
SAH fatigue and sleep dysfunction. I would suggest on the basis of the literature 
[65, 377, 509] that diffuse neuronal damage and/ or neuroendocrine dysfunction 
are also involved and could help explain some of the remaining 36-43% and 55-
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I I 
62% variance in fatigue and sleep dysfunction, respectively. In discussing the 
! 
important predictive role which PTSD has for SAH patients' experience of fatigue 
. I 
:i 
'and ·~leep dysfunction, it is important to draw attention to the high correlations 
whicr) I found between patients' fatigue, sleep and Mental HRQoL at each 
I 
respeJctive assessment (Spearman's correlation coefficients ranged from= -.45 to-
' 
, . 78). ,~lthough the correlations were not large enough to indicate that the three 
. concepts are synonymous with one another, these high correlations do, 
' 
' 
, neveritheless, indicate that the variance which PTSD is found to explain in patients' 
'i 
· fatigue, sleep and Mental HRQoL scores may not be independent, but partly the 
l 
I ' 
same. The likely explanation for this is that the content of the fatigue (MFSI-SF), 
' sleep (PSQI) and Mental HRQoL (SF-36) instruments have a degree of overlap 
! 
with bne another. For example, in addition to asking the patient questions about 
• their isocial functioning, emotional role limitations and mental health, the SF-36 
Ment~l HRQoL scale also includes questions about vitality and tiredness. Fatigue 
and sleep in this sense, should be considered correlated sub-components of a 
more global concept of outcome which is being captured by the Mental HRQoL 
scale. It is important to emphasise this point so as not to risk exaggerating the 
explanative power which PTSD holds for SAH patients' outcomes. 
i There are two potential limitations to the present study. Firstly, in assessing 
' 
the relative predictive value of clinical indices for patients' outcome it was possible 
to ilildude ·only a selection of key factors. An obvious absence from the regression 
' 1 ., ' i~iJ 
· 'models was an index of bleed severity. Although this variable did not prove 
parti~ularly useful in the meta-analysis I conducted (see Chapter 3), it would 
nevertheless have been preferable to have included it in the models . 
. Vnfqrtunately, with initial CT scans often being conducted in outside accident 
emergency and departments, scans were not available for most patients and so 
could not be systematically examined. The only CT scans which were accessible 
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for most of the patients were those derived from the angiographic examination 
which the SAH patients underwent. These are however not suitable for the rating 
of bleed distribution because not only are the angiograms conducted several 
hours/ days after the initial haemorrhage (which renders scans unreliable as blood 
rapidly becomes isodense [618]), but also the technical quality of these scans is 
not necessarily satisfactory [7 46]. A second limitation to the study which needs to 
be acknowledged is that given some SAH symptoms (such as anxiety and sleep 
disturbance) are ubiquitous to a variety of other psychiatric conditions, and that 
PTSD has a high psychiatric co-morbidity, there is the possibility that an alternate 
or concurrent disorder could be responsible for these symptoms. This is something 
my study cannot rule out. 
5.5 Conclusions 
It can be concluded that PTSD is largely responsible for the reduced HRQoL 
observed in SAH patients in both the short- and long-term. Moreover, PTSD 
appears to consistently lead to sleep problems and thereby contribute to patients' 
excessive fatigue. As such, it is important to prevent the development of PTSD 
post-SAH. Maladaptive coping strategies seem to be the best predictor for later 
PTSD. Teaching patients better coping strategies could potentially reduce the 
incidence of PTSD and fatigue -thus significantly improving HRQoL. 
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Part Two 
Family and friends of SAH patients - psychosocoal 
outcome and post ... traumatic stress disorder 
192 
Chapter 6 
Does post-traumatic stress disorder occur in 
subarachnoid haemorrhage patients' family and 
friends? Furthermore, what is its impact on patients' 
recovery? 
Work presented in this chapter has previously appeared in: 
Noble, A.J. & Schenk, T. (2008). Post-traumatic stress disorder in family and friends of 
spontaneous subarachnoid hemorrhage patients. Journal of Neurosurgery, 109: 1027-1033. 
& 
Noble, A.J. & Schenk, T. (2008). The impact of spontaneous subarachnoid haemorrhage on 
patient's families and friends (Invited review). British Journal of Neuroscience Nursing, 4: 278-285. 
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6.1 Introduction 
Increasing evidence suggests that it is not only subarachnoid haemorrhage (SAH) 
patients who are affected by the illness. Recent studies provide compelling 
evidence that the families and friends of these patients are also traumatised by 
this disorder [461, 710, 750]. Considering the life-threatening nature of a 
spontaneous subarachnoid haemorrhage (SAH), its dramatic clinical presentation 
and neuropsychological sequelae, it is understandable that overwhelming stress 
and distress can be experienced by an SAH patient's family and friends [90, 264, 
285, 286, 461' 545, 547]. 
Although two studies note positive consequences of the SAH for family and 
friends, such as gratitude for having been given a 'second chance' with their loved-
one [285] and a closer marriage [90], most concur in finding that the negative 
consequences far outweigh the positives. Patients' 'significant others' (SOs) report 
persistent psychiatric symptoms, with anxiety [285, 545], depression (18%) [90, 
545], stress (25-40%) [48, 264, 265, 461, 546] and sleep disturbance [461] 
featuring heavily. The aforementioned symptoms often co-occur with impairment in 
an SO's work [286, 545, 546], quality of life [285, 286], and family functioning [90, 
286, 451, 461, 501, 502, 519]. Buchanan et al. [90], even noted that 26% of these 
SOs reported that death was preferable to life in their current state. Importantly, 
these difficulties are not experienced solely by those SOs of patients with a poor 
outcome [48, 90, 264, 265, 286, 461, 545, 546, 746] and SOs can even 
experience higher levels of emotional distress than the patient does [90, 285, 546]. 
Pritchard et al.[545], for example, noted that 50% of SOs considered that the 
family had suffered as much as the patient as a result of the SAH. 
Two particularly remarkable features of SOs difficulties are the following. 
Firstly, they report elevated feelings of being frightened (27%) [545] and report 
perpetual fears over their loved-one suffering a further haemorrhage ( 17% ), 
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despite expert reassurance that the chances are extremely low [285, 652]. 
Secondly, they report finding discussing the event particularly harrowing [313]. In 
fact, over 25% have been found to require medication to help them with their 
anxieties [546]. 
The psychological problems of the friends and family of SAH patients 
present a significant concern for two main reasons. Firstly, it shows that the 
consequences of SAH extend beyond the patient, causing psychological problems 
also in the patient's friends and families. As things stand though, SOs of SAH 
patients hardly receive any medical attention [461 ]. On discharge from acute 
services, most SAH patients require continued care. With referral to rehabilitation 
centres restricted to a subset (10%) of patients [398, 579, 746], and involvement of 
a professional carer appearing rare [189, 264, 398, 752] the majority of care is 
therefore left to SOs [189, 264, 398, 461, 752]. Two studies for example, found 
that even up to 6.5 years after SAH, long after acute support is withdrawn, around 
55% of patients still require a high level of care [264, 461]. A second concern 
therefore, is that with SOs often acting as informal carers [90, 264, 461, 545, 546], 
that their ill psychological-health could act as a deterrent to assuming this role and 
may mean that SOs become unable or unwilling to continue in the position. 
Replacing them with professional carers would be both difficult and costly. 
Furthermore, there is tenuous evidence suggesting that poor SO health can 
reduce the quality of the care which they might offer and thus reduce their patient's 
chance of a good recovery [423, 538, 690]. For example, in a cross-sectional 
study of 27 patients examined 15 months after SAH, Toomela et al. [690] reported 
that the degree to which SAH patients reported cognitive symptoms was 
associated with a low level of social support. 
In light of these points, it is important to find ways to reduce, or even better, 
prevent the development of the psychological problems in SOs of SAH patients. 
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This however requires a better understanding of the origin of these difficulties. In 
the past, research on the impact of SAH has typically focused on the wellbeing of 
the patients only. A systematic review which I previously published [489] (see 
Appendix XI for further results of this review) showed that only 6 studies have 
looked into this aspect of SAH and out of this sample only one article focused 
exclusively on the SOs rather than the patients. It also showed that it is not useful 
to refer to the wider literature on stroke carers for any direction. With SAH being 
considered so different from the norm, SAH patients/ their SOs are typically 
excluded from studies which look to learn about the impact of stroke in general on 
SOs [14 7, 155, 235, 527, 7 41]. Our current lack of understanding of the cause of 
SOs' difficulties and hence how they should be treated, is no doubt the reason why 
the only study [548] so far which has examined the effect of an intervention (use of 
a specialist liaison nurse) for these persons, found the benefits of the treatment to 
be only negligible.[547, 548] 
The most obvious explanation for SOs' reduced well-being is that providing 
instrumental and emotional support for an SAH patient with physical, cognitive, 
and/or emotional problems can be extremely draining and leads the SO to 
experience depression and other symptoms of psychological distress. This 
explanation is supported by a number of studies showing that SOs of patients who 
have had an SAH report significant degrees of carer burden-at times as high as 
those of dementia carers [90]. The studies also show that this burden is, in turn, 
linearly associated with the degree of neurobehavioural sequelae that the patient 
illustrates [90, 264, 265, 285, 286, 461, 504, 510, 746]. The explanation that SAH 
SOs' psychosocial difficulties could be explained by the burden of the SAH 
patients' condition is given some plausibility by evidence from the wider literature 
on other conditions, which shows that the neurobehavioural sequelae associated 
with injury to the brain hold unique stress-inducing qualities. For example, it has 
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been documented that families living with brain-injured patients experience greater 
stress than those families living with the effects of physical disability (e.g. spinal 
cord injury) or other debilitating illnesses (e.g. cystic fibrosis) [9]. 
The empirical support for this explanation for SAH SOs' difficulties is 
however, not as compelling as one might expect. Firstly, many of the family 
members and friends of SAH patients who have previously been found to illustrate 
psychiatric disturbance had not actually assumed a caring role for a patient [48, 
90, 264, 265, 285, 286]. SOs therefore appear to be significantly affected by an 
SAH even if they do not directly provide the patient with care [48, 265, 285, 51 0]. 
Secondly, in the group of SOs who had been caring, if burden of care was the 
main determinant of their wellbeing, there should be a robust correlation between 
the patient's disability and the SO's wellbeing. This is not the case. Although 
correlations are found, they are not robust. They are based on small-to-moderate 
sized samples (median=52 participants), vary dramatically in size between studies 
[90, 265, 461] and in some cases, burden of care accounts for less than 10% of 
the variability in SOs' wellbeing [51 0]. It is thus clear that burden of care on its 
own, cannot explain the psychological impact of SAH on the SOs of affected 
patients. 
A study by Pritchard et a1.[545] provides a clue as to what might be in part 
responsible for much of these SOs problems. These workers found that compared 
to SOs of other neurosurgical patients with similar needs and disabilities, but 
which followed a non-emergency illness (namely, an acoustic neuroma), SOs of 
SAH patients have a significantly worse psychopathological outcome. SOs of SAH 
patients reported significantly more anxiety, depression and stress and took more 
time off from their formal occupation. Pritchard et al. postulated that it is the 
unpredictable (emergency) nature and sudden onset of SAH which is probably 
responsible for the SOs' increased psychopathology. This phenomenon of 
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persistent psychological problems following the experience of an unpredictably 
occurring traumatic event has been well-described in the psychiatric literature and 
is now recognised within the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV-TR} as an independent psychiatric illness called post-traumatic stress 
disorder (PTSD) [23]. In my view, PTSD provides a plausible and attractive 
hypothesis in the search for an explanation of SAH patents' significant others' 
reduced well-being for several reasons: Firstly, the psychological problems 
typically described by SOs of SAH patients (e.g. anxiety, fear, stress and sleep 
dysfunction) are similar to those of the PTSD syndrome (see Table 4.2, Chapter 4 
for PTSD's diagnostic symptoms) [23]. Secondly, it is known (as seen in my own 
study in Chapter 5) that the onset of an SAH often causes PTSD in the patients 
themselves [47, 295], illustrating that an SAH can be as traumatic an event as 
events which are more traditionally associated with PTSD. And finally, psychiatry 
formally recognises that PTSD can be experienced not only by those involved in a 
traumatic event (such as a medical illness), but also by those who witness it, or 
learn of its occurrence [23, 27, 771]. Evidence that SOs of SAH patients 
experience uniquely high (and unappreciated) degrees of stress in the acute 
stages of the illness could also be seen to lend credence to this possible 
explanation [90, 545]. However, since no study has formally assessed the 
incidence of PTSD in SOs of SAH patients, we do not know whether PTSD could 
be responsible for their observed psychiatric problems. 
If it were established that the psychosocial difficulties observed in SOs of 
SAH patients correspond to PTSD, it would mean that the host of information 
already uncovered about this disorder by psychiatry could be made use of. In 
particular, it could be used to provide a more accurate prognosis and more 
effective treatment for the SOs [23]. It could also mean that the possibility of being 
able to improve these particular SOs' outcome is arguably more likely than it is for 
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SOs of different groups of patients. As although many interventions (such as 
employing the use of specialized community support, social workers and 
occupational therapists) for this group of persons are commonly cited as being 
effective, several recent reviews have now concluded that these interventions 
have in reality failed to actually prove effective for any carer population [67, 201, 
723]. One finding that could have significant implications for the support of SOs is 
that the use of 'maladaptive' coping strategies (such as distraction, denial, venting 
and self-blame) can help to predict PTSD development. This means that there is 
the possibility of designing interventions to improve the coping strategies of people 
who are at risk of developing PTSD and thereby help them to avoid that fate [193, 
217]. Importantly, such prediction of SOs' later well-being could alert practitioners 
to 'at-risk' SOs, allowing monitoring and targeting of appropriate interventions 
before, rather than after, a crisis has occurred. The predictive value of maladaptive 
coping strategies does, however, need to be considered alongside other potential 
predictors identified in the wider literature on the wellbeing of SOs. It has, as 
noted, for example, been suggested that the extent of neuropsychological and 
neuropsychiatric deficits in the patient can be related to the extent of psychosocial 
problems observed in the SO [264, 285, 286]. 
The aim of this study therefore is to address the following questions: 
1) Can the experience of having a loved-one suffer and survive an SAH elicit 
post-traumatic stress disorder in SOs? 
2) Is the incidence of SO PTSD in the short- and long-term beyond that normally 
expected? 
3) Why do some SOs develop PTSD while others do not? In particular, are 
maladaptive coping strategies good predictors of PTSD in SOs of SAH 
patients? 
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4) What is the impact of SO well-being on the recovery of the patient they care 
for? 
To do this, a representative sample of 86 SAH patients and their SOs were 
examined twice over the course of 13-months. Assessment one occurred at 
approximately 3 months post-ictus and assessment two approximately 13 months 
post-ictus. All SOs were assessed with a diagnostic measure for PTSD and were 
given a questionnaire to establish their dominant coping style. All patients 
underwent a comprehensive assessment of their cognitive, physical and emotional 
state. Regression analyses were then used to explore the predictive values of the 
patients' level of impairment and the SOs' coping style for the development of 
PTSD in the SOs of SAH patients. Finally, the unique contribution of SOs well-
being - as indexed by their experience of PTSD symptomatology - to their 
patient's cognitive, neurological and emotional recovery was determined using 
sequential multiple regression analyses. 
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6.2 Methods 
Patients and Significant Others 
In this study, 86 SAH patients and their SOs were prospectively examined. All 
patients were non-institutionalised first-time victims of spontaneous SAH, admitted 
to Newcastle General Hospital or James Cook University Hospital, Middlesbrough 
between May 2005 and August 2006. SOs were approached through the patients, 
who passed an invitation on to the SO if they wished them to participate. An SO 
was defined as the person/s the patient felt closest to and who was most involved 
in helping to informally support them since their illness. Patients were recruited 
from a total of 188 patients admitted and who were eventually discharged home 
and who had a significant other. Of non-participating patient/ SO pairs, 6 were 
excluded for geographic reasons, 1 patient did not speak English, 16 recruited 
pairs had too much missing data and 79 declined to participate or were not 
available for testing. 
Diagnosis of the patents' SAH was established by computed tomography 
(CT), or if negative, xanthrochromia of cerebrospinal fluid was diagnostic. In 
aneurysmal SAH patients (ASAH), aneurysms were demonstrated by spiral CT or 
catheter angiography. 
This study was granted multi-centre approval by the Central Manchester 
Research Ethics Committee. Informed consent was obtained from all participants. 
Measures 
Instruments were chosen on the basis of having robust psychometric properties 
and ecological validity for cognitive tasks [53, 95, 107, 194, 238, 563, 657, 734, 
754, 755]. Parallel versions of the attention and memory tests were used at 
assessments one and two. 
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Significant others 
At both assessment one and two, SOs underwent a brief interview to determine 
their medical and psychiatric history, relationship with the patient, years of 
marriage (where appropriate) and whether the SO resided with the patient. The 
measures described below were then completed at both assessments (except the 
Brief COPE Inventory which was only completed at each SO's first appointment). 
The Post-traumatic Diagnostic Scale (PDS) [194] assessed whether SOs 
warranted a DSM-IV-TR diagnosis of PTSD [23]. The PDS also provides a PTSD 
severity score and a functional impairment index. In order for a diagnosis of fuii-
PTSD to be warranted SOs must have satisfied the following diagnostic criteria in 
response to their loved-ones SAH: experienced intense fear, helplessness, or 
horror at time of the event (Criterion A); persistently re-experienced the event 
(Criterion B Intrusion); persistently avoided stimuli associated with the event and 
numbing of responsiveness (Criterion C Avoidance); and had persistent symptoms 
of increased arousal (Criterion D Arousal). This full symptom picture must have 
been present for more than 1 month (Criterion E Duration) and the disturbance 
must have caused clinically significant distress or impairment in social, 
occupational or other important areas of functioning (Criterion F Functioning). The 
prevalence of sub-threshold/ sub-syndromal PTSD as defined by recent guidelines 
[477] was also recorded. In short, this syndrome was defined as one in which the 
threshold for Criterion C (Avoidance) and/or D (Arousal) was not reached, but 
there was at least one symptom of each of these criterion present. These 
symptoms, along with those of Intrusion (Criterion B), must have been present for 
at least one month (Criterion E) and have caused significant distress and/ or 
functional impairment (Criterion F). Finally, a 'PTSD Symptom Severity' score was 
calculated for all SOs regardless of PTSD diagnosis to examine the link between 
SO well-being and patient recovery through regression analyses. 
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The Brief COPE Inventory [1 07] measured SOs' dispositional use of 
'maladaptive coping strategies' (Venting, Denial, Substance Use, Behavioural 
Disengagement, Self Distraction and Self Blame). Higher scores denote more 
frequent use of the strategies. Internal consistency of this scale was satisfactory 
(a=0.7) [494]. 
Patients 
Patients' neurosurgical notes were examined and details of their medical and 
psychiatric history and SAH were recorded. Details obtained about patients' SAH 
included clinical severity on admission to hospital (World Federation of 
Neurological Surgeons grade; WFNS) [164], the origin of their haemorrhage, its 
primary treatment and, if appropriate, aneurysm location. Following a brief 
introductory interview, the following measures were completed at both 
assessments. 
The Functional Independence Measure - Motor Subscale (FIM-MS)[238] 
was completed based upon information from the SOs to index their loved-ones' 
physical disability. Measured across 13 tasks on 7-point scales, increasing values 
indicate greater levels of independence in mobility, self-care and continence. 
The Test of Everyday Attention (TEA) [563] assessed attention. The 
following tasks were used: Visual Elevator, Telephone Search, Telephone Search 
Dual Task, Elevator Counting and Lottery. 
The Behavioural Assessment of the Dysexecutive Syndrome (BADS) [754] 
measured executive skills. All but one of the tests was used: Rule Shift Cards, Key 
Search, Modified Six Elements, Temporal Judgment and Zoo Map. 
The Rivermead Behavioural Memory Test - Extended Version (RBMT-E) 
[755] measured everyday memory function. The following tests were used: Story 
Immediate, Story Delayed, Picture Recognition, Face Recognition, Orientation and 
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Date, First Names, Second Names, and Appointments and Belongings (see 
Appendix VIII for further details on all cognitive measures). 
For the purposes of analyses, an Overall Cognitive Function index for each 
assessment was generated from the performances on . the TEA, RBMT -E and 
BADS at the respective assessment. This was achieved by using normative data 
to generate attention, memory and executive function indexes for performance on 
the batteries [563, 754, 755]. Indexes were based on the following scale: 4= 
Exceptional, 3= Good, 2= Average, 1 = Poor and 0= Impaired. These indexes were 
then summed to provide the Overall Cognitive Function index. Further details on 
how the two Overall Cognitive Function indices were computed can be found in 
the methods section in Chapter 5 (section 5.2). 
The Hospital Anxiety and Depression Scale (HADS) [772] is a self report 
measure of patients' experiences of 7 anxiety (HADS Anxiety Score) and 7 
depression (HADS Depression Score) symptoms over the preceding week. It 
reduces 'noise' from somatic disorders by excluding symptoms also related to 
physical disorders. Scores were compared to UK normative data [124]. The Total 
HADS score (anxiety and depression scores combined) was used as an index of a 
patient's overall mood disturbance. 
The Post-traumatic Diagnostic Scale (PDS) [194] assessed to what degree 
patients experienced DSM-IV PTSD symptoms.[23] A 'PTSD Symptom Severity' 
score was calculated for all patients regardless of PTSD diagnosis to examine the 
link between SO well-being and patient recovery through regression analyses. 
The Pittsburgh Sleep Quality Index (PSIQ) [95] measures sleep quality over 
the preceding month. Subjective 'Sleep Quality', 'Latency', 'Duration', 'Habitual 
Sleep Efficiency' (hours sleep: hours in bed), 'Disturbances', 'Use of Sleep 
Medication' and 'Daytime Dysfunction' are all measured. A 'Global PSIQ Sleep' 
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score (0-21) was calculated and used in the present study to represent patients' 
overall sleep quality. Higher scores indicate worse sleep. 
The Multidimensional Fatigue Symptom Inventory - Short Form (MFSI-SF) 
[657] assesses how much. patients experienced fatigue symptoms over the 
preceding week. The MFSI-SF comprises 5 subscales ('General Fatigue', 
'Physical Fatigue', 'Mental Fatigue', 'Emotional Fatigue' and 'Vigour'). The sum of 
the fatigue subscales minus the 'Vigour' scale generates a Total Fatigue Score 
that was used in this study (ranging from -24 to 96). A higher score indicates more 
fatigue. 
The Short-Form 36 (SF-36) [734] assesses patients' health-related quality 
of life (HRQoL) across 8 domains: 1) 'Physical Functioning', 2) 'Physical Role 
Limitations', 3) 'Bodily Pain', 4) 'General Health', 5) 'Energy', 6) 'Social 
Functioning', 7) 'Emotional Role Limitations' and 8) 'Mental Health'. U.K. normative 
scores exist for this measure [60]. Standard algorithms aggregated scores into two 
summary HRQoL scores: 'Physical HRQoL' and 'Mental HRQoL" [733). Scores 
range from 100 (no reduction) to 0 (maximum reduction). 
Procedure 
Patients completed the TEA, RBMT-E, HADS and BADS during an appointment at 
either their home or at our testing laboratory. The FIM-MS was then completed 
either during a face-to-face or by telephone appointment, whilst the remaining 
measures were left with the patients and SOs for completion in their own time and 
collected at a later date. 
Data Analysis 
With large numbers of comparisons in some analyses, alpha levels were 
appropriately adjusted (Bonferonni) to compensate for family-wise error and to 
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keep the alpha-level at 5%. The adopted values are reported in the corresponding 
paragraphs of the Results section. When missing data exceeded 5%, a missing 
value analysis assessed its impact on the results' generalisability by examining if 
incompleteness was dependent on any variable (Little MCAR test) and whether 
cases with missing data were comparable to those without (t-tests; variables 
considered SO age and sex and their patient's WFNS grade, haemorrhage type, 
treatment type and MMSE). For the purposes of brevity, I report only on the results 
of missing variable analyses when a significant result was found. The case-
variable ratios for regression analyses were largely acceptable [290, 518]. Where 
possible, effect sizes (ES) in the form of the correlation coefficient rare reported 
for all results. All analyses were conducted using commercially available software 
(SPSS). 
Incidence of PTSD. The frequency of PTSD in the SO sample at 
assessments one and two was compared to the frequency of PTSD normally 
expected within the general population [23]. The incidence of sub-syndromal PTSD 
was also calculated. Descriptive statistics were used to show the severity of, and 
functional impairment caused by, PTSD for those diagnosed. Mann-Whitney tests 
compared the number of symptoms experienced by SOs with PTSD with the 
number in those without PTSD. The functional impairment caused by full- and sub-
syndromal PTSD compared to those not meeting its criteria at assessment one 
and two were also compared. Finally, the Wilcoxon matched-pairs signed-ranks 
test and Spearman's correlation were used to compare the PTSD reported by SOs 
who were examined both at assessment one and two. 
Prediction of PTSD. Logistic regression examined the following SO- and 
patient-related predictors for PTSD at 3- and 13-months: the patient's WFNS 
grade, Overall Cognitive Function index, FIM-MS and Total HADS and the SO's 
age, sex, psychiatric history versus none and dispositional maladaptive coping 
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use. The patients' Overall Cognitive Function Index score, FIM-MS and Total 
HADS score from assessment one were used in the model to predict PTSD in SOs 
at assessment one, whilst the patients' scores on these measures from 
assessment two were used when predicting SO PTSD at assessment two. A 
backward elimination method (likelihood ratio test) revealed the most 
parsimonious predictors. The odds ratio (OR) was used here to indicate the 
change in the odds of having or not having PTSD when the value of a predictor 
increased by one unit. The c-statistic measured the discriminative power of the 
logistic equation. Varying from 0.5 (predictions are no better than chance) to 1.0 
(model predicts without error), it is the percentage of case pairs to which the model 
correctly assigns a higher probability. Mann-Whitney U tests, box-plots and 
Kendall's tau ('r) measures of association were used where necessary to further 
explore relationships highlighted by regression. 
Please note that due to a reduced SO sample size at assessment two and 
a smaller found frequency of SO PTSD, the full- and sub-syndromal SO PTSD 
categories were collapsed for regression analyses for assessment two to increase 
the number of cases of the rarer PTSD event (and hence satisfy an assumption of 
logistic regression). This merging of groups was deemed acceptable since at 
assessment two (unlike at assessment one), SOs with sub-syndromal and fuii-
PTSD illustrated comparable levels of functional/ clinical impairment as a result of 
their PTSD syndromes (see Results incidence sections). 
Impact of significant other well-being on patient recovery. Multiple linear 
and logistic regression using two sequential blocks of entry of variables was used. 
In the first block, patients' demographics (age, sex, education) and illness 
characteristics (clinical severity, time since illness and pre-morbid health) were 
entered and formed the predictive model. The variance in patient recovery which 
these predictors accounted for was therefore, controlled. In the second entry 
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block, SOs' PTSD symptom severity was then added to the predictive model and 
the unique explanative value which this predictor added to the model was 
established. 
The aspects of patient short- and long-term recovery that were predicted 
were cognition (attention, memory and executive function individually and overall 
cognition) using logistic regression, and physical independence (FIM-MS), 
psychiatric disturbance (PTSD; HADS Anxiety; HADS Depression), fatigue (MFSI 
Total Score), sleep (PSIQ Global Score), and HRQoL (Mental HRQoL; Physical 
HRQoL) using linear regression. Parametric regression techniques were 
appropriate for most of the aspects of patient recovery (despite their ordinal 
nature), because of the number of occupied categories and the fact that it was fair 
to assume an underlying continuum and an equal distance between each ordinal 
point [677]. Logistic regression however, was used for exploring the predictors of 
patients' cognitive recovery ("impaired", score of 0/ "not impaired", score of 1-4) 
due to the limited number of categories by which cognition had been classified 
(i.e., the 4-0 scale). Due to the infrequency of impairment in attention and 
executive function, impairment in these two domains was, for the purposes of 
logistic regression defined as score that had originally been classified as either 
'Impaired' (score of 0) or 'Poor' (score of 1) [677]. 
For the linear regression models, the significance of SOs' well-being in the 
prediction of patient recovery was determined by examining whether the addition 
of this variable significantly increased the variance which the predictive model 
explained. The significance of the improvement was determined by calculating the 
incremental change in the F-ratio - which is based upon the ratio of the 
improvement due to the model and the difference between the model and 
observed data. For logistic models, the goodness-of-fit chi-square test was used to 
examine whether a variable's addition improved the match between the observed 
208 
data and the model's predictive abilities. Due to differences in their calculation, a 
larger F-ratio statistic indicates better model prediction, whilst a smaller chi-square 
statistic compared to a baseline model indicates an improved predictive ability. 
To increase the linearity between predictors and patient outcome measures 
- and hence enhance the prediction equations - square root, logarithm and (in 
one case) reflection and inversion transformations were made (where necessary) 
so that predictor variables better approached normality [677]. 
6.3 Results 
Significant others and patients 
The SO group consisted of 53 women and 33 men. All 86 SOs were examined at 
assessment one, but 12 SOs (14%) were lost from the sample at assessment two 
(Table 6.1 ). The reason for the reduced sample was due to one patient death and 
the remaining eleven SOs, either declining to participate or failing to complete the 
PDS at assessment two. No significant differences existed (in terms of their age, 
sex, or in their associated patients' WFNS grades, type of haemorrhage, treatment 
or cognitive, physical or mood disturbance at assessment one) between the SOs 
who were examined at assessment two and those who were not (all P>0.05), with 
no pattern to the missing data being found (Little's MCAR: P=.114 ). The majority of 
SOs (76.8% at assessment one; 79.7% at assessment two) were the spouse or 
partner of the patient. Average follow-up for assessment one was 112 days after 
SAH (SD 40.53; range 44-234) and 412 days after SAH for assessment two (SD 
53. 77; range 344-677). 
Three patients informed me that the person they considered to be their SO 
had changed in the-period between assessments one and two. In these cases, the 
SOs from assessment one were not assessed at appointment two, but instead, the 
patients' latest SOs were examined. 
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Table 6.1 Summary of demographic and characteristics of significant others 
examined at assessment one and two 
Factor Value(%) 
Assessment one Assessment two 
N=86 N=74 
Significant others 
Female 53 (61.6) 48 (60) 
Mean age± SO (range) (yr) 50.52 ± 13.68 (18-78) 51.41 ± 13.89 (19-79) 
Relationship with patient 
Spouse/partner 66 (76.8) 63 (79.7) 
Child 12 (14.0) 9(11.4) 
Parent 4 (4.7) 3 (3.8) 
Sibling 2 (2.3) 3 (3.8) 
Friend 2 (2.3) 1 (1.3) 
Mean years of marriage± SO (range) (yr) 27.16 ± 14.45 (0-62) 28.11 ± 14.63 (0-63) 
Living in same residence 69 (80.2) 67 (84.8) 
Mean years of formal education± SO (range) (yr) 12.19 ± 1.97 (9-18) 12.23 ± 1.98 (9-18) 
Significant history• 
Physical only 20 (23.3) 16 (21.9) 
Psychiatric only 12 (14.0) 9 (12.3) 
Both 2 (2.3) 2 (2.7) 
Note:Assessment one=mean of 112 days post-ictus; assessment two=mean of 412 days post-ictus; 
N=number; SD=standard deviation; yr=year. *Self-reported illness receiving/ received formal treatment. 
Physical illness includes: acromegaly, brain tumour unspecified, diabetes, epilepsy, hypothyroidism, 
labyrinthinitis, myocardial infarction, normal pressure hydrocephalus, viral brain infection, rheumatoid 
arthritis, transient ischemic attack, traumatic head injury. Psychiatric illness includes: anxiety unspecified 
diagnosis, depression unspecified diagnosis, alcohol abuse, schizophrenia. 
Recruited patients were representative of the population from which they 
were drawn (Table 6.2), with no differences between participators and non-
participators in age, sex, WFNS, haemorrhage type, aneurysm location or 
treatment (all P>O.OOB). A detailed description of the included patients' cognitive, 
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psychiatric and physical status at the two assessment points is presented in 
Table 6.3. 
Table 6.2 Summary of demographic and clinical data of patients who were 
examined at assessment one and two 
Factor Value (%) 
Assessment one Assessment two 
N=86 N=74 
Patients 
Female 49 (57.0) 40 (54.1) 
Mean age± SD (range) (yr) 52.40 ± 10.74 (27-80) 53.52 ± 10.62 (28-81) 
Aneurysmal SAH 63 (73.3) 51 (68.9) 
Location of ruptured aneurysm 
ACoMIACA 31 (49.2) 26 (51.0) 
ICA 13 (20.6) 10(19.6) 
MCA 16 (25.4) 12 (23.5) 
Vertebrobasilar 3 (4.8) 3 (5.9) 
Unknown origin 21 (24.4) 21 (28.4) 
Other origin 2 (2.3) 2 (2.7) 
WFNSgrade 
57 (66.3) 50 (67.6) 
II 13(15.1) 8 (10.8) 
Ill 4 (4.7) 4 (5.4) 
IV 12 (14.0) 12 (16.2) 
v 0 (0) 0 (0) 
Primary treatment 
Endovascular 37 (43.0) 28 (37.8) 
Surgery 28 (32.6) 25 (33.8) 
Conservative 21 (24.4) 21 (28.4) 
Note: ACA-anterior cerebral artery; ACoM-anterior communicating artery; assessment 
one=mean of 112 days post-ictus; assessment two=mean of 412 days post-ictus; ICA=intemal carotid 
artery; MCA=middle cerebral artery; N=number; SD=standard deviation; Vertebrobasilar=arteries of the 
vertebrobasilar system; WFNS=World Federation of Neurological Surgeons; yr=year. 
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Table 6.3 Summary of results from subarachnoid haemorrhage patients' cognitive, psychiatric, and physical examinations 
Factor N Median IQR Percentage in clinical range* N Median IQR Percentage in clinical range* 
Cognitive Impairment 
RBMT-E Memory Function 83 1.0 0.0-1.0 30.1 73 1.0 1.0-1.0 23.3 
BADS Executive Function 83 2.0 1.0-2.0 10.8 73 2.0 1.0-3.0 9.6 
TEA Attention Function 84 2.0 1.5-2.5 8.3 73 2.0 1.3-2.5 4.1 
Overall Cognitive Function index 83 5.0 4.0-6.0 - 73 5.0 3.3-6.0 
Psychiatric Status 
Total HADS Score 84 12.0 6.0-18.0 26.2 71 11.0 6.0-17.0 25.4 
HADS Anxiety Score 84 7.0 3.0-10.0 34.5 71 8.0 6.5-8.0 18.3 
HADS Depression Score 84 5.0 2.0-9.0 21.4 71 5.5 4.3-7.5 29.6 
PTSD Severity Score 80 10.0 4.0-18.8 35.0 71 7.0 3.0-14.0 35.2 
Physical Disability 
FIM-motor scale 86 90 89.0-91.0 5.8 74 7.0 7.0-7.0 12.2 
Sleep 
Global PSIQ Sleep 59 7.0 4.0-11.0 49.2 74 6.0 3.0-10.0 35.1 
Fatigue 
MFSI-SF Total Score 59 26.0 3.0-44.0 44.1 73 18.0 1.0-41.0 42.5 
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Table 6.3 Cont'd. 
Factor N Median IQR Percentage in clinical range* N Median IQR Percentage in clinical range* 
Health-Related Quality of Life 
SF-36 Mental HRQoL 83 38.6 2g,1-51.0 6g,g 72 47.8 36.7-54.2 50.0 
SF-36 Physical HRQoL 83 36.4 2g.8-43.g 74.7 72 42.g 31.4-51.5 51.4 
Note: Assessment one=mean of 112 days post-ictus; assessment two= mean of 412 days post-ictus; BADS=Behavioural Assessment of the Dysexecutive Syndrome; 
FIM-motor scale=Functional Independence Measure motor scale items, with scores ranging from 13 (total dependence) to g1 (independent); HADS=Hospital Anxiety and 
Depression Scale, with scores ranging from 0 to 42 (higher values denote more disturbance); HRQoL=health-related quality of life; IQR=interquartile range; MFSI-
SF=Multidimensional Fatigue Symptom Inventory-Short From, with scores ranging from -24-g6 (higher scores indicate worse fatigue); N=number; PDS=Posttraumatic Stress 
Diagnostic Scale, PDS Symptom Severity score ranges from 0-51 (higher scores indicating more severity); PSQI=Pittsburgh Sleep Quality Index, with scores ranging from 0-
21 (higher scores indicate poorer sleep); RBMT-E=Rivermead Behavioural Memory Test; SF-36=Short-Form 36 quality of Life measure, with scores ranging from 0-100 
(lower values indicate worse HRQoL); TEA=Test of Everyday Attention. *=Percent in clinical range for RMBT-E, BADS and TEA was a function score of 0 ("impaired"); 
percentage in clinical range for HADS scores was determined by comparing patients' scores to sex-adjusted U.K. normative values and judged as abnormal ~goth percentile 
percentage in clinical range for PDS was those with criteria for fuii-PTSD; clinical range for FIM was a median total motor score <6 (dependent on other person); percent in 
clinical range for PSIQ and MFSI-SF was ~goth quartile compared to age-sex matched control sample (see Chapter 5); finally, percent in clinical range for SF-36 was those 
with a score below the ::>10th quartile compared to normative scores. Attention, Memory and Executive Function indices range from 0 (Impaired) to 4 (Excellent); Overall 
Cognitive Function classification ranges from 0 to 12 (increasing values indicate increased cognitive ability). Values expressed as median. 
213 
PTSD Incidence in significant others 
Assessment one 
PTSD was assessed in 86 SOs. Twenty-two (25.6%) SOs were diagnosed with 
PTSD. In the general population a prevalence of 8% is expected. Median symptom 
severity for those with PTSD was moderate (median=19.0, interquartile range 
[IQR]=14.0-30.8) and caused "severe" functional impairment for the majority 
(77.3%). Those SOs with fuii-PTSD exhibited significantly higher levels of 
intrusive, avoidant and arousal symptoms and more severe levels of 
symptomatology overall compared to those without (all P<0.0001; adjusted alpha= 
P<0.01; Table 6.4). An additional 12 (14%) SOs fulfilled the criteria for sub-
syndromal PTSD. This caused mild functional impairment for 5 of these patients 
(41.7%), moderate impairment for 3 (25.0%) and severe impairment for the 
remaining 4 (33.3%) patients. Those with sub-syndromal PTSD experienced 
significantly less functional impairmenU distress as a result of their syndrome 
(median=4.0, IQR=2.0-9.0) compared to those with fuii-PTSD (median=9.0, 
IQR=8.0-9.0; P<0.003). 
Assessment two 
PTSD was assessed in 74 SOs. Twelve (16.2%) SOs were diagnosed with PTSD. 
The median symptom severity for those with PTSD was moderate (median=17.0, 
IQR=13.3-23.0) and caused "severe" functional impairment for the majority 
(75.0%). Those SOs with PTSD exhibited significantly higher levels of intrusive, 
avoidant and arousal symptoms and more severe levels of symptomatology 
overall (all P<0.0001; adjusted alpha= P<0.01; Table 6.4). An additional 5 (6.8%) 
of SOs met the criteria for sub-syndromal PTSD. This 
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Table 6.4 Comparison of significant others with and without PTSD 
Factor Assessment one Assessment two 
50s with PT5D 50s without PT5D P-value E5 50s with PT5D** 50s without PT5D P-value ES 
N Median IQR N Median IQR N Median IQR N Median IQR 
PT5D-PD5 * 
Intrusions 22 4.0 2.8-4.3 64 2.0 1.0-3.0 <0.0001 -.45 17 3.0 2.0-5.0 57 1.0 0.0-2.0 <0.0001 -.53 
Avoidance 22 5.0 3.0-6.0 64 1.0 0.0-2.0 <0.0001 -.64 17 4.0 1.5-5.5 57 0.0 0.0-2.0 <0.0001 -.54 
Arousal 22 4.0 3.0-5.0 64 1.0 0.0-2.0 <0.0001 -.60 17 3.0 2.0-5.0 57 0.0 0.0-2.0 <0.0001 -.55 
Symptom severity 22 19.0 14.0-30.8 64 4.5 2.0-9.0 <0.0001 -.62 17 14.0 10.5-20.0 57 3.0 0.0-6.5 <0.0001 -.61 
Coping -Brief COPE * 
Maladaptive coping 21 3.6 3.1-4.5 64 2.7 2.2-3.1 <0.0001 -.47 17 3.3 2.9-4.2 56 2.6 2.2-3.2 <0.007 -.32 
Self distraction 21 5.0 3.0-6.0 64 3.0 2.0-7.0 <0.004 -.32 17 4.0 2.5-5.5 56 3.0 2.0-5.0 ns -.16 
Denial 21 4.0 2.0-6.0 64 2.0 2.0-3.0 <0.003 -.32 17 3.0 2.0-4.0 56 2.0 2.0-3.0 ns -.22 
Substance abuse 21 2.0 2.0-4.0 64 2.0 2.0-2.0 ns -.23 17 2.0 2.0-3.0 56 2.0 2.0-2.0 ns -.08 
Behavioural disengagement 21 3.0 2.0-3.5 64 2.0 2.0-2.0 <0.0001 -.37 17 2.0 2.0-3.0 56 2.0 2.0-2.0 ns -.14 
Venting 21 4.0 2.0-5.0 64 2.0 2.0-3.0 ns -.26 17 4.0 3.0-5.0 56 2.0 2.0-3.0 <0.0001 -.44 
Self- blame 21 3.0 2.0-5.5 64 2.0 2.0-2.0 <0.004 -.33 17 3.0 2.0-4.0 56 2.0 2.0-3.8 ns -.17 
50s demographics 
Mean age ± SD § 22 47.6 12.1 64 51.9 14.3 ns .14 17 44.7 14.5 57 52.8 13.6 <0.05" .06 
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Table 6.4 Cont'd. 
Assessment one Assessment two 
50s with PT5D 50s without PT5D P-value E5 50s with PT5D** 50s without PT5D P-value E5 
N Median IQR N Median IQR N Median IQR N Median IQR 
SOs demographics cont'd. 
Females (%) :t: 22 12 55% 64 41 64% ns .06 17 13 76.5 57 25 43.9 ns 
With psychiatric history(%) :t: 22 4 18% 64 10 16% ns 
-
17 5 29.4 57 6 10.5 ns 
Note: ES=effect size (r); IQR=interquartile range; N=number; PDS=Posttraumatic Stress Diagnostic Scale; PDS scoring is presented as the number of intrusive (e.g., "reliving the brain 
haemorrhage, acting or feeling as if it was happening again"), avoidant (e.g., "trying to avoid activities, people or places that remind me of the brain haemorrhage") and arousal (e.g., "feeling 
irritable or having fits of anger") symptoms experienced; SOs=significant others; *=Comparisons made using Mann-Whitney tests. §=Comparison made using t-test for unequal groups; **PTSD 
group in assessment two comparisons includes 5 SOs with sub-syndromal PTSD in order to increase cell count for statistical purposes; :!:=Comparison made using i test/ Fisher exact test; 
"=Equality of variances assumed. Brief COPE scoring ranges from 2 ("strategy usually not used") to 8 ("strategy usually used a lot"). Critical alpha level adjusted for each set of family 
comparisons: PTSD block P= 0.0125, Coping block P= 0.007 and SOs' demographic block P= 0.016. All values, other than age, expressed as medians. 
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caused severe functional impairment for the majority (60.0%). In fact, those with 
sub-syndromal PTSD illustrated levels of functional impairment/ distress as a 
result of their disorder comparable to those with fuii-PTSD (sub-syndromal 
median= 9.0, IQR 1.5-9.0 vs. fuii-PTSD median= 9.0, IQR 6.8-9.0, P>0.05). 
Comparison of significant others' PTSD at assessment one and two 
Missing data (17.4%), due to a reduced sample size at assessment two, meant 
that this analysis was based on the 71 SOs who completed the PTSD 
assessments at both assessments. There was no significant difference in PTSD 
prevalence (P>0.05), experience of intrusive {P>0.05), avoidant (P>0.05) or 
arousal symptoms {P>0.05) at assessments one and two (Adjusted alpha P< 
0.01 ). The Wilcoxon test however, detected a significant reduction with time in the 
number (P<0.007) and severity of PTSD symptoms {P<0.01) experienced by SOs 
(Table 6.5). Spearman's correlation between SOs' individual PTSD status (full, 
sub-syndromal or no PTSD) at the two assessments revealed that PTSD status 
was stable for many: rs= .317, P<0.0007. In total, 67.1% of patients had the same 
status at both assessments. 
Prediction of significant others' PTSD 
Assessment one 
Analysis was based on 82 patient/ SO pairs due to missing data (4.6%) on some 
measures considered. A logistic model that provided a significant relationship 
between predictors and the occurrence of PTSD was generated <l [2] = 26.195, 
P<0.0001 ). It was found that increased use of maladaptive coping strategies (OR= 
4.292, Cl 2.070 - 8.899; Wald statistic= 15.329 [1] P<0.0001) significantly 
increased the probability of PTSD (Adjusted alpha=P<0.006; Figure 6.1 ). Using a 
probability criterion of .5, predictive classification was excellent (c = 0.84), with the 
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Table 6.5 Comparison of significant others' PTSD symptoms at assessments 
one and two 
Factor Assessment one Assessment two P-value 
N Median IQR N Median IQR 
PTSD- PDS* 
Intrusions 71 2.0 1.0-4.0 71 1.0 0.0-3.0 Ns 
Avoidance 71 1.0 0.0-4.0 71 1.0 0.0-3.0 Ns 
Arousal 71 2.0 0.0-3.0 71 1.0 0.0-3.0 Ns 
Number of symptoms 71 6.0 2.0-10.0 71 4.0 1.0-8.0 <0.007 
Symptom severity 71 7.0 2.0-13.0 71 4.0 1.0-12.0 <0.01 
Prevalence full PTSD (no. I %)** 71 15 21.1% 71 12 16.9% Ns 
Note: Assessment one= mean of 112 days post-ictus; assessment two= mean of 412 days post-ictus; ES=effect size (r); 
IQR=inter-quartile range; N=number; PDS=Posttraumatic Stress Diagnostic Scale; *=Adjusted alpha 0.0125; **=McNemar 
test with correction for continuity due to small cell size.[629] Values expressed as median. 
model assigning 84% of all possible pairs the correct probability of having PTSD. 
The bivariate relationship between coping and PTSD diagnosis was -r = .404, 
P<0.0001. Those SOs diagnosed with PTSD were found to be more predisposed 
to use all but two types of maladaptive coping strategies compared to those SOs 
without PTSD (Table 6.4). Logistic regression analysis found no other variable-
not SOs' demographic information, psychiatric history, nor patients' clinical 
severity (WFNS grade) or level of physical (FIM- MS), cognitive (Overall Cognitive 
Function index), or psychiatric (Total HADS) impairment - to hold any significant 
predictive value for the development of PTSD in SOs. 
Assessment two 
Due to missing data (2. 7% ), analysis was based on 72 patient/ SO pairs. A logistic 
model which provided a significant relationship between predictors and the 
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Figure 6.1 Graph depicting the relationship between probability of SO PTSD at 
assessments one and their use of maladaptive coping strategies 
(OR= 4.292). 
occurrence of post-traumatic stress disorders was generated (X2 [3]=13.885, 
P<0.004). The backwards elimination model retained only two predictors in the 
final model. The use of maladaptive coping strategies (OR=2.445, Cl 1.234 -
4.845; Wald statistic= 6.569 [1] P<0.01) had by far the largest effect on the 
development of full/ sub-syndromal PTSD, followed by patients' cognitive function 
(OR=0.693, Cl 0.488 - 0.990; Wald statistic= 4.053 [1] P<0.05). These two 
predictors however, did not remain significantly predictive when judged according 
to the adjusted critical alpha value (Adjusted alpha = 0.006). Indeed, at 
assessment two, SOs with PTSD were mostly indistinguishable on the basis of 
219 
their disposition to use maladaptive coping skills from those SOs without PTSD 
(Table 6.4). 
Bivariate correlations between maladaptive coping and PTSD at 
assessment two were calculated to further examine the reduced importance of 
maladaptive coping for the prediction of PTSD status at assessment two. It was 
seen that the correlation between coping and PTSD at assessment two was much 
smaller than that seen at assessment one (assessment two t=.259, P<0.01 vs. 
assessment one t= .404, P<0.0001 ). Box plots and Mann-Whitney tests (Figure 
6.2) were used to compare the disposition to use maladaptive coping by those with 
PTSD at both assessments and those newly diagnosed with PTSD at assessment 
two. Though based on small groups, the results suggested that the reason for the 
reduced predictive importance of coping methods was that those SOs newly 
diagnosed with fuii-PTSD at assessment two formed a distinct subgroup for whom 
maladaptive coping was not predictive. These SOs (n=6) reported significantly less 
disposition to use of maladaptive coping than those SOs who were diagnosed with 
PTSD at both assessment points (n=6, P<0.001; r= -.44). On the other hand, those 
SOs who at assessment two no longer warranted the diagnosis of fuii-PTSD 
(n=15) reported significantly more of a disposition to use maladaptive coping than 
those who never warranted a diagnosis of PTSD at either assessment one or two 
(n=41, P<0.01; r= -.67). Therefore, in the longer-term a sub-group of SOs seemed 
to exist for whom maladaptive coping skills did not represent a PTSD risk factor. 
Corroborating this, is the finding that the use of maladaptive coping skills, did not 
significantly discriminate between those SOs who were newly diagnosed with 
PTSD at assessment two (n=15), and those who at assessment two, for the first 
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Figure 6.2 Use of maladaptive coping skills by significant others and their 
PTSD. 
time, did not meet the diagnosis for PTSD (n=6, P>0.05; r= -.37). It should be 
noted that persons with sub-syndromal PTSD were excluded from these analyses 
due to their small number. 
Impact of significant other well-being on patient recovery 
Assessment one 
The SOs' experience of PTSD symptomatology reported at assessment one did 
not significantly add to the predictive value of any aspect of patient recovery apart 
from patient anxiety (F[1]=8.286, P<0.005) (Table 6.6). Even in this one significant 
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Table 6.6 Results from hierarchical regression analysing the unique contribution of SO well-being to patient recovery 
Factor Assessment one Assessment two 
Model N Rz; Step Ft)? p Model N R2* Step Ft)? p 
Improvement Improvement 
Attention (TEA)* 1 84 32.0 19.795 0.003 1 73 23.3 12.418 0.05 
2 84 32.0 0.009 ns 2 73 23.3 0.032 ns 
Memory(RBMT-E)* 1 83 12.1 7.430 ns 1 73 19.3 9.997 ns 
2 83 21.8 6.446 0.011 2 73 20.0 0.392 ns 
Executive (BADS)* 1 83 9.3 5.827 ns 1 73 18.2 10.210 ns 
2 83 14.6 3.494 ns 2 73 20.0 1.132 ns 
Physical (FIM-MS)* 1 86 18.7 3.031 0.01 1 72 28.2 4.326 0.001 
2 86 21.9 3.213 ns 2 72 33.0 4.594 0.04 
Sleep (PSQI) 1 60 12.1 1.218 ns 1 70 32.2 5.071 0.0001 
2 60 15.8 2.246 ns 2 70 33.1 0.795 ns 
Fatigue (MFSI-SF) 1 59 29.3 3.592 0.005 1 69 19.2 2.489 0.04 
2 59 29.9 0.400 ns 2 69 19.5 0.284 ns 
Physical HRQoL (SF-36) 1 83 13.6 1.988 ns 1 71 14.9 1.893 ns 
2 83 15.7 1.890 ns 2 71 17.2 1.799 ns 
Mental HRQoL (SF-36) 1 83 27.8 4.884 0.0001 1 71 17.0 2.212 0.05 
2 83 30.9 3.363 ns 2 71 20.9 3.161 ns 
Anxiety (HADS-A) 1 84 29.1 5.275 0.0001 1 70 18.2 2.375 0.04 
2 84 36.1 8.286 0.005 2 70 19.2 0.736 ns 
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Table 6.6 Cont'd. 
Factor Assessment one Assessment two Factor 
Model N R2* Step Fit p Model N R2* Step Fit p 
Improvement Improvement 
Depression (HADS-0) 1 84 23.1 3.859 0.002 1 70 12.9 1.578 ns 
2 84 25.2 2.074 ns 2 70 15.9 2.242 ns 
PTSD (PDS) 1 80 26.1 4.300 0.001 1 70 18.5 2.422 0.05 
2 80 29.2 3.146 ns 2 70 25.4 5.851 0.03 
Note: BADS=Behavioural Assessment of the Dysexecutive Syndrome; FIM-MS=Functional Independence Measure-Motor; HADS-A=Hospital Anxiety and 
Depression Scale -Anxiety score; HADS-D=Hospital Anxiety and Depression Scale - Depression score; MFSI-SF=Multidimensional Fatigue Symptom Inventory-
Short Form; N=sample size; PDS=Posttraumatic Stress Diagnostic Scale; PSQI=Pittsburgh Sleep Quality; f?!=variance explained by model; RBMT-E=Rivermead 
Behavioural Memory Test-Extended; TEA= Test of Everyday Attention; SF-36=Short Form-36; *=The f?1 approximation for logistic regression model is the f?1 version 
devised by Nagelkerke (note this statistic can achieve a value of 1).[478] Model 1=Constant + Covariates (education, age, sex, pre-morbid health, WFNS grade, 
time since ictus), Modei2=Constant + Covariates +concurrent SO PTSD symptom severity. 
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aspect of patient recovery, only 7% of unique variance in patients' recovery was 
accounted for by SO well-being. SO wellbeing did explain 9. 7% of unique variance in 
patients memory performance (F[1 ]=6.446, P=0.01 ), but this proved non-significant 
when judged according to the adjusted test-wise alpha (P=0.007). 
Assessment two 
The SOs' experience of PTSD symptomatology did not significantly predict any 
aspect of their patients' longer-term recovery (Table 6.6). Small associations of 5% 
and 7% were found between SO well-being and patients' physical recovery (F[1 ]= 
4.595, P=0.04) and patients' own experience of PTSD symptoms respectively (F[1 ]= 
5.851, P=0.03). Again though, these associations proved non-significant when judged 
according to the corrected alpha level (P=0.007). 
6.4 Discussion 
This study has shown for the first time that having a loved-one suffer, and survive a 
spontaneous subarachnoid haemorrhage (SAH) is sufficient to elicit post-traumatic 
stress disorder in patients' family members and friends. It was found that 
approximately 26% (over three times the normal rate) of these 'significant others' 
(SOs) warranted a diagnosis of PTSD in the early-stages following an SAH and 16% 
warranted a diagnosis over one year post-SAH. A further 14% (in the early stages) 
and 7% (at around 1 year post-SAH) met the criteria for its preclinical, debilitating 
sub-syndromal form. Given this considerably high prevalence and that PTSD is a 
disorder known to cause medical and psychosocial disability, it is clear that much 
more attention nE;leds to be given to the outcome of SOs [23). The present findings 
help to explain why SOs have previously been documented as exhibiting abnormal 
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levels of psychiatric symptoms and as having a reduced sense of well-being [48, 90, 
264, 265, 285, 286, 461, 545, 546]. The need for an increased focus on SOs is 
underscored by evidence that they are the persons who typically act as informal 
carers to the patient [90, 264, 461, 545, 546]. If support is not provided, there may 
end up being two patients to support, where previously there was only one, supported 
by a SO [520]. The importance of this is highlighted when it is considered that the 
service rendered by families and other informal carers is invaluable and dramatically 
reduces the economic burden of SAH on society [154, 215]. Moreover, recent social 
trends, such as changes in family structure, increased geographical mobility and 
greater participation of women in the workforce, means that there are fewer potential 
replacements for those SOs who become ill and end up having to abdicate from the 
caring role [522]. Also, the incidence of SAH - unlike other stroke types - remains 
stable [140, 403, 711], but the number of people who survive an SAH and who 
require subsequent care is increasing all the time [284, 364, 653]. Therefore, the 
number of SOs who will be needed to act as informal carers can be expected to rise 
in the future. 
My finding that SAH can elicit PTSD in an SO compliments the work of 
Pritchard et al. [545]. As noted in the introduction to this chapter, Pritchard and 
colleagues found that informal carers of aneurysmal SAH patients experienced a 
significantly worse psychosocial outcome (for example, feeling more frightened, 
depressed and stressed) than carers of acoustic neuroma (AN) patients, even though 
socially and clinically well-matched. The authors suggested that this difference in 
outcome could be due to the emergency (rather than elective manner as is the case 
for AN) onset of the SAH and its treatment. Pritchard et al. considered that the 
emergency onset of the SAH, which by its very nature, came without prior warning 
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and caused major disruption, was sufficiently traumatic for the SO to elicit a post-
traumatic stress-reaction. Pritchard et al. however, did not use a diagnostic measure 
for PTSD and were therefore unable to confirm their hypothesis about PTSD. The 
present study did use such a diagnostic measure and can, therefore, confirm for the 
first time that an SAH leads to significantly elevated levels of PTSD in SOs of SAH 
patients. 
It is important to highlight that it is not presumed that the finding of elevated 
PTSD is restricted to family members and friends of patients with SAH [23]. A few 
studies have indeed documented an abnormal level of PTSD symptoms in other 
populations of family and friends of patients, such as in parents of children involved in 
accidents [97, 142, 698, 771]. It is also likely that other neurological conditions could 
be sufficiently psychologically traumatic to elicit a PTSD-reaction in family or friends. 
The present findings therefore, serve to underscore the importance of considering the 
impact of an illness on persons other than the patient. 
The finding that there was not a reduction in the prevalence of PTSD in those 
SOs examined at both assessment points, and that an SOs PTSD diagnosis was 
largely stable, leads to the conclusion that PTSD in this sample is, for the most part, a 
chronic problem. This concurs with evidence from the wider literature. One large 
epidemiological study of 5877 persons in the U.S., for example, found that the 
average duration of PTSD for those who did not seek treatment was over 5 years, 
and over one-third of persons suffering PTSD never fully recover [351]. There is some 
evidence to suggest that the greatest remission of PTSD occurs within the first 3 
months [584] and that those persons who fulfil the diagnostic criteria beyond this point 
have a significantly high likelihood of their PTSD taking on a chronic course [266, 
446, 458]. Indeed, the DSM-IV-TR does recommend that if PTSD endures in a person 
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for 3 months or more, then the treating clinician should consider it to have assumed a 
chronic course [23]. 
The existence ·of sub-syndromal PTSD in this study's SO sample (7-14%) also 
warrants discussion. The inclusion of these persons in the formal incidence of PTSD 
in the SAH SO population would obviously increase the prevalence of significant 
psychological impact of an SAH on SOs. It should be borne in mind, however, that a 
consensus on the definition of sub-syndromal PTSD has only recently begun to 
emerge [477], with some [55, 101] advocating less stringent diagnostic criteria for 
sub-syndromal PTSD than employed in the present study. Using such alternative 
criteria would have further increased the incidence of stress reactions found in SAH 
patients SOs. Previous research in other populations has illustrated that such sub-
syndromal disorders are associated with similar levels of functional impairment and 
psychosocial difficulties as full-blown PTSD [72, 658, 739, 773], that it often assumes 
a chronic path [31 9, 605], and is a risk factor for delayed onset fuii-PTSD (i.e., PTSD 
which occurs more than 6 months following the trauma) [1 06]. In line with these 
findings, sub-syndromal PTSD in the present study was found to cause many SOs 
severe degrees of distress and/ or functional impairment. In fact, at the second 
assessment, the functional impairment caused to SOs by sub-syndromal PTSD was 
comparable to that experienced by SOs with fuii-PTSD. Findings such as these have, 
in fact, led many to criticise the diagnostic criteria for PTSD as being too restrictive 
and leaving many short of appropriate treatment [477, 586]. 
The high rate of PTSD in the current study clearly indicates a need to 
understand why SOs develop PTSD. It was found that for SOs of SAH patients, 
coping strategies are the single best predictor of PTSD in the short-term. The greater 
the use of maladaptive coping strategies, the higher the likelihood that an SO will 
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develop post-SAH PTSD. This mirrors similar findings obtained in persons who 
developed PTSD as a consequence of other traumatic events (such as accidents, 
terrorist incidents and having a medically ill child) [87, 206, 207, 217]. In fact, in this 
study it was found that use of information about an SO's coping strategies alone, 
allows a classification accuracy of 84%. The classic explanation for why maladaptive 
coping strategies promote PTSD refers to the slightly paradoxical phenomenon that 
by actively avoiding thoughts or situations which lead to anxiety and fear we in fact 
maintain the fear-inducing quality of those thoughts and situations. In contrast, 
successful adaptation to the experience of a trauma involves accessing of aversive 
emotions about the event, which permits habituation to anxiety and modification of 
trauma-related beliefs [88, 193]. It is therefore possible to predict at an early stage, 
which SOs are at risk of developing PTSD. Moreover, appropriate interventions, such 
as teaching SOs better coping strategies can be implemented, which should make 
possible a reduction in SO PTSD and its associated psychosocial disability. 
Encouraging in this context, are the findings from another of Pritchard et al.'s studies, 
which illustrated the potential to improve the psychosocial outcome of SAH carers 
through the enhancement of the support they are offered [547, 548]. Specifically, this 
enhanced service employed the use of a specialist liaison nurse who provided 
support and counselling for SAH patients and families from the first day of admission. 
Those receiving this enhanced support fared significantly better in their emotional 
response and employment than did a matched group of carers receiving the normal 
support. Knowing that the underlying problem in SOs is PTSD and identifying their 
use of maladaptive coping strategies should allow us to design a more specific and 
even more effective system for preventing and treating the psychosocial problems in 
SOs (the effect sizes for Pritchard et al.'s intervention were only modest). 
228 
It could be argued though, that maladaptive coping, which incorporates 
avoidant behaviors, rather than representing a PTSD risk factor, could instead be a 
symptom of it, especially given that avoidance behaviours are a diagnostic symptom 
of PTSD. As commented by other workers however, this seems unlikely given that 
avoidance behaviours describe only 2 of the 17 symptoms that define PTSD [88]. 
Furthermore, evidence from studies which fortuitously measured individuals' 
preferences for coping skills prior to a trauma, show that pre-trauma preferences for 
maladaptive coping are predictive of subsequent PTSD, suggesting that maladaptive 
coping is a cause rather than a consequence of PTSD [172, 217]. For the analysis in 
question, coping skills had been measured at the same time as PTSD. Thus, it was 
not possible to determine the causal relationship between these two variables. 
However, in light of the above-mentioned findings, it is more likely that maladaptive 
coping skills cause PTSD than the other way around. Ultimately, an intervention study 
would be required to settle this question. 
Unfortunately, it was not possible to develop a significantly effective prediction 
model for longer-term SO PTSD. It was found that the dispositional use of 
maladaptive coping strategies, when judged against the adjusted critical alpha, were 
no longer sufficient to discriminate between those with and those without PTSD at 
assessment two. In exploring the reasons for the change in the association between 
coping and PTSD, the data suggests that those SOs with PTSD at only assessment 
two were unique in that their PTSD developed regardless of whether or not they used 
maladaptive coping. Further work on predicting the development of PTSD in the 
longer-term is obviously therefore needed. Fortunately, the results from the present 
study have illustrated that (at least in the first 13 months post-SAH) only a minority 
(-30%) of SOs' PTSD status actually changes between the short- and long-term. 
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Therefore, the short-term predictive model would efficiently highlight the majority of 
SOs who are likely to need targeted support in both the early and later stages 
following their loved-one's SAH. 
Noteworthy, is the find finding that the degree of physical, cognitive and 
emotional disability an SO's patient exhibited was not associated with PTSD 
development at any point. This appears to be in conflict with other studies [394, 414], 
including two focusing on SAH SOs [265, 510], which have suggested that 
information on patient disability is important in predicting SO outcome. A close look at 
these studies however, shows that PTSD was not included in the reported outcome 
measures. Instead, more general measures such as "stress" or "incidence of divorce" 
were used. Moreover, the validity of some of these earlier findings is debatable given 
that they come from bivariate, rather than multivariate analyses and thereby did not 
control for possible confounding variables. 
As has been stated, the well-being of SAH patients' SOs is of crucial 
importance not only from the perspective of their personal suffering, but also because 
of the important economic saving which they offer society. Increased attention on SO 
well-being has, however, also been motivated by evidence from the fields of ischemic 
stroke [161, 178, 225] and traumatic brain injury (amongst others) [528, 680], which 
suggests that the adjustment of an SO to a caring role (more broadly referred to as 
the patients' social support) has significant implications for the patient's ultimate 
recovery. At times, it is believed to be as significant as the initial disability resulting 
from the patient's illness. Such findings are very attractive from the perspective of 
rehabilitation, as SO well-being is potentially much more amenable to change through 
intervention than other, more stable predictors of patient recovery, like patient 
demographics and clinical aspects of the person's illness [593]. It has been asserted 
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within the fledgling SAH SO literature that the well-being of an SO is also a likely 
determinant for SAH patient recovery [461, 469, 690). The present study employed 
hierarchical multiple regression techniques to further examine the impact/ association 
between SOs' well-being - here indexed by their experience of PTSD 
symptomatology - on different aspects of a patient's recovery, including objective 
measures of cognitive, physical and psychiatric status, as well as subjective 
measures of their health-related quality of life. Hierarchical multiple regression is well 
suited to this real-world, complex research question as it is not one which can be 
easily reduced to an orthogonal design for the laboratory setting. Through the entry of 
demographic and clinical characteristic in an initial block into the predictive models, it 
allowed the unique contribution of SO well-being to patient recovery to be gauged, as 
the variance explained by the demographic and clinical factors known already to 
predict patient recovery could be controlled [677]. The results of these analyses, 
however, largely contradicted the belief that the relationship holds for SAH patients, 
as on only 1 of the 22 measures of patient outcome that were considered was there a 
significant impact of SO well-being. How can this discrepancy be explained? The 
explanation probably lies in the fact that not only has the relationship between SO 
well-being and SAH patients' recovery simply been presumed (and not actually 
substantiated), but also because many of the studies in the wider literature which 
have claimed to have provided evidence for the relation between social support and 
patient recovery are actually seriously flawed by methodological limitations. In fact, as 
several commentators have recently noted [223, 753], there is, to date, little concrete 
evidence that ischemic stroke patients and traumatic brain injury patients actually 
have an improved outcome as a result of family interventions. 
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At time of writing, there has only been one SAH study, conducted by Toomela 
et al. [690], which has actually investigated the impact of SOs' well-being on SAH 
patients~ Since that study reported evidence contrary to the present study, it is 
important to consider it in further detail. Specifically, it was reported by Toomela et al. 
that in a sample of 27 SAH patients, it was those SAH patients who felt the least 
supported post-discharge, who experienced the worst outcome, experiencing more 
headaches, memory problems and symptoms of dizziness [690]. It is quite obvious on 
closer examination why it should be that Toomela et al.'s study reported divergent 
findings to the present as it exemplifies the methodological limitations plaguing many 
of the studies on the topic in the wider literature [162, 224, 445, 528, 562, 650]. 
Firstly, the relative of significance of SO well-being was not considered. Specifically, 
SO well-being was not considered in the context of those predictors of patient 
outcome such as, the initial severity of the illness, patient's age, sex, education, 
premorbid health and the time that has elapsed since illness onset, which are already 
recognised as being important. Without controlling for these factors, it is not possible 
to ascertain what unique contribution SO well-being has for a patient's recovery. 
Secondly, many studies conclusions have been based on critically small samples, 
which raises concerns about how well their findings generalise. Toomela et al., for 
example, studied only 27 patients which, in fact, is so small that the discriminant 
function analyses which they used are rendered invalid according to accepted 
guidelines [677]. Finally, Toomela et al. considered only patients' subjective 
experience of headaches, memory problems, dizziness and absentmindedness. 
These aspects do not broadly encompass the key features of a patient's outcome 
after an SAH. Moreover, the use of only subjective based measures of such problems 
raises the question as to whether the impact of an SO's well-being extends to 
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objective measures. In the same study it was in fact reported that these patients' 
subjective reports of memory problems and absentmindedness did not correlate 
significantly with objective measures of the same problems. Therefore, given the 
greater methodological rigor of the present study, it is not surprising that results 
contrary to Toomela et al.'s were found. Although a larger sample size and a longer 
follow-up is required to rule out that SO well-being has no bearing on patients' 
recovery, the results of the present study do still strongly suggest that the influence of 
SO recovery is small. Indeed, the effect size of the only significant relationship that 
was found - namely between SO well-being and patient anxiety in the early stages of 
recovery - was of a negligible size, explaining only 7% of variance in patients' anxiety 
scores. 
Two potential limitations to the present study require highlighting. Firstly, as 
SOs were recruited through the patients, there is the possibility of a selection bias. 
Secondly, it would have been preferable to have measured the SOs' psychiatric 
status using an interview, rather than questionnaire-based technique. Although the 
PDS is known to possess sensitivity and specificity levels which approach those 
associated with "gold-standard" interview techniques [54, 193], there exists the 
possibility, due to the ubiquitous nature of many of the SOs' symptoms to a variety of 
other disorders [23], that another disorder may be more appropriate to explain SOs' 
psychological distress. On the basis of my findings, this possibility cannot be ruled 
out. In any case, regardless of whether the observed psychological distress is most 
appropriately labelled as PTSD or not, it remains a fact that a substantial portion of 
SOs experience significant distress subsequent to a loved-one's SAH. More 
importantly, my findings suggest that the psychological distress of SOs might be 
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treatable and potentially preventable as maladaptive coping skills seem key to its 
development. 
6.5 Conclusions 
In conclusion, PTSD was found to be common in SOs of SAH patients at both 3%-
and 13-months post-ictus. The elevated incidence of this disorder helps to account for 
the previously noted psychiatric symptoms in and psychosocial disability of SOs. 
Greater attention and support needs to be given to assist with the adjustment of these 
persons to their recent experience, especially considering that they often act as 
informal carers to SAH patients. It is important to find ways to prevent the 
development of PTSD which would likely interfere with the willingness/ ability of SOs 
to care. Maladaptive coping strategies seem to be the best predictor of SO PTSD in 
the short-term, but it is unclear what predicts PTSD in the later stages. It is hoped that 
by teaching SOs better coping strategies early on, the incidence of PTSD could be 
reduced. 
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Final Chapter 
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Chapter 7 
General discussion and conclusions 
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7.1 Introduction 
Previous studies examining spontaneous subarachnoid haemorrahge (SAH) patients 
and theirfamily and friends (who often act as their informal carers), had found that 
despite a seemingly good prognosis for surviving patients, many patients and their 
family and friends nevertheless suffered an particularly poor psychosocial outcome. 
The main aim of this thesis was to look to explain the mysterious difficulties of 
patients and their 'significant others' (SOs) by building upon previous evidence which 
led me to hypothesise that an abnormal prevalence of post-traumatic stress disorder 
(PTSD) in both groups- elicited by the trauma of an SAH -could be a way to explain 
their respective difficulties. 
Two longitudinal studies were conducted- one focusing on SAH patients and 
one focusing on their SOs. Overall, the results show that the best explanation for the 
poor outcome of members of both groups is that an abnormal number of them find the 
experience of an SAH so traumatizing that they develop PTSD. However, rather than 
simply determining what the difficulties of these persons were, this thesis has also 
provided some important insights into how we could potentially treat/ prevent their 
difficulties. Specifically, I established that it is possible to reliably predict which 
patients and SOs develop PTSD on the basis of information about the stress-coping 
strategies that they employ. In the next section (7.2), I shall discuss the main findings 
and conclusions to this thesis. These are then followed by a discussion of their 
implications for the treatment of SAH patients and their SOs in section 7 .3. Finally, 
future research directions are discussed in Section 7 .4. 
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7.2 Main findings 
The overarching finding emerging from the studies presented in this thesis is that the 
(previously mysterious) poor psychosocial outcome of SAH patients (defined in terms 
of health-related quality of life [HRQoL], fatigue and sleep dysfunction) and their SOs 
(defined in terms of their psychiatric disturbance) can, to a large extent be explained 
by the fact that an abnormal number of them find the experience of an SAH so 
traumatizing that they develop PTSD. 
Evidence from Chapters 3, 5 and 6 showed that despite their very different 
roles in the event, both patients and significant others are united by the fact that they 
can experience an SAH as not only a medical emergency, but also as a 
psychologically stressful event. Overall, these findings support prior research which 
proposes that medical events can be highly traumatic for patients and that it is also 
important to consider the wider impact of medical events for patients' family and 
friends. The striking parallels between SAH patients' and their loved-ones' outcome 
accords well with previous research where similarly poor reactions have been found 
in both patients and their family members following other medical events, including 
breast cancer and heart transplant [28, 62, 85, 671]. 
Crucially, insights were provided into how patients and their family and friends 
PTSD could be reduced as findings from Chapters 5 and 6 showed that for both 
parties the degree to which they used certain psychological stress-coping strategies 
largely determined whether or not they developed PTSD as a result of the SAH. 
Those with a disposition to use 'maladaptive' coping strategies such as denial, 
avoidance, distraction, venting and behavioural disengagement, were the most likely 
to experience PTSD. Importantly, the SAH patients' PTSD was not found to be 
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associated with any characteristics of their illness, which strongly implies that the 
origins of these patients' PTSD are not neurological, but rather psychological. 
In Chapter 5, I examined SAH patients' sleep and fatigue. For the first time 
within the literature, these symptoms were both measured using validated measures 
and the patients' scores were compared to those of a control group. Using these 
techniques evidence was found which strongly suggests that many SAH patients 
experience highly abnormal levels of fatigue and sleep. Importantly, PTSD helped 
explain many of the difficulties that these patients had with their sleep and energy 
levels. This evidence means that clinicians can no longer dismiss these symptoms 
and that they symptoms require medical attention. 
Behavioural disturbances such as delirium, major depression, anxiety disorder, 
mania, psychosis, personality change and fatigue following neurological diseases 
have typically been assumed by clinicians to be the direct result of the brain damage 
associated with the disease and not a psychological disturbance [416, 531]. The 
finding of this thesis, that a psychiatric disturbance, namely PTSD (whose origins 
were psychological), is integral to understanding a patient's behavioural outcome 
following a neurological disease, is therefore highly novel and significant. In showing 
that not all behavioural disturbances or psychosocial impairment following 
neurological diseases can be understood as being the result of 'organic' brain 
damage, the findings of this thesis imply that a significantly different approach to the 
treatment of neurological patients' disturbances may be warranted. My study is 
amongst only a few studies which have considered such a 'non-organic' explanation 
for neurological patients' behavioural disturbances. For example, whilst a recent 
review article by Tedstone and Tarrier [684] revealed that a host of studies have 
considered the role of PTSD in explaining the behavioural disturbances following a 
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variety of medical incidents, including cardiac events, cancer and certain medical 
treatments, only a handful of primary studies were identified as having considered the 
possibility that this 'non-organic' disorder might explain the behavioural disturbances 
seen after neurological disease [89, 111, 615]. 
In Chapter 7, I looked at the outcome of patients' SOs in more detail. I felt that 
it was relevant to do so (a) because their health status is important for their own 
sakes and (b) because their health status is important due to their valuable role in 
supporting SAH patients. Contrary to many assertions, I found that although SO well-
being was reduced, their poor psychiatric state, at least within the time frame of this 
particular study, did not appear to have any meaningful impact on patient recovery. 
The discrepancy between the finding of this study and the findings of other studies 
may at first seem concerning. However, close examination of the literature reveals 
that the relationship between significant others' psychiatric state and patient recovery, 
had largely been assumed, or based on research in the wider literature on other carer 
groups which have not adequately controlled for obvious confounding explanations 
for patients' poor recovery. 
The key overall conclusion is that the treatment of PTSD in both SAH patients 
and their SOs could lead to a much improved outcome for both groups following an 
SAH. 
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7.3 Implications for treatment 
The fact that both SAH patients and their SOs are often afflicted by PTSD and that 
the use of maladaptive coping reliably predicts its development, has significant 
bearing on neurosurgical practice and how these persons can be better treated. 
One immediate implication of the finding that 37% of SAH patients and 16% of 
their SOs develop fuii-PTSD (and yet more its sub-syndromal form) post-SAH, is that 
health-professionals now urgently need to recognise and treat the psychiatric 
consequences of an SAH experienced by patient and significant other. At present, 
post-SAH rehabilitation programmes typically focus on only the patient, address only 
the neurological impact of an SAH and are offered to only a restricted subset of 
patients (-10%). The persistence and consequences of PTSD in the SAH population 
also add credence to calls for health-service providers to no longer simply view an 
SAH as an acute event, but rather a chronic disorder which necessitates the on-going 
support which is typically afforded to other such illnesses [240]. It is interesting to note 
when considering what support should be offered to SOs, that in my studies, I 
restricted the inclusion of SOs to only the person(s) which the patient felt were most 
involved in their support and excluded significant others whose loved-one had died. It 
is possible that additional members of the surviving patients' social networks 
(including their children) [762), as well as bereaved family members and friends, 
could have also developed PTSD as a result of the SAH [23). 
PTSD following other traumas is known to be a readily treatable disorder [255]. 
This means that there is now a real possibility that the well-being of SAH patients and 
their SOs could be significantly improved [255]. It also provides a crucial insight for 
the rehabilitation of SAH patients and SOs, as traditionally it has been assumed that 
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the principle difficulties for this group were the consequence of patients' 'organic' 
brain damage, which is known to be extremely difficult to treat. 
The failure to deliver an intervention targeted at treating PTSD could also help 
to explain why the effectiveness of interventions to improve SAH patients' and SOs' 
outcome in two previous studies proved disappointing [548, 725]. Only one of the 
studies [54 7, 548] - a non-randomised examination of a fairly non-specific 
intervention (support by a liaison nurse) - reported significant effects, but the benefit 
of this treatment (as revealed by calculated effect sizes) was small (r range=.12-. 21 ). 
An array of formal psychological interventions [195] and pharmacological 
treatments (typically selective serotonin re-up-take inhibitors) [51, 429, 656, 696] are 
available for the treatment of PTSD and could prove much more efficacious in 
improving SAH patients' and significant others' well-being. But which specific 
treatment(s) should SAH patients and their SOs be offered? A psychological, rather 
than pharmacological treatment would seem preferable [24], as persons with brain 
damage in general are at increased risk of experiencing side effects (for example, 
nausea, dizziness and insomnia) from pharmacological treatments [281]. Medications 
could also increase patients' already heightened risk of suffering from seizures and 
the cognitive side-effects common to such treatments could serve to further impair 
patients' compromised cognitive function [645]. Moreover, the National Institute for 
Health and Clinical Excellence recently concluded from a comparison of treatment 
efficacy that psychological interventions are preferable to pharmacological 
interventions for the treatment of PTSD [255]. 
Psychological therapies for PTSD come in a variety of forms, but their central 
theme is similar. Like treatments for other anxiety disorders, psychological treatments 
consider that the best way to reduce or eliminate patient fear and anxiety is by 
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exposing (in a controlled and structured manner) the patient to those stimuli which 
provoke their fear and which they so ardently try to avoid. In the case of SAH PTSD, 
these stimuli are related to the "brain haemorrhage"'. In psychological interventions, 
the traumatized person is encouraged to confront the initial trauma in order to gain 
mastery over it and extinguish the considerable anxiety associated with the horrific 
event. A recent Cochrane review concluded that eye-movement desensitization and 
reprocessing (EMDR) and trauma-focused cognitive behavioural therapy (CBT) were 
the most efficacious of the psychological treatments [50]. In EMDR, the PTSD patient 
is asked to imagine an image, thought, emotion and a bodily sensation associated 
with the traumatic event whilst making rapid eye movements (which some consider 
facilitate processing of the traumatic event) [625]. Trauma-focused CBT on the other 
hand, generally employs an approach in which, (with the help of a therapist) the 
patient identifies distorted thinking patterns regarding themselves, the traumatic event 
and the world. The patient is encouraged to challenge these distorted thoughts by 
weighing up available evidence [50]. Future treatment of SAH patients and their SOs 
could look to use either of these two therapies for the treatment of PTSD. 
An alternative treatment option would be to specifically focus on coping, since 
it was this which was found to be the best predictor of which SAH patients and SOs 
developed PTSD. In line with prior evidence, it was found that the use of coping 
strategies such as avoidance, denial, distraction and self-blame proved maladaptive 
to a patient's! SO's mental health, increasing the risk of PTSD development. Mental 
health following an SAH may therefore be improved by the facilitation of more 
adaptive coping styles. This finding is very promising as a raft of evidence from the 
wider literature suggests that coping is amenable to intervention using relatively 
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inexpensive, psychosocial 'coping-effectiveness' group-based interventions [14, 16, 
127,216,424,556,638]. 
'Coping-effectiveness' interventions are highly structured and draw on some 
elements of CST. The interventions typically focus on teaching the individuals a 
structured problem-solving technique/ framework for choosing from various coping 
strategies. The central approach converts the major tenets of Lazarus and Folkman's 
[390] stress and coping theory into a series of practical and straightforward steps. 
Participants are encouraged to actively deal with problems by seeking information or 
by talking with others, rather than engaging in avoidant behaviours such as alcohol or 
drug use. Homework exercises and written handouts are used to encourage 
individuals to practise the strategies at home and to develop personal understanding 
of the effectiveness of the strategies. 
Importantly, not only have coping effectiveness interventions proved to 
increase peoples' use of adaptive coping strategies (e.g., active coping, acceptance) 
and reduce the use of maladaptive coping (e.g., avoidance, denial, distraction), but 
these changes in coping are associated with improvements in mental health [16, 104, 
113, 127, 216, 346, 424, 556]. Moreover, this finding has been illustrated in persons 
following a variety of medical events, including cancer, spinal cord injury, sickle cell 
disease and HIV+ infection [1 04, 113, 127, 216, 346, 556, 612]. Studies have also 
involved patients' family members and friends [342, 343, 424, 485, 612]. One study 
[634] even found a significant and clinically meaningful reduction in PTSD symptoms 
in a sample of adults who had experienced childhood sexual abuse and had 
HIV/AIDS. This improvement was found in comparison to both a wait-list and a 
support group control condition. 
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If coping effectiveness training proved effective for SAH patients and SOs, it 
could be extremely advantageous compared to traditional psychological treatments. 
As whilst EMDR and CBT are offered on a one-to-one basis (typically with repeated 
sessions often over the course of weeks or months, but sometimes years), coping 
training can be delivered to a group, including both SAH patients and their SOs. This 
means that such a treatment could be more cost-effective and allow a greater number 
of persons to be treated [14, 195, 483]. Furthermore, in several studies, the 'coping-
effectiveness' intervention has been delivered by non-specialist staff [1 04, 263]. This 
raises the possibility that such programmes could be delivered to SAH patients and 
SOs by non-psychologist/ psychiatrists. It could even potentially be delivered by the 
large network of support groups and charities dedicated to brain damage which exist 
throughout the world. 
Given that the maladaptive coping models developed in Chapters 4 and 6 
proved to be quite reliable in predicting which SAH patients and SOs were most likely 
to develop PTSD, the possibility that the coping effectiveness training could actually 
be offered as a preemptive therapy is also raised. The Brief COPE measure [1 07] 
could be administered to all patients who are to be discharged and their SOs and 
those identified according to their score as being most 'at-risk' could be offered the 
intervention before the full PTSD syndrome develops. Indeed, preliminary evidence 
from one study on spinal cord injury suggests that the efficacy of coping effectiveness 
training interventions for mental health is maximized by reducing the time between 
onset of injury and the start of the intervention [347]. Moreover, early supportive 
interventions (but not single session debriefing techniques [444]) have long been 
considered helpful for acutely traumatized persons in general [24]. 
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Regardless of which non-pharmacological treatment is deemed preferable, 
adjustments to the manner in which the therapy is delivered would need to be made, 
to account for the difficulties associated with SAH patients' brain injury [14, 15, 88]. 
Memory and attention problems could, for example, affect a patient's ability to take in 
and remember information and techniques discussed in the treatment sessions, whilst 
a dysexecutive syndrome may interfere with a patient's ability to generalise adaptive 
coping strategies learnt within the treatment session and implement them in their 
everyday life [14]. Employing a highly structured framework, as well as increased use 
of practical exercises, repetition and written reminders are obvious techniques which 
could help circumvent some of these problems. Importantly, it should be 
acknowledged that coping effectiveness treatment may not be effective for all persons 
with PTSD following SAH. As although the regression models presented in Chapters 
5 and 6 were very useful, the development of PTSD in patients and SOs in the later 
stages was less reliably predicted on the basis of the coping skills which they used. 
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7.4 Implications for future research 
The findings of the research presented in this thesis lead to extremely interesting 
directions for future studies. Some of the key questions which would it be useful to 
address are now described. 
7. 4. 1 Why is the incidence of PTSD in the SAH patient population so 
high? 
As I have already noted in the discussion section to Chapter 5, it is interesting that I 
detected a remarkably high incidence of PTSD in the SAH patient population -
namely 37% in the both short- and long-term. This high incidence appears to be at 
odds with the usual pattern of low prevalence of PTSD (and psychopathology in 
general) that follows internal medical traumas [23, 476, 701]. So how can this high 
incidence in the SAH population be explained? The similarity of the incidence of 
PTSD in patients detected in this thesis and that of prior studies (full PTSD estimates 
26-32% [47, 295]) on SAH which used "gold standard" interview techniques means 
that the high incidence cannot be explained by my use of a questionnaire measure of 
PTSD which can at times, 'over-diagnose', particularly with medical patients [500, 
67 4, 675]. Rather, in my view, two (potentially complimentary) explanations could 
account for the high incidence. Firstly, I recruited a fairly large sample of patients and 
used broad inclusion sample. Previous studies examining PTSD following other 
medical events which have reported finding much lower incidences have often 
employed highly restrictive inclusion criteria which could serve to reduce their 
likelihood of finding PTSD. For example in cancer studies, it is often only early stage 
female breast cancer samples which are studied because of the relative ease of their 
recruitment [327, 476]. Evidence suggests that the relatively good prognosis of these 
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participants limits the likelihood of them developing PTSD and that the inclusion of 
persons with more advanced cancers would have increased the incidence of PTSD 
[311). 
The second explanation for the high incidence of PTSD following an SAH is its 
unusually severe nature and its aftermath. Although the severity of an event is not by 
itself sufficient for the development of PTSD (hence 63% of SAH patients did not its 
fulfill its diagnostic criteria in this thesis), nor is it the most important determinant for 
who develops the disorder in general [73, 521 ], a dose-response model is 
nevertheless predictive to some extent [576]. Specifically, events of a higher a 
severity, intensity and physical proximity have been found to pose the greatest risk for 
the development of PTSD [23, 576]. This phenomenon has most recently been 
illustrated by an epidemiological study of the incidence of PTSD in residents in 
different areas of Manhattan, following the terrorist attacks of September 11th 2001 in 
New York on the World Trade Center. It was found in multivariate analysis that 
proximity to the World Trade Center was a significant predictor of PTSD development. 
Judged according to a U.S. normative population estimate of 3.6% of PTSD [620], it 
was found that following the attacks 6.8% of persons developed PTSD who lived 
towards the north of Manhattan and furthest away from the World Trade Center, 
whilst 20% of those persons living towards the southern end of Manhattan, in the 
vicinity of the attacks, developed PTSD [209). This latter group was presumably more 
directly exposed to the trauma and/or its consequences. The phenomenon that being 
directly affected by a disaster carries a greater risk of developing PTSD [233, 492] 
explains why the incidence of PTSD is lower in SAH SOs than it is in SAH patients. 
So what is it about an SAH that makes it so severe? Not only would an answer to this 
question have significant implications for how we could possibly prevent SAH PTSD 
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(as I discuss in the next section), but it could have important ramifications for trauma 
research in general as it could help us to better understand the origins of PTSD 
reactions. 
7.4.2 Prevention of PTSD in SAH patients 
As noted by Weinert and Meller [738] with respect to the trauma of intensive care 
treatment, we are in a unique position with SAH because "[u]nlike subjects exposed 
to the stressors of combat, childhood neglect or physical assault who almost always 
present for treatment after the stressor is over ... we can ... intervene while the stressor 
is occurring ... almost no other PTSD field can feasibly do this" (p.2). This means that 
identifying what it is about an SAH that precipitates PTSD in SAH patients could have 
significant implications for prevention as attempts could be made to make the evenUs 
less traumatic. This idea of pre-emptive intervention for PTSD has previously been 
discussed by Bryant et al. [85] in the context of road-traffic accidents, who on the 
basis of their study, suggested that relatively simple changes in the future, such as 
the rapid removal of neck and back restraints on arrival to hospital and better 
communication about the trauma and its consequences, could help to reduce the 
incidence of PTSD. 
Identifying the initial stressor event which precipitates PTSD in SAH patients is 
however, challenging compared to traditional traumatic events such as rape or 
assault, as it is not a discrete event. Instead, the nature of an SAH and its requisite 
treatments means that the event of having a 'brain haemorrhage' can be protracted, 
with patients potentially being exposed to multiple stressors (including the initial 
distressing onset of symptoms, the invasive treatments, the diagnosis, etcetera). 
Each of these individual events could be considered to satisfy the DSM-IV-TR 
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definition of a traumatic event (i.e., one which poses a threat to either a person's life 
or physical integrity). Pinning down the event which precipitated SAH patients PTSD 
has not so far been achieved by SAH patient studies (including the one in this thesis) 
because awarding the diagnosis does not necessitate knowing the exact stressor. 
Criterion A for a diagnosis of PTSD rather only requires that the person has a history 
of exposure to one or more traumatogenic events and that this event or events 
subsequently mobilises the three symptom clusters of re-experiencing, avoidance and 
hyperarousal which define PTSD [23]. The criterion A event can be as specific as a 
physical assault, or as broad as being involved in military combat. SAH studies, as 
was the case in this thesis, simply ask patients about their experience of PTSD 
symptoms with reference to their "brain haemorrhage". Future studies could employ 
two techniques to potentially help determine which event(s) is the actual stressor for 
SAH patients. The first would be to use qualitative interview techniques to explore the 
content of patients' intrusions. This could help ascertain which event(s) the patients' 
psychiatric response is centred upon. Alternatively, a novel approach would be to use 
psychophysiological techniques to determine which specific events of the whole SAH 
trauma are associated with the most stress. Patients could for example, be asked to 
generate personal scripts of their SAH experience. These could then be recorded in a 
neutral voice and recounted back to the patient. It may then be possible to identify the 
events which precipitated SAH patients' PTSD by determining which aspects of the 
recounted trauma were associated with the greatest physiological reaction in the 
patients. 
It is interesting to note however, that it could actually be the complexity of an 
SAH and the fact that it exposes its patients to multiple traumas in a short space of 
time that causes an SAH to lead to such a high incidence of PTSD. Evidence is 
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available for instance, to suggest that individuals exposed to prolonged, repeated or 
multiple stressful events exhibit greater PTSD symptoms compared to individuals who 
experience discrete and single events [356, 447, 642]. 
In discussing the prevention of PTSD in SAH patients, it is also interesting to 
note that there has been recent interest in the administration of medication in the 
initial stages of a trauma to prevent PTSD- something possible in the case of SAH. 
Specifically, there is some evidence, albeit preliminary [51], that PTSD symptoms can 
be reduced following intravenous administration of hydrocortisone in victims of septic 
shock in intensive care [601 ], as well as in those undergoing cardiac surgery [7 40]. 
Such treatment is informed by studies - though not recent ones [770] - which found 
PTSD patients show neuroendocrine system alteration (such as lower basal cortisol 
concentrations [768] and high noradrenergic activity [457]). It is suggested that 
disrupting memory retrieval mechanisms with glucocorticoids during the initial stages 
of a trauma could act protectively against the development of PTSD by preventing 
recall of traumatic memories [600]. Future studies could consider the role of 
hydrocortisone and its ability to reduce PTSD in SAH patients. 
7.4.3 What else can help explain HRQoL reduction in SAH patients? 
Including PTSD into this thesis' explanative models of HRQoL substantially improves 
our ability to comprehend SAH patients' outcome. Nevertheless, even with the 
inclusion of this factor, there remains a proportion of variability in SAH patients' 
HRQoL that cannot be explained (52% of variance in Mental HRQoL and 67% of 
variance in Physical HRQoL). It is important for future studies to identify the factors 
that explain this reduction beca,use currently there are some patients with a reduced 
HRQoL who we do not know how to help. 
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Given that conceptualising an SAH as a potential psychological stressor has 
proved useful in helping us to better explain SAH HRQoL, one possibility is to explore 
whether such a concepualisation could even further help to explain SAH patients' 
HRQoL. One interesting point raised by trauma-research in general is that it could be 
useful for future SAH studies to consider what psychiatric disorders other than PTSD 
are being elicited in patients by the trauma of their SAH [443, 607, 623]. A recent 
meta-analysis of psychiatric disorders following civilian traumas for instance, found 
that although PTSD was the most common psychiatric disorder to develop, 
generalised anxiety disorder, substance abuse, phobias and major depressive 
disorder are also common [80]. It could be that by measuring only PTSD symptoms, a 
group of patients who do not develop PTSD, but who do experience another 
psychiatric disorder post-SAH are excluded. This could explain their unexplained 
HRQoL reduction. Partial support for this possibility comes from three SAH studies 
which examined SAH patients' PTSD symptoms and found only modest correlations 
between the degree to which patients experienced PTSD and their scores on broader 
measures of psychiatric disturbance [295, 540, 541]. Hutter [295] for instance, 
measured the PTSD symptoms of intrusion and avoidance in a sample of 45 SAH 
patients and reported that their experience of these symptoms shared around only 
25% of variance with their scores on a measure of mood disturbance (namely the 
Beck Depression Inventory [36]). This suggests that although a relationship exists 
between SAH patients' PTSD and mood disturbance, the two are relatively 
independent. Continuing along this theme of taking guidance from trauma research in 
general, future studies could also consider the added explanative value that comes 
from incorporating information into predictive models about the psychiatric co-
morbidity experienced by those SAH patients with PTSD. It is well known from the 
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wider literature for example, that an additional formal psychiatric diagnosis is often 
warranted in PTSD patients [68, 125, 351] and that co-morbidity worsens a patient's 
HRQoL and functioning [431, 623]. 
With respect to which non-psychiatric factors could also potentially be involved, 
it is difficult to sift through the plethora of factors which have been implicated (see 
Tables 2.1 and 2.2 in Chapter 2) and suggest which hold the most promise. Studies 
examining them have typically not reported effect size data (or information necessary 
for its calculation). However, as I debated in the discussion section of my meta-
analysis which I presented in Chapter 3 (see section 3.4), there is some evidence to 
suggest that it might be prudent for future studies to re-examine the relationship 
between bleed severity and SAH patients' HRQoL, but when bleed severity is indexed 
using a more detailed scale. The rationale for this suggestion being that Fisher's CT 
rating score [191] which is almost always used to index SAH bleed severity is 
potentially too crude to reflect the true variability in anatomical distribution and 
quantity of extravasated blood seen on patients' CT scans [306, 363, 371]. Indeed, it 
should be highlighted at this point that the Fisher scale was not designed to predict 
long-term HRQoL or describe bleed severity, but rather to simply categorise patients 
according to the risk that their bleed carried for the development of cerebral 
vasospasm [363, 496]. More appropriate scales for future HRQoL studies are 
however available. For example, Hidjra et al.'s [270] scale individually quantifies the 
presence of blood in the 10 major subarachnoid cisterns. The use of such scales 
could reveal that bleed distribution is better correlated with HRQoL than presently 
suggested. 
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7.4.4 What else can help predict PTSD development post-SAH? 
Dispositional maladaptive coping proved to be highly predictive for the development 
of PTSD in SAH patients and SOs in the early stages post-ictus, as well as for most 
patients in the longer-term. This finding accords well with extensive evidence- from 
both prospective and retrospective studies - that shows that PTSD is highly 
associated with these types of coping strategies [87, 88, 165, 172, 217, 328, 493, 
635, 655]. The failure however, to predict a subset of those SOs who develop PTSD 
in the later stages post-SAH and the reduced discriminative abilities of the model for· 
long-term patient prediction, suggests that future work needs to look to refine the 
predictive models developed in Chapters 5 and 7 of this thesis and consider including 
additional, potentially predictive variables which have been implicated in the wider 
literature [73, 521]. 
7.4.5 What else predicts fatigue and sleep dysfunction in SAH patients? 
In the current thesis, PTSD was found to be able to explain a staggering 58% and 
42% of variance in SAH patients' experience of chronic fatigue and sleep symptoms, 
respectively. Previously these symptoms had remained unexplained. A large 
correlation in Chapter 5 between SAH patients' concurrent quality of sleep and fatigue 
(assessment one r-.53; assessment two r-.55) suggests that some of the fatigue was 
the consequence of impaired sleep which resulted from PTSD. This concurs with 
more general research on fatigue in sleep disorders,[166] where fatigue has been 
found to be elevated in those with sleep disorders (e.g., apnea, restless leg 
syndrome, narcolepsy [395, 471]) and a causal pathway is suggested, as treatment of 
these disorders leads to reduced fatigue [471]. Nevertheless, future research should 
examine how it is that PTSD can produce the remainder of SAH patients' fatigue, not 
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explained by induced sleep dysfunction. Possibilities could include the constant state 
of arousal which a PTSD patient can experience and the adverse health behaviours 
associated with the disorder (e.g., smoking, lack of exercise, alcohol use etc.) [351, 
389,606]. 
The finding that a proportion of fatigue and sleep dysfunction cannot be 
explained by PTSD, means that future studies need to determine which other factors 
are also involved. The fact that a proportion of fatigue remains unexplained is 
however, not unexpected as findings from the wider literature suggest that its cause is 
often multifactorial, with a variety of causes, including other health conditions (e.g., 
bacterial or viral infections, autoimmune illness) [120, 426], life-style choices (e.g., 
alcohol or caffeine intake, psychosocial stressors) [120, 426] and medications (e.g., 
anticonvulsants, analgesics) [38, 200, 648]. 
7.5 Conclusions 
At the beginning of this thesis, it was stated that SAH is associated with very high 
societal and personal costs because the illness affects relatively young persons and 
because it causes its survivors and their family and friends to experience significant 
psychosocial disability. Unfortunately, it was not known what treatment could be 
offered to the survivors and their SOs to improve their outcome because the cause of 
their problems remained mysterious. This thesis has however, helped resolve this 
mystery by illustrating that the poor psychosocial outcome of SAH patients and their 
SOs is caused, to a large extent, by the fact that an abnormally high number of these 
persons develop PTSD as a result of the trauma of an SAH. Future studies are 
urgently needed to consider the implications of this finding. Importantly, studies need 
to determine whether offering treatment for PTSD to SAH survivors and their family 
255 
and friends reduces the burden associated with this illness. Studies would also be 
wise to determine whether teaching patients and their SOs more effective stress-
coping strategies can reduce/ prevent PTSD and what it is that makes SAH so 
traumatizing that the illness stands out from other medical traumas as causing such a 
high degree of PTSD. 
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Appendix 1: 
World Federation of Neurological Surgeons scale 
The World Federation of Neurological Surgeons (WFNS) scale [164] is a reliable 
scale for the rating of a subarachnoid haemorrhage patient's level of clinical severity 
on admission to hospital. Higher scores indicate worse clinical presentation. 
The scoring for the scale is based upon the patient's score on the Glasgow 
Coma Scale (GCS) [683]. The GCS is a tool for the assessment of the level of 
consciousness (Table I.A). The GCS assesses responses to stimuli to measure the 
patient's ability to engage with his or her immediate surroundings. In the GCS a 
separate score is given for assessment of eye opening response, verbal response 
and motor response. These three scores are then added together to give a total score 
(between 3 and 15). The total GCS scores are then converted to a WFNS score as 
seen on the following page (Table I. B). 
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Table I.A The Glasgow Coma Scale 
Glasgow Coma Scale 
Eyes 
Verbal 
Motor 
Table I.B 
2 3 
Does not open Opens eyes in Opens eyes in 
eyes 
Makes no 
sound 
Makes no 
movements 
response to response to 
painful stimuli voice 
lncomprehensi Utters words, 
ble sounds 
Extensor 
(rigid) 
response, 
decerebrate 
posture 
but not 
coherent 
Abnormal 
(spastic) 
flexion, 
decorticate 
posture 
4 
Opens eyes 
spontaneously 
Confused, 
disoriented 
conversation 
Flexion I 
withdraws to 
painful stimuli 
5 
Orientated, 
converses 
normally 
Localizes pain 
The conversion of GCS to WFNS scores 
WFNS Grade 
Glasgow Coma Scale score Motor deficit 
1 15 Absent 
2 13-14 Absent 
3 13-14 Present 
4 7-12 Absent or present 
5 3-6 Absent or present 
6 
Obeys 
Commands 
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Appendix II: 
The Hunt and Hess Scale 
The Hunt and Hess scale [293] is a useful measure for the rating of a patient's clinical 
severity on admission to hospital (Table II.A). Higher scores indicate a worse clinical 
presentation. 
Table II.A Hunt and Hess Scale 
Hunt and Hess Grade 
Grade 0 Non-ruptured aneurysm 
Grade 1 Asymptomatic or mild headache and/ or slight nuchal stiffness 
Grade 2 Moderate to severe headache and/ or pronounced nuchal stiffness and/ or cranial nerve deficits, 
photophobia 
Grade 3 Drowsiness and/ or mild disorientation and/ or slight pareses and/ or dysphasia 
Grade 4 Stupor, moderate to severe hemiparesis and/ or dysphasia 
Grade 5 Deep coma, decerebrate rigidity, moribund appearance 
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Appendix m: 
Fisher's Rating Scale for Bleed Severity 
Fisher's scale [191] for the rating of head computed tomographic scans for 
subarachnoid haemorrhage is presented below (Table III.A). A higher score indicates 
a more severe haemorrhage. 
Table III.A Fisher's CT rating scale 
Fisher Grade 
0 No scan available 
1 No blood detected on CT 
2 Diffuse deposition or thin, localised layer of blood in all vertical layers (interhemispheric fissure, insular 
cistem, ambient cistem), less than 1 mm in thickness 
3 Localised blood clots and/or vertical layers of blood, 1 mm or greater in thickness 
4 Diffuse or no subarachnoid blood, with intracerebral or intraventricular blood present 
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Appendix IV: 
Glasgow Outcome Scale 
The Glasgow Outcome Scale (GOS) [318] for the rating of physical recovery following 
a subarachnoid haemorrhage is presented below (Table IV.A). A higher grade 
indicates more physical disability. 
Table IV.A The Glasgow Outcome Scale 
GOS Score 
Excellent recovery- Independent, no/ minimal neurological deficit 
2 Good recovery - Moderate disability, independent with moderate deficit (e.g., aphasia, hemiparesis, 
ataxia or memory deficit)? 
3 Poor recovery- Severe disability, dependent but conscious with severe deficits 
4 Poor recovery- Vegetative state, dependent, persistent vegetative state 
5 Dead 
It should be noted that the scale is presented in the form in which it is typically 
used within SAH research. In its original form however, the scores were placed in 
reverse order (i.e., 5="good recovery", 1 ="death"). 
In the extended version of the GOS [758), the first three categories are each 
subdivided into two to increase its sensitivity for those patients with ratings in the 
upper end of the scale. 
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Appendix V: 
Comparability in mean scores of limited Brazilian SF-36 population 
data and Swedish SF-36 population scores used to calculate 
summary scores for Rocha-Filo et al.'s study 
Rocha-Filo et al. [569] examined a sample of Brazilian subarachnoid haemorrhage 
(SAH) patients' health-related quality of life (HRQoL) using the Medical Outcomes 
Study Short-Form 36 (SF-36) questionnaire. Unfortunately, only unpublished mean 
scores (and not standard deviations) are available for the Brazilian population for this 
measure [619]. Both population mean scores and standard deviations are needed 
however, for the calculation of the summary scores to represent patients' Physical 
HRQoL and Mental HRQoL scores. The means and standard deviations of a large 
Swedish population [673] for the SF-36 were used therefore for the purposes of 
calculating the summary scores, as the mean scores for this population on the SF-36 
were the most comparable to the limited mean SF-36 scores available for the 
Brazilian population (see Tables V.A-8). 
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Table V.A Comparison of mean scores of Brazilian and Swedish population 
MOS SF-36 
Physical Functioning 
Physical Role Limits 
Bodily Pain 
General Health 
Energy 
Social Functioning 
Emotional Role Limits 
Mental Health 
Brazilian National Urban 
Population Norms [619) 
Mean so 
83 
87 
73 
75 
70 
84 
86 
73 
Swedish General Population 
Norms [673] 
Mean so 
87.9 19.6 
83.2 31.8 
74.8 26.1 
75.8 22.2 
68.8 22.8 
88.6 20.3 
85.7 29.2 
80.9 18.9 
Difference in means 
-4.9 
3.8 
-1.8 
-0.8 
1.2 
-4.6 
0.3 
-7.9 
Table V.B Comparison of mean scores of Brazilian population to other norms 
PF PRL BP GH EN SF ERL MH Total 
difference in 
means 
Brazilian[619) 83 87 73 75 70 84 86 73 
Difference in means 
Canadian [287] -5.2 1.3 -5 -2.6 -7.6 -4.3 -1 -6 33 
u.s 1998 [733) 8 0 4 12 -2 4 -3 34 
U.K. 1996 [66) 2 7 -4 6 7 -1 2 -2 31 
U.K. 91-92 [316, 317] -5 -9 9 4 3 33 
U.K. 92 ONS [60) -7 3 -10 5 -5 -2 4 37 
Croatian [430) 14 25 8 20 17 10 17 11 122 
Spanish [11] 2 4 -6 7 3 -6 -3 0 31 
Australian [651] 0 -7 -4 -3 -5 -1 3 -3 26 
Swedish [673] -5 4 -2 -1 -3 0 -8 24 
Note: BP=Bodily Pain; GH=Generai Health; EN=Energy; ERL=Emotional Role Limitations; MH=Mental Health; 
ONS=Office of National Statistics; PF=Physical Functioning; PRL=Physical Role Limitations; SF=Social Functioning. 
361 
Appendix VI: 
Modified Rankin Scale 
The modified Rankin Scale is a reliable measure of physical/ functional disability 
(Table VI.A) [550, 713]. Higher scores indicate more physical disability. 
Table VI.A The modified Rankin Scale 
mRS Score 
0 No symptoms at all 
No significant disability: despite symptoms, able to carry out all usual duties and activities 
2 Slight disability: unable to carry out all activities as previously, but able to look after own affairs without assistance 
3 Moderate disability: requires some help, but able to talk without assistance 
4 Moderately severe disability: unable to walk without assistance and unable to attend to own bodily needs without 
assistance 
5 Severe disability, bedridden, incontinent and requiring constant nursing care and attention. (Also some studies 
include dead in this category) 
It should be noted that this is a measure heavily focused on physical mobility. It 
mixes impairments and disabilities and is not a measure of "handicap" [726] as some 
have claimed. 
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Appendix VII: 
Barthel Index 
The Barthel Index is a measure of functional/ physical disability (Table VII.A) [421]. 
Although higher scores on this scale (in its original format) indicate less physical 
disability, for the purposes of my meta-analysis the direction of the effect size was 
reversed to standardise its interpretation with other measures of physical disability. 
Table VII.A The Barthel Index 
Barthel Area 
Bladder 
Grooming 
Toilet use 
Feeding 
Transfer 
(bed to chair and back) 
Mobility 
O=incontinent, or catheterised and unable to manage alone 
1 =occasional accident (max. once per 24 hours) 
2=continent 
O=needs help with personal care 
1 =independent face/ hair/ teeth/ shaving (implements provided) 
O=dependent 
1 =needs some help, but can do some things alone 
2=independent (on and off, dressing, wiping) 
O=unable 
1 =needs help cutting, spreading butter, etc. 
2=independent 
O=unable, no sitting balance 
1 =major help (one or two people, physical} can sit 
2=minor help (verbal or physical) 
3=independent 
O=immobile 
1 = independent in a wheelchair, including comers 
2=walks with help of another person (verbal or physical) 
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Table VII.A Cont'd. 
Barthel Area 
Mobility Cont'd. 
Dressing 
Stairs 
Bathing 
3=independent (but may use aid, for example a stick) 
O=dependent 
1 =needs help but can do about half unaided 
2=independent (including buttons, zips, laces; etc.) 
O=unable 
1 =needs help (verbal, physical, carry aid) 
2=independent 
O=dependent 
1 =independent (or in shower) 
Total 0-20 
Note: Adapted from Wade [726] 
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Appendix VIII: 
Further details on cognitive tasks used in patient study in Chapter 5 
Attention 
The Test of Everyday Attention [563, 564] 
Visual Elevator. A timed task in which subjects count up and down as they follow a 
series of visually presented floors in the elevator. Factor analysis shows that this task 
is a measure of attentional switching (.78). It also loads on visual selective attention/ 
processing speed (.22) and working memory (.22). 
Elevator Counting: Subjects are asked to pretend that they are in an elevator 
whose floor-indicator is not functioning. They therefore have to establish which floor 
they have arrived at by counting a series of auditory tones. This measure loads on 
sustained attention (.56), processing speed (.27) and attentional switching (.28). 
Telephone Search: Subjects must look for key symbols while searching 
through pages in a simulated telephone directory. This test loads on 'selective 
attention' (.80), and to a lesser degree on attentional switching (.25) and working 
memory (.21 ). 
Telephone Search while Counting: In this task, the subject must once again 
search through a telephone directory while simultaneously counting strings of auditory 
tones. Comparing search performance in this task to that illustrated in Telephone 
Search, allows for calculation of a divided attention score. This task loads on 
sustained attention (.72) and to a lesser extent on working memory (.31 ), attentional 
switching (.24) and visual selective attention/ processing speed (.21 ). 
Lottery: Subjects have to listen for their winning lottery number, which ends in 
two numbers (e.g., '55') given to them at the beginning of the exercise. The patient 
must listen to a 1 0 minute series of audio-tape-presented numbers in the form 
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'BS 143', 'LD'967', etc. The task is to write down the two letters preceding all numbers 
ending in their two numbers. The total number of 'relevant' combinations is 1 0. This 
task loads on sustained attention (.70), processing speed (.25) and attentional 
switching ( .18 ). 
Executive Function 
Behavioural Assessment of the Dysexecutive Syndrome [754] 
Rule-Shift Cards: A timed task in which participants are required to respond to stimuli 
(red or black playing card) according to one of two rules that are presented 
consecutively. Performance is scored according to how successfully the respondent 
shifts from applying the first rule to applying the second rule. This test looks to 
identify perseverative tendencies. 
Key Search: The patient is presented with a square representing a field in 
which they have lost their keys. They are asked to draw a line, starting at a black dot, 
to show how they would walk to search the field to make absolutely sure that they 
would find their keys. This test assesses the person's ability to devise a solution to a 
problem. The person's search is scored according to its functionality (how systematic 
it was, its efficiency, its likely success and the time taken to complete the task). 
Modified Six Elements: This time-management task involves the person having 
to divide a period of available time (10 minutes) between a number of tasks (2 picture 
naming, 2 arithmetic and 2 dictation), while not contravening a set of rules. The score 
is based on the number of tasks completed minus any errors for rule infringements 
and excessive time spent on single tasks. This is a measure of the person's ability to 
plan, organise and monitor behaviour. 
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Temporal Judgement: The respondent is required to estimate times of four 
everyday events. This task assesses judgement and abstract thinking, with the 
patients' answers being scored according the degree of deviation from the answers 
most commonly provided by a normative sample. 
Zoo Map: In these two timed trials, subjects are given a map of a zoo and a set 
of instructions relating to places they have to visit and rules that they most follow 
(such as not cutting across paths or reusing a certain path). The patient must show 
how they would visit the series of designated locations on the map, whilst not 
contravening the set of rules. In this task, participants are assessed on their ability to 
minimise errors by modifying their performance on the basis of feedback, given when 
a rule is broken. 
Memory 
The Rivermead Behavioural Memory Test- Extended Version [755] 
First and Second Names: The subject is shown three photographic portraits and 
asked to remember the first and second names of all three of the people in the 
photographs. This is a measure of short-term memory for names. 
Appointments and Belongings: The subject is requested to ask, following a 
given prompt at the end of the memory battery test, for two of their belongings 
previously hidden by the examiner in different locations, and to remember where they 
have been hidden. They are also required to ask the examiner two set questions 
when a timer, which was set for 20 minutes, rings. This is a measure of prospective 
memory. 
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Picture Recognition: The subject must recognise 20 previously-seen line 
drawings and distinguish them from distractor items (a filled -5 minute delay occurs 
between presentation and recall). This is a measure of visual memory. 
Face Recognition: The subject must recognise 15 previously-seen faces and 
distinguish them from distractor items. This is a measure of visual memory. 
Story Immediate and Delayed: The subject must recall a short passage of 
newspaper prose, immediately following it being read to them and then again after a 
delay (filled delay of 20 minutes). These two tests are measures of verbal memory. 
Orientation and Date: The subject is asked 12 orientation questions and to give 
the correct date. 
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Appendix IX: 
Supplementary analysis on the possible confounding impact of 
psychiatric history on the relationship between coping and SAH 
patients' PTSD 
In Chapter 5, I contend that the dispositional use of maladaptive coping strategies is a 
risk factor for post-traumatic stress disorder {PTSD) subsequent to a subarachnoid 
haemorrhage (SAH). This conclusion was motivated by the results of the logistic 
regression analyses of assessments one and two PTSD which showed that 
dispositional use of maladaptive coping emerged as the most powerful predictor of 
PTSD in both the short- and long-term. Further supporting evidence for this 
conclusion is derived from previous studies which fortuitously measured individuals' 
preferences for coping skills prior to a trauma and found that pre-trauma preferences 
for maladaptive coping were predictive of subsequent PTSD [172, 217]. Up to 
approximately 30% of patients in the patient sample examined as part of the study 
presented in Chapter 5 do, nevertheless, have a history of other psychiatric illness, 
including depression, anxiety, and/or alcohol abuse (Table IX.A). Although this is not 
unusual and similar rates are reported in prior SAH studies [31, 159, 268, 305], there 
does remain the possibility that use of maladaptive coping skills does not represent a 
risk factor for PTSD, but that a significant association between coping and PTSD is 
found because those patients with PTSD could have experienced a prior psychiatric 
history which had promoted the use of maladaptive coping skills. This alternative 
explanation of the relationship between coping and PTSD was, however, not 
supported by the results of Chapter 5. 'Prior psychiatric history' had been included as 
a potential predictor in the original regression models for PTSD, but was eliminated 
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Table IX.A Psychiatric history in SAH patients examined for PTSD at assessment 
one and assessment two 
Factor Value(%) 
Assessment one Assessment two 
N=95 N=81 
Significant psychiatric history* 25 (26.3) 22 (27.2) 
Note: N=number. *=Self-reported illness receiving/ received formal treatment. 
Psychiatric illnesses included: Anxiety unspecified diagnosis, Depression unspecified 
diagnosis, Alcohol abuse. 
from the final model as it did not prove to be associated with PTSD in either the short-
or long-term. In any case, the possibility that prior psychiatric history is a confounding 
variable for the relationship between coping and PTSD warrants further examination 
given the importance of establishing risk factors for the debilitating stress disorders 
which SAH patients experience. To do this, the unique and shared variance between 
PTSD, psychiatric history and coping was examined in order to further elucidate the 
relationship between these factors. 
Methods 
Nonparametric zero-order correlation and partial correlation coefficients were 
calculated between the following combinations of variables at both assessment one 
and assessment two: PTSD symptomatology and coping, PTSD symptomatology and 
prior psychiatric history and PTSD symptomatology and psychiatric history. 
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Results 
The results of these supplementary correlation analyses are presented in Table IX.B. 
The results firstly show that the magnitude/ effect size of the relationship between 
coping and PTSD is consistently larger than the relationship between coping and 
psychiatric history. This substantial difference in effect sizes serves to underline the 
relative triviality of psychiatric history in explaining the presence of maladaptive 
coping. Secondly, the minimal reduction in the size of the correlation coefficients 
between PTSD and coping and between coping and psychiatric history when partial 
correlations are calculated which control for the shared variance between PTSD and 
psychiatric history, illustrates that these two factors are largely independent of one 
another in their relation to coping (Figures IX.A-8). 
Discussion and conclusion 
The results from the correlation analyses illustrate that PTSD holds a unique and 
substantial relationship with coping skills. Having controlled for the potential shared 
variance which PTSD and psychiatric history hold with coping, it is apparent that 
PTSD and psychiatric history are largely independent variables. In conclusion, 
psychiatric history holds little relevance for explaining the presence of poor coping 
skills or PTSD. The evidence therefore serves to corroborate the conclusion of 
Chapter 5, that coping skills seem largely the cause of PTSD in SAH patients in both 
the short- and long-term. 
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Table IX:B. Zero-order and partial correlation coefficients between PTSD, psychiatric history and maladaptive coping strategies 
Variable N Zero- P-value Partial P-value 
order correlation 
correlation controlling for 
with coping other variable 
r. '·2 faY(X1.x2) fsY(X1.x2)2 
PTSD assessment 1 91 0.636 40.4% <0.0001 0.623 38.8% <0.0001 
Psychiatric history assessment 1 91 0.216 4.67% <0.05 0.066 0.4% >0.05 
PTSD assessment 2 81 0.459 21.1% <0.0001 0.452 20.4% <0.0001 
Psychiatric history assessment 2 81 0.234 5.5% <0.05 0.156 0.2% >0.05 
Note: N=sample size; PTSD=post-traumatic stress disorder; r.=Spearman's rank order correlation; r} =Spearman's correlation r-squared equivalent; 
r.v(X1.x2,=Spearman's partial rank order correlation; r.v(x1.x2/=Spearman's partial rank order correlation r-squared equivalent.. 
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Coping 
Psychiatric 
history 
PTSD 
F7'l 
L.l.2ld 
• 
Unique shared variance between coping 
and PTSD 
Unique shared variance between coping 
and psychiatric history 
Shared variance between PTSD, 
psychiatric history and coping 
Unique shared variance between PTSD and 
psychiatric history 
Figure IX.A Venn diagram illustrating the unique and shared variance between coping, PTSD and psychiatric history at assessment 
one. 
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Coping 
Psychiatric 
history DI2J 
• 
• 
Unique shared variance between coping 
and PTSD 
Unique shared variance between coping 
and psychiatric history 
Shared variance between PTSD, 
psychiatric history and coping 
Unique shared variance between PTSO and 
psychiatric history 
Figure IX.B Venn diagram illustrating the unique and shared variance between coping, PTSD and psychiatric history at assessment 
two. 
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Appendix X: 
Supplementary analysis on the predictive value of aneurysm 
location for PTSD in SAH patients 
The majority of surviving subarachnoid haemorrhage (SAH) patients examined in 
Chapter 5 had suffered their haemorrhage as the result of a ruptured cerebral 
aneurysm. As is typical, the neuroanatomical location of a patient's ruptured 
aneurysm varied between patients (Table X.A). Before further investigating other 
clinical explanations/ risk factors for post-traumatic stress disorder (PTSD) in SAH 
patients, it is important to comprehensively evaluate the effect of aneurysm location. 
Historically, it has been believed that differently located aneurysms pose different 
risks to the psychiatric sequelae which SAH patients' experience [57, 295, 537]. In 
particular, many traditionally believed that those patients whose SAH was due to a 
ruptured anterior cerebral artery aneurysm - especially those on the anterior 
communicating artery (ACoA) [8] - were likely to experience a unique pattern of 
psychiatric sequelae [295]. Older studies suggested that these patients could 
experience a psychiatric outcome akin to Korsakoff's syndrome [400, 513, 724]. 
ACoA patients for example, were seen to classically illustrate a distinctive 
neuropsychiatric profile of amnesia, confabulation and altered personality (including 
impulsivity, disinhibited behaviour, apathy, emotional lability and depression) [433]. 
The parallels between this profile and that of patients who had suffered damage to 
the prefrontal lobe [412] led to the belief that the type of neurobehavioural sequelae 
experienced post-SAH was largely due to the result of ischemic/ haemorrhagic 
damage in the territory supplied by the artery on which the aneurysm had ruptured 
[433]. Other factors, such as the fact that different locations of ruptured aneurysms 
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Table X. A Haemorrhage characteristics of those SAH patients who were 
examined for PTSD at assessment one and assessment two 
Factor 
Aneurysmal SAH 
Location of ruptured aneurysm 
ACoAIACA 
ICA 
MCA 
Vertebrobasilar 
Unknown origin 
Other origin 
Value(%) 
Assessment 
one 
N=95 
69 (72.6) 
31 (44.9) 
17 (24.6) 
17 (24.6) 
4 (5.8) 
23 (24.2) 
3 (3.2) 
Assessment 
two 
N=91 
56 (69.1) 
27 (48.2) 
11 (19.6) 
14 (25.0) 
4 (7.1) 
23 (28.4) 
2 (2.5) 
Note: ACA=anterior cerebral artery; ACoA=anterior communicating artery; ICA=intemal 
carotid artery; MCA=middle cerebral artery; N=number; SD=standard deviation; 
Vertebrobasilar=arteries of the vertebrobasilar system; yr=year; 
cause different bleed patterns (e.g., circle of Willis aneurysm results in symmetrically 
distributed basal blood, middle cerebral artery aneurysm asymmetrical pattern, 
anterior circulation blood accumulates between the frontal lobes and around the 
corpus callosum [666]), that intracerebral extension is more common with bleeds 
originating from aneurysms of the posterior communicating and middle cerebral 
artery, whilst intraventricular extension is characteristic of a bleed originating from an 
anterior cerebral artery [17, 43, 45], and that differently located aneurysms can 
require different neurosurgical approaches, also led many to assume that aneurysm 
376 
location was important in determining SAH outcome [295]. Nonetheless, the 
importance of the location of the ruptured aneurysm for SAH patients' 
neurobehavioural sequelae has in contemporary studies, proved debatable, with the 
majority studies, despite being well-powered, failing to detect a difference between 
the outcomes of patients with differently located aneurysms [57, 295, 433]. Instead, 
most now advocate that an SAH leads to unspecific brain damage that is, for the 
greater part, independent of the localisation of the ruptured aneurysm. In support of 
this position, is evidence that patients whose SAH was of an unknown origin, 
experience difficulties comparable to those patients whose bleed was caused by a 
ruptured aneurysm [34, 141, 296, 300, 302, 382, 409, 504, 507, 597, 643]. Yet further 
support can be found in the results presented in Chapter 5 which showed that 
aneurysmal SAH patients were no more, or no less prone to develop PTSD than 
other SAH patients. Even so, given the benefits of being able to reliably predict which 
patients will develop PTSD and also being able to understand the aetiology of the 
disorder, it is still important to explore the association between of aneurysm location 
and SAH PTSD. 
With this in mind, this supplementary section now presents the results of 
bivariate/ univariate analyses of the association between aneurysm location (anterior 
vs. posterior; ACoA vs. other) and PTSD in both the short- and long-term. Also, to 
further explore the role of aneurysm location, PTSD severity and prevalence was 
compared between those patients whose bleed was of an aneurysmal origin and 
those patients whose bleed was of an unknown, non-aneurysmal origin. 
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Methods 
The chi-square test (corrected for continuity [633]) and the Fisher exact test were 
used to determine the association between the experience of PTSD post-SAH and 
the location of a patient's ruptured aneurysm. The Mann-Whitney test examined the 
degree to which PTSD symptom severity in SAH patients was dependent on the 
location of the ruptured aneurysm. Comparisons were made between 1) ACoA 
aneurysms and all other locations, 2) anterior cerebral artery aneurysms (including 
ACoA) and all other locations and 3) between patients with an SAH of an aneurysmal 
origin and those who bleed was of an unknown origin. It was not possible to conduct 
a more detailed analysis of PTSD by specific aneurysm location because too small a 
number of patients had aneurysms of vertebrobasilar and too small a number of 
patients had aneurysms on arteries of locations other than the anterior cerebral 
artery. This is not however, a limitation specific to the present study, but a difficulty 
pervasive to many studies of SAH outcome which reflect the natural distribution of 
ruptured cerebral aneurysms in SAH patients [48, 300, 357, 374, 378, 507, 510, 687, 
689]. 
Results 
No significant association was found between PTSD prevalence or symptom severity 
and aneurysm location at either assessment one or assessment two (all P>0.05). 
Furthermore, there was no significant difference between the prevalence of PTSD or 
the severity of those patients' PTSD which resulted from a ruptured aneurysm and 
those whose bleed was of an unknown origin (Table X.B). 
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TableX.B The impact of aneurysm location on PTSD prevalence and severity 
Haemorrhage aetiology 
ACoA Other ACA Other ASAH Unknown 
No.(%) no.t(%) P·value no.(%) no.:t: (%) P-value no.(%) no.(%) P-value 
Assessment one 
PTSD 
Yes 5 22 11 16 27 7 
No 12 30 .510. 16 26 1.00 42 16 .618 
PTSD severity 
Median 10.0 10.5 11.0 10.0 10.0 10.0 
JQR 5.5-22.0 5.0-22.5 .775 5-28 4.5-19.5 .386 5.0-22.0 3.0-14.0 .308 
Assessment two 
PTSD 
Yes 6 11 10 7 17 9 
No 10 29 .527. 13 26 .137 39 14 .599 
PTSD severity 
Median 10.5 6 10. 6 6.5 8 
IQR 3.5-12.0 3.0-11.75 .561 3.0-12.0 3.5-10.0 .339 3.0-12.0 5.0-14.0 .402 
Note: ACoA = anterior communicating artery; ACA = anterior cerebral artery. • Fisher's exact test. t 'Other' location group includes aneurysms located on the internal carotid 
artery, middle cerebral artery, in the vertebrobasilar system and those of the anterior cerebral artery, excluding anterior communicating aneurysms. + 'Other' location group includes 
aneurysms located on the internal carotid artery, middle cerebral artery and in the vertebrobasilar system. 
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Discussion 
The results. of this supplementary analysis show that the location of subarachnoid 
haemorrhage (SAH) patients' ruptured aneurysms does not significantly determine 
the likelihood of SAH patients developing post-traumatic stress disorder (PTSD), nor 
the severity of the PTSD that an SAH patient experiences. These findings concur 
with the multiple regression analyses presented in Chapter 5, where aetiology of 
bleed did not significantly add to the final predictive models for PTSD. It also accords 
with the majority of contemporary studies which have not found an association 
between long-term psychosocial outcome (such as anxiety, depression) and the 
location of a patient's ruptured aneurysm [17, 242, 24 7, 294, 297, 302, 425, 469, 507, 
508, 546, 594, 649, 687, 722]. Indeed, aneurysm location is increasingly being seen 
as unrelated too to other aspects of SAH outcome, such as cognitive function [189, 
247, 262, 357, 388, 432, 507, 543, 558, 590, 598, 649, 746, 750], fatigue [65, 247, 
510, 649, 722], sleep dysfunction [510] and neuroendocrine dysfunction [375]. 
Historically however, many have proposed/ found that different aneurysm 
locations - particularly those of the anterior communicating artery (ACoA) - can 
cause different neurobehavioural sequelae of SAH [8, 331, 513, 617, 652]. How then 
can the discrepancy between these older and newer studies (including the current 
one) be explained? I would concur with the conclusions of two recent reviews on this 
important question produced by Hutter and colleagues [295, 306], who argue that 
aneurysm location (at least indirectly) was once an important explanation for SAH 
patients' neuropsychiatric changes, but that it is now largely irrelevant (and so not 
found to be important in contemporary studies) because of the drastically improved 
management of SAH which has occurred with the passage of time. These 
improvements include the introduction of the operating microscope, the use of 
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modern aneurysm clips, the abandonment of trapping procedures of the aneurysm 
bearing vessel, the principle of early surgical repair, as well as better techniques for 
the diagnosis and prevention of cerebral vasospasm (e.g., the calcium antagonist 
nimodipine and transcranial Doppler sonography, which reduce likelihood of cerebral 
infarction). It is commented that the introduction of the operating microscope and 
modern aneurysm clips for instance, has allowed neurosurgeons to spare the small 
perforators which originate from the AcoA that were previously inadvertently damaged 
during surgery and which caused distinct psychiatric problems. These perforators 
supply the anterior hypothalamus, septum pellucidum, anterior parts of the gyrus 
cinguli, parts of the fornix and anterior parts of the corpus callosum [697] and so 
damage to them can easily account for the elevated incidence of dysfunction -
specifically, memory loss, confabulation and altered personality- that was previously 
found to be associated with ruptured AcoA aneurysms. Gade for example, provided 
compelling evidence showing a relationship between intraoperative trapping of the 
AcoA and the postoperative development of memory disturbance [208]. Increased 
methodological rigor to studies has also no doubt likely contributed to the discrepancy. 
as older studies often only examined selective samples (case studies) rather than 
consecutive series of patients. Furthermore, older studies typically lacked adequate 
control patients whose ruptured aneurysms were of a different location. 
Conclusion 
In conclusion, the location of an SAH patient's ruptured aneurysm appears not 
to be associated with PTSD in SAH patients and so should not be considered a risk 
factor for its development or severity. 
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Appendix XI 
Previous studies considering the impact of SAH on patients' SOs (From a published systematic literature review of mine [489]) 
Author SAH details Study population Design Time Measures Main results 
(1)type; (i) number of participants; (yrs) (a) psychological; 
(2) inclusion criteria. (ii) information source; (b) carer burden; 
(iii) sociodemographics; (c) social health; 
(iv) country of origin. (d) other. 
Berry et al. [48] ( 1) aneurysm; (i) 48; Cross- 0.7 (a) BDI; GHQ-28; -Significantly higher score on the GHQ-28 indicating psychological 
(2) age <60; clipped. (ii) partner/ next of kin; sectional (b) nil; disturbance. No difference on BDl. 
(iii) not provided; (c) nil; 
(iv) England. (d) nil. 
Buchanan et al.[90] (1) aneurysm; AVM; (i)27; Cross- 1.6 (a) BSI; - On BSI 65% illustrated clinical levels of stress. 
(2) GOS 1-11, (ii) supporting "primary sectional (b) Likert Strain - Relatives were more stressed in the acute stages of the illness. 
surgically treated, relative"; Scale; Zarit Burden - According to the burden interview, 66% of scores fell in the 
Hunt and Hess I-IV. (iii) not provided; Interview; moderate or high range. Scores similar to Alzheimer carers. 
(iv) Canada. (c) n-s measure; - Burden correlated with patient distress. 
(d) Adjective - 26% considered death preferable to the quality of their outcome. 
Checklist. - 3 spouses actively reinforced their husband's decreased libido. 
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Appendix XI Cont'd. 
Author 
Fertl et al.[189] 
Hellawell et al.[265] 
Hellawell & Pentland [264] 
SAH details 
(1) type; 
(2) inclusion criteria. 
( 1 )aneurysm; 
(2)GOS 1-11; 
( 1) aneurysm; 
idiopathic; 
(2) CT confirmed 
SAH only. 
(1) SAH; 
(2) CT confirmed 
SAH only. 
Study population 
(i) number of participants; 
(ii) information source; 
(iii) sociodemographics; 
(iv) country of origin. 
(I) 40; 
(II) patients; 
(Ill) not provided; 
(IV) Austria. 
(i) 36, 33, 28; 
(ii) relatives; 
(iii) not provided; 
(iv) Scotland. 
(i) 58; 
(ii) close friend/ relative 
informant; 
(iii) 67% spouse or partner; 
(iv) Scotland. 
Design 
Cross-
sectional 
Longitudinal 
Cross-
sectional 
Time 
(yrs) 
1.8 
0.5, 1.0, 
2.0 
6.5 
Measures 
(a) psychological; 
(b) carer burden; 
(c) social health; 
(d) other. 
(a) nil; 
(b) nil; 
(c) Patient QoL; 
(d) n-s measure. 
(a)RQ; 
(b) nil; 
(c) nil; 
(d) nil. 
(a) RQ; 
(b) nil; 
(c) nil; 
(d) nil. 
Main results 
-Of the patients, 33 had been living with a life partner. One patient 
had split from their partner which was attributed to be as a result of 
the 'sequelae of the SAH', whilst two further patients reported 
dissatisfaction with their relationships on QoL instrument. 
- Stress correlated with patient impairment at follow-up point. 
- 55% of patients required care. 
- SAH informants experience stress as a result of patients SAH. 
- Correlation between informant stress and patients impairment. 
- Social behaviour, emotional disturbance, degree of dependency, 
and disturbed behaviour were most strongly associated with 
informant stress. Memory, language and physical impairment 
illustrated the weakest association. 
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Appendix XI Cont'd. 
Author 
Hop et al. [285, 286]* 
;;, 
SAH details 
(1) type; 
(2) inclusion criteria. 
(1) aneurysm; 
(2) nil. 
Study population 
(i) number of participants; 
(ii) information source; 
(iii) sociodemographics; 
(iv) country of origin. 
(i) 51; 
(ii) patient's closest significant 
other- 'partner'; 
(iii) 90% spouse or partner; 
(iv) Netherlands. 
Design 
Longitudinal 
Time 
(yrs) 
0.3, 1.5 
Measures 
(a) psychological; 
(b) carer burden; 
(c) social health; 
(d) other. 
(a) nil; 
(b) nil; 
(c) SF-36; SIP; VAS; 
(d) n-s measure. 
Main results 
- At assessment one, carers illustrated reduced Qol on SIP, 
particularly psychosocial reductions. At assessment two, reductions 
found for SIP domains sleep and rest, emotional behaviour and 
recreation and pastimes. 
- SF-36 and SIP scores between 4 and 18 months varied, with 
some improvement (in social functioning, mental health), but also 
reductions (in pain, general health). Overall QoL, assessed by the 
VAS, did not improve between assessments one and two. 
- At assessment one, partners reported anxiety and uneasiness. 
Partners were afraid to leave the patient alone, especially if they 
had witnessed the initial event. Some expressed fear of having sex. 
especially if SAH was coital. 
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Table XI Cont'd. 
Author SAH details Study population Design Time Measures Main results 
(1)type; (i) number of participants; (yrs) (a) psychological; 
(2) inclusion criteria. (ii) information source; (b) carer burden; 
(iii) sociodemographics; (c) social health; 
(iv) country of origin. (d) other. 
Hop et al. [285, 286]* - At assessment two, 50% of employed carers reported occupation 
Cont'd. change related to SAH. 3 carers reported divorce/ "severe marital 
difficulties" caused by the patients' personality change. 
- Hop et al. [285] explored partners' QoL at assessment one and 
reported an association with patient dependence. Nevertheless, 
even partners of independent patients still experienced emotional 
role limitations- at times more than their patient. 
Jarvis [313] (1) SAH; (I) 8; Cross- 1.1-1.5 (a) nil; - Common themes from qualitative interviews included: relationship 
(2) nil. (II) patients; sectional (b) nil; difficulties as a result of the SAH and relatives/ friends finding it very 
(Ill) not reported; (c) nil; traumatic to talk about the SAH event with the patient. 
(IV) England. (d) n-s measure. 
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Table X~ Cont'd. 
Author 
Mezue et al. [461] 
SAH details 
(1)type; 
(2) inclusion criteria. 
( 1) aneurysm; 
(2) GOS 1-11. 
Study population 
(i) number of participants; 
(ii) information source; 
(iii) sociodemographics; 
(iv) country of origin. 
(i) 52; 
(ii) carers; 
(iii) 74.6% spouse or partner; 
13.6% other family member; 
(iv) England. 
Design 
Cross-
sectional 
Time 
(yrs) 
3.0 
Measures 
(a) psychological; 
(b) carer burden; 
(c) social health; 
(d) other. 
(a) GHQ-12; 
(b) Caregiver Strain 
Index; 
(c) nil; 
(d) Adjective 
Checklist. 
Main results 
- 54% complained of care-related strain, particularly in emotional 
and social areas. Emotional problems included upsetting patient 
behaviour (44.2%), emotional adjustment (28.9%), feeling 
overwhelmed (25%) and disturbed sleep (19.3%). 
-Social problems included changes in personal plans (28.9%), work 
(17.3%) and family (17.3%). 
- 25% of carers reported that they were distressed to an 
'overwhelming' degree. 
- Carer distress/ strain correlated with neurobehavioural change in 
the patient. 
- No relation between clinical/ demographic variables and stress. 
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Table XI Cont'd. 
Author 
Oder et al. [501] 
Oder et al. (502] 
SAH details 
(1)type; 
(2) inclusion criteria. 
~I 
(1)SAH; 
(2) Less severe and 
idiopathic cases 
overrepresented 
(61%). 
(1) idiopathic; 
(2) Less severe 
patients. 
Study population 
(i) number of participants: 
(ii) information source; 
(iii) sociodemographics; 
(iv) country of origin. 
(i) 67; 
(ii) patients: 
(iii) not reported; 
(iv) Austria. 
(i) 41; 
(ii) patients; 
(iii) not reported; 
(iv) Austria. 
Design 
Cross-
sectional 
Cross-
sectional 
Time 
(yrs) 
7.1 
7.6 
Measures 
(a) psychological; 
(b) carer burden; 
(c) social health; 
(d) other. 
(a) nil; 
(b) nil; 
(c) n-s measure: 
(d) nil. 
(a) nil; 
(b) nil; 
(c) n-s measure; 
(d) nil. 
Main results 
- Patients rated the degree of disability in family relationships. 
- Association between amount of familial disturbance and patient 
disability. 
- Association between patients working status and familial 
handicap. 
- No relationship between clinical/ demographic variables and carer 
stress, although neurologic deficit on admission was predictive of 
later family disturbance. 
-In total17.1% of patients reported persistent "family tensions" after 
the SAH. 
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Table XI Cont'd. 
Author 
Ogden et al. [51 0] 
Pritchard et al.[546] 
SAH details 
(1)type; 
(2) inclusion criteria. 
(1) aneurysm; 
idiopathic; 
(2) nil. 
( 1) aneurysm; 
(2) nil. 
Study population 
(i) number of participants; 
(ii) information source; 
(iii) sociodemographics; 
(iv) country of origin. 
(i) 123; 
(ii) patients; 
(iii) not reported; 
(iv) New Zealand. 
(i) 98; 
(ii) carers; 
(iii) 76% partners, 63% female, 
53% aged <54 years; 
(iv) England. 
Design 
Cross-
sectional 
Cross-
sectional 
Time 
(yrs) 
4.0-7.0 
0.5-1.6 
Measures 
(a) psychological; 
(b) carer burden; 
(c) social health; 
(d) other. 
(a) nil; 
(b) nil; 
(c) n-s measure; 
(d) nil. 
(a) nil; 
(b) nil; 
(c) Wessex 
Questionnaire; 
(d) nil. 
Main results 
- Of the patients asked about changes in family structure, 4.1% 
reported divorcing as a result of SAH. Most due to partners failure 
to cope with SAH changes. 
- Association between family disruption and neurological status in 
the early stages of illness and experience of seizures. 
- Carers were positive about in-patient care, though 63% remained 
fearful during the patient's hospital stay and 30% felt depressed. 
- Post-discharge, 50% felt unsupported, 40% stressed, 25% 
required medication and 14% said they made 'unnecessary' calls to 
their GP. Carers reported significantly more psychological burdens 
than patients. 
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Table XI Cont'd. 
Author 
Pritchard et al.[546] Cont'd. 
Pritchard et al.[545] 
:-·· 
SAH details 
(1) type; 
(2) inclusion criteria. 
(1) aneurysm; 
(2) nil. 
Study population 
(i) number of participants; 
(ii) information source; 
(iii) sociodemographics; 
(iv) country of origin. 
(i) 98; 
(ii) primary carers: 
(iii) 63% male; 
(iv) England. 
Design 
Cross-
sectional 
Time 
(yrs) 
0.5-2.0 
Measures 
(a) psychological; 
(b) carer burden; 
(c) social health; 
(d) other. 
(a) nil; 
(b) nil; 
(c) Wessex 
Questionnaire; 
(d) nil. 
Main results 
- No association between outcomes and clinical variables. -
Criticism of 'Community Care'. It was the patients' families (96%) 
and neighbours (68%) who were the most involved in supporting 
patients. 
- 33% reported financial difficulties 
- 86% of carers lost 2 or more weeks and 15% lost 17 or more. 
-'Lost productivity' was estimated at £182,000. 
- Compared outcome of a well-matched emergency cohort of SAH 
carers and an elective cohort of acoustic neuroma carers (AN). 
- SAH carers reported greater psychosocial disturbance than AN 
carers. In both the inpatient and post-discharge stages, SAH carers 
were more depressed, frightened, anxious and stressed 
- Economic cost: 85% of AN compared to 77% of SAH lost S16 
weeks, but 23% of ASAH carers lost between 17-30 weeks. For 
AN, time off work cost £52,440. For SAH carers, it was £182,000. 
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Table XI Cont'd. 
Author SAH details Study population 
(1)type; (i) number of participants; 
(2) inclusion criteria. (ii) information source; 
(iii) sociodemographics; 
(iv) country of origin. 
Stegen & Freckman [652] (1) aneurysm; (i) 87; 
(2) nil. (ii) next of kin; 
(iii) not reported; 
(iv) Germany. 
Wermer et al.[746] (1) aneurysm; (i) 610; 
(2) mRS s 3; <71 (ii) patients; 
years old; clipping (iii) not reported; 
only. (iv) Netherlands. 
Design Time 
(yrs) 
Cross- 1.0 
sectional 
Cross- 8.9 
sectional 
Measures 
(a) psychological; 
(b) carer burden; 
(c) social health; 
(d) other. 
(a) n-s measure; 
(b) nil; 
(c) nil; 
(d) nil. 
(a) nil; 
(b) nil; 
(c) nil; 
(d) n-s measure. 
~-
Main results 
- 17% reported concerns about the possibility of re-bleeding. 
- 75 of the 520 (14%) formerly married patients had divorced after 
the SAH, 34 of whom (7%) reported that this was the result of the 
SAH. The main reason was that the partner could not cope with the 
changes in the SAH patient. 
Note: AN=acoustic neuroma; AVM=arteriovenous malformation; BDI=Beck Depression Inventory; BSI=Brief Symptom Inventory; GHQ-28=General Health Questionnaire-28; GOS !=Glasgow Outcome Scale I-
no/ minimal impairment, "good recovery"; GOS II=Giasgow Outcome Scale II - modest impairment/ needs no impairment, "fair recovery; Hunt and Hess !=Grade I - mild headache and/ or nick stiffness on initial 
presentation; Hunt and Hess II=Grade II -severe headache and/ or pronounced neck stiffness and/ or cranial nerve deficits, photophobia; mRS=modified Rankin Scale; n-s measure=non-standardised measure; 
RQ=Relatives Questionnaire; SAH=subarachnoid haemorrhage; SF-36=Short-Form 36 Health Survey; SIP=Sickness Impact Profile; TBI=traumatic brain injury; Qol=Quality of Life; VAS=Visual Analogue Scale. 
*=Hop et al. (2001) contains data from 4 month assessment originally presented by Hop et al. (1998). For this review, searches of the Medline (1951 to April 2008), IS/ Web of Science (1945 to April 2008) and 
Psyc/NFO databases (1887 to April 2008) was made using the term 'subarachnoid' plus: 'family', 'friend', 'carer', 'partner', 'relative' and 'rehabilitation'. The searches excluded 'stroke' as a term because SAH is 
considered a .distinct form of stroke due to its differences in pathology (requiring differences in careJ:·Yo~ger mean age of occurrence and differences in intervention (surgery for SAH) [71 0]. 
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